{"name": "perturbation_10_d", "predictions": {"real": [-0.028739213943481445, 0.13274724483490008, 0.112689232826233, -0.045257186889648526, -0.007407855987549006, 0.0944810628890993, 0.06126286983490026, 0.1860276460647583, 0.026322460174560636, 0.23405933380126953, -0.013815546035766513, 0.2710876226425172, 0.03218197822570801, 0.22423195838928223, -0.11163740158081037, 0.0967860221862793, 0.2907813072204588, 0.045321059226989924, -0.09388210773468009, 0.2052959442138671, 0.1048055171966551, -0.08287391662597665, 0.10299122333526611, 0.14021272659301776, 0.15527577400207537, 0.09164454936981237, 0.11025316715240496, 0.028087615966796875, 0.19634785652160636, 0.09880955219268817, 0.04952321052551234, 0.11766166687011737, 0.027893733978271662, 0.10194487571716326, -0.19309349060058612, -0.14667041301727313, 0.12385642528533936, -0.12983169555664054, 0.069281053543091, 0.08555161952972412, 0.1107177734375, 0.1564429759979249, 0.12170076370239258, 0.059714770317077726, 0.0002270460128785956, 0.1091151952743532, 0.06000108718872088, 0.14905605316162118, 0.16914005279541033, 0.0335080623626709, 0.03605275154113752, 0.24937076568603533, 0.23576228618621808, 0.17161953449249268, -0.05341651439666739, 0.11255097389221191, 0.281959629058838, 0.2518164157867431, 0.18521623611450178, 0.05571908950805682, -0.059382820129394887, 0.18231520652771005, 0.11875095367431632, 0.1806235074996949, 0.159879517555237, 0.15767755508422843, 0.2943157196044921, 0.17460100650787336, 0.12585422992706308, 0.13953983783721924, 0.1264810562133789, 0.06323087215423584, 0.08811502456665021, 0.058912014961242765, 0.030414390563964666, 0.22011566162109375, 0.0697472095489502, 0.07184860706329355, 0.07405333518981916, 0.15773439407348633, 0.008971023559570135, -0.08928902149200457, 0.17794451713561976, 0.16346144676208496, 0.15659544467926034, -0.21822357177734375, 0.17758166790008545, 0.1164024353027342, 0.0415379762649537, 0.0007020950317384589, -0.05484042167663583, 0.14666030406951913, 0.05444808006286639, 0.3049628734588623, 0.208790969848633, 0.12321667671203596, 0.09700477123260498, -0.015709400177001953, 0.06767601966857928, 0.1970282077789305, 0.2196434736251831, 0.11628079414367676, 0.08887968063354457, 0.10198445320129412, 0.107873487472534, 0.08263428211212176, 0.10488917827606192, 0.07670495510101283, 0.11922035217285165, -0.003773212432861328, -0.14919800758361834, 0.0, 0.12608492374420166, 0.07057068347930873, 0.08178391456603995, 0.07397704124450666, -0.04911952018737775, 0.09374744892120379, 0.104266381263733, 0.06578180789947519, 0.03654356002807635, 0.06173558235168475, -0.005106973648071111, 0.0510178804397583, 0.16287093162536603, 0.15330367088317853, 0.08051764965057373, 0.08710749149322528, 0.1442361116409301, 0.045556378364563166, 0.1977697134017946, 0.28849363327026367, 0.1535080909729003, 0.05955903530120832, 0.02062215805053702, 0.21156527996063268, 0.11452000141143781, 0.056438231468200595, 0.03686268329620379, 0.19317309856414777, -0.002759766578674494, 0.005730342864990412, 0.10264377593994123, -0.016533398628234774, 0.1491947650909422, 0.24496173858642578, 0.01879925727844256, 0.3416153669357298, 0.24658467769622794, 0.11417834758758527], "samples": [0.1822263717651369, 0.18213264942169172, 0.26152398586273184, 0.20787653923034677, 0.35909879207611084, 0.16114602088928232, 0.20104970932006827, 0.2154308557510376, 0.11612498760223389, 0.194209909439087, 0.243765878677368, 0.16174029111862187, 0.15776970386505118, 0.2537773132324217, 0.7901325464248656, 0.10756220817565909, 0.19068822860717782, 0.11810767650604248, 0.2260029077529908, 0.18715186119079608, 0.14134149551391584, 0.11640198230743426, 0.33976736068725577, 0.24870746135711652, 0.12713942527771005, 0.22340726852416992, 0.16187047958374023, 0.3180042266845704, 0.1913090825080872, 0.294523072242737, 0.3107874393463135, 0.24736013412475577, 0.09477388858795166, 0.23453590869903573, 0.2826536417007448, 0.12559316158294687, 0.24168665409088153, 0.15008652210235596, 0.1845402836799621, 0.2633035182952881, 0.27324373722076434, 0.1194164037704466, 0.09369473457336408, 0.24092644453048706, 0.26954709291458134, 0.2567609786987304, 0.24835851192474356, 0.23409342765808105, 0.11781868934631357, 0.10644075870513925, 0.10823631286621094, 0.2612191677093505, 0.22491283416748065, 0.17682058811187762, 0.3990525960922242, 0.24502432346343994, 0.5209508895874024, 0.19384639263153058, 0.22472548484802246, 0.22843286991119394, 0.15429604053497314, 0.43272347450256365, 0.174767827987671, 0.278896188735962, 0.3792323589324953, 0.18300733566284189, 0.20423057079315177, 0.22222957611083993, 0.29718804359436035, 0.20184726715087908, 0.20980410575866681, 0.06978740692138663, 0.20524489879608154, 0.26525535583496085, 0.12188427448272687, 0.3415802478790284, 0.20640916824340838, 0.2883463144302367, 0.20948476791381854, 0.2703218460083008, 0.23918495178222665, 0.1298737049102785, -0.22500381469726527, 0.02226047515869123, 0.0699478864669798, 0.14990396499633807, -0.07241142988204974, 0.25037848949432373, 0.1872737169265748, 0.1669242858886717, 0.20005786418914795, 0.1903004169464113, 0.19717164039611834, 0.2813246250152588, 0.2866448163986206, 0.1356795549392702, 0.24983139038085955, 0.1669217348098755, 0.11523215770721418, 0.10522835254669172, 0.19755516052246103, 0.27144448757171613, 0.29268107414245614, 0.2250269889831542, 0.17325592041015625, 0.11154716014862043, 0.2900491952896118, 0.1353078365325926, 0.2004368543624877, 0.14298691749572745, 0.16443309783935556, 0.0, 0.06313798427581796, 0.30999326705932617, 0.17418353557586652, 0.25646488666534406, 0.08106925487518302, 0.08249213695526114, 0.07916839122772235, 0.28971378803253156, 0.09473993778228751, 0.25046865940093976, 0.15046911239624006, 0.28451390266418475, 0.28236660957336435, 0.1862497329711914, 0.15001740455627433, 0.2369441032409667, 0.13329591751098624, 0.25013523101806623, 0.21112711429595965, 0.09108431339263934, 0.2483347177505495, 0.21577906608581543, 0.20267369747161856, 0.04890596866607666, 0.23640596866607666, 0.2559868335723876, 0.29111411571502677, 0.11848111152648944, 0.18107950687408447, 0.1575744867324831, 0.11540298461914045, 0.23566198348999023, 0.14809005260467512, 0.30157437324523917, 0.20510470867156982, 0.3209036350250245, 0.24037458896636954, 0.21768894195556632]}, "info": {"pct_words_masked": 0.3, "span_length": 2, "n_perturbations": 10, "n_samples": 150}, "raw_results": [{"original": "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.", "sampled": "Question: Is an advance care planning model feasible in community palliative care? Answer: Yes. A comprehensive strategy that includes the use of strategies for identifying and treating patient-related, chronic and long-term acute conditions should be implemented to reduce access to preventive care services. Health care providers should consider", "perturbed_sampled": ["is an advance social health model feasible in community palliative care? Answer: Yes. A comprehensive strategy that includes the use of strategies for identifying and treating patient-related, chronic and long-term acute conditions should be implemented to reduce access to preventive care services. Health care providers should consider", "Question: Is an effective therapeutic planning model feasible in community hospitals? Answer: Yes. A comprehensive strategy that includes the use of strategies for identifying and treating patient-related, chronic and long-term acute conditions should be implemented to reduce access to primary care services. Health care providers should consider", "Question: Is an advance care planning model feasible in community palliative care? Answer: Yes. A comprehensive strategy that includes the management of risks, opportunities and benefits and identifying and treating patient-related, chronic and long-term acute conditions should be implemented to reduce risk of developing the right preventive care services. Health care providers should consider", "Question: Is an advance care planning to be made effective in community palliative care? Answer: Yes. A comprehensive strategy that includes the use of strategies to avoid and treat chronic and long-term acute conditions should be implemented to reduce access to preventive care services. Health care providers should consider", "Question: Is an advance care planning model feasible in community palliative care? Answer: A comprehensive strategy that includes the use of strategies for treatment of and treating patient-related, chronic and long-term acute conditions should be implemented to reduce access to preventive care services. Health care providers should consider", "Question: Is an advance care planning model feasible in community palliative care? Answer: Yes. A comprehensive strategy for the use of strategies for treating and treating patient-related, chronic and long-term acute conditions should be implemented to reduce costs of preventive care services. Health care providers should consider", "Question: Is an advance care planning model feasible in community palliative care? Answer: A comprehensive strategy that includes the use of strategies for identifying a number of patient-related, chronic and long-term acute conditions should be implemented to develop effective solutions to preventive care services. Health care providers should consider", "Question: Is an advance care planning model feasible in palliative care? Answer: Yes. A comprehensive strategy for the use of predictive care for identifying and treating patient-related, chronic and long-term acute conditions should be implemented to reduce access to preventive care services. Health care providers should consider", ", an advance care plan is not feasible in community palliative care? Answer: Yes. A comprehensive comprehensive plan that includes the use of strategies for identifying and treating patient-related, chronic and long-term acute conditions should be implemented to reduce access to preventive care services. Health care providers should consider", "Question: Is an advance care planning model feasible in community palliative care? Answer: Yes. A comprehensive strategy that will make use of strategies for identifying and addressing patient-related, chronic and long-term acute conditions should be implemented to ensure access to preventive care services. Health care providers should consider"], "perturbed_original": ["Question: Is an advance care planning model feasible for community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with the advance care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care services? Answer: An advance care planning model is feasible for community palliative care services. Quality assurances are an essential component of the Model with documentation of progress in a forward care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in advance care? Answer: An advance care planning model is feasible for advance care services. Quality audit processes are an essential component of the Model with documentation of advance care planning models being considered as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care plan documentation established as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning and early care planning model is feasible for community palliative care services. Evaluation of advance care planning processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an important part of the Model . We have extensive areas of advance care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in community service services? Answer: An advance care planning model is feasible for community service services. Quality audit processes are an essential component of assessment process, with documentation of advance care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of our approach to improving the outcomes with documentation of advance care planning model as an important outcome measure.", "Question: Is advance care planning model feasible in community palliative care? Generally, the advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of an advance care planning model, with documentation of advance care planning discussion established as an important outcome measure.", "Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. These processes are an essential element in the Model with documentation of advance care planning discussion established to a important outcome measure."], "original_ll": -3.686828136444092, "sampled_ll": -3.1857428550720215, "all_perturbed_sampled_ll": [-3.4839110374450684, -3.2194132804870605, -3.504533529281616, -3.1936004161834717, -3.4468960762023926, -3.3425490856170654, -3.5401451587677, -3.2572150230407715, -3.3036837577819824, -3.387744903564453], "all_perturbed_original_ll": [-3.538684844970703, -3.679129123687744, -3.7391343116760254, -3.7505791187286377, -3.448279857635498, -3.7405993938446045, -3.852921962738037, -3.4163668155670166, -3.5192558765411377, -3.895937919616699], "perturbed_sampled_ll": -3.3679692268371584, "perturbed_original_ll": -3.6580889225006104, "perturbed_sampled_ll_std": 0.11742062796659566, "perturbed_original_ll_std": 0.15902417662441343}, {"original": "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "sampled": "Question: Is coeliac disease screening in risk groups justified? Answer: No, not by itself, but with the following caveats: 1) As with other diseases, coeliac disease screening does not work in some circumstances; 2) It is recommended that clinicians be aware of coeliac disease screening as an alternative to screening", "perturbed_sampled": ["Question: Is coeliac disease screening in risk groups justified? Answer: No, not by itself, under the following caveats: 1) To help with other diseases, coeliac disease screening does not be justified under some circumstances; 2) It is recommended that clinicians be aware of coeliac disease screening as an alternative to screening", "Question: Is coeliac disease screening in risk groups justified? Answer: No, not by itself, but with the following caveats: 1) As with other diseases, coeliac disease screening does not work in some cases (by itself). 2) It is recommended that clinicians consider alternatives of coeliac disease screening as an alternative to screening", "Question: Is coeliac disease screening in risk groups justified? This may appear not by itself, but with the following caveats: 1) As with other diseases, coeliac disease screening does not work in some circumstances; 2) It is recommended that clinicians be aware of coeliac disease screening as an alternative to screening", "Question: Is coeliac disease screening in risk groups justified? Answer: No, coeliac disease screening does not affect itself, but with the following caveats: 1) As with other diseases, coeliac disease screening does not affect screening under some circumstances; 2) It should be recommended that clinicians be aware of coeliac disease screening as an alternative to screening", "Is the use of coeliac disease screening in risk groups justified? Answer: No, not by itself, but with the following caveats: 1) As with other diseases, coeliac disease screening does not work in some circumstances; 2) It is recommended that participants be aware of coeliac disease screening as an alternative to screening", "Question: Is coeliac disease screening in most groups justified? Answer: No, not by itself, but with the following caveats: 1) As with other diseases, coeliac disease screening does not work in some circumstances; 2) It is recommended that clinicians consider the use of coeliac disease screening as an alternative to screening", "Question: Is coeliac disease screening in certain risk groups justified? Answer: No, not by itself, but with the potential of outcomes. 1) As with other diseases, coeliac disease screening does not work in some circumstances; 2) It is recommended that clinicians be aware of coeliac disease screening as an alternative to screening", "Question: Is coeliac disease screening in risk groups justified? Answer: No, not by itself, but with the following caveats: 1) As with other diseases, coeliac disease screening does not work in risk groups and 2) It is recommended that clinicians be aware of coeliac disease screening as an alternative to screening", "Question: Is coeliac disease screening in risk groups justified? Answer: No, not by itself, but with the following caveats: 1) As with other diseases, coeliac disease screening does not work in some circumstances; 2) It is recommended that clinicians be patiently diagnosed with coeliac disease screening as an alternative to screening", "Question: Is coeliac disease screening in risk groups justified? Answer: No, coeliac disease screening is just itself, but with the following caveats: 1) As with other diseases, coeliac disease screening does not work in some circumstances; 2) It is only logical that clinicians should consider the benefits of coeliac disease screening as an alternative to screening"], "perturbed_original": ["Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was a significant factor. Age of life and bone mineral density were comparable with a number of non-coeliac subjects and the general population. Active screening in coeliac disease risk groups is considered to be reasonable rather than harmful.", "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in coeliac disease risk groups was good. Quality of life and bone weight were comparable with those in non-coeliac subjects and the overall survival of the adult. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "Question: Is coeliac disease screening in risk groups justified? Answer: The overall risk of compliance in screen-detected patients was good. Quality of life and bone mineral levels were comparable with those in non-coeliac disease in the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in the non-coeliac patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects in the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density significantly improved with those in non-coeliac subjects and the general population. Active screening in such risk groups seems to be reasonable rather than harmful.", "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of bone mineral density and bone mineral density were comparable with screening in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "Question: Is coeliac disease screening in risk groups justified? It seems that dietary compliance in screen-detected patients was good. Quality of life and bone care were comparable to that in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.", "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were best among those in non-coeliac subjects and the male population. Active screening in coeliac disease risk groups was assumed to be reasonable rather than harmful.", "Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac disease cases in the general population. Active screening in coeliac disease prevention seems to be reasonable or harmful.", "Question: Is coeliac disease screening in risk groups acceptable? Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac disease groups in the general population. Active screening in disease risk groups seems to be reasonable rather than harmful."], "original_ll": -3.3509790897369385, "sampled_ll": -2.4468579292297363, "all_perturbed_sampled_ll": [-2.852511405944824, -2.646916389465332, -2.655808687210083, -2.5242910385131836, -2.5610427856445312, -2.4060189723968506, -2.7483322620391846, -2.455289840698242, -2.8111326694488525, -2.6285617351531982], "all_perturbed_original_ll": [-3.5453100204467773, -3.257284164428711, -3.4065163135528564, -3.0453789234161377, -3.9826488494873047, -3.4476704597473145, -3.62052583694458, -3.5700485706329346, -3.4512670040130615, -3.510613203048706], "perturbed_sampled_ll": -2.628990578651428, "perturbed_original_ll": -3.4837263345718386, "perturbed_sampled_ll_std": 0.13924354500494673, "perturbed_original_ll_std": 0.2305090655747617}, {"original": "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis", "sampled": "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: No. Blood pressure, if taken in a controlled way, does not change with treatment. A patient has to be taken for this type of blood pressure adjustment to take the right steps for his or her own comfort and safety.", "perturbed_sampled": ["Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: No. Blood pressure, if taken in a normal way, does not change with treatment. A patient has to be taken for this type of discomfort or adjustment to take the right steps for his or her own comfort and safety.", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is performed by a physician or a nurse? Answer: No. Blood pressure, if taken in a controlled way, does not change with treatment. No medication has to be taken for this to prevent an excessive blood pressure adjustment to take the right steps for his or her own comfort and safety.", "Question: Does blood pressure have been treated differently, depending on how blood pressure is measured by a physician or a pharmacist? No. Blood pressure, if taken in a controlled way, does not change with treatment. A patient has to be taken for this type of blood pressure adjustment to take the right steps for his or her own comfort and safety.", "Question: Does blood pressure affect the treated hypertensive patients depending on whether it is taken by a physician or a nurse? Answer: No. Blood pressure, if taken in a controlled way, does not change with treatment. A patient has to be taken for this type of blood pressure to take the right steps to maintain his or her own comfort and safety.", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is referred to as a physician or a nurse? Answer: No. Blood pressure, if taken in a controlled way, does not change with treatment. Blood pressure has to be adjusted with this type of blood pressure adjustment to take the right measures. Each patient must consider his or her own comfort and safety.", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Do you know that? Blood pressure, which changes in a controlled way, does not change with treatment. A patient needs to be taken for this type of blood pressure adjustment to take the right steps for his or her own comfort and safety.", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Blood pressure, if taken in a controlled way, does not change with treatment. A patient has to be taken for this type of blood pressure adjustment to be taken the right steps to ensure he or her own comfort and safety.", "Question: Does blood pressure change on hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: No. Blood pressure, if taken in a controlled way, does not change with treatment. The treatment has to be taken for any type of blood pressure adjustment . A patient has to take the right steps for his or her own comfort and safety.", "Does a blood pressure change in the patients depending on whether it is measured by a physician or a nurse? Answer: No. Blood pressure, if taken in a controlled way, does not interfere with treatment. A patient has to be taken for this type of blood pressure adjustment to take the same medication for his or her own comfort and safety.", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: No. Blood pressure, if taken in a patient does not change with treatment. A measure of the level of stress has to be taken for this type of blood pressure adjustment to determine the right steps for his or her own comfort and safety."], "perturbed_original": ["Question: Is blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or by a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is crucial not only for diagnosis", "Question: Does blood pressure change in treated hypertensive patients depends on whether it is measured by the physician or a nurse? Blood pressure or BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable only for diagnosis", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by the physician or a nurse? Answer: Systolic BP measured by the nurse in hypertensive patients is significantly lower than BP obtained by the physician, and are almost identical for ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is evaluated by a physician or a nurse? Answer: Systolic BP measured by a physician in treated hypertensive patients is significantly lower than the readings obtained by a physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis", "Question: Does the BP change in treated hypertensive patients depending on whether the BP is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to baseline BP monitoring. The determination by the nurse is desirable not only for diagnosis", "Question: Is the blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse to treated hypertensive patients is higher than the readings obtained by the physician, and is identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis", "Question: Does blood pressure change in treated hypertensive hypertensive blood pressure? Question: Do you decide on whether it is measured by a physician or a nurse? Systolic BP measured by the nurse in treated hypertensive blood pressure is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Blood pressure measured by a physician in treated hypertensive patients is significantly lower than the blood pressure readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is based only for diagnosis", "Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a doctor? Systolic BP assessment by the nurse in treated hypertensive patients is significantly lower than the readings by the physician, and are almost twice as high as ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis", "Question: Does blood pressure change in treated hypertensive patients depending on whether blood pressure is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients are significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis"], "original_ll": -3.0541651248931885, "sampled_ll": -2.5679197311401367, "all_perturbed_sampled_ll": [-2.9232492446899414, -2.8387610912323, -2.673982858657837, -2.6554629802703857, -2.812018871307373, -2.9193029403686523, -2.8943417072296143, -2.811983585357666, -2.7992541790008545, -2.9660797119140625], "all_perturbed_original_ll": [-3.041689395904541, -3.234109878540039, -3.1640865802764893, -3.115180015563965, -3.269577980041504, -3.2102019786834717, -3.301710367202759, -3.0837390422821045, -3.2996890544891357, -2.948559284210205], "perturbed_sampled_ll": -2.8294437170028686, "perturbed_original_ll": -3.1668543577194215, "perturbed_sampled_ll_std": 0.09787715751524052, "perturbed_original_ll_std": 0.11211187472371935}, {"original": "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal stage, is controversial.", "sampled": "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: There is a need to investigate the possibility of neck dissection. We are aware that many patients with cervical cancer experience the possibility of neck dissection. However, in our experience, none of the conditions discussed are commonly seen as possible, so no such investigation should be considered. The question for future studies", "perturbed_sampled": ["carcinoma. We consider transporting cervical carcinoma to the cervical nodes from an unknown head to the primary site: Is there a need for neck dissection? There is a need to investigate the possibility of neck dissection. We are aware that many patients with cervical carcinoma are also experiencing the possibility of neck dissection. However, in our experience, none of the conditions discussed are commonly seen as possible, so no such investigation should be considered. The question for future studies", "Question: Metastatic examination of the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: There is a need to investigate the possibility of neck dissection. We are aware that many patients with cervical cancer experience the possibility of neck dissection. However, in our experience, none of the conditions discussed on our examination may be seen at all, so no such concerns may be considered. The question for future studies", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for further research? Answer: There is a need to investigate the possibility of neck dissection. We have found that many patients with cervical cancer experience the possibility of cervical cancer. However, in our experience, the conditions and the conditions discussed are commonly seen as possible, so no such investigation should be considered. The question for future studies", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary source. Is there a need for neck dissection? Answer: There is a need for the possibility of neck dissection. We are aware that many patients with cervical cancer are unable to investigate the possibility of neck dissection. However, in our experience, none of the conditions discussed are commonly seen , so no such investigation should be done, and we are therefore ready to discuss this question for future studies", "Question: Metastatic cancer of the cervical nodes from an unknown cervical neck primary site: Is there a need for neck dissection? Answer: There is a need to investigate the possibility of neck dissection. We are told that many patients with cervical cancer experience the same sex as it could have been with neck dissection. However, in our experience, none of the complications discussed are commonly seen as possible, so no such investigation should be considered. The question for future studies", "oblique carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for an Answer: There is a need to investigate the possibility of neck dissection. We are aware that many patients with cervical cancer experience the possibility of neck dissection. However, in our experience, none of these issues being discussed are commonly seen as possible, so no such investigation should be considered. The question for future studies", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: There is a need to investigate the possibilities of neck dissection. We are aware that many patients with cervical dissection have the possibility for neck dissection. However, in our experience, none of the conditions discussed should be seen as possible, and not such investigation should be considered. The question for future studies", "Question: Metastatic research is underway on the cervical nodes from an unknown head and neck primary . Is there a need for neck dissection? There is no need to investigate the possibility of neck dissection. We are aware that many patients with cervical cancer have the possibility of neck dissection. However, in our experience, none of the conditions discussed are commonly seen as possible, so no such investigation should be considered. The question for future studies", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: There is a need to investigate the possibility of neck dissection. We are aware that many patients with cervical cancer experience the possibility of neck dissection. However, in our experience, some of the conditions discussed are commonly seen as possible, and some of the evidence in such investigation remains to be considered. The question of undergoing invasive studies", "Question: Metastatic carcinoma to different nodes from an unknown head and neck primary region? Question: Is there a potential problem with neck dissection? Answer: There is a need to investigate the possibility of neck dissection. We are aware that many patients with cervical cancer experience the possibility of neck dissection. However, in our experience, none of the conditions discussed on this topic should be seen as possible, so no such investigation should be considered. I ask this question for future studies"], "perturbed_original": ["Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is key to achieve a good local control rate and unknown primary cancer diagnosis in the head and neck. The indication for neck dissection, or for cervical cancer diagnosis at this stage, is controversial.", "Question: Metastatic carcinoma to the cervical nodes from the head and neck primary site: Is there a need for neck dissection? Answer: In fact, definitive radiotherapy to the neck and neck primary site in mucosal tissues, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early cervical cancer, is controversial.", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there indication for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, either by neck dissection or not, is effective at a good local control rate in the unknown primary cancer type in the unknown head and neck primary site. The indication for neck dissection, in particular for early nodal stage, is controversial.", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck, a serious primary site: Is there a need for neck dissection? Answer: In our experience, definitive diagnosis of the neck and the potential mucosal sites, whether it be for neck dissection or not, is effective to achieve a good local control rate on an unknown primary cancer of the head and neck. The concept of neck dissection, in particular for early nodal stage, is controversial.", "Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary tumor is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the cervical nodes from these sites, whether preceded by neck dissection or not, is effective to achieve a certain control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal cancers, can be wildly controversial.", "Question: Metastatic cancer in the cervical nodes from an unknown or unknown neck primary site: Is there a need for neck dissection? In our experience, definitive radiotherapy for the neck and the potential mucosal sites, whether preceded by neck dissection or not, has shown to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal stage, is controversial.", "Question: Are there any signs of neck dissection in certain cervical sites related to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and neck primary nodes from potential mucosal sites, either by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer underlying cervical cancers of head and neck. The indication for neck dissection, in particular in the cervical nodal stage, is controversial.", "Question: Metastatic carcinoma to the cervical gland and an unknown primary cancer and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal stage, is controversial.", "Question: Metastatic carcinoma to the neck from an old head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck primary site in the neck secondary and potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck secondary sites. The indication for neck dissection, especially for early nodal stage, is controversial.", "Question: Metastatic carcinoma of cervical nodes of the unknown head and neck. MCU-associated primary cancer of the head and neck: Does the primary cancer and it is likely the site: Is there a need for neck dissection? Answer: In our opinion, a combination of oral and radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal stage, is controversial."], "original_ll": -3.847614049911499, "sampled_ll": -3.0388824939727783, "all_perturbed_sampled_ll": [-3.151228189468384, -3.105764389038086, -3.3258564472198486, -3.172062873840332, -3.417152166366577, -3.4256138801574707, -3.212413787841797, -3.1792352199554443, -3.327829360961914, -3.1504340171813965], "all_perturbed_original_ll": [-3.814924478530884, -3.5322518348693848, -3.9178719520568848, -3.8743948936462402, -3.744702100753784, -3.9836084842681885, -3.90163254737854, -3.8233304023742676, -3.708613872528076, -3.722238063812256], "perturbed_sampled_ll": -3.246759033203125, "perturbed_original_ll": -3.8023568630218505, "perturbed_sampled_ll_std": 0.11111003240609907, "perturbed_original_ll_std": 0.1238250490698116}, {"original": "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable", "sampled": "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the China Daily and National Science Foundation. All rights reserved.", "perturbed_sampled": ["Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the Daily and National Science Society. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? All rights reserved. Evaluation of basal metabolic rate in Chinese. Copyright 2015 by the China Daily and National Science Foundation. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the National Science Foundation and National Science Foundation. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the National Foundation and the Chinese Foundation. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 All rights reserved. All <unk> 2019: the China Daily and National Science Journal. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the China Daily and National Science Foundation. All rights reserved.", "Estimation of basal metabolic rate in Chinese: Are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the China Daily and National Science Foundation. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the China Daily and the Chinese Foundation. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese. How are the current prediction equations applicable? Answer: Estimation of basal metabolic rate in Chinese.\n\n\u00a9 2008 by the China Daily Journal Science Foundation. All rights reserved.", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations used? Estimation of basal metabolic rate in Chinese? <unk> 2019 China Daily. <unk> 2019 by the China Daily and National Science Foundation. All rights reserved."], "perturbed_original": ["Question: Estimation of basal metabolic rate in Singapore with the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction derived from Chinese and is applicable", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To the point where the newly developed Singapore equation is the most accurate BMR s of all generation in Chinese and is applicable", "Question: Estimation of metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly cited prediction equation is the most accurate BMR prediction equation in Chinese and is applicable", "Question: Estimation of basal metabolic rate in Chinese is the current prediction equations applicable? Answer: To date, the newly proposed prediction equation is the most accurate BMR prediction equation in Chinese and is applicable", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations? Answer: To date, the newly developed version of the new equation is the most accurate BMR prediction equation in Chinese and is applicable", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly introduced BMR prediction equation is the most accurate BMR prediction equation in Chinese .: is the current prediction equation applicable", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR used in the study. However, the same equation is applicable", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The prediction equation - the newly developed Singapore equation is the main BMR prediction equation in Chinese and is applicable", "Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate data equation in Chinese . Answer: Are the predicted predictions applicable", "Question: Estimation of basal metabolic rate in Chinese: Is the new current prediction equations applicable? Answer: To date, the newly developed prediction equation is the most accurate BMR prediction equation in Chinese and is applicable"], "original_ll": -4.212801933288574, "sampled_ll": -2.8638219833374023, "all_perturbed_sampled_ll": [-3.243116855621338, -3.3880727291107178, -2.801535129547119, -3.132396697998047, -3.849390745162964, -2.8638219833374023, -3.0854294300079346, -3.0440304279327393, -2.982161521911621, -3.839252233505249], "all_perturbed_original_ll": [-4.590605735778809, -4.618552207946777, -4.151431560516357, -4.314388751983643, -3.9792349338531494, -3.5911948680877686, -3.976022243499756, -4.327139377593994, -4.504819393157959, -4.000551700592041], "perturbed_sampled_ll": -3.222920775413513, "perturbed_original_ll": -4.205394077301025, "perturbed_sampled_ll_std": 0.34979925627877273, "perturbed_original_ll_std": 0.3100511824187518}, {"original": "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "sampled": "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and practices can be shared freely.\n\nSome areas in particular are ripe for improvement", "perturbed_sampled": ["Question: Recovery Outcome Measures: Is There a Difference between Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and beliefs can be shared freely.\n\nSome areas in particular are ripe for improvement", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, however, no question that emerging cultural values, cultural values, beliefs, and practices can be shared freely.\n\nSome areas in particular are ripe for improvement", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Practices? Answer:\n\nThere is, for me, an emerging cultural landscape where cultural values, beliefs, and practices can be shared freely.\n\nSome areas in particular are ripe for improvement", "Question: Measures and Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and practices can be shared and shared \u2014 and there in particular are ripe for improvement", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and experiences can be shared freely.\n\nSome areas in life are ripe for improvement", "Question: Recovery Outcome s: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and beliefs can be shared freely.\n\nSome areas in particular are ripe for improvement", "Question: Recovery Outcome s: Is There a Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging age where cultural values, beliefs, and practices can be shared freely.\n\nSome areas in particular are ripe for improvement", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Practices? There is, indeed, an emerging cultural landscape where cultural values, attitudes, and practices can be shared freely.\n\nSome areas in particular are ripe for improvement", "Question: Recovery Outcome Measures: Is it a Good Place for Culture, Attitudes, and Faith? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and values can be shared freely.\n\nSome areas in particular are ripe for improvement", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Practices? Answer:\n\nThere is, indeed, an emerging cultural landscape where cultural values, beliefs, and practices can be shared freely.\n\nSome areas in our ecosystem seem ripe for improvement"], "perturbed_original": ["Question: Recovery : Is There a Place for Culture, Attitudes, and Faith? This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is Australia a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcomes measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in the RAQ process and identifies the best way to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This section discusses the cultural appropriateness of Australian experiences in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: What if Is Australian Recovery a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the use of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This is based on the cultural appropriateness of the RAQ in Australian settings, and on the need to develop rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Awareness? This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need for more rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural challenges of using the RAQ in Australian settings, and identifies the need for rigorous, inclusive recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural role of the RAQ in Australian settings, and identifies the need to develop the recovery outcome measures.", "Question: Recovery Outcome Measures: Is There a Reason for Australian Culture, Attitudes, and Organizational Ability? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures."], "original_ll": -3.9180994033813477, "sampled_ll": -3.142951250076294, "all_perturbed_sampled_ll": [-3.3026275634765625, -3.3343207836151123, -3.140171766281128, -3.463928461074829, -3.3144373893737793, -3.352599859237671, -3.379744291305542, -3.1761276721954346, -3.278529405593872, -3.298485517501831], "all_perturbed_original_ll": [-4.252115249633789, -4.000759124755859, -3.800523519515991, -3.930361747741699, -4.306872844696045, -3.918170213699341, -3.853886365890503, -4.083024024963379, -3.946748733520508, -4.0333428382873535], "perturbed_sampled_ll": -3.3040972709655763, "perturbed_original_ll": -4.012580466270447, "perturbed_sampled_ll_std": 0.08864339665472483, "perturbed_original_ll_std": 0.1548150600796792}, {"original": "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with evolving understanding of spinal cord perfusion, endovascular repair of the entire thoracic aorta should ultimately be possible without spinal cord injury.", "sampled": "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: yes (the two major types of aneurysm are those that result in an aneurysm, and those that result in aneurysms, including those that occur after aneurysm replacement surgery. In the first case, the aneurysms will develop before the procedure.)\n\nWhat type of aneurysm should I undergo and how does it affect my life? Aneurysms typically occur at younger ages and are caused by a rupture of a vertebral core", "perturbed_sampled": ["Question: Thoracic and surgical aneurysm repair: is reimplantation of spinal cords a waste of time? Answer: yes (the two major types of aneurysm are those that result in aneurysm replacement surgery) and those that result in aneurysms, including those that occur after aneurysm replacement surgery. In the first case, the aneurysms will develop before the surgery is done. Question: What type of aneurysm should I undergo and how does it affect my life? Aneurysms typically occur at younger ages and are caused by a rupture of a vertebral core", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: yes (the two causes of aneurysm are those that result in an eurysm replacement surgery, and those that result in aneurysms, including those that occur after aneurysm replacement surgery. In that case, the aneurysms will develop after an external procedure.)\n\nWhat type of aneurysm should I undergo and how does it affect my life? Aneurysms typically occur when aneurysm ages and are caused by a rupture of a vertebral core", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of the vertebral arteries a waste of time? Answer: yes (the two major types of aneurysm s are those that result in an aneurysm, and those that result in one, including those that result in an aneurysm replacement , in the first case, the aneurysms will develop before the procedure.)\n\nWhat type of aneurysm should I undergo and how does it affect my life? Aneurysms typically occur at younger ages and often result by a rupture of a vertebral core", "Question: Thoracic and cervical repair: is reimplantation of spinal cords a waste of time? Answer: yes (the two major types of aneurysm are those that result in aneurysms and others that may result in aneurysms, including those that occur after aneurysm replacement surgery. In the near future, the aneurysms will be treated under the procedure.)\n\nWhat type of aneurysm should I undergo and how does it affect my life? Aneurysms typically occur at younger ages and are caused by a rupture of a vertebral core", "Question: Thoracic and thoracoabdominal aneurysm s (aneurysms) Is the reimplantation of spinal cord arteries a waste of time? Answer: yes (the two major types of aneurysm are those that result in an aneurysm, and those that cause significant aneurysms, including those that do not develop after aneurysm replacement surgery. In the first case, the aneurysms will develop before the procedure.)\n\nWhat type of aneurysm should I undergo and how did it affect my life? Aneurysms typically occur during the ages and are caused by a rupture of a vertebral core", ", and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: yes (the two major types of aneurysm are those that result in an aneurysm, and those that result in aneurysm replacement) and those that occur after aneurysm replacement surgery. In the first case, the aneurysms will develop before the surgery. What type of aneurysm should I undergo and how does the surgery affect my life? Aneurysms typically develop at younger ages and are the result of a rupture of a vertebral core", "Question: Do I need thoracoabdominal aneurysm repair: is reimplantation of cord arteries a waste of time? Answer: yes (the two major types of aneurysm are those that result in an aneurysm, and those that result in aneurysms, and those that occur after aneurysm . In the first case, the aneurysms will likely undergo the procedure.)\n\nWhat type of aneurysm should I undergo and how does it affect my life? Aneurysms typically occur at younger ages and are caused by a rupture of a vertebral core", "Question: Thoracic artery aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: yes , two major types of aneurysm are associated with the nerves that result in an aneurysm, and some that result in it similar to those that occur after aneurysm replacement surgery. In the first case, the aneurysms will develop before the procedure.)\n\nWhat type of aneurysm should I undergo and how does it affect my spine? (These types of aneurysms typically occur at younger ages and are caused by a rupture of a vertebral core", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries the first treatment of time? Answer: yes (the two major types of aneurysms are those that result in an aneurysm, and those that result in aneurysms, including those that result in aneurysm replacement surgery. If I get the first case, the aneurysms will develop before the procedure.)\n\nWhat type of aneurysm should I undergo and how does it affect my life? Aneurysms often occur at younger ages and are caused by the maintenance of a vertebral core", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: The two major types of aneurysm are those that result in an eurysm replacement surgery; and those that result in aneurysms, including those that occur after aneurysm replacement surgery. (In the first case, I will start in the process of the procedure.)\n\nWhat type of aneurysm should I undergo and how does it affect my life? Aneurysms typically occur in all ages and are caused by a rupture of a vertebral core"], "perturbed_original": ["Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as two and lumbar arteries with TAA/A repair is safe, resulting in acceptably low rates of immediate and affordable surgical replacement. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that an evolving understanding of spinal cord surgery and repair of the entire thoracic aorta should be possible without spinal cord injury.", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries in the longest of time? Answer: With monitoring of the SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience indicates that routine surgical implantation of spinal cord arteries is not indicated, and that, with evolving understanding of spinal cord perfusion, endovascular repair of the entire spinal cord should ultimately be possible without spinal cord injury.", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a possible time? Answer: At the standard of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal spinal cord arteries a repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine reimplantation of segmental vessels is not indicated, and with evolving understanding of spinal cord perfusion, endovascular repair of the entire thoracic aorta should ultimately be possible without spinal cord injury.", "Question: What exactly is thoracoabdominal aneurysm repair: is cutting down or remodeling the spinal cord arteries a waste of time? Answer: With both MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during surgical procedures is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is not indicated, and that, with evolving understanding of spinal cord perfusion, endovascular repair of the entire thoracic spinal cord may ultimately be possible with spinal cord injury.", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that surgical implantation of segmental vessels is not effective and that, with evolving understanding of peripheral perfusion, endovascular implant of the entire thoracic aorta may be possible on spinal cord injury.", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal spinal cord arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience in routine surgical implantation of segmental vessels is not surprising that, with evolving understanding of spinal cord s, repair of the entire thoracic aorta can not be possible without spinal cord injury.", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries is a waste of resources, and repair is safe, resulting in acceptably reduced levels of immediate and delayed paraplegia. This study suggests that routine surgical implantation of segmental vessels is not indicated, but with evolving understanding of spinal cord perfusion, endovascular repair of a thoracic aorta should ultimately be possible without spinal cord injury.", "Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries for short periods of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate aorta and acute artery paraplegia. This experience suggests that routine surgical reimplantation of segmental vessels is not indicated, and with evolving understanding of spinal cord perfusion, endovascular repair of the entire spinal cord aorta should ultimately be possible without spinal cord injury.", "Question: Thoracic and thoracoabdominal aneurysm repair: is a lack of spinal cord injury a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed repair. Clinical experience suggests that routine surgical treatment of segmental joints may not indicated, and that, with careful control of spinal cord perfusion, endovascular repair of the entire thoracic aorta should ultimately be possible without spinal cord injury.", "Question: Thoracic and thoracoabdominal aneurysm have made reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 surgical implantations of spinal lumbar arteries during TAA/A repair , resulting in acceptably low rates of immediate and delayed paraplegia. This fact shows that routine surgical implantation of segmental arteries is not indicated, and that, with evolving understanding of spinal cord perfusion, endovascular repair of the entire thoracic aorta should ultimately be possible without spinal cord injury."], "original_ll": -3.9618704319000244, "sampled_ll": -2.465787649154663, "all_perturbed_sampled_ll": [-2.5297913551330566, -2.6403441429138184, -2.8308608531951904, -2.6164402961730957, -2.657515525817871, -2.5870320796966553, -2.644134759902954, -2.792361259460449, -2.7190916538238525, -2.650801658630371], "all_perturbed_original_ll": [-4.08944034576416, -3.986292600631714, -3.904665946960449, -3.9166111946105957, -4.04274845123291, -4.1375885009765625, -3.8874616622924805, -4.108205795288086, -3.999821662902832, -4.158496856689453], "perturbed_sampled_ll": -2.6668373584747314, "perturbed_original_ll": -4.023133301734925, "perturbed_sampled_ll_std": 0.08639569436556133, "perturbed_original_ll_std": 0.09440917802085223}, {"original": "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.", "sampled": "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes. However, the authors of the current meta-analysis did not include this issue in their analyses. In that case, we would like to clarify that sports medicine practitioners and athletes should be", "perturbed_sampled": ["Question: Are sports medicine journals relevant and applicable to sports medicine practitioners and athletes? Answer: Yes. However, the authors of the current meta-analysis would like to include this issue in their review. In that case, we would like to clarify that sports medicine practitioners and athletes should be", "Question: Are sports medicine journals relevant and applicable to sports medicine practitioners and athletes? Answer: Yes. However, the authors of the current meta-analysis did not include this issue in the report. In that case, I would like to clarify that sports medicine practitioners and athletes should be", "Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes. However, the authors of the current meta-analysis did not include this issue in their meta-analysis. In that case, we would like to clarify that sports medicine practitioners and athletes should be", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes. However, the journals and sports medicine journals in the current meta-analysis did not present this issue in their analyses. In that case, we would like to clarify that sports medicine journals for practitioners and athletes should be", "Question: Are sports medicine are not relevant and applicable to practitioners and athletes? Answer: Yes. However, the authors of the current meta-analysis did not include these questions in their analyses. In a summary we would like to clarify that sports medicine practitioners and athletes should be", "Question: Are sports medicine journals relevant and applicable to sports medicine practitioners and athletes? Answer: Yes. However, the authors of the current meta-analysis did not include this issue in their research that they would like to clarify that sports medicine practitioners and athletes should be", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes. However, the authors of the journal did not address this issue in their analyses. In that case, we wanted to clarify that sports medicine practitioners and athletes should be", "Question: Are sports medicine journals relevant and applicable to sports medicine practitioners and athletes? Answer: Yes. The authors of the current meta-analysis did not include the articles in their analyses. In that case, we would like to clarify that sports medicine practitioners and athletes should be", "Is the sports medicine journals relevant and applicable to practitioners and athletes? ? However, the authors \u2019 current meta-analysis did not include this issue in their analyses. In that case, we would like to clarify that sports medicine practitioners and athletes should be", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes. However, the authors of the current meta-analysis did not include this in their analysis. In that case, we would like to clarify how sports medicine practitioners and athletes should be"], "perturbed_original": ["Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a substantial number of studies addressing diagnostic and treatment interventions in the sports medicine field. The evidence base is that sports medicine must continue to increase in terms of volume and quality.", "Question: Are sports medicine journals just as applicable to sports medicine journals aimed at the athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine journals continues to continue to increase in terms of volume and quality.", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a wide range of studies addressing diagnostic and treatment interventions in the sports medicine literature. The theoretical base for sports medicine must continue to increase with the development of volume and quality.", ". Are sports medicine journals and sports medicine journals applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic s and interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment needs of the sports medicine literature. The evidence in sports medicine must continue to increase in a greater volume and quality.", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of research based on methods and research in sports medicine. There are additional issues addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine research can continue to increase in volume, volume and quality.", "Question: Are sports medicine journals relevant and applicable to practitioners ? Answer: There is also the need for many years of studies addressing effective and effective treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is an almost dearth of studies addressing diagnostic and treatment interventions in the sports medicine journals. The evidence base for sports medicine must continue to increase in individual publications to promote sports medicine in terms of volume and quality.", "Question: Are sports medicine relevant and applicable to practitioners and athletes? Answer: There is a dearth of evidence to suggest that sports medicine is not addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of diagnostics or treatment quality.", "Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a wide range of studies addressing diagnostic and treatment interventions in sports medicine literature. The evidence base of sports medicine must continue to increase in terms of volume and quality."], "original_ll": -3.3213512897491455, "sampled_ll": -2.687255859375, "all_perturbed_sampled_ll": [-2.5328288078308105, -2.5983901023864746, -2.76845383644104, -2.971867561340332, -3.082686185836792, -2.802046298980713, -3.041701316833496, -2.677140235900879, -3.8085756301879883, -2.7431771755218506], "all_perturbed_original_ll": [-3.336906909942627, -3.3672218322753906, -3.686297655105591, -3.6484975814819336, -3.5600974559783936, -3.34065318107605, -3.651729106903076, -3.6625585556030273, -3.4162166118621826, -3.4036104679107666], "perturbed_sampled_ll": -2.9026867151260376, "perturbed_original_ll": -3.507378935813904, "perturbed_sampled_ll_std": 0.3479940159787558, "perturbed_original_ll_std": 0.13971541637806947}, {"original": "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "sampled": "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "perturbed_sampled": ["Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic metabolism of encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the common type associated with tachycardia", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type associated with tachycardia and is the most common type associated with tachycardia", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "Question: Transient tachypnea of the newborn (TTN): are the genetic expressions responsible for polymorphisms in the beta-adrenergic sequence encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "newborn (TTN) Transient tachypnea of the newborn (TTN) plays a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "Question: Transient tachypnea of the newborn (TTN): a common type of tachycardia, it contains significant polymorphisms in the beta-adrenergic receptor (ADRB) receptor. Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in gene expression in beta-adrenergic receptor s in genes? Answer: Transient tachypnea of the newborn (TTN) is a common type of tachycardia, the most common type associated with tachycardia", "Question: Transient tachypnea of the baby (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is a common type affecting the immune system tachycardia. This type of response is the most common type associated with tachycardia", "Question: Transient tachypnea of the newborn (TTN): a role for the role of the beta-adrenergic receptor (ADRB) encoding genes? Answer: Transient tachypnea of the newborn (TTN) is the type of tachycardia, the most common type associated with tachycardia"], "perturbed_original": ["Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that the homozygosity and TACC haplotype of ADRB2 gene, presumably caused by genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that cellular and cellular variations of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea my of adult newborn (TTN): a role for the role of the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", ", tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) and peptide domain. Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the ADRB2 gene may play a role for polymorphisms in the beta-adrenergic gene encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea e for newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding ADRB1. We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Parenting of TTN genes of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: Question: Please understand that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): the risk for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function , may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic pathway for encoding genes? Answer: We conclude that homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.", "Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? We may conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function hormones, may predispose to TTN."], "original_ll": -3.904130220413208, "sampled_ll": -2.479994297027588, "all_perturbed_sampled_ll": [-2.687971830368042, -2.545912981033325, -2.479994297027588, -2.479994297027588, -2.675746440887451, -2.654198408126831, -2.3289382457733154, -2.698507785797119, -2.8765389919281006, -2.5333895683288574], "all_perturbed_original_ll": [-3.5186758041381836, -3.5922470092773438, -4.19295597076416, -3.9385697841644287, -3.997702121734619, -4.067265033721924, -4.104480266571045, -4.0544352531433105, -3.804374933242798, -4.033820629119873], "perturbed_sampled_ll": -2.5961192846298218, "perturbed_original_ll": -3.9304526805877686, "perturbed_sampled_ll_std": 0.14562987310805794, "perturbed_original_ll_std": 0.21175340711631074}, {"original": "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.", "sampled": "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: No, it isn't. When it comes to the actual disease, we really don't have much knowledge about it. In fact, in the end, I'm very, very biased towards the latter. It's very simple. Our knowledge of it is not the same as ours as a", "perturbed_sampled": ["Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: No, it isn't. When it comes to the actual disease, we really don't have much knowledge about how to diagnose the disease. In fact, in the end, I'm very, very comfortable with the latter. It's very simple. Our knowledge of this is not the same as when a", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: No, it isn't. When it comes to the latter, we really don't have much knowledge about it. In fact, in fact, I'm very, very biased towards the latter. It's an evil. Our knowledge of it is not the same as ours as a", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: No, it isn't. When it comes to the good \u2013 we really don't have much thought about it. In fact, in the end, I'm very, very biased towards the latter. It's very simple. We all know the good parts of it and make it much the same as ours as a", "Question: What are we missing some of your knowledge? The Answer: No, it isn't. When it comes to the actual disease, we really don't have much knowledge about it. In fact, in the end, I'm very, very biased towards the latter. It's very simple. Our idea of it is not the same ; I've seen it as a", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: No, it isn't. When it comes to an actual disease, we really don't have much knowledge about this illness. In fact, in the end, I'm very, very biased towards it. It's very simple. Our knowledge of it is not the same as ours as a", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Because it isn't. When it comes to the actual disease, we really don't have much knowledge about it. In fact, in the end, I'm very, very biased towards the latter. It's very difficult to get knowledge of it, but it's not as serious as ours as a", "Question: Hepatorenal syndrome: are we missing any factors? I think it isn't. When it comes to the actual disease, we really don't have much knowledge about it. In fact, in the end, I'm very, very biased towards the latter. I think it might be simple. Our knowledge of it is not the same as ours as a", "Question: Hepatorenal syndrome: are we missing some information about Hepatorenal syndrome? Answer: No, it isn't. When it comes to the former, we really don't have much knowledge of it. In fact, in the end, I'm very, very biased towards the latter. It's very simple. Our knowledge of it is not the same as ours as a", "Question: Hepatorenal syndrome: are we missing some prognostic insight? No, it isn't. When it comes to the actual disease, we really don't have much knowledge . In fact, in the end, I'm very, very biased towards it. It's very simple. Our knowledge of it is not the same as ours as a", "Question: Hepatorenal syndrome: are we missing the proper diagnosis and treatment factors? Answer: No, it isn't. When it comes to the latter, we really have much knowledge about it. Then in the end, I'm very, very biased towards the latter. It's very simple. Our knowledge of it is not the same as ours as a"], "perturbed_original": ["Question: Why are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function of serum creatinine (<unk>4 mEq/l (<unk>5 mEq/l serum creatinine) and urinary Na (<5 mEq/l) at the time of treatment are found to be associated with survival, suggesting that early treatment might increase survival.", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We used the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) of NS, as well as SR Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that this might increase survival.", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We tested for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum Na) and the urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with ESLD, suggesting that it might increase survival.", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: There is for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) levels of survival at the time of diagnosis were found to interfere with survival, suggesting that early studies could increase survival.", "Question: Hepatorenal syndrome: are we missing some extra protein in survival? Answer: We discussed the first time ESLD etiology as a prognostic factor for survival. The renal Na (septrile creatinine known as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.", "Question: Hepatorenal syndrome: are we missing some answers? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (specifically: serum creatinine) and serum creatinine (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment was not necessarily correlated with survival.", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: First, for the first time ESLD was a great diagnosis for survival. The renal function (expressed as serum creatinine) of ESLD Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.", "Question: Hepatorenal syndrome: are we missing the factors? Answer: We report for the first time ESLD to be a prognostic factor for survival. The renal edema such as urinary Na (<unk> 6 mg/l) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, suggesting that early treatment might increase survival.", "Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and the renal function (<5 mEq/l) at the time of diagnosis were found to correlate with survival, suggesting that early detection or treatment might increase survival.", "Question: Why are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (SLD etiology (<unk>5 mEq/l serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with survival, and early treatment might increase survival."], "original_ll": -3.3490052223205566, "sampled_ll": -2.819157123565674, "all_perturbed_sampled_ll": [-2.9333271980285645, -2.9274253845214844, -3.234524965286255, -2.9776229858398438, -2.935976505279541, -3.08209490776062, -3.0033254623413086, -2.6697628498077393, -3.1582117080688477, -3.2113983631134033], "all_perturbed_original_ll": [-3.243495464324951, -3.692105293273926, -3.578035354614258, -3.677760362625122, -3.810289144515991, -3.2796850204467773, -3.6486475467681885, -3.768526554107666, -3.412266254425049, -3.719834566116333], "perturbed_sampled_ll": -3.013367033004761, "perturbed_original_ll": -3.583064556121826, "perturbed_sampled_ll_std": 0.1590769248026687, "perturbed_original_ll_std": 0.1914249649842644}, {"original": "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.", "sampled": "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: I believe this question does, and it is of utmost importance that the woman who has an excess kidney disease may be treated with corticosteroid (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation.", "perturbed_sampled": ["Question: Does this in pregnancy damage the kidney in women with more parities? Answer: I believe that does, and it is of utmost importance that the woman who has an excess kidney disease may be treated with corticosteroid (a corticosteroid that is the active ingredient for vitamin C e) and/or calcium supplementation.", "Question: Does glomerular hyperfiltration can damage the kidney in women with more parities? Answer: I believe this question does, and it is of great importance that the woman who has an excess kidney disease may be treated with calcium supplementation, vitamin B and P (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: I believe this question does, and it is of great importance that the woman who has suffered kidney disease may be treated with corticosteroid (a corticosteroid that is an essential ingredient of corticosteroids) and/or calcium supplementation.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: I believe this question does, although it is of utmost importance to the woman who has an excess kidney disease . The kidney can be treated with corticosteroid (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: I believe this question does, and it is of great importance that the women who has an excess kidney disease may be treated with a corticosteroid (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: I believe this question does, and it is of the utmost importance that the woman with an excess kidney should be treated with corticosteroid (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation.", "Question: Does glomerular hyperfiltration in pregnancy damage have in sufficient hypofiltration with more parities? Answer: I believe this question does, and it is of utmost importance that the woman who has an excess kidney disease may be treated with corticosteroid (a corticosteroid , the active ingredient of corticosteroids) and/or calcium supplementation.", "Could glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: I believe this question does, but it is of utmost importance that the woman who has an excess kidney disease may be treated primarily by calcium supplements (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation.", "Question: Does glomerular and glomerular pregnancy damage the kidney in women with more parities? Answer: I believe this does, and therefore, it is of utmost importance that the woman who has an excess kidney disease may be treated with corticosteroid (a corticosteroid that is the active ingredient of corticosteroids) and/or calcium supplementation.", "Question: Does ant hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: I believe this question does, and it is of utmost importance that the woman who has an excess kidney disease may be treated with corticosteroid (a corticosteroid , or the active ingredient of corticosteroids) and/or calcium supplementation."], "perturbed_original": ["has glomerular hyperfiltration in pregnancy or affects kidney in women with more parities? In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our article, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on the kidney in women with more parities. Pregnancy may have more adverse effects on kidney and it may also have adverse effect mechanisms for kidney against adverse effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have similar mechanisms for kidney damage due to pregnancy and negative effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for preventing pregnancy, thus reducing the adverse effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? In fact, we suggest that glomerular hyperfiltration due to pregnancy does not damage the kidney in women with more parities. However, it can cause adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration in pregnancy damage kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy may not have adverse effects on kidney in women with more parities. Pregnancy may have possible treatment for kidney against adverse effects of glomerular hyperfiltration.", "Question: Can glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we discovered that the pregnancy of glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy has possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration due to pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may be protective against the kidney against adverse effects of glomerular hyperfiltration.", "Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: According to a study, we suggest that glomerular hyperfiltration in prior to pregnancy does not have adverse effects on the kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration."], "original_ll": -2.9906833171844482, "sampled_ll": -2.960944890975952, "all_perturbed_sampled_ll": [-3.2123160362243652, -3.320216417312622, -3.081862688064575, -3.1425788402557373, -3.067347288131714, -2.9199953079223633, -3.693618059158325, -3.4631690979003906, -2.8677515983581543, -3.278252363204956], "all_perturbed_original_ll": [-3.215611219406128, -2.9908413887023926, -2.9906833171844482, -2.9208030700683594, -2.8874692916870117, -2.728950262069702, -3.057910680770874, -3.1669998168945312, -2.8136911392211914, -2.9957175254821777], "perturbed_sampled_ll": -3.20471076965332, "perturbed_original_ll": -2.9768677711486817, "perturbed_sampled_ll_std": 0.23602201952346766, "perturbed_original_ll_std": 0.14130926013394718}, {"original": "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.", "sampled": "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: The same question is posed by Kwan-yeon Shin, who is currently researching and writing a book on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "perturbed_sampled": ["Question: Is high-sensitivity C-reactive protein correlated with carotid atherosclerosis in healthy Koreans? Answer: The same question is asked in his memoir Kwan-yeon Shin, who is currently researching and writing a book on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in your health? Answer: The same question is posed by Kwan-yeon Shin, who is currently researching and writing a book on the study of high-sensitivity C-reactive protein associated with carotid atherosclerosis in your health. Kwan-yeon", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: The same question is posed by Kwan-yeon which is currently researching and writing new chapters on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in Koreans? (1) Kwan-yeon Shin Answer: The same question is posed by Kwan-yeon Shin, who is currently researching and writing a book on this subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? The same question is posed by Kwan-yeon, who is currently researching and writing a book on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in Koreans? Answer: The same question is posed by Shin, who is currently researching and writing a book on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "Question: Is high-sensitivity protein associated with carotid atherosclerosis in healthy Koreans? Answer: This question is posed by Kwan-yeon Shin, who is currently researching and writing a book on the subject: Is high-sensitivity protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: The same question is posed by Kwan-yeon Shin, who is currently researching and writing a book on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Kwan-yeon", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: The same question is posed by Kwan-yeon Shin, who is currently writing a book writing a book on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: The same question is posed by Kwan-yeon Shin, who is currently researching and writing a book on the subject: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans?\n\n(2) Kwan-yeon"], "perturbed_original": ["Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in Korean adults? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional hsCRP and IMT factors, but there was no independent relationship between hsCRP levels and carotid IMT in healthy Korean adults.", "Question: Is high-sensitivity C-reactive protein associated with the C-reactive protein in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were associated with conventional determinants to play a role in predicting C-reactive protein growth. There were no other differences between high-sensitivity C-reactive protein and associated factor factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both the C-reactive protein and the carotid IMT were strongly correlated with cardiovascular risk factors, but there was no independent association between C-reactive protein and carotid IMT in healthy Korean adults.", "Question: Is high-sensitivity C-reactive inflammation associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and their sensitivity atherosclerosis in healthy Korean adults.", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there were independent correlations between hsCRP levels and carotid IMT in Korean adults.", "Question: Is the C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were significantly associated with conventional and conventional factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.", "a high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults.", "Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Myocardial levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between the probiotic and human hemoglobin levels in healthy Korean adults.", "Question: Is a strong protein associated with carotid atherosclerosis in healthy Koreans? In healthy Korean adults, hsCRP levels and the carotid IMT were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between protein level and carotid IMT in healthy Korean adults.", "Question: Is high-sensitivity C-reactive protein associated with inflammatory IMT levels in healthy Koreans? Answer: Both C-reactive protein levels and the C-reactive protein levels were strongly correlated with conventional cardiovascular risk factors, but there was no independent association between hsCRP levels and carotid IMT in healthy Korean adults."], "original_ll": -2.42130184173584, "sampled_ll": -1.8374992609024048, "all_perturbed_sampled_ll": [-2.1572506427764893, -2.081892967224121, -2.1285767555236816, -2.035095691680908, -1.843932867050171, -2.149388551712036, -2.0370051860809326, -1.7741590738296509, -1.9475945234298706, -1.8374992609024048], "all_perturbed_original_ll": [-2.4687018394470215, -2.661480665206909, -2.0724194049835205, -3.0930914878845215, -2.5848402976989746, -2.6687560081481934, -2.6388044357299805, -3.092235565185547, -2.857434034347534, -2.786130905151367], "perturbed_sampled_ll": -1.9992395520210267, "perturbed_original_ll": -2.692389464378357, "perturbed_sampled_ll_std": 0.13318871980788488, "perturbed_original_ll_std": 0.2840452929602775}, {"original": "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We", "sampled": "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that cup-cage reconstruction with large cup size and excessive padding for jointed bones will prevent anterior extensor injuries during knee joint reconstruction. Further studies will explore the mechanisms that play a role in anterior extension of injured knees.", "perturbed_sampled": ["Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures. Research has demonstrated that cup-cage reconstruction with high bone size and excessive padding for jointed bones will prevent anterior extensor injuries and thereby prevent anterior extension of damaged knees. We will review these mechanisms for joint reconstruction. Further studies will also investigate the key mechanisms that play a role in anterior extension of injured knees.", "A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures. Studies have demonstrated that cup-cage reconstruction with large cup size and excessive padding for jointed bones will prevent anterior extensor fractures from being damaged in knee joint reconstruction. Further studies will explore the mechanisms that play a role in anterior extensor fractures in injured knees.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups provides initial stability in THA for osteoporotic fractures? Answer: This study demonstrated that cup-cage reconstruction with large cup size and excessive padding for knee joint reconstruction will prevent anterior extensor injuries during knee joint reconstruction. Further studies will explore the mechanisms that play a role in anterior extension of injured knees.", "Can a cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that cup-cage reconstruction with excessive cup size and excessive padding in oversized bones will prevent anterior extensor ization of knee joints from being repaired, which also could increase knee joint reconstruction. Further studies will explore the mechanisms that play a role in anterior extension of injured knees.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures. A recent study demonstrated that cup-cage reconstruction with large cup size and excessive cup size jointed bones will prevent anterior extension during knee joint reconstruction. Further studies will review the mechanism and mechanisms that play a role in anterior extension of knees.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that cups with large cup size and excessive cup size will improve in jointed bones will prevent anterior extensor injuries during knee joint reconstruction. Further studies explore the mechanisms that play a role in anterior extension of injured knees.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with heavy cups can provide initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that cup reconstruction with large cup size and excessive padding in the bones will prevent anterior extensor injuries during knee joint reconstruction. Further studies explore the mechanisms that play a role in anterior extension of injured knees.", "Question: Does cup-cage reconstruction with cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that a cup reconstruction with large cup size and excessive padding for jointed bones will prevent anterior extensor injuries during knee joint reconstruction. We will explore different factors that play a role in anterior extension of injured knees.", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: A cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that cup-cage reconstruction with large cup size and excessive padding for jointed knee joints could prevent anterior extensor for injury and promote posterior extension of injured knee joint reconstruction. Further studies will explore the mechanisms that have a key role in anterior extension of injured knees.", "A cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures. A cup-cage reconstruction with oversized cups can provide initial stability in THA for osteoporotic acetabular fractures. This study demonstrated that cup-cage reconstruction with large cup size and excessive padding for oversized cups will prevent anterior extensor injuries during knee joint reconstruction. Further studies showed that cup-cage reconstruction with large cup size and excessive padding for oversized cups decrease the mechanisms that play a role in anterior extension of injured knees."], "perturbed_original": ["Question: Does cup-cage reconstruction with oversized cups provide initial stability for healing purposes for osteoporotic acetabular fractures? Answer: The majority of acetabular components in BRT were stable with a small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary THA but it remains to be determined whether these limits apply to this fracture of frail osteoporotic patients. We", "Question: Does cup-cage reconstruction with oversized cups provide stability in THA for osteoporotic acetabular components? The majority of acetabular components in this cohort were stable despite the contact surface achieved between the component and pelvic bone. Three of 10 migrated in the previous cohorts. We looked at the limits that predict later loosening in primary THA patients, but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We", "Question: Does cup-cage reconstruction with oversized cups provide initial resurfacing in secondary THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in the cohort were caused by the small contact surface achieved between the component and pelvic bone. Three of the eight cage reconstructions were in excess of THA. I have three results that predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We", "Question: Does that have no impact with oversized cups ? Question: Do these limits enhance stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved at the pelvic bone component and pelvic bone. Three of 10 fractures were in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of secondary patients. We", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of these limits that predict later loosening in osteoporotic fractures but it remains to be determined whether these limits apply to a selected group of frail osteoporotic patients. We", "Question: Does cup-cage reconstruction with bone structure provide initial stability in the patient\u2019s osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these were due to this wide range of frail osteoporotic patients. We", "Question: Does a cup with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were found to have a large plastic tube and had the small contact surface achieved between the lower and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits apply to the selected group of patient patients. We", "Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in a particular group were stable despite the small contact surface achieved between the upper leg and pelvic bone. This group of 10 migrated in excess of the limits that predict later loosening in primary sulfate tissue ages and it remains to be seen if the limits apply to this selected group of frail osteoporotic patients. We", "Question: Does the elastic cups and the smaller cups with oversized cups provide initial relief of THA for osteoporotic acetabular fractures? Answer: The four acetabular components in this cohort were stable despite the low contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits apply to the group of frail osteoporotic patients. We", "Question: Could the initial reconstruction with oversized cups provide initial stability in THA for bone fractures? Answer: The majority of acetabular patients in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of our patients were in excess of the limits that predict later loosening in primary THA but it remains to be seen whether these limits apply to this selected group of frail osteoporotic patients. We"], "original_ll": -4.39340353012085, "sampled_ll": -2.899731159210205, "all_perturbed_sampled_ll": [-3.088820695877075, -2.91652774810791, -3.049678087234497, -3.1751163005828857, -2.965162754058838, -3.209527015686035, -3.2037343978881836, -3.1782419681549072, -3.0523407459259033, -2.735858917236328], "all_perturbed_original_ll": [-4.59013557434082, -4.371037006378174, -4.286344051361084, -4.420130252838135, -4.311598777770996, -4.580250263214111, -4.363583087921143, -4.52462911605835, -4.402720928192139, -4.405426025390625], "perturbed_sampled_ll": -3.0575008630752563, "perturbed_original_ll": -4.425585508346558, "perturbed_sampled_ll_std": 0.14346778202037072, "perturbed_original_ll_std": 0.10048258442796068}, {"original": "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "sampled": "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes and no. Most MMT patients have at least one medical history.\n\nIf you are using heroin and methadone, please talk with your GP about the history of your addiction.\n\nDo you have any prescription drug or drug addiction treatment programs available? Answer: There are prescription drugs available.\n\nWe also see this as a \"safe, effective\" treatment. Read our Guide", "perturbed_sampled": ["Question: Are opioid dependence and methadone utilization (MMT) documented in the medical record? Answer: Yes . Most MMT patients have at least one medical history.\n\nIf you are using heroin e, please talk with your GP about the history of heroin addiction.\n\nDo you have any prescription drug or drug addiction treatment programs available? Answer: There are prescription drugs available.\n\nWe also see this as a \"safe, effective\" treatment. Read our Guide", "Question: Are opioid dependence and methadone maintenance problems documented in the medical record? Answer: Yes and no. Most MMT patients have at least one medical history.\n\nIf you are using heroin and drug abuse you must talk with your GP about the history of your experience. Do you have any prescription drug or drug addiction treatment ? Answer: There are prescription drugs available.\n\nWe also see this as a \"safe, effective\" solution. Use our Guide", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the RIM? Answer: Yes and no. Most MMT patients have at least one medical history.\n\nIf you have heroin and methadone, speak with your GP about the history of your addiction.\n\nDo you have specific drug or antibiotic treatment programs available? Answer: There are prescription drugs available.\n\nWe also see this as a \"safe, effective\" treatment. Read our Guide", "Question: Are opioid or methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes and no. Most MMT patients have at least one medical history.\n\nIf you are using heroin and methadone, please consult your GP about the history of your addiction.\n\nDo you have any prescription drug or drug addiction treatment programs available? Answer: Yes, no. There are no prescription drugs available.\n\nWe also see how a drug use can occur during treatment. Read our Guide", "Question: Are opioid dependence and methadone dependence (MMT) documented in the medical record? Answer: Yes and no. Most MMT records must have at least one medical history.\n\nIf you are using opioid dependence and methadone, please talk with your physician about the history of your addiction.\n\nDo you have any prescription drug or drug addiction treatment programs available? Answer: There are prescription drugs available.\n\nWe also see this as a \"safe, effective\" treatment. Read our Guide", "Question: Are opioid dependence and methadone withdrawal (MMT) documented in the medical record? Answer: Yes and no. Most MMT patients have only one medical history.\n\nIf you are using heroin and methadone, visit with your GP about the history of your addiction.\n\nDo you have any prescription drug or drug addiction treatment programs available? There are prescription drugs available.\n\nWe also see this as a \"safe, clean, and affordable\" drug. Read our Guide", "Question: Are opioid dependence and methadone maintenance treatment available in the medical record? Answer: Yes and no. Most MMT patients have only one medical history. If you are using heroin and methadone, please talk to your GP about the history of your addiction.\n\nDo you have any prescription drug /methadone prescription drugs or any addiction treatment programs available? Answer: There are prescription drugs available.\n\nWe also see this as a \"safe, effective\" treatment. Read our Guide", "Question: Are heroin heroin and heroin dependence and methadone (Methadone) drugs and drug addiction treatment programs (MMT) documented in the medical record? Answer: Yes . Most MMT patients have at least one medical history of the same substance. If you are using heroin and methadone, please talk with your GP about the cause of your addiction.\n\nDo you have any prescription drug or drug addiction treatment programs available? Answer: There are prescription drugs available.\n\nWe also see this as a \"safe, effective\" treatment. Read our Guide", "Question: Are opioid dependence and heroin drug treatment (MMT) documented in the guide? Answer: Yes and no. Most MMT patients have at least one medical history.\n\nIf you are using heroin and methadone, please talk with your GP about the history of your addiction.\n\nDo you have any drug or drug addiction treatment programs available? Yes or no. What are prescription drugs available.\n\nWe also see this as a \"safe, effective\" treatment. Read our Guide", "Question: Are opioid and methadone maintenance treatment (MMT) documented on your medical record? Answer: Yes and no. Most MMT patients have at least one medical history.\n\nIf you are using heroin and methadone, please talk with your GP about the history of your treatment. Question: Do you have any heroin or drug addiction treatment programs available? Answer: There are prescription drugs for marijuana, but I see this as a \"safe, effective\" treatment. Read our Guide"], "perturbed_original": ["Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical records, many people are treated with different levels of opioid dependence and MMT in the medical records. The medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that are associated with methadone. This study highlights opportunities for improved coordination between medical records with opioid dependence and MMT.", "Question: Are opioid dependence and maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at medical sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed antibiotics that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care from different sites, documentation of opioid dependence and MMT in the medical record is missing the majority, but is missing a substantial number of patients. Most of these patients are not that skilled with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving both medical care at different sites, documentation of opioid dependence and MMT in the medical record is not for the majority, but is missing in a substantial number of patients. Most of these treatment are medications that potentially interact with methadone. This presents opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are just that they do not receive treatment with methadone. This highlights opportunities for improved information about opioid dependence, medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving medical medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing evidence. A substantial number of patients using one or more of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved records of opioid dependence and mMT in the medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients with prescriptions, medical and medical care at different sites, finding opioid dependence and MMT in the medical record provides for example, but is missing a substantial number of patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) in the medical record? In patients receiving MMT and medical care at different sites, documentation of OPTC and MMT in the medical record occurs for the majority, while MMT is often missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different stages, the percentage of opioid dependence and MMT in the medical record occurs for the majority, but is missing a substantial number of patients. Most of the patients who are prescribed methadone potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT.", "Question: Are opioid dependence and methadone maintenance treatment missing in the medical record? Answer: Among patients receiving different services of medical care at different times of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a substantial number of patients. Most of these patients are prescribed medications that potentially interact with methadone. This study highlights opportunities for improved coordination between medical care and MMT."], "original_ll": -3.0324795246124268, "sampled_ll": -2.585069179534912, "all_perturbed_sampled_ll": [-2.996464967727661, -3.155970335006714, -2.8415486812591553, -2.6935536861419678, -2.6455721855163574, -2.7432661056518555, -2.861957550048828, -2.8021810054779053, -2.8445348739624023, -2.803415536880493], "all_perturbed_original_ll": [-3.077516794204712, -3.2372148036956787, -3.1941492557525635, -3.2128632068634033, -3.069300413131714, -3.290043354034424, -3.462989091873169, -3.3630294799804688, -3.1488559246063232, -3.511152505874634], "perturbed_sampled_ll": -2.838846492767334, "perturbed_original_ll": -3.256711483001709, "perturbed_sampled_ll_std": 0.1400661179344287, "perturbed_original_ll_std": 0.14310433513096332}, {"original": "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.", "sampled": "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: If patients are taking pre-arranged supplements (eg, polysorbate 20, niacin) which may lead to", "perturbed_sampled": ["Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: If you\u2019re taking pre-arranged supplements for phase 20, niacin) which may lead to", "Question: Do symptoms matter when waiting for phase I clinical trials? Answer: If patients are taking pre-arranged medication (P = polysorbate 20, niacin) which may lead to", "Question: Do symptoms matter when preparing for phase -d trials? Answer: If patients are taking pre-arranged supplements (eg, polysorbate 20, niacin) which may lead to", "Question: Do symptoms matter in patients for phase I clinical trials? Answer: If patients are taking pre-arranged steroids (P-P-1 hydroxy oxidi<unk> ( polysorbate 20, niacin) which may lead to", "Question: Does this matter when considering patients for phase I clinical trials? Answer: If patients are taking pre-arranged supplements (eg, polysorbate 20, niacin) the placebo effect may lead to", "Question: Which matter when considering patients for phase I clinical trials? Answer: If patients are taking pre-arranged medication or taking anticyclidine (phosphataa( azoic polysorbate 20, niacin) which may lead to", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: If symptoms occur after taking pre-arranged dosage (pre-determined quantities polysorbate 20, niacin) which may lead to", "Question: Do symptoms matter when considering patients \u2019 involvement in I clinical trials? Answer: If patients are taking pre-arranged supplements (eg, polysorbate 20, etc), these conditions may lead to", "Question: Do symptoms matter when considering patients for phase I clinical treatment? If patients develop the need to take pre-arranged supplements (eg, polysorbate 20, niacin) which may lead to", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: If patients are taking supplements (eg, polysorbate ) which may lead to"], "perturbed_original": ["why should more symptoms matter when considering patients for phase I clinical trials? Answer: Older adults diagnosed with PICT with more symptoms may sacrifice QOL for experimental treatment.", "Question: Do symptoms matter when considering the phase I clinical trials? Answer: Older adults enrolled in phase I trials or those with more symptoms may sacrifice QOL for experimental treatment.", "Question: Do symptoms matter to patients for phase I clinical trials? Answer: Patients enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.", "Question: Do symptoms differ? Are adults considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may be considering patients for experimental treatment.", "Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with QOLs may sacrifice QOL s as a part of phase I treatment.", "Question: Do symptoms matter when considering patients for phase I clinical treatment? Older adults enrolled in PICT with more symptoms may sacrifice and delay experimental treatment.", "Does symptoms matter when enrolling for phase I clinical trials? Question: Do we qualify for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.", "Question: Do symptoms matter to patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL Q treatment.", "Question: Do newer adults sacrifice QOL when considering patients for phase IV trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.", "Question: Do you know what to consider when considering patients for phase d trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment."], "original_ll": -4.9236741065979, "sampled_ll": -3.131972074508667, "all_perturbed_sampled_ll": [-4.622198104858398, -3.9456114768981934, -3.6481308937072754, -4.674742698669434, -3.0509557723999023, -4.245139122009277, -3.5886099338531494, -4.281497478485107, -3.406649589538574, -3.7575111389160156], "all_perturbed_original_ll": [-4.997933864593506, -4.505077362060547, -4.67303991317749, -4.494808197021484, -4.710080623626709, -5.153449535369873, -4.328971862792969, -5.354205131530762, -5.024643421173096, -4.878157138824463], "perturbed_sampled_ll": -3.9221046209335326, "perturbed_original_ll": -4.81203670501709, "perturbed_sampled_ll_std": 0.5028546091117513, "perturbed_original_ll_std": 0.3086365762314202}, {"original": "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "sampled": "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no reliable evidence that breast pathology assessment of the ductal carcinoma is", "perturbed_sampled": ["Question: Is breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no evidence that breast pathology assessment of the ductal carcinoma is", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no reliable evidence that breast pathology assessment of the ductal carcinoma is", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in ductal carcinoma? There is no reliable evidence that breast pathology assessment of the ductal carcinoma is", "Are expert women taking breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no reliable evidence that breast pathology assessment of the ductal carcinoma is", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no suggestion that breast pathology assessment needed to evaluate the level of the ductal carcinoma is", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in your system? There is no reliable evidence that breast pathology assessment and diagnosis of ductal carcinoma is", "Question: Is expert breast pathology assessment necessary for the management of cancer breast cancer in situ or in situ? Answer: There is no evidence that breast pathology assessment of the ductal carcinoma is", "Question: Is expert breast pathology assessment necessary for the examination of the ductal carcinoma in situ? Answer: There is no reliable evidence that expert breast pathology assessment of the ductal carcinoma is", "Diagnostic and expert breast pathology assessment necessary for the management of ductal carcinoma in humans. There is no reliable evidence that breast pathology assessment of the ductal carcinoma is", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: There is no reliable evidence that breast pathology assessment of the ductal carcinoma is"], "perturbed_original": ["Question: Is expert breast pathology assessment necessary for the management of DCIS in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessments continue to be necessary for the management of ductal carcinoma ? ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is the breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary for the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of ductal disease in situ ? Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary for the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of carcinomous breast carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessments necessary for the management of ductal carcinoma in situ . Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessment necessary for management of DCIS in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.", "Question: Is expert breast pathology assessment necessary for the diagnosis of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the treatment of DCIS.", "Question: Is expert breast pathology assessment necessary for the management of cervical or cervical carcinoma? Question: Is expert breast pathology assessment required for ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary for the management of DCIS."], "original_ll": -3.7497522830963135, "sampled_ll": -3.078169822692871, "all_perturbed_sampled_ll": [-2.839031219482422, -3.078169822692871, -3.1181588172912598, -3.43483829498291, -3.250653028488159, -3.3265631198883057, -3.4370131492614746, -2.915132999420166, -3.3795900344848633, -3.078169822692871], "all_perturbed_original_ll": [-3.781987190246582, -3.7058801651000977, -3.9560794830322266, -4.383068561553955, -3.6813881397247314, -3.9715914726257324, -4.183797359466553, -3.926863431930542, -3.6736276149749756, -3.2010996341705322], "perturbed_sampled_ll": -3.18573203086853, "perturbed_original_ll": -3.8465383052825928, "perturbed_sampled_ll_std": 0.20197917548582872, "perturbed_original_ll_std": 0.3055181495108514}, {"original": "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "sampled": "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: NO. The current clinical trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease and it is important to identify additional mechanisms involved. A new approach to identify the risk factors for endometrial polyp formation is presented by Meehan and", "perturbed_sampled": ["Question: Is endometrial polyp formation associated with increased expression of endothelial growth factor and transforming growth factor-beta1? Answer: The current clinical trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease and it is important to identify additional mechanisms involved. A new approach to finding potential risk factors for endometrial polyp formation is presented by Meehan and", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial polyp and transforming growth factor-beta1? Answer: NO. The current clinical trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease ; it is important to identify additional mechanisms involved. A novel diagnostic approach to identify the risk for endometrial polyp formation is presented by Meehan and", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: The current clinical trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease and it is important to identify additional risk factors to consider. A prospective study to identify the risk of endometrial polyp formation is presented by Meehan and", "Question: Is endometrial polyp formation associated with increased risk of vascular endothelial growth factor and transforming growth factor-beta1? Answer: NO. The current clinical trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease and it is important to identify additional mechanisms involved. A new study to identify the mechanisms associated with growth factors for endometrial polyp formation is presented by Meehan and", "Question: Is endometrial polyp formation associated with increased expression of vascular disease as a growth factor and transforming growth factor-beta1? Answer: NO. The current clinical trial indicates that endometrial polyp formation is associated with increased risk for vascular disease and it is important to identify additional mechanisms for endometrial polyp formation. A new approach to identify the risk factors for endometrial polyp formation is presented by Meehan and", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: NO. A prospective clinical trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease and it is important to consider the risk factors and mechanisms involved. A new approach to identify the risk factors for endometrial polyp formation presented by Meehan and", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming gene activity? Answer: NO. My clinical trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease and it is important to identify the mechanisms involved. A new approach to identify the risks for endometrial polyp formation is presented by Meehan and", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: NO. The current clinical trials say that endometrial polyp formation is not associated with increased risk for vascular disease and it is important to identify additional mechanisms involved. A new approach to reduce the risk of endometrial polyp formation is presented by Meehan and", "Question: Is polyp formation associated with increased expression of the growth factor and transforming growth factor-beta1? Answer: NO. The current clinical trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease and it is important to identify additional mechanisms involved. A new approach to identify the risk factors involved in endometrial polyp formation is presented by Meehan and", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: NO. The current clinical trial indicates that endometrial polyp formation is not associated with increased risk for vascular disease and it is necessary to identify risk factors involved. A new approach to identify the risk factors for polyp formation is presented by Meehan and"], "perturbed_original": ["Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to normal endometrial polyps. Several studies have suggested that these cytokines might play a role in endometrial polyp formation. Thus, there was a significant correlation between VEGF expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There were numerous correlations between gene expression of TGF-\u03b21 and VEGF in polyps of adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between growth factor receptor expression , growth factor expression, and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming pathway to receptor expression? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent , adjacent tissue. It suggested that these cytokines played a role in endometrial polyp formation. In addition, there was a significant correlation between vascular endothelial growth factor and differentiation in receptor expression and VEGF and TGF-\u03b21 expression.", "Question: What function was polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to lymph endometrial tissue. It suggested that these cytokines might play a significant role in endometrial tissue growth and TGF-<unk>1. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that cytokines might play a role in endometrial polyp formation. In addition, there was no correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation an increased expression of steroid receptor expression in polyps using the growth factor and growth factor-beta1? Answer: There was increased expression of growth factor-beta1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyps associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? There was increased expression of steroid receptors and VEGF in polyps compared to to vascular endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation associated with increasing expression of a growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. Therefore, there was a significant correlation between steroid TGF-<unk>1 and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation associated with the expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased correlation between TGF-\u03b21 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression.", "Question: Is endometrial polyp formation associated with the formation of vascular endothelial growth factor and transforming the cells in endometrial tissue? Answer: There was increased expression of TGF-\u03b21 and VEGF -<unk>1 compared to adjacent normal endometrial tissue. It suggested that these cytokines played a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-\u03b21 expression."], "original_ll": -2.4146218299865723, "sampled_ll": -2.402770757675171, "all_perturbed_sampled_ll": [-2.539783239364624, -2.8295836448669434, -2.4373250007629395, -2.5618581771850586, -2.5465006828308105, -2.4503355026245117, -2.7302420139312744, -2.5128543376922607, -2.800800085067749, -2.5253071784973145], "all_perturbed_original_ll": [-2.1540424823760986, -2.6454131603240967, -2.9807536602020264, -2.966871738433838, -2.546334743499756, -2.690256118774414, -2.5927035808563232, -3.000889301300049, -2.5271193981170654, -2.9496471881866455], "perturbed_sampled_ll": -2.5934589862823487, "perturbed_original_ll": -2.705403137207031, "perturbed_sampled_ll_std": 0.13399384044913823, "perturbed_original_ll_std": 0.25860526024078173}, {"original": "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "sampled": "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: No, and if you do, you might be in a better situation, because your patient might be in a better place at home, that's because you are treating patients who have a physical or mental illness, or a special case, or a disability. If you know this, that patient could be in a better place. Do you have any guidance", "perturbed_sampled": ["Question: Preparing patients at high risk of falls for discharge and rehabilitation: Can you meet the guidelines? Answer: No, and if you do, you might be in a better situation, because your patient might be in a better condition to return home, because you are treating patients who have a physical or mental illness, or a special case, or a disability. If you know this, that patient is in a better place. Do you have any guidance", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: No, if you do, you might be in a better situation, because you might be in a better place at home, that's because you are treating patients who have a physical impairment, or an illness, or a special case, or a disability. If you know this, that patient could be in a better place. Do you meet the guidance", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? If yes, we know more, and if you do, you might be in a better place at that time. But your patient might be in a better place at that time, because you are treating patients who have a physical or mental illness, or a special case, or a disability. If you know this, that patient could be in a better place. Do you have any guidance", ", patients at high risk of falls for discharge home care in the United States. Do we meet the guidelines? Answer: No, and if you do, you might be in a better situation, because your patient might be in a better place at home, that's because you are not treating patients who have a physical or mental illness, a special case, or a disability. If you know this, that patient could be in a better place. Do you have any guidance", "Question: Preparing patients at high risk and waiting for discharge home after rehabilitation: Do we meet the guidelines? Answer: No, if you do, you might be in a better situation, because your patient might be in a better place at home, that's because you are treating patients who have a physical or mental illness, or a special illness or a disability. If you know this, that patient could be in a better situation, or for a new patient. Do you have any guidance", "treating patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: No, if you do, you might be in a better situation, because your patient might be in a better place at home, that's because of treating patients who have a special medical or mental illness, or a special case, or a disability. If you know this, that patient could be in a better place. Do you have any guidance", "Question: Preparing patients at high school when they are discharged because of falls for discharge home after when we meet this topic. Answer: No, and if you do, you may be in a better situation, because your patient might be in a better place at home, that's because you are treating patients who have a physical or mental illness, or a special case, or a disability. If you know this, that patient could be in a better place. Do you have any guidance", "Question: Your patient may be at high risk of death after being discharge home . Question: Do we meet the guidelines? Answer: No, and if you do, you might be in a better situation, because your patient might be in a better position at home, or because you are treating patients who have a physical or mental illness, or a special case, or a disability. If you know this, that patient could be in a better place. Do you have any guidance", "Question: Preparing cases where there is a high risk of falls for discharge after rehabilitation: Do we meet the guidelines? Answer: No, and if you do, you might be in a better place at home. If your patient might be in a better place at home, that's because you are treating patients who have no health or mental illness, or a special case, or a disability. If you know this, that patient could be in a better place. Do you have any guidance", "Question: Preparing patients at high school falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: No, and if you do, you might be in a better situation, because your patient might be in a better place at home, that's because we were treating patients who have a physical or mental disability, a special case, or a disability. If you know this, that might be in a better situation! Do you have any guidance"], "perturbed_original": ["Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do you follow the guidelines? Answer: There was little evidence that people at high risk of falls received systematic fall assessment during rehabilitation. When this was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to significant complications post-discharge. Geriatr Gerontol Int ., LLC (2001) 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment . When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors would provide very limited fall prevention to patients. Failure to adequately address risks during hospitalization could be a good way to prevent falls . Gerontol Int 2016; 16: 570-576.", "Question: Preparing patients with risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high school with falls received systematic falls risk after rehabilitation. If risk was identified, generally , no appropriate treatment was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "falls in patients at high risk of falls. So for a decision after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls in their patients during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Research Int 2016; 16: 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we follow falls prevention guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk analysis after rehabilitation. When a risk was identified, generally a strategy was implemented. However, attempts to assess some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks after hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int ., 620-969, 570-576.", "Question: Preparing patients at high risk of falls for discharge during rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received a risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might have contributed to the prevention strategies offered. Failure to adequately address risks during recovery can contribute to falls post-discharge. Respiratory and Int 2016; 16: 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do you follow the guidelines? Answer: There was little data on how people at high risk of falls received systematic falls risk assessment during rehabilitation. Once a particular patient at high risk was identified, generally a strategy was implemented. However, failure to assess some risk factors might negatively affect the fall prevention strategies offered. Failure to adequately address risks during hospitalization could contribute to falls risk assessment. Geriatr Gerontol Int 2016; 16: 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There are no evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was developed. However, when an opportunity to assess some risk, then we might have limited fall prevention strategies . Failure to adequately address risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a falls risk assessment was identified, generally , this was implemented. However, failure to identify the appropriate falls risk factors might have contributed to falls risk assessment prevention strategies offered. Failure to assess falls risks during hospitalization could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576.", "Interdisciplinary surveys of patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that patients at high risk of falls received systematic falls risk assessment during rehabilitation. When a fall risk assessment strategy was identified, generally a strategy was implemented. However, failure to address some risk factors might have limited fall prevention strategies offered. Failure to adequately address risks of falls could contribute to falls post-discharge. Geriatr Gerontol Int 2016; 16: 570-576."], "original_ll": -3.9579806327819824, "sampled_ll": -2.9387502670288086, "all_perturbed_sampled_ll": [-2.9425642490386963, -3.003561019897461, -2.9847869873046875, -2.948467254638672, -2.996809720993042, -3.1891605854034424, -3.270444631576538, -2.8579394817352295, -2.956415891647339, -3.4184296131134033], "all_perturbed_original_ll": [-4.103931903839111, -3.9764020442962646, -4.308588981628418, -3.943490505218506, -4.257116794586182, -3.7312369346618652, -3.858287811279297, -4.069948196411133, -3.8679702281951904, -3.916043519973755], "perturbed_sampled_ll": -3.056857943534851, "perturbed_original_ll": -4.003301692008972, "perturbed_sampled_ll_std": 0.16732204239145776, "perturbed_original_ll_std": 0.17247273760607895}, {"original": "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.", "sampled": "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: In some patients, including those with the most severe side effects, the dose of chemotherapy used for treatment of cervical cancer, such as chemotherapy, is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer", "perturbed_sampled": ["Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in all patients? Answer: In most patients, including those with the most severe side effects, the dose of chemotherapy used for treatment of cervical cancer, such as chemotherapy, is not recommended. In the US, the use of cancer chemotherapy is recommended for the treatment of cervical cancer", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? In some patients, along with the most severe side effects, the type of chemotherapy used for treatment of cervical cancer, such as chemotherapy, is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: In some patients, including those with significant or potentially severe side effects, the dose of chemotherapy used for treatment of cervical cancer, such as chemotherapy, is not recommended. In the US, cancers have been treated in a variety of cancer drugs for treatment of cervical cancer", "Question: Could the extent of lymphadenectomy be determined by neoadjuvant chemotherapy in cervical cancer? Answer: In some patients, including those with the most severe side effects, the dose of chemotherapy used for treatment of cervical cancer, such as cancer treatment is not recommended. In the US, the use of cancer drugs in cervical cancer can greatly decrease the incidence of cervical cancer", "Question: Could the extent of cervical cancer therapy have been modified by neoadjuvant chemotherapy in cervical cancer? Answer: In general, those including those with the most severe side effects, a standard type of chemotherapy used for treatment of cervical cancer, such as chemotherapy, is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: In the UK, including those with the most severe side effects, the dose of chemotherapy used in the treatment of cervical cancer, such as lymphadenectomy, is not recommended. In the US, the use of cancer drugs to chemotherapy is recommended for patients of cervical cancer", "will the extent of lymphadenectomy be modified by neoadjuvant therapy to treat cervical cancer. In some patients, including those with the most severe side effects, the dose of chemotherapy used for treatment of cervical cancer, such as chemotherapy, is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: In some patients, including those with the associated side effects, the use of cancer drugs for treatment of cervical cancer, such as chemotherapy, is not being used in a major global cancer treatment area in the US, the use of cancer drugs for treatment of cervical cancer", "Question: Could the extent of the treatment modified by neoadjuvant chemotherapy in cervical cancer? Answer: In some patients, including those with the most severe side effects, the dose of chemotherapy for treatment of cervical cancer, such as cervical cancer, is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in patients with terminal cervical cancer? Answer: In some patients, including those with most severe side effects, the traditional chemotherapy used for treatment of cervical cancer, such as chemotherapy, is not recommended. In the US, the use of cancer drugs for treatment of cervical cancer"], "perturbed_original": ["Question: Could the extent of lymphadenectomy be modified by chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with LNM plus the amount of LNM recommended to NACT.", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The enzymatic and topographic distribution of lymphadenectomy was not modified by NACT, and clinical non-responders showed more involved in the study. Considering that systemic and extensive lymphadenectomy should be altered in cervical cancer, patients treated with NACT plus surgery regardless of the response to NACT.", "Question: Could the extent of LNM is modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency or distribution of LNM are not modified by NACT, but non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with LNM after the surgery regardless of the response to NACT.", "Question: Could the extent of LNM be modified by neoadjuvant s for cervical cancer? Answer: The frequency and topographic distribution of LNM s can be modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with LNM from LNM and should be performed after the surgery regardless of the response to NACT.", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The length and topographic distribution of lymphadenectomy were not modified by chemotherapy in cervical cancer when clinical non-responders showed more involved LNs. A systemic measurement of lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.", "Question: Could the extent of LNM been modified by neoadjuvant chemotherapy in cervical cancer? The frequency and topographic distribution of LNM are not affected in patients treated with NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of response to NACT.", "Question: Could the distribution of lymphadenectomy be modified by neoadjuvant chemotherapy in the patient? Answer: The frequency and topographic distribution of LNM s could be modified by NACT, since patients non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.", "Question: Why can the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNs are not consistent with NACT, and clinical non-responders showed more involved LNs. A systemic and morphological imaging should be performed in patients treated with NACT plus surgery regardless of the response to NACT.", "Question: Can the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic properties of LNM are not modified by NACT, and clinical non-responders showed more patients. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus the frequency of the response to NACT.", "Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in patients with NACT? Answer: The frequency and topographic distribution of LNM are not modified by chemotherapy. In patients with NACT clinical non-responders showed more involved LNs. A very extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the frequency and the topographic distribution of NACT."], "original_ll": -3.9893767833709717, "sampled_ll": -2.56767201423645, "all_perturbed_sampled_ll": [-2.638841390609741, -2.784735679626465, -2.9265480041503906, -2.780489683151245, -2.844132661819458, -2.7907180786132812, -2.7135608196258545, -2.9678783416748047, -2.7220146656036377, -2.7678298950195312], "all_perturbed_original_ll": [-4.152552604675293, -3.771939516067505, -3.9499754905700684, -4.038592338562012, -3.5598316192626953, -4.023031234741211, -3.958353042602539, -3.9216349124908447, -4.018565654754639, -3.5604703426361084], "perturbed_sampled_ll": -2.793674921989441, "perturbed_original_ll": -3.8954946756362916, "perturbed_sampled_ll_std": 0.09327669805646031, "perturbed_original_ll_std": 0.19124520226002234}, {"original": "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.", "sampled": "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Yes, but it may not have been necessary. Many different studies have shown that lipids control colon cancer. A small study by Yost and colleagues", "perturbed_sampled": ["Question: Does the lipid-lowering peroxisome proliferator-activated receptors directly prevent colon cancer and assist those with coronary artery disease? Answer: Yes, but it may not have been necessary. Many different studies have shown that lipids control colon cancer. A small minority of Yost and colleagues", "and the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease. Answer: Yes, but it may not have been necessary. Many different studies suggest that lipids control colon cancer. A small study by Yost and colleagues", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with cancer or colon cancer disease? Answer: Yes, but it may have been necessary. Many different studies have shown that lipids control colon cancer. A small study by Yost and colleagues", "Question: Does the presence of proliferator-activated receptors ligand bezafibrate prevent coronary artery cancer in patients with coronary artery cancer? Yes, but it may not have been necessary. Many different studies have shown that lipids control colon cancer. A small study by Yost and colleagues", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Yes, no diagnosis may not have been necessary. Many different studies have shown that lipids control colon cancer. A collaboration by Yost and colleagues", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate control colon cancer in patients with coronary heart disease? Answer: Yes, but it may not have been necessary. Many different studies have shown that lipids control colon cancer. A small study by patients and colleagues", "Question: Does the lipid-lowering receptors ligand bezafibrate receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Yes, but it may not have been necessary. Many different studies have shown that lipids -lowering receptors ligand bezafibrate can cause colon cancer. A small study by Yost and colleagues", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors actually prevent colon cancer in patients with coronary disease? Answer: Yes, but it may not have been necessary. Many different studies have shown that lipids control colon cancer. A recent study by Yost and colleagues", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors significantly prevent colon cancer in patients with coronary artery disease? Answer: Yes, but it may have been necessary. Many studies have shown that lipids control colon cancer. A small study by Yost and colleagues", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Yes, but it seems to have been necessary. Many different studies have been carried out in lipids control . A small study by Yost and colleagues"], "perturbed_original": ["Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery cancer? Our data, derived from patients with coronary artery cancer, can support a discussion of the medical literature regarding a possible preventive effect of bezafibrate on the development of colon cancer.", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, collected in patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with heart disease? Answer: Our data, derived from patients with coronary disease, support the hypothesis of the possible preventive effect of bezafibrate on the development of colon cancer.", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate affect colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding its preventive effect of drug ligand bezafibrate on the development of colon cancer.", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate cause colon cancer in patients with coronary artery disease? Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of ligand bezafibrate on the development of colon cancer.", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible impact of bezafibrate on the cause of colon cancer.", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Several results, derived from patients with coronary artery disease, support the hypothesis regarding a possible effect of bezafibrate on the health of patients with colon cancer.", "Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate have a potential preventive effect on colon cancer . Can the peroxisome receptors bezefibrate induce colon cancer? Are those patients with coronary artery disease? These data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.", "Question: Does the lipid-lowering peroxisome in the ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of ligand bezafibrate on a ligand of colon cancer.", "Question: Does the lipid-lowering peroxisome ligand bezafibrate and ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a direct effect of the peroxisome on the development of colon cancer."], "original_ll": -2.843569755554199, "sampled_ll": -2.9766039848327637, "all_perturbed_sampled_ll": [-3.0384979248046875, -3.3247294425964355, -3.1378414630889893, -3.750025987625122, -3.5232863426208496, -3.12166428565979, -3.097700357437134, -2.607963800430298, -2.657261848449707, -3.378587007522583], "all_perturbed_original_ll": [-3.056499481201172, -2.85101056098938, -3.018577814102173, -3.1329894065856934, -3.000516176223755, -2.922743797302246, -2.9533162117004395, -3.284658193588257, -3.2745580673217773, -2.9937872886657715], "perturbed_sampled_ll": -3.1637558460235597, "perturbed_original_ll": -3.0488656997680663, "perturbed_sampled_ll_std": 0.3365972192817287, "perturbed_original_ll_std": 0.13569892272564021}, {"original": "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in activities such as facing down while reading warrants further study.", "sampled": "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half as wide at the base of the nose, and is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about", "perturbed_sampled": ["Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half as wide at the base of the nose, and is not affected in pseudoexfoliation syndrome. The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half as good as the nose or the nose, and is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half as wide at the middle of the nose, and is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly more widely for those who wear long or long sleeves. The anterior chamber depth is about", "Question: Does positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half as wide at the base of the nose, and is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is half as wide at the base of the body and is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is less than about", "Question: Does head positioning affect the posterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half as wide at the base of the nose, and is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half the length at the base of the neck is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is considerably greater for those who wear long or long sleeves. The anterior chamber depth is about half as wide at the end of the head. An anterior chamber depth is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those who wear long or long sleeves. The posterior chamber depth is about", "Does the posterior chamber depth head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half as wide at the base as the nose, and is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: The posterior chamber depth is significantly greater for those who wear long or long sleeves. The anterior chamber depth is about half as wide at the base of the nose, and is not affected in pseudoexfoliation syndrome.\n\nThe posterior chamber depth is significantly greater for those with long or long sleeves. The posterior chamber depth is about"], "perturbed_original": ["Question: Does head positioning allow chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a much shallower anterior region in which the head is placed in a prone position, this fact does not lead to transient pupillary block when engaging in activities such as facing down while reading warrants further study.", "Question: Does head positioning influence pupillage depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the upper extremity. This results in a shallower anterior chamber when the head is placed in a more prone position. This fact might potentially lead to transient pupillary block age. Such a low contrast in activities such as facing down while reading warrants further study.", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation ? In patients with clinically apparent unilateral ultrasound, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is having a weaker surface. Whether this fact might be related to transient pupillary block when engaging in activities such as facing down while reading warrants further study.", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: Compared with clinically apparent unilateral pseudoexfoliation, the head tends to be more mobile in the affected eye. This results in a shallower anterior chamber depth, while the head is prone to a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in pseudoexfoliation syndrome, such as facing down while reading warrants further study.", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more shallow in the affected eye. This results in a shallower anterior chamber when the head is placed in a shallower anterior chamber. Whether the head position might potentially be transient or unable to be aligned with the eye when engaging in activities such as facing down while reading warrants further study.", "Question: Does the lens positioning influence anterior chamber depth in the first place? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be slightly shallower in the second place. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to transient pupillary block when engaging in a sectional lens, such as facing down while reading warrants further study.", "Question: Does head positioning influence anterior position in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, head position seems to be more mobile in the affected eye. This occurs in a central chamber when the head is placed in a prone position. Whether this fact might potentially lead to a more narrow block when engaging in activities such as facing down while reading warrants further study.", "Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be placed in the affected eye. This indicates that for patients with a shallower anterior chamber depth, the head is placed in a shallower anterior chamber position. Whether this fact might potentially lead to transient pupillary block when engaging in activities such as facing down while in pain is a question given in further study.", "Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In the clinically apparent unilateral lens, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a more active and prone position. Whether an angle might potentially lead to transient pupillary block when engaging in activities such as facing down while reading warrants further study.", "Question: Does head positioning influence anterior chamber positioning in pseudoexfoliation syndrome? Answer: In patients with mild unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position. Whether this fact might potentially lead to a pupillary block when engaging with reading disorders such as this should let the pupillary chamber go down while reading warrants further study."], "original_ll": -4.250141620635986, "sampled_ll": -2.3694233894348145, "all_perturbed_sampled_ll": [-2.657026767730713, -2.511491060256958, -2.6164705753326416, -2.3849494457244873, -2.5546650886535645, -2.3065502643585205, -2.4541616439819336, -2.539083242416382, -2.5320074558258057, -2.551243305206299], "all_perturbed_original_ll": [-4.538917064666748, -4.3661370277404785, -4.71541690826416, -4.193783283233643, -4.07011604309082, -4.273073673248291, -4.269599914550781, -4.05836820602417, -4.792675018310547, -4.271384239196777], "perturbed_sampled_ll": -2.5107648849487303, "perturbed_original_ll": -4.354947137832641, "perturbed_sampled_ll_std": 0.0990569170436842, "perturbed_original_ll_std": 0.23907029812697544}, {"original": "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more process-oriented view of professionals.", "sampled": "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: I believe that all providers would love to have more resources to assist in the delivery of care and are ready to be involved in making informed decisions about whether or not they can do so. This may or may not be in the best interest of patients and providers, and is", "perturbed_sampled": ["Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: I believe that all patients would love to have more resources to assist in the delivery of care and are ready to be involved in making informed decisions about whether or not they can do so. This may or may not be in the best interest of patients and providers, and is", "Question: Does case-mix based reimbursement s support the development of process-oriented care delivery? Answer: I believe that all providers would love to have more resources to assist in the delivery of care and are ready to be involved in making informed decisions about whether or not they can . This may or may not be in the minds of patients and providers, and is", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care ? Question: I believe that all providers would like to have more individualized information to assist in the delivery of care and are ready to be involved in making informed decisions about whether or not they can do anything that may or may not be in the best interest of patients and providers, and is", "Question: Does case-mix based reimbursement stimulate the implementation of more process-oriented care ? I believe that all providers would love to have more resources to assist in the delivery of care and are ready to be involved in making informed decisions about whether or not they can do so. This may or may not be in the best interests of patients and providers, and is", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: I believe that all providers would love to have more resources to assist in the delivery of care and are ready to be involved in making informed decisions about whether or not they can do so. Who may or may not be in the opinion of patients and providers, and is", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: I believe that all providers need to have more resources and resources in the delivery of care and that every provider needs to be involved in making informed decisions about whether or not they can do so. This may or may not be in the best interest of patients and providers, and is", "Question: Does a decrease in reimbursement stimulate the development of the quality of the delivery? I believe that all providers would love to have the resources to assist in the delivery of care and are ready to be involved in making informed decisions about whether or not they can do so. This may or may not be in the best interest of patients and providers, and is", "Question: Could data based reimbursement help facilitate the development of process-oriented care delivery? Answer: I believe that all providers would love to have more resources to assist in the delivery of care and are ready to be involved in making decisions about whether or not they can do so. This may or may not be in the interest of patients and providers, and is", "Question: Does case-mix based reimbursement support help in the development of process-oriented care delivery? Answer: I believe that all providers would love to have more resources to assist in the delivery of care and are ready to be aware of the process, making informed decisions about whether or not they can do so. This may or may not be in the best interest of those providers and providers, and is", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: I believe that providers would love to have more resources and guidance in the delivery of care and are ready to assist patients in making informed decisions about whether or not they can do so. This may or may not be in the best interest of patients and providers, and is"], "perturbed_original": ["How could the case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to show whether the establishment of care programmes will in time indeed lead to a more process-oriented approach to healthcare professionals.", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital physicians can stimulate the development of care programmes by the adoption of case-mix reimbursement in budgeting processes. It is recommended to confirm this finding and to determine whether the establishment of care programmes for patients over time indeed lead to a more process-oriented view of professionals.", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care delivery due to the adoption of case-mix based reimbursement and hospitals' budgeting . Further research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more process-oriented delivery of care professionals.", "Question: Does case-mix reimbursement stimulate the development of process-oriented care delivery? Answer: This study finds that case-mix reimbursement within hospital management can stimulate the development of care delivery through the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more productive and efficient career of professionals.", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of process-oriented care delivery. Question: Does case-mix reimbursement stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' treatment planning. Future research is recommended to confirm this finding to determine whether the establishment of care programmes will in turn lead to a more process-oriented view of professionals.", "Question: Does case-mix based reimbursement stimulate the development of care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm the feasibility of case-mix reimbursement and to determine whether the use of care programmes in time indeed lead to a more process-oriented view of professionals.", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study examines whether hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and discuss whether the establishment of care programmes will in time indeed lead to the process-oriented view of professionals.", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care programmes? This finding indicates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. It is important to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more process-oriented view of professionals.", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the use of case-mix reimbursement in budgeting processes. Future research can be used to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more process-oriented view of professionals.", "Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This suggests that case-mix reimbursement can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm the case-mix reimbursement scheme and to determine whether the establishment of care programmes will in time indeed lead to a more process-oriented view of professionals."], "original_ll": -3.8974390029907227, "sampled_ll": -3.027855396270752, "all_perturbed_sampled_ll": [-3.0658249855041504, -3.4669182300567627, -3.368551254272461, -3.1675331592559814, -3.321016788482666, -2.9564766883850098, -2.7942638397216797, -2.9579150676727295, -3.244365930557251, -3.099707841873169], "all_perturbed_original_ll": [-4.0176496505737305, -3.993739128112793, -3.750128746032715, -3.598722457885742, -3.619234561920166, -3.72725248336792, -4.0687479972839355, -3.797020435333252, -3.78821063041687, -3.784944772720337], "perturbed_sampled_ll": -3.144257378578186, "perturbed_original_ll": -3.814565086364746, "perturbed_sampled_ll_std": 0.19920892652549205, "perturbed_original_ll_std": 0.1537377479391909}, {"original": "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with men.", "sampled": "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes and no. The reason why is that there is no known risk of thrombolysis (i.e., acute or chronic) of a stroke. A large body of studies indicate that a higher frequency of thrombolysis can cause significant morbidity and mortality in patients at low risk of stroke.", "perturbed_sampled": ["Question: Does sex influence oral linkage to intravenous thrombolysis or stroke? Answer: Yes and no. The reason why is there is no known risk of thrombolysis (i.e., acute or chronic) of a stroke. A large body of studies indicate that a higher frequency of thrombolysis can cause significant morbidity in stroke in patients at low risk of stroke.", "Question: Does it provide a great explanation for the response to intravenous thrombolysis in ischemic stroke? Answer: Yes and no. The reason why is that there is no response to intravenous thrombolysis in patients at risk of thrombolysis (i.e., acute or severe) of a stroke. A large body of studies indicate that a higher frequency of thrombolysis can cause stroke mortality and mortality in patients at low risk of stroke.", "Question: Does sex sexual thrombolysis is an inductive response to intravenous thrombolysis in ischemic stroke? Answer: Yes , yes. The reason why this happens is that there is no known risk of thrombolysis (i.e., acute or chronic) of a stroke. A large body of research claims that a higher frequency of thrombolysis can cause significant morbidity and mortality in patients at low risk of stroke.", "Question: Does sex influence the response of thrombolysis in ischemic stroke? Answer: Yes and no. The key issue is that there is no known risk of stroke (both acute or chronic) of a stroke. A large body of studies indicate that a higher frequency of thrombolysis can cause significant risk of stroke mortality in patients at low risk of stroke.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes and no. The truth is that there is no known risk of thrombolysis (i.e., acute or chronic) of a stroke. A large body of studies indicate that a higher risk of thrombolysis can cause significant morbidity and mortality in patients at low risk of stroke.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Yes and no. The reason why is that there is no known risk for thrombolysis (i.e., acute or chronic) of a stroke. A large number of studies indicate that a higher frequency of thrombolysis can cause significant morbidity and mortality in stroke patients at a low risk of stroke.", "Question: Does sex influence any risk of direct exposure to intravenous thrombolysis in ischemic stroke? Answer: Yes and no. The reason why is that there is no known risk of thrombolysis (i.e., acute or chronic) of a stroke. A number of studies indicate that a higher frequency of thrombolysis can cause high risk for stroke disease and mortality in patients at risk of stroke.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic patients? Yes and no. The reason why is because there is no known risk of thrombolysis (i.e., acute or chronic) of a patient? A large body of studies indicate that a higher frequency of thrombolysis can reduce morbidity and mortality in patients at low risk of stroke.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic ? Yes and no. The reason why is that there is no known risk of stroke (i.e., acute or chronic) of a stroke? A large body of studies indicate that a higher frequency of thrombolysis can reduce pulmonary morbidity and mortality in patients at low risk of stroke.", "Question: Does sex influence the response of thrombolysis in ischemic stroke? Answer: Yes and no. The reason why is that there is no known risk or duration of stroke (i.e., acute or chronic) of stroke. A large body of studies indicate that a higher frequency of strokes cause significant morbidity and mortality in patients at low risk of stroke."], "perturbed_original": ["Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the outcome of an ischemic stroke, including a reduced number of treatment options and recovery in men and men expected in the course of an ischemic stroke, with a possible larger effect on the risk effect in women when compared with men.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the effects of intravenous thrombolysis on male men and also improves the effects for men expected in the natural course of an ischemic stroke, revealing a possible larger beneficial treatment effect in men compared with men.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Presented from Safe Implementation of Treatments in the Stroke Thrombolysis Register . intravenous thrombolysis may modify the observed survival and recovery advantage for men over the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with men.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe r Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the responses of men and men. A greater treatment effect for men expected in the natural course of an ischemic stroke indicates a possible larger beneficial treatment effect in women when compared with men.", "Question: Does sex ico thrombolysis change the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected at a natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when treated for men.", "Question: Do intravenous thrombolysis influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from the National Association of Treatments in Stroke-International Stroke International suggest that intravenous thrombolysis may modify the survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in women when compared with men.", "or sex influence the response to intravenous thrombolysis in stroke. Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for women in the natural course of a stroke, with a possible larger beneficial treatment effect in women when compared with men.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data on Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis will modify the observed survival risk advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial treatment effect in men compared with men.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from The Implementation of Treatments in the Cardiovascular Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an stroke with a possible larger beneficial treatment effect in women when treating men.", "Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation Methods in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may be the main observed survival and recovery advantage for men expected in the natural course of an ischemic stroke, with a possible larger beneficial role in women in adherence with men."], "original_ll": -3.3666269779205322, "sampled_ll": -2.1815600395202637, "all_perturbed_sampled_ll": [-2.696922779083252, -2.257413864135742, -2.714244842529297, -2.72137188911438, -2.218339204788208, -2.182389259338379, -2.5010361671447754, -2.4933581352233887, -2.7612357139587402, -2.666962146759033], "all_perturbed_original_ll": [-3.079986810684204, -3.4120190143585205, -3.6072311401367188, -3.4145405292510986, -3.6928088665008545, -3.014925956726074, -3.674301862716675, -3.587392807006836, -3.582578182220459, -3.630396842956543], "perturbed_sampled_ll": -2.5213274002075194, "perturbed_original_ll": -3.4696182012557983, "perturbed_sampled_ll_std": 0.21549000694480516, "perturbed_original_ll_std": 0.22979039492424572}, {"original": "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring emergency surgery, development of clear management protocols for such patients or perhaps even considering centralisation of emergency surgical services to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for post-discharge care.", "sampled": "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The general view is that the majority of the available literature indicates that the risk of mortality from laparotomies of the heart is decreased after 30 days of hospitalization, and that this may occur as early as 12 months of follow-up. The following table gives an overview of potential causes of the reduction in risk of death from laparotomies of the heart: mortality from laparotomies: causes of mortality by hospital-based cause of death and type of hospital-based cause of death: time from first laparotomies to last laparotomies,", "perturbed_sampled": ["Question: 30-Day and 12 hours in emergency general surgery laparotomies: an area of concern and need to consider. Answer: The general view is that the use of the available literature indicates that the risk of mortality from laparotomies of the heart is decreased after 30 days of hospitalization, and that this may be possible after as early as 12 months of follow-up. The following table gives an overview of potential causes of the reduction in risk of death from laparotomies of the heart: mortality from laparotomies: causes of mortality by type of death and type of mortality by type of death: time from first laparotomies to last laparotomies,", "Question: 30-Day s mortality in surgery and surgery laparotomies: an area of concern and need for discussion. The general view is that the majority of the available literature suggests that the risk of mortality from laparotomies of the heart is decreased after 30 days , and that this may occur as early as 12 months of follow-up. The following table gives an overview of potential causes of the reduction in risk of mortality from laparotomies of the heart: mortality from laparotomies: causes of mortality by hospital-based cause of death and type of hospital-based cause of death: time from first laparotomies to last laparotomies,", "Question: 30-Day and 1-year mortality in emergency situations with laparotomies: an area you will appreciate and need for improvement? Answer: The general view is that the majority of the available literature suggests that the risk of mortality from laparotomies of the heart is decreased after 30 days of hospitalization, and that this may occur within as early as 12 months of communization. The following table gives an overview of potential causes of the reduction in risk of death from laparotomies of the heart: mortality from laparotomies: causes of mortality by hospital-based cause of death and type of hospital-based cause of death: time from first laparotomies to last laparotomies,", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: The general view is that the majority of the available literature indicates that the risk of mortality from laparotomies of the heart is decreased after 30 days of hospitalization, and that this may occur as early as six months before hospitalization. The following table gives an overview of all of the studies evaluating the latest evidence in risk of death from laparotomies of the heart: mortality from laparotomies: causes of mortality by hospital-based cause of death: causes of mortality by hospital-based cause of death: causes of mortality by hospital-based cause of death: causes of mortality by hospital-based cause of death by hospital-based cause of death: type of hospital-based cause of death: causes of mortality from first laparotomies to last laparotomies,", "Question: 30-Day and 30-Day mortality in emergency general surgery laparotomies: an answer to this concern and need for improvement? Answer: The general view is that the majority of the available literature indicates that the risk of mortality from laparotomies of the year is decreased after 30 days of hospitalization, and that this may occur as early as 12 months of follow-up. The following table gives an overview of potential causes of the reduction in risk of death from laparotomies of the year, or mortality from laparotomies: mortality by hospital-based cause of mortality by hospital-based cause of death , risk of hospital-based cause of death: time from first to last laparotomies,", "Question: 30-Day and 1-year mortality in emergency cardiac laparotomies: an area of concern and need for improvement? The general view is that the majority of the available literature indicates that the risk of mortality from laparotomies of the heart is decreased after 30 days of hospitalization, and that this may occur as early as 12 months of follow-up. The following table gives an overview of potential causes of the reduction in risk of death : the extent of the risk of mortality from laparotomies: causes of mortality by hospital-based cause of death and type of hospital-based cause of death: time from first laparotomies to last laparotomies,", "Question: Could this reduce 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: My view is that the majority of the available literature on the reduction in the risk of mortality from laparotomies of the heart is decreased after 30 days of hospitalization, and that this may occur as early as five months of hospitalization. This is the following table , providing a brief overview of potential causes of the reduction in risk of death from laparotomies of the heart: mortality from laparotomies: causes of mortality by hospital-based cause of death and type of hospital-based cause of death: time from first laparotomies to first laparotomies,", "Question: 30-Day and 1-year mortality in emergency general ization is an area in generalization and need for improvement? Answer: The general view is that the majority of the available literature indicates that the risk of mortality from laparotomies of the heart is decreased after 30 days of hospitalization, and that this may occur as early as 12 months of follow-up. The following table gives an overview of potential causes of the reduction in risk of mortality from laparotomies of the heart: mortality from laparotomies: causes of death from first laparotomies: the main hospital-based cause of death: and type of hospital-based cause of mortality from first laparotomies to last laparotomies,", "Question: 30-Day and 3 Month delay in emergency general surgery laparotomies: an area of concern and an area of improvement? Answer: The general view is that the majority of the available literature indicates that the risk of mortality from laparotomies of the heart is decreased after 30 days of hospitalization, and that this increases as early as 30 days of follow-up. The following table gives an overview of potential causes of the reduction in risk of death from laparotomies of the heart: mortality , causes of mortality by hospital-based cause of death, and the risks of hospital-based cause of death: time from first laparotomies to last laparotomies,", "Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an important concern and need for improvement? Answer: The general view is that the majority of the study indicates that the risk of mortality from laparotomies of the heart is decreased after 30 days of hospitalization, and that this may occur as early as 12 months of hospitalization. The following table gives an overview of the effects of the reduction in risk of death from laparotomies of the heart from laparotomies: causes of mortality : cause of death and type of hospital-based pathology of death: time from first laparotomies to last laparotomies,"], "perturbed_original": ["1-year and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of four years, and more needs to be done to improve the outcomes for patients in this group. This could involve increasing acute surgical care manpower, early recognition of the health and safety of patients through emergency surgery, development of clear management protocols for emergency surgery, or perhaps even considering centralisation of emergency surgery and interventions to specialist centres with multidisciplinary teams involving emergency medical care staff and care of the elderly physicians in hospital and related community outreach services for post-discharge care.", "Question: 30-Day and 1-year high emergency general surgery laparotomies: are there any areas of concern that are for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care , recognition of patients requiring emergency surgery, development of clear management protocols for such hospitals and medical services, perhaps even considering centralisation of emergency surgical services to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital and related community outreach units, other areas of post-discharge care.", "Question: 30-Day and 1-year mortality rates in general surgery laparotomies: an area of health care that includes prevention and community outreach to make sure that interventions are undergoing improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve training in surgical care manpower, early recognition of the prevalence of emergency surgery, development of management protocols for such patients or perhaps even considering centralisation of emergency surgical services to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in other related community outreach services for post-discharge care.", "Question: 30-Day and a half-day ill-treatment for elderly patients in emergency surgical laparotomies: an area which remains prone to mortality and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the next 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early detection for patients requiring emergency surgery, development of new procedures and protocols for such patients or perhaps even considering centralisation of emergency surgical services to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for emergency care.", "Question: What is 1-year mortality in emergency general practitioners? First, this is an area of concern and need for improvement. Emergency laparotomy has a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to help improve the lives of other patients in this group. This could involve increasing acute surgical care , recognition of patients requiring emergency surgery, development of clear management protocols for such patients or perhaps even considering centralisation of emergency surgical services to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for post-discharge care.", "Question: 30-Day and 12-Day reduction in emergency general surgery laparotomies: What types of concern and need for improvement? Answer: Emergency laparotomy s have an increased risk of high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve evaluating the surgical care manpower, early recognition of patients requiring emergency surgery, development of clear management protocols for emergency procedures, or perhaps even considering centralisation of emergency surgical services to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital facilities, or community outreach services for post-discharge care.", "Question: 30-Day and 1-year mortality in emergency general surgery is another area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 or younger. Even more needs are done to improve outcomes, particularly in this group. This may include increasing acute surgical care manpower, early recognition of patients requiring emergency surgery, development of clear management protocols for such patients or perhaps even considering centralisation of specialist services to specialist centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians , and related community outreach services for post-discharge care.", "Question: Is 1-year mortality in emergency surgery an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of medical expenses requiring emergency surgery, development of clear management protocols for such patients or perhaps even providing additional services to a number of emergency surgical services to specialist services. The result could be multidisciplinary teams involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for post-discharge care.", "1-year and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially among those over the age of 70 years, and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care and quality recognition , especially if requiring emergency surgery, development of clear management protocols for such patients or perhaps even considering centralisation of emergency surgical services . This could be due to an international network of emergency hospital centres with multidisciplinary teams involving emergency surgeons and care of the elderly physicians , and related community outreach services for post-discharge care.", "Question: 30-Day and 1-year mortality in emergency surgical laparotomies: an area of concern and need . Answer: Emergency laparotomy carries a high rate of mortality, especially in those over 60% of those over 70% in emergency medical care. Unfortunately, more and more needs to be done to improve outcomes, particularly in this group. This could involve increasing acute surgical care manpower, early recognition of patients requiring emergency surgery, development of management protocols for emergency treatment, or perhaps even considering centralisation of emergency surgical services to specialist centres with responsibilities involving emergency surgeons and care of the elderly physicians in hospital and related community outreach services for post-discharge care."], "original_ll": -3.5579025745391846, "sampled_ll": -2.3208224773406982, "all_perturbed_sampled_ll": [-2.6165170669555664, -2.4647586345672607, -2.647386312484741, -2.1840004920959473, -2.650475263595581, -2.53938627243042, -2.5977134704589844, -2.691194772720337, -2.5871899127960205, -2.716677188873291], "all_perturbed_original_ll": [-3.5781445503234863, -3.6415884494781494, -3.7762508392333984, -3.842487096786499, -3.5074398517608643, -3.658512830734253, -3.955345869064331, -3.6414132118225098, -3.660071849822998, -3.7198984622955322], "perturbed_sampled_ll": -2.5695299386978148, "perturbed_original_ll": -3.6981153011322023, "perturbed_sampled_ll_std": 0.14591127543338744, "perturbed_original_ll_std": 0.124002672820174}, {"original": "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "sampled": "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is considered to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will", "perturbed_sampled": ["Question: Does bone tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer is considered to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will", "Question: Does bone tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer is considered to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will", "Question: Can computerised tomography replace bone scintigraphy in which you can produce metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is considered to be incurable with long-term treatment. In some cases, surgery to remove osteoscopies of cervical cancer will", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? The risk of breast cancer (BC) is expected to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is considered to be the standard stage of long-term treatment. In some cases, surgery to prevent breast cancer will", "Question: Can computerised tomography employ scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is considered to be incurable with long-term treatment. In some cases, surgery to detect bone metastases from breast cancer will", "Will computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is considered to be a serious concern for cancer patients with long-term treatment. In some cases, surgery to remove breast cancer will", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor ized breast cancer (BC) is considered to be incurable with long-term treatment. In some cases, surgery to detect bone metastases from breast cancer will", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer (BC) is thought to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer:\n\nTumor of breast cancer is considered to be incurable with long-term treatment. In some cases, surgery to remove breast cancer will"], "perturbed_original": ["Question: Can computerised and micro-computerised bone detection methods utilise the data for detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone scintigraphy after a breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is able to prevent breast cancer even if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can you replace bone scintigraphy in detecting bone metastases from bone metastases? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy after bone metastases from breast cancer? Answer: Our findings suggest that the graft of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in patients diagnosed with breast metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and abdomen) is performed.", "Question: Does breast tomography replace BS in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest that BS of patients presenting with MBC is not required if breast (or abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings confirm that BS of patients presenting with MBC is not required if CT (thorax, brain, pelvis) is performed.", "Could computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS scan of breast cancer patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.", "Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC (in the sarup required if CT (of both abdomen and pelvis) is performed."], "original_ll": -3.9390928745269775, "sampled_ll": -2.90850567817688, "all_perturbed_sampled_ll": [-2.8337833881378174, -2.8337833881378174, -3.386923313140869, -3.1660053730010986, -3.148066520690918, -2.902904510498047, -3.1744141578674316, -3.0848472118377686, -2.9487533569335938, -2.876969814300537], "all_perturbed_original_ll": [-4.129871368408203, -3.8771791458129883, -4.147528171539307, -3.8658175468444824, -4.079732418060303, -4.114278316497803, -4.06759786605835, -3.928309202194214, -3.9354074001312256, -4.797965049743652], "perturbed_sampled_ll": -3.03564510345459, "perturbed_original_ll": -4.094368648529053, "perturbed_sampled_ll_std": 0.17508593481583556, "perturbed_original_ll_std": 0.2554824587135477}, {"original": "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "sampled": "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Q: Where is the current research using imaging technique? A: It is in the latest version of the NMR and a recent revision of the UMR, with a new methodology and an improved method. There is a small but significant improvement in the histology of", "perturbed_sampled": ["Question: Diffusion-weighted MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Q: Where is the current research using imaging technique? A: It is in the latest version of the manuscript and a recent revision of the manuscript, which is used with a new methodology to find an improved method. There is a very small but significant improvement in the histology of", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Q: Where is the current research using imaging technique? A: It is in the latest version of the NMR and a recent revision of the NMR with a new methodology and an improved method. There is a small but very interesting variation in the histology of", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different subtypes possible? Q: Where is the current research using imaging technique? A: What is current research in the latest version of the NMR and a new version of the UMR, with a new methodology and an improved method. There is a relatively significant improvement in the histology of", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Q: Where is the current research using imaging imaging for primary parotid gland tumors? It is in the latest version of NMR and a recent revision of the concept using a new methodology and an existing methodology. There is a small but significant improvement in the histology of", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Diffusion-weighted MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Q: Where is the current MR imaging technique? A: It is the latest version of the NMR and a recent revision of the UMR, with a new methodology and a new method. We've found a small but significant improvement in the histology of", "Question: Diffusion-weighted echo-planar MR imaging of the gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted MR imaging of the gland tumors: is a prediction of different histologic subtypes possible? Q: The research is based on the current research using imaging . It is the latest version of the NMR and a recent revision of the UMR, with a new methodology and an improved method. There is a small but significant improvement in the histology of", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: are prediction of different histologic subtypes possible? Answer: Diffusion-weighted MR imaging of primary parotid gland tumors: are prediction of different histologic subtypes possible? Q: Where is the current research on this technique? This technique is in the latest version of the NMR and a recent revision of the UMR, with a new methodology and an improved method. There is a small slight improvement in the histology of", "Question: Diffusion-weighted echo-planar imaging of primary parotid gland tumors: is a prediction of different histologic subtypes . Q: Diffusion-weighted MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Q: Where is the current research using imaging technique? A: It is in the latest version of the NMR and a recent revision of the UMR, with a little alterations and an improved method. What Is a small but significant improvement in the histology of", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? A: Diffusion-weighted MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Q: Where is the current research paper on this technique? A: It is in the latest version of NMR and a recent revision of the UMR, with a new methodology , a new improved method. There is a small but important breakthrough in the histology of", "Question: Diffusion-weighted echo-planar MRI of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Q: Currently, MR imaging of primary parotid gland tumors offers a prediction of different histologic subtypes . Q: Where is the current research using imaging technique? A: It is in the latest version of the NMR and a recent revision of the UMR, with a new methodology and an improved method. There is a small but significant improvement in the histology of"], "perturbed_original": ["Question: Are MR imaging as a new model for early detection of primary and secondary tumor tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other entities. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on the basis of subjective values solely. Therefore, further studies combining DWI, MR imaging techniques and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid ary patients. Question: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas in other examined cohorts. Due to an overlap not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on the basis of ADC values as further as DWI, morphologic criteria, and probably other MR conditions do not seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of several histologic subtypes possible? Answer: epiDWI has the potential to differentiate the epi-wild gland and myoepithelial adenomas from all other examined entities. Due to an overlap not only between a group of benign and adolescent tumors, but also between groups, diagnoses should not be analyzed on the basis of ADC values solely. Therefore, further studies combining this experimental with medical criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different conditions of MR imaging possible? Answer: epiDWI has the potential to represent adenoma and myoepithelial adenomas from all adenoma entities. Due to an unusually rare association only within the group of benign and malignant lesions that can be isolated from between groups, diagnoses should not be addressed on the basis of the disease solely. Therefore, further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is the diagnosis of different histologic subtypes possible? Question: has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas among other examined entities. Due to an overlap not only among the group of benign ovarian lesions but also between groups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging can be performed in different parotid units. Question: Is it possible that is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all common entities. Due to an overlap not only within the group of benign and malignant adenomas, but also between groups, diagnoses should be addressed on the basis of ADC values and ADC values. No further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted MR imaging of primary parotid gland tumors: is a prediction of such subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. For example, an overlap not only within the group of benign and common adenomas but also between the three populations should not be addressed on the basis of ADC values solely. Therefore, the possibility of combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is prediction of different diagnosis possible? Answer: Results are not the only studies that differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an increased link with the diagnosis not only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland s makes a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas between other examined entities. Due to an overlap not only between group of benign and malignant lesions but also between groups, epiDWI has to not be addressed on the basis of ADC values solely. Therefore, further studies combining the above criteria, and probably other MR models, may seem warranted.", "Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic and myoepithelial adenomas (IBDs) from other examined and/or treated to an ADC index, only within the group of benign and malignant lesions but also between groups, diagnoses should not be addressed on the basis of ADC values solely. Therefore, further studies combining DWI, morphologic criteria, and probably other MR imaging techniques seem warranted."], "original_ll": -4.091708660125732, "sampled_ll": -2.577810287475586, "all_perturbed_sampled_ll": [-2.5821571350097656, -2.6182124614715576, -2.7492270469665527, -2.699232339859009, -2.6088485717773438, -2.9048895835876465, -2.762256145477295, -3.1855056285858154, -2.8141298294067383, -3.087716817855835], "all_perturbed_original_ll": [-3.9470763206481934, -4.460855007171631, -4.2814717292785645, -4.201231479644775, -4.199962615966797, -4.0236029624938965, -3.9603660106658936, -4.142972946166992, -4.246204376220703, -4.369788646697998], "perturbed_sampled_ll": -2.801217555999756, "perturbed_original_ll": -4.183353209495545, "perturbed_sampled_ll_std": 0.1933338856728854, "perturbed_original_ll_std": 0.16082263649659487}, {"original": "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.", "sampled": "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: Yes, but cholecystectomy, also known as cholecystectomy, is not considered a diagnostic diagnostic. Some medical professionals and others have suggested that it is not. It is also not necessary to have cholecystectomy. If you do, your family will know you", "perturbed_sampled": ["Question: Is cholecystectomy an indication for concomitant and mild hereditary spherocytosis? Answer: Yes, but cholecystectomy, also known as cholecystectomy, is not considered a diagnostic diagnostic. Some medical professionals and others have suggested that it is not necessary to have cholecystectomy, but it is also not necessary to have cholecystectomy. If you do, your family will know you", "Question: Is cholecystectomy really effective for those in mild hereditary spherocytosis? Answer: Yes, but cholecystectomy, also known as cholecystectomy, is not considered a diagnostic diagnostic. However, some professionals and others have suggested that it is not. It is also not necessary to have cholecystectomy. If you do, your family will know you", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: Yes, but cholecystectomy, later known as cholecystectomy, is not considered a diagnostic diagnostic. Some may agree that it is effective, and others suspect that it is not. It is not necessary to have cholecystectomy. If you do, your family will know you", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The term cholecystectomy, also known as cholecystectomy, is not an effective diagnostic diagnostic. Some medical professionals and others have been saying it is not. It is also not necessary to have cholecystectomy. If you do, your family will let you", "Question: Is cholecystectomy really an indication for concomitant diseases such as mild hereditary spherocytosis? Answer: Yes, but cholecystectomy, also known as cholecystectomy, is not considered a diagnostic diagnostic. Some medical professionals don\u2019t have any medical diagnostic diagnostics; it is very unlikely that it is also not necessary to have cholecystectomy. If you do, your family will know you", "Question: Is cholecystectomy really an indication for concomitant and mild hereditary spherocytosis? Answer: Yes, but cholecystectomy, also known as cholecystectomy, is not considered a diagnostic diagnostic. Some medical institutions have suggested that it is not diagnostic in any manner, but others have suggested that it is not. It is also not necessary to have cholecystectomy. If you do, you will know you", "Question: Is cholecystectomy really an indication for clinical success in mild hereditary spherocytosis? I had heard nothing about it, but cholecystectomy, also known as cholecystectomy, is not considered a diagnostic diagnostic. Some medical professionals and others have suggested that cholecystectomy is not. It is also not necessary to diagnose. If you do, your family will know you", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild er children? Answer: Yes, but cholecystectomy, also known as cholecystectomy, is not considered a diagnostic diagnostic. Some medical professionals and doctors may have suggested that it is not. It is also not necessary to do so. If you do, your family will know you", "Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: Yes, but cholecystectomy, also known as cholecystectomy, is considered a diagnostic diagnostic. Some medical professionals and others have suggested that it is not. It is sometimes necessary to have cholecystectomy. If you have, the family will know you", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? You may have cholecystectomy, but cholecystectomy, also known as cholecystectomy, is not considered a diagnostic diagnostic. Some suggest that it isn't necessary for cholecystectomy, and others have suggested that it is not. It is not necessary to have cholecystectomy. If you do, your surgeon will know you"], "perturbed_original": ["is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform anesthesia in splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, anesthesia for splenectomy in such children should be judged on its own merits.", "Question: Is cholecystectomy really an indication for splenectomy in mild hereditary spherocytosis? Answer: The advice to consider concomitant splenectomy in children of HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.", "Question: Is cholecystectomy really an indication for gallstone fractures in mild hereditary spherocytosis? Answer: The advice to know that concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs a careful examination. In the era of minimal access surgery, the need for splenectomy in children should be judged on its own merits.", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform concomitant splenectomy in children with mild anemia is cholecystectomy for symptomatic problems while revisiting. In the case of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.", "Question: Is cholecystectomy really an indication for concomitant splenectomy or is cholecystectomy hereditary spherocytosis? The advice to perform a small HS in children with a mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The sensitivity of patients to perform a concomitant splenectomy in the mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the primary primary reason for splenectomy in children should be judged on its own merits.", "Question: Is cholecystectomy really an option to undergo concomitant splenectomy in mild patients? Answer: The advice to perform a concomitant splenectomy in children with chronic gallstones undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to prevent concomitant splenectomy in a mild HS undergoing surgery for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in children should be judged on its own merits.", "Question: Is there an indication for concomitant gallstone pain, mild hereditary spherocytosis? Answer: The advice to perform pediatric splenectomy in children in children in HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.", "Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild -spherocytosis is that the advice of the doctor to perform cholecystectomy for children with milderosclerosis needs revisiting. In the era of minimal access surgery, the clinical use of concomitant splenectomy in such children was judged on its own merits."], "original_ll": -3.5392746925354004, "sampled_ll": -2.482008695602417, "all_perturbed_sampled_ll": [-2.2314305305480957, -2.5157527923583984, -2.5788185596466064, -2.740058660507202, -2.997520923614502, -2.542536973953247, -2.759570598602295, -2.7902560234069824, -2.873553991317749, -2.409292697906494], "all_perturbed_original_ll": [-4.129067420959473, -3.613617420196533, -3.6927449703216553, -3.460171937942505, -3.6305272579193115, -3.7338132858276367, -3.2730114459991455, -3.704223155975342, -3.975642681121826, -3.282459020614624], "perturbed_sampled_ll": -2.6438791751861572, "perturbed_original_ll": -3.6495278596878054, "perturbed_sampled_ll_std": 0.21861801919058982, "perturbed_original_ll_std": 0.25734855444672616}, {"original": "Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.", "sampled": "Question: Does menopausal transition affect the quality of life? Answer: Not at all. At least not in the sense of 'not very much', 'not very much'. Menopausal transition is a 'life changing' experience. As the number of menopause cycles increases over time,", "perturbed_sampled": ["Question: Does menopausal transition affect the quality of life? Answer: Not at all. It's not in the sense of 'not very much', 'not very much'. Menopausal transition is a 'life changing' experience. As the number of menopause cycles increases over time,", "Question: Does menopausal transition affect the quality of life? Answer: Not at all. At least not in terms of 'not very much', 'not very much'. Menopausal transition is a 'life changing' experience. As the number of people taking over life increases over time,", "Question: Does menopausal transition affect the quality of life? Answer: Not at all. At least not in the definition of 'not very much', 'not very much'. Menopausal transition is a 'life .' As the number of menopause s peaks over time,", "How did menopausal transition affect the quality of life? Answer: First of all. At least not in the sense of 'not very much', 'not very much'. Menopausal transition is a 'life changing' experience. As the frequency of menopause cycles increases over time,", "Question: Does menopausal transition affect the length of their life? Answer: Not at this moment, or at least not in the sense of 'not very much', 'not very much'. Menopausal transition is a 'life changing' experience. The number of menopause cycles increases over time,", "Question: Does menopausal transition affect the quality of life? Answer: Not at all. At least not in the sense of 'not very much', 'not very much'. Menopausal transition is a personal experience. As the number of cycles increases over time,", "Question: Does menopausal transition affect the quality of life? Answer: Not at all. At least not in the sense of 'not very much', 'not very much'. Menopausal transition is a 'life changing' experience. As the number of cycles of life progresses over the long cycles of life change. On a short time,", "Question: Does menopausal transition affect the quality of life? Answer: Not at all. At least in the end, the person becomes 'not very much', 'not very much'. Menopausal transition is a long-term experience. As the number of menopause cycles increases over time,", "Question: Does menopausal transition affect the quality of life? Answer: Not at all. At least not in the sense of 'not very much', 'not very much'. Menopausal transition is a stressful experience. As the amount of time involved in the transitions of menopause cycles increases over time,", "Question: Does menopausal transition affect the quality of life? Answer: Not at all. At least not in the sense of 'not at all' or 'not very much'. Menopausal transition is a 'life changing' experience. As the number of times we transition from time to time increases over time,"], "perturbed_original": ["Question: Does menopausal transition affect the quality of life? Answer: This longitudinal studies show no significant effect of menopausal transition on the quality of life among Taiwanese women. The decline in the role limitations and emotional problems was related to vasomotor symptoms.", "Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the rate of women who had severe bowel limitations due to emotional problems was the result of some vasomotor symptoms.", "Question: Does menopausal transition influence quality of life? Answer: This longitudinal study found no evidence of the effect of menopausal transition on quality of life for Taiwanese and Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.", "Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant impact of menopausal transition on quality of life among Taiwanese women. The decline in the role of pressure on motor function is due to emotional symptoms related to vasomotor symptoms.", "Having to think of the role limitations, menopausal factors, on the quality of life? Answer: This longitudinal study found no significant effect for gender transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.", "Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study indicates a significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the prevalence of role limitations due to menopausal transition was related to vasomotor symptoms.", "Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in age limitations due to pregnancy and stroke was related to vasomotor symptoms.", "Question: Does menopausal transition affect quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to women was related to vasomotor symptoms.", "Question: Does menopausal transition affect the quality of life? Answer: This report found no effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was due to vasomotor symptoms.", "Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study indicates that there was no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in male role limitations due to emotional problems was related to psychological problems, emotional conditions and emotional symptoms."], "original_ll": -3.4842090606689453, "sampled_ll": -2.532646417617798, "all_perturbed_sampled_ll": [-2.650141477584839, -2.951366901397705, -3.1559791564941406, -3.0715925693511963, -2.776247024536133, -2.7051618099212646, -3.0126845836639404, -2.876230478286743, -2.8132519721984863, -2.4938504695892334], "all_perturbed_original_ll": [-3.6126763820648193, -3.444185733795166, -3.5943784713745117, -3.3503496646881104, -4.0053486824035645, -3.1924355030059814, -3.3602242469787598, -3.618936777114868, -3.578235387802124, -3.3661959171295166], "perturbed_sampled_ll": -2.8506506443023683, "perturbed_original_ll": -3.512296676635742, "perturbed_sampled_ll_std": 0.19357318391466855, "perturbed_original_ll_std": 0.2129042913473095}, {"original": "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.", "sampled": "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: It is not aneurysm repair for aneurysm subarachnoid hemorrhage, but is aneurysm repair for a subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the definition of subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "perturbed_sampled": ["Question: Is aneurysm repair justified for the patients aged 80 to 70 year after aneurysmal subarachnoid hemorrhage? Answer: It is not aneurysm repair for aneurysm subarachnoid hemorrhage, but is aneurysm repair justified for aneurysm subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the definition of subarachnoid hemorrhage and the definition of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: How long is not aneurysm repair for aneurysm patients, but is aneurysm repair used? The problem is, is there a subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the definition of subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "repair for aneurysm subarachnoid hemorrhage, is an emergency care treatment for the patients aged 80 or older after aneurysmal amputations. Answer: It is not aneurysm repair for aneurysm subarachnoid hemorrhage, but is aneurysm repair for a subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the treatment of aneurysm subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "Question: Is aneurysm justified for the patients aged 80 or older after aneurysm subarachnoid hemorrhage? Answer: It is not an aneurysm repair for aneurysm subarachnoid hemorrhage, but is aneurysm repair for a subarachnoid hemorrhage? Answer: This article explains the definition of subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "Question: Is aneurysm repair justified for the patients aged 80 or older after a bronchial hemorrhage? Answer: It is not aneurysm repair for aneurysm subarachnoid hemorrhage, but is not sufficient for a subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the definition of aneurysm and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "Are aneurysm repair justified for the patients aged 80 or older with aneurysm subarachnoid hemorrhage? Answer: It is not aneurysm repair for aneurysm subarachnoid hemorrhage, but is aneurysm repair for a subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the definition of subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" is termed subarachnoid", "Question: Is aneurysm repair justified for the patients aged 80 years after aneurysmal subarachnoid hemorrhage? Answer: It is not aneurysm repair for aneurysm subarachnoid hemorrhage, but is aneurysm repair justified on a subarachnoid hemorrhage? Answer: This page explains the definition of subarachnoid hemorrhage and the definition for aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "Question: Is the treatment justified for the patients aged 80 or older after aneurysmal or aneurysmal? Answer: It is not aneurysm or aneurysm subarachnoid hemorrhage, but is aneurysm or a subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the definition of subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "Question: Is aneurysm repair justified for the elderly aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Is not aneurysm repair for aneurysm subarachnoid hemorrhage, but is aneurysm repair for a subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the treatment of aneurysm subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage? The term \"subarachnoid hemorrhage\" encompasses subarachnoid", "Question: Is aneurysm repair justified for patients aged 80 years after aneurysmal subarachnoid hemorrhage? Answer: Is aneurysm repair justified not aneurysm repair for aneurysm subarachnoid hemorrhage, but is aneurysm repair for a subarachnoid hemorrhage.\n\n2.2\n\n1.1\n\nThis chapter explains the definition of subarachnoid hemorrhage and the treatment of aneurysm subarachnoid hemorrhage. The term \"subarachnoid hemorrhage\" encompasses subarachnoid"], "perturbed_original": ["Question: Is aneurysm repair justified for children aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was achieved when a ruptured aneurysm was repaired in the elderly than it was treated in an elderly. Answer: Based on the results of this study, we should not hesitate to provide definitive surgery for the elderly with aSAH.", "Question: Is this justified for the patients aged 80 or older after aneurysmal surgical intervention? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of these outcomes we should not hesitate to offer the definitive surgery for those in the elderly with aSAH.", "Question: Is aneurysm repair justified for the patients aged 3 - 4 years older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the patients with aSAH and after aSAH it was repaired more conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for patients faking the elderly with aSAH.", "Question: Is aneurysm repair justified in patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was diagnosed for the elderly than it was treated conservatively. Based on the results of this study, we should not hesitate to suggest the use of definitive surgery for the elderly with aSAH.", "Question: Is aneurysm repair satisfactory with the patients aged 80 s to 80 years after hemorrhage and hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to give definitive surgery for the elderly with aSAH.", "Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly . The patients aged 80 or older and the surgery was treated better. Based on the results of the study, we would not hesitate to offer the definitive surgery for the elderly with aSAH.", "Question: Is aneurysm repair justified for the patients aged 80 and 80 years after a severe hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not go further and offer the definitive surgery for the elderly with aSAH.", "Question: Is aneurysm repair justified for adults aged 80 or older after cardiac hemorrhage? Answer: Better prognosis was obtained when aneurysm was repaired in the elderly than it was treated . Answer: If you can not find the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.", "Question: Is it justified for the patients aged 80 or 65 who had ruptured aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was involved in the elderly than it was treated conservatively. From the results of this study, we should be able to offer the definitive surgery for the elderly with aSAH.", "Question: Is aneurysm repair in the patients aged 80 or over affected the elderly aside from an aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we did not hesitate to offer the definitive surgery that worked in the elderly with aSAH."], "original_ll": -3.4250407218933105, "sampled_ll": -1.5792100429534912, "all_perturbed_sampled_ll": [-1.6823946237564087, -2.0221455097198486, -1.7785574197769165, -1.6657344102859497, -1.9061399698257446, -1.645104169845581, -1.8337594270706177, -1.8301422595977783, -1.6789534091949463, -1.6622600555419922], "all_perturbed_original_ll": [-3.2617452144622803, -4.020036697387695, -3.5037899017333984, -3.279496431350708, -3.9091248512268066, -3.369499683380127, -3.8075926303863525, -3.785780429840088, -3.6635544300079346, -3.6132655143737793], "perturbed_sampled_ll": -1.7705191254615784, "perturbed_original_ll": -3.621388578414917, "perturbed_sampled_ll_std": 0.1199611190223422, "perturbed_original_ll_std": 0.25075169233849753}, {"original": "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.", "sampled": "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: The fracture can develop spontaneously during growth or in a number of stages that are likely to cause the child to miss a normal development. The initial shock of an earthquake or earthquake-like event may cause an", "perturbed_sampled": ["Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: The fracture can develop after growth or in a number of stages that are often overlooked. These fractures may cause the child to miss a normal development. The initial shock of a catastrophic or earthquake-like event may cause an", "Question: Sternal : Adult growing children : A rare and often overlooked fracture? Answer: The fracture can develop in a certain stage of adult growth or in a number of stages that are likely for the child to miss a normal development. The initial shock of an earthquake or earthquake-like event may cause an", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: The fracture occurs spontaneously , in or in a number of stages that are likely to cause the child to experience normal development. The initial shock of an earthquake or earthquake-like event may cause an", "Question: Sternal fracture in growing children : A rare and often overlooked condition. The fracture can develop spontaneously during growth or in a variety of stages that are likely to cause the child to miss a break. The initial shock of an earthquake or earthquake-like event may cause an", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: The fracture can develop spontaneously during growth in a number of stages that are likely to cause the child to miss a normal development. The initial shock of an earthquake or any other event may cause an", "Question: Sternal fracture in children : A rare and often overlooked fracture? Answer: The fracture can develop at several stages of normal growth or in a number of stages that are likely to cause the child to miss a normal development. The initial shock of an earthquake or a hurricane may cause an", "Question: Sternal fracture in growing children : A rare and sometimes unpredictable fracture? Answer: The fracture can develop spontaneously during growth or in a number of stages that are likely to cause the child to miss a normal normal normal. The initial shock of a rupture or earthquake-like event may cause an", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: The fracture can develop spontaneously during growth or in a number of stages , and is more likely to cause the child to miss a chance to fracture. The initial shock of a major break or earthquake-like event may cause an", "Question: Sternal fracture in toddlers : A rare and often overlooked fracture? Answer: The fracture can develop spontaneously during growth or in stages of stages that are likely to cause the child to miss a normal development. The shock of an earthquake or earthquake-like event may cause an", "Question: Sternal fracture in growing children : \u2013 why is this the most painful and often overlooked fracture? Answer: The fracture can develop spontaneously during growth or in a number of stages that are likely to cause the child to break through its normal development. The initial shock of an earthquake or earthquake-like event may cause an"], "perturbed_original": ["Question: Sternal fracture in the U.S. : A rare and often overlooked fracture? Answer: Isolated sternal fractures in the U.S. are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for diagnosis, and radiography is the method of choice for visualization of the extent of the dislocation.", "Question: Sternal fracture in growing children : sternal fracture, overlooked and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic brain damage. Radiography is a useful diagnostic tool for fracture detection and radiography is the method used for visualization of the extent of the dislocation.", "Question: Sternal fractures in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture s in childhood and radiography is the method of choice for visualization and analysis of the extent of the dislocation.", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often overlooked due to typical age-related traumatic incidents. Ultrasonography is a highly effective tool for fracture detection and radiography is the method of choice for visualization of fracture detection and the analysis of the dislocation.", "Question: Sternal , growing children : A rare and often unknown Answer: Isolated injuries in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.", "Question: Sternal fracture in growing children : A rare and often overlooked question: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Finding a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of dislocation.", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful way for fracture detection and radiography is a techniques of choice for visualization of the extent of the dislocation.", "Question: Sternal fracture fractures in children : A rare and often overlooked fracture? Answer: Isolated fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for determining the extent of the dislocation.", "Question: Sternal fracture in growing -up children: A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often overlooked in typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and is the method of choice for visualization of the extent of the dislocation.", "Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the ultimate choice for visualization of the extent of the dislocation."], "original_ll": -3.8446812629699707, "sampled_ll": -3.4450199604034424, "all_perturbed_sampled_ll": [-3.8787999153137207, -3.9152464866638184, -3.7303454875946045, -3.554762601852417, -3.6093392372131348, -3.551429271697998, -4.000227928161621, -3.877545118331909, -3.622204303741455, -3.6555299758911133], "all_perturbed_original_ll": [-3.2316815853118896, -3.979645252227783, -3.944918394088745, -3.965447425842285, -4.320980072021484, -4.236724376678467, -4.002346038818359, -3.6391398906707764, -4.138796329498291, -3.975228786468506], "perturbed_sampled_ll": -3.7395430326461794, "perturbed_original_ll": -3.943490815162659, "perturbed_sampled_ll_std": 0.1564161636073358, "perturbed_original_ll_std": 0.29532908419940357}, {"original": "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as DL that may be easily misdiagnosed by non-emergency DBE.", "sampled": "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: This approach is still in the early phase. However, a single-point approach may have the potential to treat the bleeding-induced oedema more effectively than multiple-point approaches or to treat other complications involving the hemorrhagic process.\n\n(Dr. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "perturbed_sampled": ["Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule s for the study? Would that feasible combined approach would overt-obscure gastrointestinal bleeding? Answer: The trial process is still in the early phase. However, a single-point approach may have the potential to treat the bleeding-induced oedema faster than multiple-point approaches or to treat other complications involving the hemorrhagic process.\n\n(Dr. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 2014, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure s. Answer: This approach is still in its early phase. However, a single-point approach may have the potential to treat the bleeding-induced oedema more effectively than multiple-point approaches that treat other complications involving the hemorrhagic process.\n\n(Dr. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 April 2014 Information Publication Name: Emergency Triple-Balloon Enteroscopy", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in reducing gastrointestinal bleeding? Answer: This approach is still in the process. However, a single-point approach may have the potential to treat the oedema more rapidly than multiple-point approaches or to treat other complications involving the patient. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach to overt-obscure gastrointestinal bleeding? An approach could reoccur gastrointestinal bleeding and decrease bleeding in the early phase. However, a single-point approach may have the potential to treat the bleeding-induced oedema more effectively than multiple-point methods to treat other complications involving the hemorrhagic process.\n\n(Dr. Gaddi, M.D., PhD)\n\nJOURNAL , October 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute acute bleeding? Answer: This approach is still in the unknown. However, a single-point approach may have been effective to treat the bleeding-induced oedema more effectively than multiple-point methods to treat other complications involving the hemorrhagic hemorrhagic disease. <unk> M.D., PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "Question: Emergency double-balloon enteroscopy combined with viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: This approach is still in the clinical practice of treatment. However, a single-point approach may have the potential to treat the bleeding-induced flow more effectively than multiple-point approaches or to alleviate the complications involving the hemorrhagic process.\n\n(Dr. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 2016 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: This approach is still in the early stages, and a single-point approach may provide potential medical treatment to treat the bleeding-induced oedema more effectively than multiple-point approaches or to treat other complications involving the hemorrhagic process.\n\n(Dr. James Lee, PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: Surgical Enteroscopy", "Question: Does enteroscopy combined with real-time viewing data on endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: This approach is still in the works. However, a single-point approach may have the potential to treat the bleeding-induced oedema more effectively than multiple-point approaches or to treat other complications involving the hemorrhagic process.\n\n(Dr. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: American Enteroscopy", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal emergencies. This approach is still in the works. However, a single-point approach may have the potential to treat the bleeding-induced oedema more effectively in acute acute acute gastrointestinal illnesses using conventional approaches or to treat severe complications involving the hemorrhagic process.\n\n(Dr. Gaddi, M.D., PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy", "Emergency double-balloon enteroscopy combined with real-time viewing data in general. Then gastrointestinal endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: This approach is still in the early phase. However, a single-point approach may have the potential to treat the bleeding-induced oedema more effectively than the bleeding-induced oedema or several other complications involving the hemorrhagic process.\n\n(Dr. Peterson, PhD)\n\nJOURNAL \u25a0 April 20, 2013\n\nArticle Information Publication Name: Emergency Triple-Balloon Enteroscopy"], "perturbed_original": ["Question: Emergency DBE combined with real-time emergency capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Non-emergency DBE is feasible, safe and effective in acute OGIB and may avoid major complications in and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as DL that may have been misdiagnosed by non-emergency DBE.", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure patients. Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by ultrasound is especially useful for acute recurrent bleeding vascular lesions such as pulmonary cancer may be easily avoided with non-emergency DBE.", "Question: Emergency double-balloon enteroscopy combined with the examination of ACI is a feasible combined approach in acute OGIB because of hemodynamic bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach by CE based patient viewing by CE is especially useful to identify recurrent coronary lesions such as DL that may be easily misdiagnosed by non-emergency DBE.", "Question: Emergency double-balloon enteroscopy combined with real-time medical capsule s is feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: A combination approach is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT or CE is feasible to identify recurrent bleeding vascular lesions such as DL that may be easily misdiagnosed by non-emergency DBE.", "Question: Emergency double-balloon enteroscopy with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure . Answer: Emergency DBE is feasible, safe and effective in acute overt-obscure. It may avoid major surgery, diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially effective in acute undertobscure. This method can identify recurrent bleeding vascular lesions such as DL and LC and can be easily misdiagnosed by non-emergency DBE.", "Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible approach to diagnose and treat gastrointestinal bleeding in acute overt-obscure gastrointestinal bleeding? RT viewing by CE by DBE is feasible, safe and effective in acute OGIB and may avoid recurrent bleeding while diagnosing and successfully treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding . It is only randomized controlled trials such as DL that may have been misdiagnosed by non-emergency DBE.", "Question: Emergency double-balloon enteroscopy combined approach with viewing of capsule endoscopy: a feasible combined approach with to overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients. Combined approach to viewing by CE is especially useful to identify recurrent gastro intestinal lesions such as DL that may be easily misdiagnosed by non-emergency DBE.", "Question: Emergency double-balloon enteroscopy combined with RT viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and treating most patients. Combined approach with RT viewing by CE is required to identify additional vascular lesions such as DL that may be induced by non-emergency DBE.", "Question: Emergency double-balloon enteroscopy combined with real-time laser capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: If it is feasible, safe and effective in acute bleeding, the patient may avoid major surgery, diagnosing and treating most patients. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as chest-swollen clone that may be easily misdiagnosed by non-emergency DBE.", "ECG double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute IL-treated bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating DM. Combined approach with RT viewing by CE is especially useful to identify recurrent bleeding vascular lesions such as DL that may be easily misdiagnosed by modifying emergency DBE."], "original_ll": -4.674497127532959, "sampled_ll": -3.15360426902771, "all_perturbed_sampled_ll": [-3.5883822441101074, -3.4429500102996826, -3.4251437187194824, -3.521507740020752, -3.595241069793701, -3.4664742946624756, -3.543444871902466, -3.1817922592163086, -3.459540367126465, -3.419440507888794], "all_perturbed_original_ll": [-4.545504570007324, -4.778354167938232, -4.758814334869385, -4.873145580291748, -4.301019668579102, -4.5661444664001465, -4.892694473266602, -4.75191593170166, -4.637300491333008, -5.13530969619751], "perturbed_sampled_ll": -3.4643917083740234, "perturbed_original_ll": -4.724020338058471, "perturbed_sampled_ll_std": 0.1122131609687891, "perturbed_original_ll_std": 0.2163404164267053}, {"original": "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.", "sampled": "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: No. The vast majority of families have no choice but to work, to care for themselves, or to take care of a sick relative who needs help with a chronic illness, such as cancer or HIV.\n\n\nThe Centers for Medicare and Medicaid Services is working on a comprehensive health care", "perturbed_sampled": ["Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: No. The vast majority of families have no choice but to work, to care for themselves, or to take care of a loved one who needs help with a chronic illness, such as cancer or HIV.\n\n\nThe Centers for Medicare and Medicaid Services is working on a comprehensive health care", "Question: Are the caregivers of the frail elderly family caregivers of the frail elderly? Answer: No. The vast majority of families have no right to work, to work, for themselves, or to take care of a sick relative who needs help with a chronic illness, such as cancer or HIV.\n\n\nThe Centers for Medicare and Medicaid Services is working on a comprehensive health care", "Question: Are physicians meeting the needs of physicians or the needs of the frail ? No. The vast majority of families have no choice but to work, to care for themselves, or to take care of a sick relative who needs help with a chronic illness, such as prostate cancer or HIV.\n\n\nThe Centers for Medicare and Medicaid Services is working on a comprehensive health care", "Question: How is the hospital meeting the needs of family caregivers of the frail elderly? Answer: No. The vast majority of families have no choice but to work, to care , or to care for the needs of a sick relative who needs help with a chronic illness, such as cancer or HIV.\n\n\nThe Centers for Medicare and Medicaid are working on a comprehensive health care", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: No. The sick children of the elderly have no choice but to work, to care for themselves, or to take care of a sick relative who needs help with a chronic illness, such as cancer or HIV.\n\n\nThe Centers for Medicare and Medicaid Services is working on a comprehensive health care", "Question: Are physicians meeting the expectations of other family caregivers of the frail elderly? Answer: No. The vast majority of families have no choice but to work, to care for themselves, or to take care of a sick relative who needs help with a chronic condition such as HIV or HIV.\n\n\nThe Centers for Medicare and Medicaid Services is working on a comprehensive health care", "Question: Are there any concerns about the needs of family caregivers of the frail elderly? Answer: No. The vast majority of families have no choice but to work, to care , or to take care of a sick relative who needs help with a serious illness, such as cancer or HIV.\n\n\nThe Centers for Medicare and Medicaid Services is working with families to provide comprehensive health care", "Question: Are physicians meeting the needs of a large number of the frail elderly? Answer: No. The vast majority of physicians have no choice but to work, to care for themselves, or to take care of a sick relative who needs help with a chronic illness, such as HIV or HIV.\n\n\nThe Centers for Medicare and Medicaid Services is working on a comprehensive health care", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: No. The majority of families have no choice but to work, to care for families, or to take care of a family caregiver who needs help with a chronic illness, such as cancer or HIV.\n\n\nThe Ministry of Medicare and Medicaid Services is working on a comprehensive health care", "Question: Are physicians meeting the needs of the family caregivers of the frail elderly? Answer: No. The vast majority of families have no choice but to leave to care for themselves, or to take care of a sick relative who needs help with a chronic illness, such as cancer or HIV.\n\n\nThe Centers for Medicare and Medicaid Services are working on a standard of health care"], "perturbed_original": ["Question: Are physicians meeting the expectations of family caregivers of the frail elderly? Answer: Hypotheses for this issue have been presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions they supervised as usual for caregivers; and being a professional caregiver for family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in counseling, even if they were receptive to counseling sessions; they could be poorly remunerated for the usual counseling sessions that are usual for caregivers; and being a professional caregiver to others is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even though they were receptive to counseling caregivers, they may be poorly remunerated for the types of counseling sessions that were appropriate for caregivers; and being a professional caregiver to family caregivers may have a problem in itself.", "Are physicians meeting the needs of the caregivers and of the frail elderly? Answer: Hypotheses for this question may not be presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling services are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.", "Question: Does it help with meeting the needs of family caregivers or the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians were typically uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual ; and being a professional caregiver to family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses of discontent are presented. Physicians may be uninterested in helping caregivers; if they were receptive to counseling caregivers, they could be remunerated for the types of counseling they are usual for caregivers; and being a professional caregiver to family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in counseling caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions as usual for caregivers; and the relationship from professional caregiver to family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in counseling caregivers; even if they were receptive to counseling caregivers, they may be poorly remunerated for the types of counseling sessions that are facilitating their need for family caregivers; counseling a professional caregiver to family caregivers is demanding in itself.", "Question: How does this discontent occur in meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; if they were receptive to counseling caregivers, then merely wouldn\u2019t be poorly remunerated for the types of counseling sessions that were needed for caregivers; and being a professional caregiver to family caregivers is demanding in itself.", "Question: Are physicians meeting the needs of family caregivers and raising the frail elderly? Answer: Hypotheses for caring caregivers are presented. Physicians may be uninterested in helping their caregivers; if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a listener to family caregivers is demanding in itself."], "original_ll": -3.9701955318450928, "sampled_ll": -2.3526010513305664, "all_perturbed_sampled_ll": [-2.337066888809204, -2.6850807666778564, -2.6126322746276855, -2.893465042114258, -2.497169256210327, -2.6975250244140625, -2.469860553741455, -2.5487265586853027, -2.6657795906066895, -2.592305898666382], "all_perturbed_original_ll": [-3.992130756378174, -4.038270950317383, -3.9926514625549316, -3.990093946456909, -4.183345794677734, -4.076053142547607, -4.143933296203613, -3.9430463314056396, -4.380934238433838, -4.1381120681762695], "perturbed_sampled_ll": -2.599961185455322, "perturbed_original_ll": -4.08785719871521, "perturbed_sampled_ll_std": 0.143767359058451, "perturbed_original_ll_std": 0.12330286302384913}, {"original": "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS only, and this demonstrates that RPS is a valuable QA method.", "sampled": "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities (PD) are detected by sequential prescreening to prevent the development of non-pharmacological (neuropathic) reactions associated with a PDS.\n\nA PDS is a medical condition (including many of the above) in which the patient has had the medication administered. It is caused by an allergic", "perturbed_sampled": ["Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are detected by sequential prescreening to prevent the development of non-pharmacological (neuropathic) reactions associated with a PDS.\n\nA PDS is a medical system (like many of the above) in which the patient had had the medication administered. It is usually an allergic", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities (PD) are detected by rapid prescreening to prevent the development of non-pharmacological (neuropathic) disorder, especially those with a PDS.\n\nA PDS is a medical condition (including many of the reasons) in which the patient has had the medication administered. It is caused by an allergic", "Question: Pap smears with glandular cell abnormalities (PD) Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities (PD) are detected by sequential prescreening to prevent the development of non-pharmacological (neuropathic) symptoms. Do they require an initial dose with a PDS.\n\nA PDS is an active medical condition (including many of the above) in which the patient has had the medication administered. It is caused by an allergic", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid screening? Pap smears with glandular cell abnormalities (PD) are detected by sequential prescreening to prevent the development of non-pharmacological (neuropathic) reactions associated with a PDS.\n\nA PDS is a medical condition (like any of the above) in which the patient has had the medication administered. PDS is caused by an allergic", "Question: Pap smears with PD abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with PD abnormalities (PD) are detected by sequential prescreening to confirm the development of non-pharmacological (neuropathic) reactions associated with a PDS.\n\nA PDS is a medical condition (including many of the above) in which the patient has had the medication administered. It is a medical condition in which the patient has an allergic", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities (PD) are detected by sequential prescreening to prevent the development of non-pharmacological (neuropathic) reactions associated with a PDS.\n\nA PDS is a medical condition (including many of the conditions) in which the patient has had the ability to have a PD. It is caused by an allergic", "Question: Pap smears with glandular cell abnormalities (PD) are what they detected by sequential prescreening. Answer: Pap smears with glandular cell abnormalities (PD) are detected by sequential prescreening to prevent the following non-pharmacological (neuropathic) reactions associated with a PDS.\n\nA PDS is one medical condition (including many of the above) in which the patient has had the medication administered. It is caused by an allergic", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities : Are they detected by sequential prescreening to prevent the development of non-pharmacological (neuropathic) reactions associated with PDS. PDS is a medical condition (including many of the above) in which the patient is given the medication administered. PDS is caused by an allergic", "Question: Pap smears with glandular cell abnormalities: Are they detected after sequential prescreening? Answer: Pap smears with glandular cell abnormalities (PD) are detected after sequential prescreening to prevent the development of non-pharmacological (neuropathic) reactions associated with a PDS.\n\nA PDS is a medical condition (including many of the above) in which a patient has had the ability to develop PDS. It is caused by an allergic", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities (PD) are detected by sequential prescreening to prevent the development of allergic (neuropathic) reactions associated with a PDS.\n\nA PDS is a medical condition (and one of the above) in which the patient has had the medication administered. It is caused by the allergic"], "perturbed_original": ["Question: Pap smears with glandular cell abnormalities: Are you surprised by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS only, but this demonstrates that RPS is a highly effective method.", "Question: Pap smears with glandular cell abnormalities are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). This indicates that some cases of AGC are detected on Pap smears with glandular cell abnormalities only through RPS only, and this demonstrates that RPS is a valuable QA method.", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, which results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears as abnormal only, and this demonstrates that RPS is a valuable QA method.", "Question: Pap smears with glandular cell abnormalities: should they be detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS only, and this demonstrates that RPS is a valuable QA method.", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid detection? Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this indicates a sensitivity of 36.4% (so it is below the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS only, and this demonstrates that RPS is a valuable QA method.", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this typically results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected , but Pap smears with glandular cell abnormalities are detected with RPS only, and this demonstrates that RPS is a valuable QA method.", "Question: Pap smears with glandular cell abnormalities typically are abnormal by RPS. Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often abnormal or abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap on RPS only, and this demonstrates that RPS is a valuable QA method.", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormalities by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some glandular cell abnormalities in AGC are detected on Pap smears by RPS only, and this demonstrates that RPS has a valuable QA method.", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as Pap smears by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). In some cases of this, I suspect that Pap detected Pap smears by RPS only, and this demonstrates that RPS is a valuable QA method.", "Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are identified as abnormal by RPS, and this results in a sensitivity of AGC (at the AGC threshold). Most importantly, some cases with glandular cell abnormalities are detected as Pap smears by RPS only, and this demonstrates that RPS is a valuable QA method."], "original_ll": -3.6503050327301025, "sampled_ll": -2.938793182373047, "all_perturbed_sampled_ll": [-3.2579660415649414, -2.966470718383789, -2.997316837310791, -3.1053619384765625, -2.9869744777679443, -2.9728803634643555, -3.09151554107666, -3.047621726989746, -2.809781312942505, -3.0997817516326904], "all_perturbed_original_ll": [-3.667684316635132, -3.6589243412017822, -3.8168692588806152, -3.645430564880371, -3.731945753097534, -3.574291467666626, -3.8254013061523438, -3.665311336517334, -3.6641812324523926, -3.5319480895996094], "perturbed_sampled_ll": -3.0335670709609985, "perturbed_original_ll": -3.678198766708374, "perturbed_sampled_ll_std": 0.11189242832246561, "perturbed_original_ll_std": 0.08825599595858864}, {"original": "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a", "sampled": "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with greater increases in LDL cholesterol and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "perturbed_sampled": ["Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat lipoprotein groups are associated with increases in LDL cholesterol and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with greater increases in LDL cholesterol and triglycerides relative to non-fat diet. [pdf file]", "Question: Does having a low-fat diet at surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with greater increases in LDL cholesterol than triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "Question: Does airway surgery lower blood pressure levels in sleep apnea patients? Answer: A low-fat diet is associated with greater increases in LDL cholesterol and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A similar effect is associated with greater increases in LDL and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "Question: Does airway surgery lower serum lipid levels in the respiratory and apnea patients? Answer: A low-fat diet is associated with greater protein levels in LDL cholesterol and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "How can airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with greater increases in LDL and LDL triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "Question: Does the diet have lower serum lipid levels in obstructive sleep apnea patients? Answer: A lower serum lipid levels in this diet is associated with greater increases in LDL cholesterol and triglycerides relative to non-fat lipoprotein groups.\n\n[PDF file]", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with increases in LDL cholesterol and triglycerides relative to other groups.\n\n[PDF file]", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: A low-fat diet is associated with greater than 50 percent of LDL cholesterol levels relative to non-fat lipoprotein groups.\n\n[PDF file]"], "perturbed_original": ["Question: Does airway surgery lower serum lipid levels in acute apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative OSA, yielding a", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery can lower serum and blood lipid levels in patients with OSA, especially in patients with dyslipidemia, potentially yielding a", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Airway surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative vision, yielding a", "Question: Does airway surgery lower serum lipid levels in obstructive airway patients? Answer: Surgery may improve blood lipid levels in patients with hyperlipidemia, especially in patients with preoperative dyslipidemia, potentially yielding a", "Question: Does airway surgery lower serum lipid levels in obstructive sleep ? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery lowers blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a", "Question: Does airway surgery lower serum lipid levels in the apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially those with preoperative dyslipidemia, potentially yielding a", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve serum lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a", "Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Does airway surgery improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a", "Question: Does airway surgery improve blood lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a"], "original_ll": -3.3090710639953613, "sampled_ll": -2.7743232250213623, "all_perturbed_sampled_ll": [-2.7893941402435303, -3.028411865234375, -2.8666460514068604, -2.871389865875244, -3.1566803455352783, -3.3377139568328857, -3.155550479888916, -2.87760591506958, -3.0044264793395996, -3.00077223777771], "all_perturbed_original_ll": [-3.7223992347717285, -3.3164191246032715, -3.533762216567993, -3.2032055854797363, -3.684847593307495, -3.4215898513793945, -3.6610517501831055, -3.2334160804748535, -3.232898712158203, -3.100569248199463], "perturbed_sampled_ll": -3.008859133720398, "perturbed_original_ll": -3.4110159397125246, "perturbed_sampled_ll_std": 0.16015522569026686, "perturbed_original_ll_std": 0.21480642433117247}, {"original": "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.", "sampled": "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: No. It seems as if a significant dose of a medication has a significant effect on the effects of withdrawal. So, if you", "perturbed_sampled": ["? In question: Is withdrawal withdrawal-induced anxiety a problem based on beta-endorphin deficiency? Answer: No. It seems as if a significant dose of a medication has a significant effect on the effects of withdrawal. So, if you", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: No. It seems as if a significant dose of anxiety has a significant effect on the form of withdrawal. So, if you", "Question: Is withdrawal-induced anxiety in some cases dependent on beta-endorphin deficiency? Answer: No. It seems as if a significant dose of a medication has a significant effect on the overall outcome of withdrawal. So, if you", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: No. It seems as if a dose of a medication has a little influence on the effects of withdrawal. So, if you", "Question: Is withdrawal-induced anxiety and mood based on beta-endorphin deficiency? Answer: No. It seems as if a significant dose of a medication has a significant effect on the effects of withdrawal. So, if you", "and withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: No. It seems as if a significant effect on a medication has a significant effect on the effects of withdrawal. So, if you", "Question: Is withdrawal-induced anxiety in alcoholism based on anxiety? Answer: No. It seems as if a combination of a medication has a significant effect on the effects of withdrawal. So, if you", "Question: Is withdrawal-induced anxiety control based on beta-endorphin e? No. It seems as if a significant dose of a medication has a significant effect on the effects of withdrawal. So, if you", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin ? No. It seems as if a significant dose of a medication has a significant effect on the effects of withdrawal. What\u2019s you", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: No. We feel as if a prescription of a medication has a significant effect on the effects of withdrawal. So, if you"], "perturbed_original": ["Question: Is withdrawal-induced anxiety in tolerant on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common sign that the withdrawal can negatively impact this state.", "Question: Is withdrawal-induced anxiety as a signification for alcohol withdrawal based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a signification for depression during this state.", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results provide evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a result of the lowered beta E during this state.", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that beta E during alcohol withdrawal may contribute to anxiety -induced anxiety, a common disturbance during this state.", "Question: Is withdrawal-induced anxiety in humans based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta -endorphin deficiency or a higher level of alcohol withdrawal may contribute to anxiety as a common disturbance during this state.", "Question: Is alcoholism based on beta-endorphin deficiency a factor of anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal causes anxiety to be a common disturbance during this state.", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? The results give first evidence that lowered beta -endorphin deficiency in alcohol withdrawal may contribute to anxiety as a common disturbance during this state.", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence whether beta E during alcohol withdrawal may contribute to anxiety as well as a common disturbance during this state.", "Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results provide evidence that lowered beta E during withdrawal may contribute to anxiety as a common disturbance during this state."], "original_ll": -4.212550163269043, "sampled_ll": -3.0407514572143555, "all_perturbed_sampled_ll": [-3.1482982635498047, -3.2756638526916504, -3.015054225921631, -3.15714955329895, -3.001983642578125, -3.5941882133483887, -3.3686132431030273, -3.4782416820526123, -3.903808355331421, -3.2910499572753906], "all_perturbed_original_ll": [-4.520442008972168, -4.039163589477539, -3.51220440864563, -4.192722797393799, -3.8016936779022217, -3.5975990295410156, -4.3287177085876465, -3.9783549308776855, -4.194741249084473, -4.028927326202393], "perturbed_sampled_ll": -3.3234050989151003, "perturbed_original_ll": -4.019456672668457, "perturbed_sampled_ll_std": 0.2638618927375379, "perturbed_original_ll_std": 0.29870242542929415}, {"original": "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "sampled": "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a difference. This is true for the incidence of discoloration and", "perturbed_sampled": ["So, can there be differences between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a difference. This is true for the incidence of discoloration and", "Question: Is there any relation between cervical cord plaques and discopathy in patients with cervical cord plaques? Answer: Yes, there is a difference. This is also true for the incidence of discoloration and", "Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a difference. This is true due to a higher incidence of discoloration and", "Question: Is there any relation between cervical cord plaques and discopathy that result from complications with multiple sclerosis? Answer: Yes, there is a difference. This is true for the incidence of discopathy and", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is no difference. This is true for the incidence of discoloration and", "Question: Is there any relation between cervical cord injury and discopathy in patients with cervical cords? Answer: Yes, there is a difference. This is true for the incidence of discoloration and", "Question: Is there any relation between cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a difference. This is true for patients with both the incidence of discoloration and", "Question: Is the relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: Yes, there is a difference. This is true for the incidence of discoloration and", "Question: Is there any difference between cervical cord plaques and discopathy in patients with multiple plaques? Yes, there is a difference. This is true for the incidence of discoloration and", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? If there is a relationship between aging, discopathy and discopathy, it is true for the incidence of discoloration and"], "perturbed_original": ["Question: Is there any relation between cervical cord plaques and discopathy in a person with multiple sclerosis? Answer: The study data suggests a relationship between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple MS plaques? The study data suggests a possible correlation between cervical discopathy and a double-sided MS plaque.", "Question: Is there any relation between cervical cord plaques and discopathy in patients with cervical MS plaques? Answer: The study provides a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord plaques and discopathy associated with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical cord plaques in patients with multiple MS plaque.", "Question: Is there any correlation between cervical discopathy and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord plaques and cervical MS plaque in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there a possible correlation between cervical MS plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical spinal cord plaques and discopathy in the case of multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.", "Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The question suggests a possible correlation between cervical cord plaques and discopathy and cervical MS plaque.", "Question: Is there a correlation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical cord plaques and cervical MS plaque."], "original_ll": -3.731715440750122, "sampled_ll": -2.950165271759033, "all_perturbed_sampled_ll": [-3.090959072113037, -2.723931312561035, -3.181614398956299, -3.413870334625244, -3.0402629375457764, -2.8789968490600586, -3.0085957050323486, -3.1393167972564697, -3.066338300704956, -3.213698625564575], "all_perturbed_original_ll": [-3.76418399810791, -4.040760517120361, -3.686960220336914, -3.5523571968078613, -3.364318370819092, -3.5523102283477783, -3.447852611541748, -3.5863823890686035, -3.4567418098449707, -3.398582935333252], "perturbed_sampled_ll": -3.07575843334198, "perturbed_original_ll": -3.585045027732849, "perturbed_sampled_ll_std": 0.17809556706423577, "perturbed_original_ll_std": 0.1926311963649866}, {"original": "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "sampled": "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:\n\nNo. Although many people believe musculoskeletal problems exist, there are still few effective treatments. To find out if you can eliminate musculoskeletal symptoms in your life, take a physical exam or take a prescription for musculoskeletal medicines. There are some physical symptoms that may be associated with the prescription, like headaches, nausea and vomiting, weakness and dizziness. Also, if you feel any problems, it's important to take a physical exam with your doctor before you", "perturbed_sampled": ["Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing pain key to eliminating these symptoms? Answer:\n\nNo. Although many people believe musculoskeletal problems exist, there are still few effective treatments. Find out if you can eliminate musculoskeletal symptoms in your life, take a physical exam or take a prescription for musculoskeletal medicines. There are some physical symptoms that are associated with the prescription, like headaches, nausea and vomiting, weakness and dizziness. Also, if you feel any problems, it's important to take a physical exam with your doctor before you", "Question: Aromatase inhibitor-related musculoskeletal conditions are key to eliminating their symptoms. Is preventing osteoporosis the key to eliminating these symptoms? Answer:\n\nNo. Although many people believe this is just about all symptoms exist, there are still few effective ways to find out if you can eliminate musculoskeletal symptoms in your life, take a physical exam or take a prescription for musculoskeletal medicines. There are some physical symptoms that may be associated with the symptoms of headaches, nausea and vomiting, weakness and dizziness. Also, if you feel any problems, it's important to take an exam with your doctor before taking one. with you", "Question: Aromatase inhibitor-related arthritis is preventing osteoporosis the key to eliminating these symptoms? Answer:\n\nNo. Although many people believe musculoskeletal arthritis is the best cure, there are still few effective treatments. To find out if you are experiencing musculoskeletal arthritis in your life, take a physical exam or take a prescription for musculoskeletal medicines. There are some problems that may be associated with the prescription, like headaches, nausea and vomiting, weakness and dizziness. Also, if you feel any problems, it's important to take a physical exam with your doctor before you", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating osteoporosis? Answer:\n\nNo. Although many people find physical problems exist, there are still few effective treatments. To find out if you can eliminate musculoskeletal symptoms in your life, take a physical exam or take a prescription of musculoskeletal medicines. There are some physical symptoms that may be associated with the prescription, like headaches, nausea and vomiting, and dizziness. Also, if you may have any problems, it's important to take a physical exam with your doctor before you", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:\n\nNo. Although many people believe musculoskeletal problems exist, there are still limitations to prescription medication and treatments. To find out if you can eliminate musculoskeletal symptoms in your state, please take a physical exam or take prescription for musculoskeletal medicines. There are other symptoms that may be associated with the prescription, like headaches, nausea and vomiting, weakness and dizziness. Also, if you feel any problems, it's important to take an exam with your doctor before you", "Question: Aromatase inhibitor-related musculoskeletal problems preventing osteoporosis the key to eliminating these symptoms? Answer:\n\nNo. While most people believe musculoskeletal problems exist, there are still few effective treatments. To find out if you can eliminate musculoskeletal symptoms in your life, take an online exam or take a prescription to prescribe musculoskeletal medicines. There are a number of physical symptoms that may be associated with the prescription, like headaches, nausea and vomiting, weakness and dizziness. Also, if you feel any problems, it's important to take a physical exam with your doctor before you", "Question: Aromatase inhibitor-related musculoskeletal problems are preventing osteoporosis the key to eliminating these symptoms. Although many known musculoskeletal problems exist, there are still few effective ways to find out if you have any known musculoskeletal symptoms in your life, take a physical exam or take a prescription for musculoskeletal medicines. There are some physical symptoms that may be associated with the prescription, like headaches, nausea and vomiting, weakness and dizziness. Also, if you feel any problems, it's important to take a physical exam with your doctor before you", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:\n\nNo. Although many people believe musculoskeletal problems exist, many still have treatments. To find out if you can eliminate musculoskeletal symptoms in your life, take a physical exam or take a medical trip for musculoskeletal medicines. There are some physical symptoms that may be more common on the prescription, like headaches, nausea and vomiting, weakness and dizziness. Also, if you feel any problems, it's important to take a physical exam with your doctor before you", "Question: Aromatase and anti-musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer:\n\nNo. Although many people believe musculoskeletal problems exist, there are still few . To find out if you can eliminate musculoskeletal symptoms in your life, take a physical exam or take a prescription for musculoskeletal medicines. There are some physical symptoms that may arise with the prescription, like headaches, nausea, vomiting, weakness and dizziness. Also, if you have any problems, it's important to take a physical exam with your physician.. If you", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating osteoporosis? Answer:\n\nNo. Although many people believe musculoskeletal problems exist, there are still few effective treatments. To find out if this treatment is effective to eliminate musculoskeletal symptoms in patients, take a physical exam or take prescription medications for musculoskeletal medicines. There are some physical symptoms that may be associated with the prescription, like nausea and vomiting, weakness and dizziness. Also, if you feel any problems, it's recommended to take a physical exam with your doctor before you"], "perturbed_original": ["Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to lower AI symptoms? Answer: Many patients on AIs who develop neuromusculoskeletal symptoms are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the incidence of osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs are more likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: Is osteoporosis the key to eliminating these symptoms? Studying on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients receiving tamoxifen before AIs were less likely to suffer AI-related musculoskeletal symptoms. We recommend that patients with AIs should be offered Ca/Bis to reduce the incidence of AI-related symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "AI inhibitor-related musculoskeletal symptoms: Is osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at higher risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs are less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs should be diagnosed to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms? Question: Why is preventing osteoporosis the key to eliminating these symptoms? Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Providing Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. It is best to assume that patients receiving steroidal AIs should be offered Ca/Bis to reduce the incidence of disease and fracture, especially if patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who have osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with tamoxifen increases the likelihood for disease-related musculoskeletal symptoms. Patients who received tamoxifen before AIs were more likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs should be offered Ca/Bis to reduce the incidence of disease and fracture, especially if they were receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: Is osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who have experienced osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs be offered medication to reduce the incidence of osteoporosis and fracture, but we cannot recommend patients are receiving steroidal AI and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. In fact, patients with AIs who received AIs on AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs should be offered the option to reduce the incidence of these symptoms and fracture, especially if patients on AIs have a steroidal AI and/or did not receive tamoxifen before AIs.", "/ inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the incidence of AI-related brain activity for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were allowed to develop AI-related musculoskeletal symptoms. We recommend that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, especially if patients are receiving CBT and/or did not receive tamoxifen before AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood of musculoskeletal symptoms and musculoskeletal symptoms. Patients taking tamoxifen before AIs were less likely to report inflammatory and AI-related musculoskeletal symptoms. We recommend that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and bone fracture, especially if patients are receiving steroidal AI and/or patients who receive steroidal AIs.", "Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Most AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients have received tamoxifen before AIs and are less likely to develop AI-related musculoskeletal symptoms. The American Society of Medicine and Research recommend that patients on AIs should be offered Ca/Bis to reduce the incidence of musculoskeletal symptoms and fracture, indicating patients are receiving steroidal AI and/or did not receive tamoxifen before AIs."], "original_ll": -2.5729708671569824, "sampled_ll": -2.267977237701416, "all_perturbed_sampled_ll": [-2.473813056945801, -2.7900023460388184, -2.4793789386749268, -2.4172654151916504, -2.5569818019866943, -2.473733425140381, -2.492964744567871, -2.5211575031280518, -2.4510743618011475, -2.440267324447632], "all_perturbed_original_ll": [-2.5652694702148438, -2.81777286529541, -2.646596908569336, -2.610772132873535, -2.6932857036590576, -2.7017428874969482, -2.748762607574463, -2.637442111968994, -2.6959140300750732, -2.8507142066955566], "perturbed_sampled_ll": -2.5096638917922975, "perturbed_original_ll": -2.6968272924423218, "perturbed_sampled_ll_std": 0.10075671313332807, "perturbed_original_ll_std": 0.08473870019332636}, {"original": "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.", "sampled": "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of data that shows that D-dimer can be associated with increased", "perturbed_sampled": ["Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of data and data that D-dimer is associated with increased", "Question: Can D-dimer become a new diagnostic parameter for appendicitis? Answer: There is a growing population of data that shows that D-dimer can be associated with increased", "Question: Can one establish a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of data that shows that the effects of an acute appendicitis can be associated with increased", "Question: Can D-dimer become a new diagnostic parameter for acute acute disease? There is a growing body of data that shows that the problem can be associated with increased", "Does D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of research in the clinical field that shows that D-dimer can be associated with increased", "Question: Can we see a new diagnostic treatment solution for acute appendicitis? Answer: There is a growing body of data that shows that D-dimer can be associated with increased", "Question: Has D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of data that shows that D-dimer can be associated with increased", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of data that shows that D-dimer could be associated with increased", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: There is a growing body of evidence that shows that D-dimer is associated with increased", "Question: Can D-dimer become a new diagnostic tool for acute appendicitis? Answer: There is a growing body of data that shows that D-dimer can be associated with increased"], "perturbed_original": ["Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels can be considered as a tool in diagnosis of acute appendicitis.", "Question: Can D-dimer become a diagnostic parameter for acute appendicitis? Question: Do these levels decrease? D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.", "Question: Can D-dimer establish a new diagnostic parameter for acute appendicitis? Answer: Increased number of D-dimeres should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.", "Question: Can D-dimer levels become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in acute acute appendicitis.", "Question: Can D-dimer levels be considered a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter for acute appendicitis. Answer: Increased D-dimer levels should not be considered as a diagnosis of acute appendicitis.", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter for acute appendicitis. Question: Can D-dimer become the new diagnostic parameter for acute appendicitis? Question: Can D-dimer become a diagnostic parameter for acute appendicitis?? : Questions? of acute appendicitis.", "Question: Can we apply a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.", "Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Increased D-dimer levels should not be considered as a diagnostic parameter in acute appendicitis. Answer: Can D-dimer become a diagnostic parameter for acute acute appendicitis.", "Question: Can D-dimer become a diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis."], "original_ll": -3.1155216693878174, "sampled_ll": -3.0485403537750244, "all_perturbed_sampled_ll": [-3.4833109378814697, -3.379601240158081, -2.937310218811035, -3.993279218673706, -2.7893824577331543, -3.361959218978882, -2.93540620803833, -3.1451823711395264, -3.0471785068511963, -2.913658380508423], "all_perturbed_original_ll": [-3.4127533435821533, -3.2119524478912354, -3.5285279750823975, -3.070798873901367, -2.2110891342163086, -2.421588659286499, -3.2194554805755615, -3.0393025875091553, -2.755619764328003, -2.985811471939087], "perturbed_sampled_ll": -3.1986268758773804, "perturbed_original_ll": -2.985689973831177, "perturbed_sampled_ll_std": 0.34409286709274467, "perturbed_original_ll_std": 0.3954951508904978}, {"original": "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.", "sampled": "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "perturbed_sampled": ["Question: Does automatic transmission improve driving speed for older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 413, 998-93. You can answer this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, J. Automatic transmission speeds improve driving behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, B. and Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic Transmission and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission improve driving behavior in older drivers? J. Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Brac, A. & Kranjic, M. and Kranjic, J. & Kranjic, J. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "speeds and driver behavior in older drivers? Does an automatic transmission speed and driver behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission improve speed and driver behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Speed and driver behavior in older drivers. How to improve driver speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission and driving speeds and driver behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. & Pomerantz, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle", "Question: Does automatic transmission improve s automatic transmission speeds and driver behavior in older drivers? Answer: Yes.\n\nCitation: Kranjic and Kranjic, J. , and Kranjic, E. (2010). Automatic transmission speeds and driver behavior in older drivers. Traffic Sci. 13(2), 508\u2013515. doi:10.1016/j.trailsc.2010.08.007\n\nhttp://www.infodetics.com/article/article/3049\n\nAdvertisements\n\nShare this: Print\n\nEmail\n\nTwitter\n\nFacebook\n\nPinterest\n\nLinkedIn\n\nReddit\n\nGoogle"], "perturbed_original": ["Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain autonomous driving behaviors, and thereby the quality of vehicle mobility.", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to transmission may be recommended for older drivers as a means to maintain safe , accurate and easy driving, and thereby the quality of their transport mobility.", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission is highly recommended for older drivers as it encourages older drivers to maintain safe driving and thereby the quality of their transport mobility.", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a way to maintain safe driving and ensure the best quality of their transport mobility.", "Question: Does automatic transmission affect normal driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain the safety of their vehicles, and thereby the quality of their transport mobility.", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission is recommended for older drivers as a means to maintain their safety and safety in cars and thereby the quality of their transport mobility.", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers , but this is a means to maintain safe driving and thereby the quality of their transport mobility.", "Question: Does automatic transmission improve the correct driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a way to maintain safe driving and thereby the quality of their transport mobility.", "Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a way to maintain safe driving and thereby the quality of their transport mobility.", "Question: Does automatic transmission improve driving behavior in older drivers? Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the improving their transport mobility."], "original_ll": -3.491124391555786, "sampled_ll": -1.7649333477020264, "all_perturbed_sampled_ll": [-2.595360040664673, -1.8458566665649414, -1.794271469116211, -1.7974711656570435, -1.8704594373703003, -1.8686610460281372, -1.9770427942276, -1.9033057689666748, -1.9467101097106934, -1.8955978155136108], "all_perturbed_original_ll": [-3.4208080768585205, -3.9081296920776367, -3.4090723991394043, -3.394042491912842, -3.2211880683898926, -3.5390143394470215, -3.6969239711761475, -3.6027112007141113, -3.4828197956085205, -3.929344415664673], "perturbed_sampled_ll": -1.9494736313819885, "perturbed_original_ll": -3.560405445098877, "perturbed_sampled_ll_std": 0.2221877308734262, "perturbed_original_ll_std": 0.2165794288801547}, {"original": "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "sampled": "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: A study has examined the efficacy of fluoxetine on patients with silent myocardial ischaemia using SPECT and found that it eliminated all non-specific ischaemic (positive) and localized (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of non-infected patients. In a parallel study, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients", "perturbed_sampled": ["Question: Should HIV-infected patients be screened for silent myocardial ischaemia with an gated myocardial perfusion SPECT? Answer: A study has examined the efficacy of screening on patients with silent myocardial ischaemia using the system. We found that it eliminated all non-specific ischaemic (positive) and localized (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of non-infected patients. In a parallel study, we used an ELISA-based quantitative myocardial perfusion method for patients", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using fluoxetine perfusion SPECT? Answer: A study has examined the efficacy of fluoxetine on patients with silent arechaemia using SPECT and found that fluoxetine showed up on all non-specific ischaemic (positive) ischaemic (P<unk>0.01) and the peripheral myocardial (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of rats. In a parallel study, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients", "Question: Should HIV-infected patients be receiving silent myocardial ischaemia using myocardial perfusion SPECT? Answer: A study has examined the efficacy of fluoxetine on patients with nonspecific myocardial ischaemia using SPECT and found that it eliminated all non-specific , isolated and localized (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of non-infected patients. In a parallel study, we examined an ELISA-based quantitative myocardial perfusion (QFIM) for patients", "Question: Should HIV-infected patients be treated for silent myocardial ischaemia using gated fluoxetine using SPECT? Answer: We have found that our NIH-based clinical study has examined the efficacy of fluoxetine on patients with silent myocardial ischaemia using SPECT and found that it eliminated all non-specific ischaemic (positive) and localized (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of non-infected patients. In a parallel study, we investigated the use of ELISA-based quantitative myocardial perfusion (QFIM) for patients", "Question: Should HIV-infected patients be exposed to silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: We has examined the efficacy of fluoxetine on patients with silent myocardial ischaemia using SPECT and found that it eliminated all non-specific ischaemic fluoxetine localized (negative) plaques and the presence of amyloid plaques in the peripheral blood stream patients. In a parallel study, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia gated myocardial perfusion SPECT? Answer: A study has shown the efficacy of the antiinvasive perfusion strategy on patients with silent myocardial ischaemia using the ELISA. Our results found that it eliminated all non-specific ischaemic (positive) and localized (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of non-infected patients. In a parallel study, we used an ELISA-based quantitative FIM (QFIM) for patients", "Question: Can patients be screened for silent myocardial ischaemia using myocardial perfusion SPECT? Answer: A study has examined the efficacy of fluoxetine on patients with silent myocardial ischaemia using SPECT and found that it eliminated all localized (positive) and localized (negative) ischaemic (P<0.01) amyloid plaques in the peripheral blood of non-infected patients. In a parallel study, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia with silent myocardial perfusion SPECT? Answer: A study has examined the efficacy of fluoxetine on detecting silent myocardial ischaemia using SPECT and found it eliminated all non-specific ischaemic (positive) and localized (negative) ischaemic (P<0.01) found in the peripheral blood of non-infected patients. In this study, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients", "Question: Should HIV-infected patients be treated for silent myocardial ischaemia using gated myocardial perfusion? Answer: A study has examined the efficacy of fluoxetine on patients who live with silent myocardial ischaemia using SPECT and found that it eliminated all non-specific ischaemic (positive) and localized (negative) (P<0.01) amyloid plaques in the peripheral blood of non-infected patients. In a large range of samples, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: A recent study examined the efficacy of fluoxetine in patients with silent myocardial ischaemia using SPECT and found that it eliminated all non-specific ischaemic (positive) and other ischaemic (P<0.01) amyloid plaques in the cells of non-infected patients. In a parallel study, we used an ELISA-based quantitative myocardial perfusion (QFIM) for patients"], "perturbed_original": ["How can male HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? For male HIV-infected patients older than 52 years and with at least 2 CRFs, screening for SMI using myocardial SPECT was about four times lower in HIV patients, but it was more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "Question: Should SMI be screened for silent myocardial ischaemia , MPH or myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial perfusion technique is about four times more likely to be positive than the general population. This may motivate physicians to advise these patients to undergo more tests for SMI using this technique.", "Question: Should HIV-infected patients be screened for silent screening using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 13 years and with at least two months of screening , using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo silent screening for SMI using this technique.", "Can HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least four CRFs, screening for SMI using myocardial perfusion techniques is about four times more likely to be positive than in the male. This may motivate physicians to advise women to undergo more systematic screening for SMI using this technique.", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial SPECT? Answer: In male HIV-infected patients older than 52 years and with less than two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using your SPECT technique.", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 7 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in a female HIV-infected population. This would motivate physicians to advise the patient to undergo screening using myocardial perfusion SPECT. We recommend that physicians conduct screening for SMI using this technique.", "Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two weeks of screening time, screening for SMI using myocardial SPECT is four times more likely to be positive than the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using this technique.", "Question: Could HIV-infected patients be screened for silent myocardial SPECT using the gated myocardial perfusion SPECT? Answer: In male HIV-infected patients aged between 50 and 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more screening for SMI using this technique.", "Question: Should HIV-infected patients be screening for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least 5 CRFs, screening for SMI using myocardial SPECT was about one-third more likely to be detected in the general population. This may motivate physicians to encourage these patients to undergo more systematic screening for SMI using this technique.", "Question: Should HIV-infected patients be screened for severe ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the rest of the population. This may motivate physicians to advise these patients to conduct a systematic screening for SMI using this technique."], "original_ll": -3.2096824645996094, "sampled_ll": -2.2999463081359863, "all_perturbed_sampled_ll": [-2.557309150695801, -2.6762595176696777, -2.602299451828003, -2.489473342895508, -2.729336977005005, -2.7858335971832275, -2.324038028717041, -2.460918664932251, -2.579890489578247, -2.4271390438079834], "all_perturbed_original_ll": [-3.2772293090820312, -3.4854652881622314, -3.4733853340148926, -3.379460334777832, -3.225803852081299, -3.034409999847412, -3.205188274383545, -3.244462728500366, -3.264183521270752, -3.3627521991729736], "perturbed_sampled_ll": -2.5632498264312744, "perturbed_original_ll": -3.2952340841293335, "perturbed_sampled_ll_std": 0.13542518557937838, "perturbed_original_ll_std": 0.12821957098204867}, {"original": "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.", "sampled": "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes.\n\nWhat is the most important and common risk factors for obesity or any type of obesity in obese patients?\n\nA number of potential factors, such as:\n\nthe severity of the condition and severity of", "perturbed_sampled": ["Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes.\n\nWhat is the most common and common causes for obesity or any type of obesity in the UK? Answer: There are a number of potential factors, such as:\n\nthe severity of the condition and severity of", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes.\n\nWhat is the most important and common risk factors for obesity ? What is the most common risk factors for any type of obesity in patients?\n\nA number of potential factors, such as:\n\nthe risk factors for the condition and severity of", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes.\n\nWhat is the most important and common risk factors for obesity or any type of obesity in general? Answer: There are a number of potential factors, such as:\n\nthe severity of the condition and the duration of", "Question: Does a preoperative medically supervised weight loss program improve bariatric health? Answer: Yes.\n\nWhat are the most important and common risk factors for obesity or any type of obesity in obese patients?\n\nA number of potential factors, such as:\n\nthe risk, the condition and severity of", "Question: Could an preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes.\n\nWhat is the most important and common risk factors for obesity or any type of obesity in obese people? Regardless of potential factors, such as weight, of the condition and severity of", "Question: Does a preoperative medically supervised weight loss operation require bariatric surgery ? Yes.\n\nWhat is the most important and common risk factors for obesity ? What is the type of obesity in obese patients?\n\nA number of potential factors, such as:\n\nthe severity of the condition and severity of", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery ? Yes.\n\nWhat is the most important and key factors for obesity ? Are there any particular type of obesity in obese patients?\n\nA number of potential factors, such as:\n\nthe severity of the condition and severity of", "Question: Does a health care provider provide supervised weight loss treatment that would provide a bariatric or medication based on a routine exercise regime? Answer: Yes.\n\nWhat is the most important and common risk factors for obesity or any type of obesity in obese patients?\n\nA number of potential factors, such as:\n\nthe severity of the condition and severity of", "Question: Does a preoperative medically supervised weight loss regimen improve your bariatric surgery outcomes? Answer: What are the most important and common risk factors for obesity or any type of weight loss in obese patients?\n\nA number of potential factors, such as:\n\nthe severity of the condition and severity of", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: Yes.\n\nWhat is the most common and common risk factors for reducing any type of obesity in obese patients?\n\nA number of important factors exist, such as:\n\nthe severity of the condition and severity of"], "perturbed_original": ["Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not necessarily confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of both the preoperative and most behavioral and behavioral strategies. LAGB in our patient population.", "Question: Does a preoperative medically appropriate weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery program, in terms of weight loss and most behavioral outcomes generally occur in our patient population.", "Question: Is preoperative medically supervised weight loss and most behavioral outcomes after LAGB in our preoperative bariatric surgery outcomes? Answer: MSWM does not appear to confer weight loss outcomes as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional weight loss outcomes compared to the standard preoperative bariatric surgery protocol in terms of weight loss and behavioral outcomes after LAGB in the patient population.", "Question: Does a preoperative medically supervised weight loss program improve s the perception and outcomes? Answer: MSWM does not appear to confer attention to weight loss outcomes as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after the surgery in our patient population.", "Question: Does a preoperative medically supervised weight loss supplement improve bariatric surgery outcomes? Answer: MSWM does not use preoperative weight loss therapy to confer additional benefit , including the enhancement of weight loss to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the preoperative bariatric surgery protocol in terms of the weight loss process and most behavioral outcomes after LAGB in the population.", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery programs. In terms of weight loss, most behavioral health interventions use an LAGB in our patient population.", "Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? This is a non-participatory assessment of weight loss outcomes that does not appear to confer additional benefit as a result of the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after the treatment of our patient population.", "Question: Does a preoperative medically supervised weight loss program deliver adverse surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative screening protocol in terms of weight loss outcomes but produces the most behavioral outcomes after LAGB in our patient population."], "original_ll": -3.8269500732421875, "sampled_ll": -2.5426278114318848, "all_perturbed_sampled_ll": [-2.629096508026123, -2.6821959018707275, -2.479612112045288, -2.8470382690429688, -3.3042306900024414, -2.8501741886138916, -3.077742338180542, -2.8402514457702637, -2.7949516773223877, -2.6534223556518555], "all_perturbed_original_ll": [-4.147195816040039, -3.7631914615631104, -3.86920428276062, -3.8143162727355957, -4.095271587371826, -4.054884910583496, -3.9121291637420654, -3.8924787044525146, -3.438831329345703, -4.389174938201904], "perturbed_sampled_ll": -2.815871548652649, "perturbed_original_ll": -3.9376678466796875, "perturbed_sampled_ll_std": 0.22415736897851965, "perturbed_original_ll_std": 0.24253173731682126}, {"original": "Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the best way to respond to the excessive burden of chronic disease and disability of middle-aged Indigenous people.", "sampled": "Question: Do Indigenous Australians age prematurely? Answer: No, they are born prematurely and there's no need to be.\n\nAboriginal men and women are more likely to be born prematurely and live longer in urban centres.\n\nIn comparison, Indigenous women are a little more likely to live more than 50 years longer.\n\nThe survey suggests that the \"overweight\" Indigenous population is growing, while it's not", "perturbed_sampled": ["Question: Do Indigenous Australians age prematurely? Answer: Indigenous Australians are born prematurely , and there's no need to be.\n\nAboriginal men and women are more likely to be born prematurely and live longer in urban centres.\n\nIn comparison, Indigenous women are a little more likely to live more than two years longer.\n\nThe survey suggests that the Aboriginal population is growing, while it's not", "Question: Do Indigenous Australians age prematurely? Answer: No, they are born prematurely and there's no need to be.\n\nAboriginal men and women are more likely to be born prematurely and live at urban centres.\n\nIn comparison, Indigenous women are a little more likely to live more than 50 years. A recent survey suggests that the \"overweight\" Indigenous population is growing, and that the population is not", "Question: Do Indigenous Australians age prematurely? Answer: No, they are born prematurely and there's no need to be.\n\nAboriginal men and women are more likely to be born prematurely and live longer in urban centres.\n\nIn comparison, Indigenous women are a little more likely to be born prematurely for more than 50 years. The survey suggests that the Indigenous Australian population is growing, while it's not", "Question: Do Aboriginal Australians age prematurely? Answer: No, they are born prematurely and there's no way they will be.\n\nAboriginal men and women are more likely to be born prematurely and live longer in urban centres.\n\nIn comparison, Indigenous women are a little more likely to live in urban centres, but only about 50 years longer.\n\nThe survey suggests that the \"overweight\" Indigenous population is growing, while it's not", "Question: Do Indigenous Australians age prematurely? Answer: No, indigenous Australians are born prematurely and there's no need to be.\n\nAboriginal men and women are more likely to age prematurely and live longer in urban centres.\n\nIn comparison, Indigenous women are much more likely to live more than 50 years longer.\n\nThe survey suggests that the \"overweight\" Indigenous population is growing, which is not", "Question: Do Indigenous Australians age prematurely? Answer: No, they are born early, and there's no need to be.\n\nAboriginal men and women are more likely to be in rural areas and live longer in urban centres.\n\nIn the UK, men and women are a little more likely to live more than 50 years longer.\n\nThe survey has shown that the \"overweight\" Indigenous population is growing, while it's not", "Question: Do Indigenous Australians age prematurely? Answer: No, they are born prematurely, and there's no need to be.\n\nAboriginal men and women are more likely to be born prematurely and live longer in urban centres.\n\nIn comparison, Indigenous women are a little more likely to live more than 50 years longer.\n\nThe survey suggests that the \"overweight\" Indigenous population is growing, while it's not", "Question: Do Indigenous Australians age prematurely? Answer: No, they are born prematurely so no need to be.\n\nAboriginal Australian women are more likely to be born prematurely and live longer in urban areas. Indigenous women are a little more likely to live more than 50 years longer.\n\nThe study notes that the \"overweight\" Indigenous population is growing, while it's not", "Question: Do Indigenous Australians age prematurely? Answer: No, they are better and there's no need to be.\n\nAboriginal men and women are more likely to be born prematurely and live longer in urban centres.\n\nIn comparison, Indigenous people are a little more likely to live more than 50 years longer.\n\nThe question points out that the \"overweight\" Indigenous population is growing, while it's not", "Question: Do Indigenous Australians age prematurely? Answer: No, they are born prematurely and do not need to be.\n\nAboriginal men and women are more likely to be born prematurely and live longer in urban centres.\n\nIn comparison, Indigenous women are a little more likely to live more than 50 years longer.\n\nThe survey suggests the \"overweight\" Indigenous population is growing, while it's not"], "perturbed_original": ["Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not supported by this study of a series of discrete conditions. The current focus on the provision of services provided by the health sector may not be the best way to respond to the excessive burden of chronic disease and disability of middle-aged Indigenous people.", "Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services in the aged care sector may not be the most effective way to respond to the excessive ly chronic disease and disability of middle-aged Indigenous people.", "Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous Australians age prematurely is not well supported by this study of a series of discrete conditions. The type of age and type of ageing by the aged care sector may not be the best way to respond to the excessive burden of chronic disease and disability of Indigenous people.", "Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of the problem of discrete conditions. The current focus and type of services provided by the Indigenous Australian sector may not be the basis for attempts to respond to the excessive burden of chronic fatigue and disability of middle-aged Indigenous people.", "Question: Do Aboriginal people age prematurely? Answer: The idea that Indigenous people age prematurely is not accompanied by this study of a series of discrete conditions. The time focus and type of services provided by the aged care sector may not be the best way to respond to the excessive burden of chronic disease and the risk of middle-aged Indigenous people.", "Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this idea and it is a result of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the most suitable way to respond to the needs of chronic disease and disability of Indigenous people.", "Question: Do Indigenous people age prematurely? Answer: The idea that Indigenous people age prematurely is strongly supported by this study of a series of independent aged care services. The current focus and type of services provided by the aged care sector may not be the best way to respond to the excessive burden of chronic disease and disability of middle-aged Indigenous people.", "Question: Do Indigenous people age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this issue as Indigenous people age prematurely in a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the best to respond to the issues of chronic disease and disability of middle-aged Indigenous people.", "Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by the idea of a series of discrete conditions. The current focus and type of ageing by the aged care sector may not be the best way to respond to the excessive incidence, chronic disease and disability of middle-aged Indigenous people.", "Question: Do Indigenous Australians age prematurely? The idea that Indigenous people age prematurely is not well -known in this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be the best to respond to the excessive burden of age and disability of middle-aged Indigenous people."], "original_ll": -3.4855172634124756, "sampled_ll": -2.4269142150878906, "all_perturbed_sampled_ll": [-2.497950553894043, -2.6755788326263428, -2.517319917678833, -2.467170238494873, -2.5432004928588867, -2.537902593612671, -2.415822982788086, -2.716736316680908, -2.6411609649658203, -2.45046329498291], "all_perturbed_original_ll": [-3.3271660804748535, -3.9465386867523193, -3.5618104934692383, -3.8618056774139404, -3.792938470840454, -3.445263147354126, -3.3217148780822754, -3.458493709564209, -3.6905407905578613, -4.013330459594727], "perturbed_sampled_ll": -2.5463306188583372, "perturbed_original_ll": -3.6419602394104005, "perturbed_sampled_ll_std": 0.09512530189263096, "perturbed_original_ll_std": 0.241784311582705}, {"original": "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "sampled": "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: No. As mentioned above, many lay doctors agree that having a spouse or family member to protect health and safety are not only appropriate, but necessary to", "perturbed_sampled": ["Question: Do other people and health professionals find it necessary to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: No. As mentioned above, many lay doctors agree that having a spouse or family member to protect health and safety are not only legally necessary, but also necessary to", "Question: Do French lay people and health professionals find it acceptable or not to lack confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: No. As mentioned above, many lay doctors agree that having a spouse or family member to protect a patient from sexually transmitted disease and safety are not necessary to protect but necessary to", "Question: Do French doctors and health professionals find it acceptable to breach confidentiality to protect a physician from a sexually transmitted disease? Answer: No. As I know, many lay doctors agree that having a spouse or family member to protect health and safety are not only appropriate, but necessary to", ". What types of security violations do French, French lay people and health professionals find it acceptable to breach confidentiality by protecting a patient's wife from a sexually transmitted disease? Answer: No. As mentioned above, many lay doctors agree that having a spouse or family member 's health and safety are not only appropriate, but necessary to", "Question: Do French lay physicians or health professionals find it acceptable to breach confidentiality to protect a physician from a transmitted disease? Answer: No. As mentioned above, many lay doctors agree that having a spouse or family member to protect health and safety are not only appropriate, but necessary to", "Question: Do French lay people and health care workers agree that having a spouse or family member is it acceptable to have a spouse or family member to protect a patient's wife from a sexually transmitted disease? Answer: As I mentioned above, many lay doctors agree that having a spouse or family member to protect health and safety are not only appropriate, but necessary to", "Question: Do a large number of people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually committed sexual assault? Answer: No. As mentioned below, lay doctors agree that having a spouse or family member to protect health and safety are not only appropriate, but necessary to", "Question: Do French lay people and health professionals think it's not acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: No. As mentioned above, many lay doctors agree that having a spouse or family member 's health and safety are not only appropriate, but necessary to", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a rare disease? The question is: As mentioned above, many lay doctors agree that a breach of confidentiality of a spouse or family member to protect health and safety are not only appropriate, but necessary to", "Question: Do French lay doctors or health professionals find it acceptable to have spouse or family members to protect a patient's wife from a sexually transmitted disease? Answer: No. As mentioned above, many lay doctors believe having a spouse or family member to protect health and safety are not only appropriate, but necessary to"], "perturbed_original": ["Question: Do French lay people and health service providers believe it acceptable to breach confidentiality to protect a patient's wife from a STD or a heart disease? When considering confidentiality, many lay people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "Question: Do most people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people who choose their spouse are influenced by their decisions when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "Question: Do French lay people and psychiatrists find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect their spouse from a patient infected with STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by a number of factors when deciding if a physician should breach confidentiality to protect the spouse of a patient with a STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a patient's wife would breach confidentiality to protect her from one of the most infected with STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted illness? Most people in France are influenced by situational factors, such as deciding if a physician should breach confidentiality to protect the spouse of a patient with STD.", "Question: Do French lay professionals or health professionals find it easy for a physician to breach confidentiality to protect a patient's spouse of a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.", "Question: Do lay people and health professionals find it acceptable to breach confidentiality to protect a patient from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of the patient infected with STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a lay woman breaches confidentiality? Answer: We breach confidentiality to protect the spouse of a patient 's wife from a STD.", "Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most of the decisions in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the wife of a patient infected with STD."], "original_ll": -3.5996556282043457, "sampled_ll": -3.305102825164795, "all_perturbed_sampled_ll": [-3.075251579284668, -3.430461883544922, -3.391679525375366, -4.033602714538574, -3.655683994293213, -2.8290719985961914, -3.412745475769043, -3.4925026893615723, -3.5302486419677734, -3.1367270946502686], "all_perturbed_original_ll": [-3.9064319133758545, -3.5335564613342285, -3.7802345752716064, -3.357574701309204, -3.8098270893096924, -3.9625208377838135, -3.670027494430542, -3.714024782180786, -3.8755009174346924, -3.603865146636963], "perturbed_sampled_ll": -3.398797559738159, "perturbed_original_ll": -3.7213563919067383, "perturbed_sampled_ll_std": 0.31531353419907665, "perturbed_original_ll_std": 0.17651232574446177}, {"original": "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This \"cr\u00eape-paper\" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for patients with symptoms with minimal morbidity, despite development of disquieting lesions in response", "sampled": "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Leventhal B (2012). The esophageal mucosa. Am. J. Respir. Med. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full Text\n\n2. Dickson-Jones A (2006). \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "perturbed_sampled": ["Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Leventhal B (2012). The esophageal mucosa. Am. J. Med., 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full Text 2. Leventhal A (2006). \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 4, 12\u2013162. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences on John B (2012). The esophageal mucosa. Am. Clin Med. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full Text 2. Dickson-Jones A (2006). \"A novel, novel approach to the endoscopic sign of primary eosinophilic esophagitis.\" J. Med. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: 1. Leventhal B (2012). The esophageal mucosa. Am. J. Respir. Med. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full ard A (2006). \"A novel, novel , a novel in the diagnosis of primary eosinophilic esophagitis.\" J. Cardiol. Med. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full ard H", "Question: is the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Question: is the diagnosis of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Leventhal B (2012). \"Esophageal mucosa. Am. J. Respir. Med. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 -1210. CrossRef Full Text\n\n2. Dickson-Jones A (2006). \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 721\u2013920. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "Answer: Answer: A novel, novel approach to diagnosis of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: A novel approach to diagnosis of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Leventhal B (2012). The esophageal mucosa. Am. J. Respir. Med. 6, 63\u2013734. doi: 10.1154/JRS.8.923.923 . CrossRef Full Text\n\n2. Dickson-Jones , \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Leventhal B (2012). The esophageal mucosa. Am. J. Respir. Med. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full Text 2. Dickson-Jones A (2006). A novel approach to the diagnosis of primary eosinophilic esophagitis? Am. J. Nephrol. Dis. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Leventhal B (2004). Fragility of the esophageal mucosa. J. Respir. Dis. 13, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef 1. Dickson-Jones A (2006). \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 723\u2013725. doi: 10.1093/JRS.8.923.923 CrossRef Full Text\n\n3. Bekker H", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Leventhal P (2011). The esophageal mucosa. Am. J. Respir. Med. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full Text 3. Dickson-Jones A (2006). \"A retrospective approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Dickson-Jones B (2012). The esophageal mucosa. Am. J. Nephrol. Dis. 6, 923\u2013920. doi: 10.1154/JRS.8.923.923 CrossRef Full Text\n\n2. Dickson-Jones A (2006). \"A novel, novel approach to the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 723\u2013725. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text 2. Bekker H", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis?\n\nReferences 1. Leventhal B (2012). The esophageal mucosa. Am. J. Respir. Med. 12, doi: 10.1154/JRS.8.923.923 CrossRef Full Text\n\n2. Dickson-Jones A (2006). \"A novel, novel approach for the diagnosis of primary eosinophilic esophagitis.\" J. Nephrol. Dis. 13, 2013. doi: 10.1530/jnm.2012.071.723-725. CrossRef Full Text\n\n3. Bekker H"], "perturbed_original": ["Question: Fragility of the esophageal mucosa is a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that are developed in response to minor and otherwise uneventful diagnostic endoscopy. This \"cr\u00eape-paper\" can be used to alert endoscopists to the presence of the disease after mucosal alterations are lacking. Dilation is effective for patients with symptoms with minimal morbidity, despite development of disquieting lesions in response", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic disease. Primary eosinophilic disease is characterized by fragile esophageal mucosa that readily forms in response to minor trauma during otherwise uneventful diagnostic endoscopy. This \"cr\u00eape-paper\" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation occurs for patients with symptoms with minimal pain requiring development of disquieting lesions in response", "Question: Fragility of the retinal laterality of the retina is a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by an esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. An endoscopic sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for patients with relatively minimal morbidity, reducing the likelihood of disquieting lesions in response", "Question: Fragility of secondary esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma through uneventful diagnostic endoscopy. This \"cr\u00eape-paper\" sign is a key sign that is commonly used by endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for patients with symptoms with minimal morbidity, despite development of certain lesions in response", "Question: Primary hemodynamic instability of the esophageal mucosa: What is the endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is a fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This \"cr\u00eape-paper\" sign may result in the failure to change the status of the disease when other mucosal alterations are lacking. Dilation is effective for patients with symptoms with minimal morbidity, despite development of disquieting lesions in response", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis. Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in and relieves minor trauma during their diagnostic endoscopy. This \"cr\u00eape-paper\" sign may alert endoscopists to the presence of the disease when other mucosal alterations occur. Dilation is effective for patients with symptoms with minimal morbidity, with immediate pain and the possibility of disquieting lesions in response", "Question: Fragility of primary esophageal mucosa: a key sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa and tears in response to minor trauma during otherwise painful endoscopy. This \"cr\u00eape-paper\" sign may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for patients with symptoms with minimal morbidity, despite patients with disquieting lesions in response", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis has often been characterized by a swelling of esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This approach may alert endoscopists to the presence of the disease when other mucosal alterations are lacking. Dilation is effective for treating the symptoms with minimal morbidity, despite development of disquieting abnormalities that occurred when symptoms occur. A reversal of esophageal mucosa may cause an abnormal response", "Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic mucosa characterized by fragile esophageal mucosa which cannot become readily tears in response to minor trauma during otherwise uneventful times. This \"cr\u00eape-paper\" sign may alert endoscopists to the presence of the disease when other mucosal alterations are shown. This is effective for patients with symptoms of morbidity, despite development of disquieting lesions in response", "Question: Primary eosinophilic esophagitis was introduced in the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is treated by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This \"cr\u00eape-paper\" sign may alert endoscopists in presence of the disease when other mucosal alterations are lacking. Dilation is effective for patients who use the disease with minimal morbidity, despite development of the disease in response"], "original_ll": -3.4177308082580566, "sampled_ll": -1.72190523147583, "all_perturbed_sampled_ll": [-2.0516366958618164, -2.2453575134277344, -2.1982998847961426, -1.9093130826950073, -1.9540377855300903, -1.7979300022125244, -1.8537962436676025, -1.8279677629470825, -1.8162214756011963, -1.9737563133239746], "all_perturbed_original_ll": [-3.313138008117676, -3.6501152515411377, -3.455015182495117, -3.5137124061584473, -3.4925425052642822, -3.509477138519287, -3.4309496879577637, -3.3522796630859375, -3.624403953552246, -3.4328219890594482], "perturbed_sampled_ll": -1.9628316760063171, "perturbed_original_ll": -3.4774455785751344, "perturbed_sampled_ll_std": 0.14999249687464786, "perturbed_original_ll_std": 0.1006481694382595}, {"original": "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP,", "sampled": "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P.\n\nS. G.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201 PubMed Abstract | CrossRef Full Text | Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "perturbed_sampled": ["Question: Are stroke patients' reports for blood and blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P.\n\nS. G. John D. Johns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201 PubMed Abstract | CrossRef Full Text | Google Scholar Karen W. Michele P. S. G. John D. E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' reports of home blood pressure readings in the home blood pressure range or what should be done? Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P.\n\nS. G.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201 PubMed Abstract | CrossRef Full Author PubMed Crossref Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' reports of home blood pressure readings good for stroke patients? Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P. S. G. John D. Johns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201 Abstract | CrossRef Full Text | Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' reports of home blood pressure readings reliable? PubMed Authors: NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P.\n\nS. G.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201 PubMed Abstract s | Full Text | Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P. S. G. John D. Johns Hopkins School of Public Health\n\nCincinnati, Ohio 44114-0201 PubMed Abstract | CrossRef Full Text | Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P.\n\nS. G.\n\nJohns Hopkins Bloomberg School of Public Health Cincinnati, Ohio 44114-0201 PubMed Abstract | CrossRef Full Text | Google Scholar E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P.\n\nS. G.\n\nJohns Hopkins Bloomberg School of Public Health Cincinnati, Ohio 44114-0201 PubMed Abstract | PubMed Text Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' reports of home blood pressures reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health Cincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P.\n\nS. G.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201 PubMed Abstract | PubMed Text | Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.\n\nMichele P.\n\nS. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P.\n\nS. G.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201 PubMed Abstract | Google Text | Google Scholar Jennifer E.J.\n\nKunst mann | Louis B.A.\n\n", "Question: Are patients' reports of home blood pressure readings reliable? Answer: Yes.\n\nClinicalTrials.gov NCT01338946\n\nPubMed\n\nCrossref\n\nGoogle Scholar\n\nKaren W.K. Michele P. S. G.\n\nJohn D.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201\n\nKaren W.K.\n\nMichele P.\n\nS. G.\n\nJohns Hopkins Bloomberg School of Public Health\n\nCincinnati, Ohio 44114-0201 Karen W.K. Michele P. S. Abstract | CrossRef Full Text | Google Scholar\n\nLukacs C.J.\n\nWalt E.J.\n\nKunst D.\n\nGarcia J.\n\nSt. Louis B.A.\n\n"], "perturbed_original": ["Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home, but their bias was small and would not need to affect management. Since BP readings in a GP surgery were a poor indication of true BP,", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their daily blood pressure reading at home. Any bias was assumed and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP,", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: Two-thirds of elderly stroke patients were able to record blood pressure readings reliably at home. Any bias was small and would be unlikely to affect management. Since BP and the risk factors for a GP surgery are often a poor indication of true BP,", "Question: Are the reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. This bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP,", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group showed that stroke patients were able to read their BPs reliably at home. Any bias was small and would have to affect management. Since BP readings in a GP surgery are often a poor indication of true BP,", "Question: Are stroke patients' reports of blood pressure and blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and they were unlikely to affect management. Since BP readings in a GP surgery are often a poor measure of a true BP,", "Is the stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indicator of a true BP,", "Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were unable to record BP reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are a very poor indication of true BP,", "Question: Are stroke patients' reports of home blood pressure readings reliable? A group of elderly stroke patients were able to record their BPs reliably at home. Any diagnosis was small and would be unlikely to be reported by stroke management. Since BP readings in a GP surgery are often a poor indication of true BP,", "Question: Can it be the patients' reports of home blood pressure or death? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Low blood pressure readings in a GP surgery are often a poor indication of true BP,"], "original_ll": -4.0465497970581055, "sampled_ll": -1.5633275508880615, "all_perturbed_sampled_ll": [-1.7910984754562378, -1.902796983718872, -1.8700727224349976, -1.9639073610305786, -1.7986632585525513, -1.6706945896148682, -1.7491387128829956, -1.750487208366394, -1.9798178672790527, -1.8520692586898804], "all_perturbed_original_ll": [-4.068586349487305, -4.013686656951904, -3.79917049407959, -4.103409767150879, -4.085193157196045, -3.969501256942749, -4.093544960021973, -4.105345726013184, -4.0251336097717285, -4.204196453094482], "perturbed_sampled_ll": -1.8328746438026429, "perturbed_original_ll": -4.046776843070984, "perturbed_sampled_ll_std": 0.09403221818465844, "perturbed_original_ll_std": 0.10217684205359767}, {"original": "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.", "sampled": "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Yes. It is important to note that the incidence of pregnancy-associated serum concentrations (ADs) has been well documented. ACRs of 1\u20137.0 ng/dL are associated with a 17%", "perturbed_sampled": ["Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Yes. It is important to note that a significant proportion of pregnancy-associated serum concentrations (ADs) has been documented. ACRs of 1\u20137.0 % are associated with a 17%", "in the U.S. is the first urinary albumin/creatinine ratio , making women with suspected preeclampsia a prognostic factor for maternal and neonatal reproductive health. Answer: Yes. It is important to note that the incidence of pregnancy-associated serum concentrations (ADs) has been well documented. ACRs of 1\u20137.0 ng/dL are associated with a 17%", "Question: Is the sodium/ample albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Yes. It is important to note that the incidence of acidine concentrations (ADs) has been well documented. ACRs of 1\u20137.0 ng/dL are associated with a 17%", "Question: Is the serum albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor to predict pregnancy and neonatal adverse outcome? Answer: Yes. It is important to note that the incidence of pregnancy-associated serum concentrations (ADs) has been well documented. ACRs of 1\u20137.0 ng/dL are associated with a 17%", "Question: Is the first urinary albumin/creatinine (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Yes. It is important to note that the incidence of pregnancy-associated serum concentrations (ADs) has been well documented. ACRs of 22% are associated with a 17%", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with diabetes a prognostic factor for maternal pregnancy or is it an adverse outcome? Answer: Yes. It is important to note that the incidence of pregnancy-associated serum concentrations (ADs) is well documented. ACRs of 1\u20137.0 ng/dL are associated with a 17%", "Question: Is the increased albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse effects? Yes. It is important to note that the incidence of pregnancy-associated serum concentrations (ADs) has been well documented. ACRs of 26% are associated with a 17%", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a major reason for a neonatal adverse outcome? Answer: Yes. It is important to be aware that the incidence of pregnancy-associated serum concentrations (ADs) has been well documented. ACRs of 1\u20137.0 ng/dL are associated with a 17%", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: Yes. It is important to note that the incidence of pregnancy-associated serum ink has been increased in women with ACRs of 1\u20137.0 ng/dL , with a 17%", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: It is important to note that the incidence of pregnancy-associated serum concentrations (ADs) has been decreasing. ACRs of 1\u20137.0 ng/dL are associated with a 17%"], "perturbed_original": ["Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes? ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in women with preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia as a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an excerbatory factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk and predict a prognostic model.", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be used to inform risk predictions within the clinical and clinical model.", "Question: Is the first urinary and fetal corticocytosis treatment for suspected preeclampsia (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? It is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.", "Question: Is the first urinary albumin/creatinine ratio for women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. This may be useful to inform risk predictions within a prognostic model.", "Question: Is the first urinary albumin/creatinine (CVC) in women suspected preeclampsia an independent prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes? Answer: ACR is an important factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may have to inform risk predictions within a prognostic model.", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in women. ACR may be useful to provide predictions within a prognostic model.", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcomes? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes for maternal and neonatal adverse outcomes for women with suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model.", "Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcome in suspected preeclampsia. ACR may be useful to inform risk predictions within a prognostic model."], "original_ll": -2.757969856262207, "sampled_ll": -2.6757867336273193, "all_perturbed_sampled_ll": [-2.903968334197998, -3.221364736557007, -3.2981150150299072, -2.6598334312438965, -2.86299467086792, -2.7282207012176514, -3.0132131576538086, -2.812546730041504, -3.0442306995391846, -2.780989646911621], "all_perturbed_original_ll": [-2.6996514797210693, -3.1453771591186523, -2.800147294998169, -3.1613595485687256, -2.7865991592407227, -3.131237268447876, -2.907752275466919, -2.8269529342651367, -2.4646358489990234, -2.7471375465393066], "perturbed_sampled_ll": -2.9325477123260497, "perturbed_original_ll": -2.8670850515365602, "perturbed_sampled_ll_std": 0.1987918071603817, "perturbed_original_ll_std": 0.21270406391091295}, {"original": "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.", "sampled": "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: It depends. One important factor is the pH of the urine, which is considered to be about 40 to 50% acidic. A urine pH of about 80-90 is considered an ideal level, because it is easy to", "perturbed_sampled": ["Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of study for maximal blood flow? It depends. One important factor is the pH of the urine is considered to be about 40 to 50% acidic. A urine pH of about 80-90 is considered an ideal level, because it is considered to", "Question: Can there be another way of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for a urine pH? Answer: It depends. One important factor is the pH of the urine, which is considered to be about 40 to 50% acidic. A urine pH of about 80-90 is considered an ideal level, because it helps to", "Question: A model of drinking water treatment in Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? The temperature depends. One important factor is the pH of the urine, which is considered to be 40 to 50% . The urine pH of about 80-90 is considered an ideal level, because it is easy to", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an effective method of acid suppression for urine and acid healing? Answer: It depends. Another factor is the pH of the urine, which is considered to be about 40 to 50% acidic. A urine pH of about 80-90 is not an ideal level, because it is easy to", "Question: A model of healing for Los Angeles gastro and D reflux oesophagitis: is there an optimal time of acid suppression for maximal acid suppression? It depends. One important factor is the pH of urine, which is considered to be about 40 to 50% acidic. A urine pH of about 80-90 is considered an ideal level, because it is easy to", "Question: A model of healing of Los Angeles grades C of reflux oesophagitis: is there an optimal level of acid suppression for maximal healing? Answer: It depends. One important factor is the pH or pH of the urine, which is considered to be about 40 to 50% acidic. A urine pH of about 80-90 is considered an ideal level, and it is easy to", "Question: A model of healing of Los a C and his oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: It depends. One important factor of treatment is the urine pH of the urine, which is considered to be about 40 to 60. A urine pH of about 80-90 is considered an ideal level, because it is easy to", "Question: A model of healing of Los s C and D reflux oesophagitis: is there an optimal time of acid ic and maximal healing? Answer: It s important factor is the pH of the urine, which is considered to be about 40 to 50% acidic. The pH of about 80-90 is considered an ideal level, because it is easy to", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of suppression for maximal healing? Answer: Answer: One important factor is the pH of the urine, which is considered to be about 40 to 50% acidic. The pH of about 80-90 is not an ideal level, because it is easy to", "Question: A model of reflux treatment of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: It depends. One important factor is the pH of the urine, which is considered to be 20% to 50% acidic. A urine pH of about 80-90 is an ideal , and it is easy to"], "perturbed_original": ["Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for LA grades C and D? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, acid suppression appears to reach a threshold above which is unlikely to be achieved in response to an increase in number of hours with intragastric pH>4.", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal solution for acid suppression for maximal healing? Answer: After discontinue acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved : increase in number of hours with intragastric pH>4.", "Question: A model of healing of Los Angeles grades C and D reflux syndrome. Question: Is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy of Los Angeles grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite a decline in number of patients with intragastric pH>4.", "Question: A potential healing of Los Angeles grades C and D oesophagitis is the optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be possible due to an increase in number of hours with intragastric pH>4.", "Question: A model of therapeutic treatment for Los Angeles grade C and D reflux oesophagitis: is there an optimal time , direction and suppression for healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.", "a model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' study for LA grade C or D oesophagitis, the YPRA appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of patients with intragastric pH>4.", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful acid suppression therapy is likely to reach a threshold above which is unlikely to be achieved despite an increase in number of hours during pH>4.", "Question: A model of healing of LA grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C and D reflux, a potential threshold for optimal healing appears to reach a threshold above which is unlikely to be achieved despite an increase in number of hours with intragastric pH>4.", "Question: A model of healing of Los Angeles grade C and D reflux oesophagitis: Whether there is an increased risk of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved . Question: An increase in number of hours with intragastric pH>4.", "Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is this an optimal time of acid suppression for maximal healing? Answer: After 4 hours of intragastric therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold when pH and pH improvements are unlikely to be reached, despite an increase in number of hours with intragastric pH>4."], "original_ll": -3.8805081844329834, "sampled_ll": -3.3675506114959717, "all_perturbed_sampled_ll": [-3.5856821537017822, -3.4424946308135986, -3.877261161804199, -3.504390239715576, -3.635826349258423, -3.333568811416626, -3.551211357116699, -4.166195869445801, -3.5597102642059326, -3.5027503967285156], "all_perturbed_original_ll": [-3.5896413326263428, -4.055010795593262, -3.942430257797241, -3.9374749660491943, -4.086404800415039, -4.089756488800049, -3.9608070850372314, -3.8527889251708984, -3.943295955657959, -3.947482109069824], "perturbed_sampled_ll": -3.6159091234207152, "perturbed_original_ll": -3.9405092716217043, "perturbed_sampled_ll_std": 0.2268931171326052, "perturbed_original_ll_std": 0.13709678714073475}, {"original": "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "sampled": "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: This is a common question for trans people who have been diagnosed with prostate cancer, as long as they are in good health and have undergone prostate surgery and have completed treatment.\n\n1. The surgeon's previous experience or past surgical experience may influence the prostate cancer diagnosis.\n\nIf an individual is diagnosed with prostate cancer, it is", "perturbed_sampled": ["Question: Is the ability to perform transurethral procedures for the prostate influenced by the surgeon's previous experience? Answer: This is a common question for trans people who have been diagnosed with prostate cancer, but as they have been doing a good job, have undergone prostate surgery and have completed treatment.\n\n1. The surgeon's previous experience or past surgical experience may influence the prostate and their ability to perform transurethral procedures. 2. If an individual is diagnosed with prostate cancer, it is", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience or past surgical experience? This is a common question for trans people who have been diagnosed with prostate cancer, as long as they are in good health who have undergone prostate surgery before they have completed treatment.\n\n1. The surgeon's previous experience or past surgical experience may influence the prostate cancer diagnosis.\n\nIf an individual is diagnosed with prostate cancer, it is", "Question: Is the ability to perform and use of the prostate influenced by the surgeon's previous experience? Answer: This is a common question for patients who have been diagnosed with prostate cancer, as long as they are in good health and have undergone prostate surgery and have completed treatment.\n\n1. The surgeon's previous experience or past surgical experience may influence the prostate 's status. 2. When an individual is diagnosed with prostate cancer, it is", "Question: Is the previous experience of the surgical surgical operation or did they have done it to perform transurethral surgery on the prostate influenced by the surgeon's previous experience? Answer: This is a common question for individuals who have experienced prostate cancer with prostate cancer, as long as they are in good health and have undergone prostate surgery and have completed treatment.\n\n1. The surgeon's previous experience or past surgical experience may influence the prostate cancer diagnosis.\n\nIf an individual is diagnosed with prostate cancer, it is", "Question: Is the surgeon's experience when trying to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: This is a common question for trans people who have been diagnosed with prostate cancer, as long as they are in the prostate, have been in prostate surgery and have undergone prostate surgery and have completed treatment.\n\n1. The surgeon's previous experience or previous surgical experience may influence the prostate cancer diagnosis.\n\nIf an trans person is diagnosed with prostate cancer, it is", "Question: Is the surgeon's ability to perform transurethral surgery or surgery on the prostate influenced by the surgeon's previous experience? Answer: This is a question for trans people who have been diagnosed with prostate cancer, as long as they are in good health and have undergone prostate surgery and have completed treatment.\n\n1. The surgeon's previous experience or past surgical experience can influence the prostate cancer diagnosis.\n\nIf an individual is diagnosed with prostate cancer, it is", "Is the ability to undergo resection of the prostate influenced by the surgeon's previous experience? Answer: This is a common question for trans people who have been diagnosed with prostate cancer as long as they are in good health and have undergone prostate surgery and other prostate treatment.\n\n1. The surgeon's previous experience or past surgical experience may influence the prostate cancer diagnosis.\n\nIf an trans person is diagnosed with prostate cancer, it is", "2. Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: This is a common question for trans people who have been diagnosed with prostate cancer as long as they have been in good health and have undergone prostate surgery and have completed treatment.\n\n1. The surgeon's previous experience or past surgical experience may influence the prostate cancer . 2. If an individual is diagnosed with prostate cancer, it is", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? This is a good time for trans people who have been diagnosed with prostate cancer, as long as they are in good condition, have undergone prostate surgery and have completed treatment.\n\n1. The surgeon's previous experience or past surgical experience may influence the prostate cancer diagnosis.\n\nIf the patient is diagnosed with prostate cancer, it is", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's experience? Answer: There is a common question for individuals who have been diagnosed with prostate cancer, as long as they are in good health and have undergone prostate surgery and have completed treatment.\n\n1. Do you have previous experience or experience with prostate cancer? 2. Do you have a better understanding of the treatment experience may influence the prostate cancer diagnosis.\n\nIf an individual is diagnosed with prostate cancer, it is"], "perturbed_original": ["Question: Is the ability of the transurethral resection of the tissue decreased by the surgeon's previous experience? Answer: The surgeon was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas is that were incompletely resected. However, the incidence of secondary TURP is not the same between the three groups.", ". How did the ability to perform transurethral resection of the tissue was influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's decision would be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was reduced due to the relatively weak relationship between the three groups.", "Question: Is the ability to complete resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more prostate time unit than the more complex TURP. Therefore, a surgeon's experience may be important to reduce the incidence of secondary TURP due to recurring adenomas or adenomas that were caused by the treatment of TURP. However, the incidence of complications was the same between the three groups.", "Question: Is the ability to perform transurethral resection of the prostate influenced by surgeon's previous experience? Answer: The senior urologist was capable of producing 2 times more tissue per time unit than the more inexperienced surgeon, but a surgeon's experience may be important to reduce the risk of complications on the TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "surgery. This made the ability to perform transurethral surgery on the prostate influenced by the surgeon's previous experiences. The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience is very important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "Question: Is the decision to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per unit with more inexperienced surgeons. Therefore, a surgeon's experience may have to reduce the incidence of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's experience? A senior urologist was capable of resecting 100 or more tissue per time unit than the three inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was significantly improved between the three groups.", "Question: Is the ability to perform transurethral resection of the prostate influenced by a surgeon's previous experience? Answer: The senior urologist was capable of performing transurology four times more accurately per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may allow the surgeon to reduce the risk of secondary TURP due to cysts or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups.", "Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? A senior urologist was capable of resecting four times more tissue per unit than the more complex tissue. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or adenomas when incompletely resected. However, the incidence of complications should be the same between the three groups.", "Question: Is it possible to perform transurethral resection of the prostate despite the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per year than the more inexperienced surgeon. Nevertheless, a surgeon's experience may be important to reduce the risk of complications and prevent complications associated with TURP due to recurring adenomas or adenomas that were incompletely resected. However, the incidence of complications was the same between the three groups."], "original_ll": -3.2850184440612793, "sampled_ll": -2.2950735092163086, "all_perturbed_sampled_ll": [-2.5326883792877197, -2.2366926670074463, -2.5746541023254395, -2.8654427528381348, -2.4826297760009766, -2.3967714309692383, -2.5228805541992188, -2.5785937309265137, -2.5399436950683594, -2.5613722801208496], "all_perturbed_original_ll": [-3.4081742763519287, -3.416398048400879, -3.4701993465423584, -3.44718599319458, -3.5664448738098145, -3.504826545715332, -3.505025863647461, -3.346855401992798, -3.500274419784546, -3.1753602027893066], "perturbed_sampled_ll": -2.5291669368743896, "perturbed_original_ll": -3.4340744972229005, "perturbed_sampled_ll_std": 0.14967773123212685, "perturbed_original_ll_std": 0.10437659995154012}, {"original": "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "sampled": "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the", "perturbed_sampled": ["Question: Cervical analysis in geriatric blunt trauma patients with low-energy mechanism: are these predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the", "Question: Cervical spine fractures in geriatric blunt trauma patients : mechanism: are clinical predictors adequate? Answer: Not directly. It is important to note that it has been shown that, in geriatric patients, the", "Question: Cervical spine fractures in blunt trauma patients with low-energy energy are no clinical predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the", "Question: Cervical spine fractures in geriatric patients: are this clinical predictors adequate? Answer: In geriatric patients with low-energy mechanism: are clinical predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the", "Question: Cervical spine fractures in geriatric blunt trauma in geriatric patients by a low-energy mechanism: are the fractures adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the", "Question: Cervical predictors in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Not . Question: While not, it is important to note that it has been shown that, in geriatric patients, the", "Question: Cervical spine fractures in acute acute trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that for more geriatric patients, the", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The answers to this question remain unknown. However, it is important to note that it has been observed that in geriatric patients, the", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy dietary supplementations have clinical predictors adequate? Answer: Not to mention that it is important to note that it has been shown that, in geriatric patients, the", "Question: Cervical spine fractures in geriatric blunt trauma : a low-energy mechanism: are clinical predictors adequate? Answer: Not directly. However, it is important to note that it has been shown that, in geriatric patients, the"], "perturbed_original": ["Question: Cervical predictors appear inadequate for evaluation of the cervical spine in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Clinical predictors appear inadequate for the evaluation of the cervical spine fractures in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear in the clinical literature for the evaluation of the cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine fractures in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate . For evaluation of the cervical spine in geriatric trauma patients with low energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism. Are clinical predictors adequate? Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism. Question: What are clinical predictors adequate? Clinic predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.", "Question: Cervical spine fractures in geriatric trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the fractures in the cervical spine in geriatric trauma patients with low-energy mechanism."], "original_ll": -3.374971628189087, "sampled_ll": -3.453695297241211, "all_perturbed_sampled_ll": [-3.5162699222564697, -3.6177399158477783, -3.647829055786133, -3.143620729446411, -3.3646697998046875, -3.9407711029052734, -3.703441858291626, -3.4447357654571533, -3.7841644287109375, -3.5518972873687744], "all_perturbed_original_ll": [-3.2053236961364746, -3.6277759075164795, -3.5639615058898926, -3.3067705631256104, -3.348001718521118, -3.924471616744995, -3.6498396396636963, -3.3913230895996094, -3.951746940612793, -3.4719021320343018], "perturbed_sampled_ll": -3.5715139865875245, "perturbed_original_ll": -3.5441116809844972, "perturbed_sampled_ll_std": 0.21267896326139943, "perturbed_original_ll_std": 0.2382305816050167}, {"original": "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be advisable to postpone elective colectomy because desmoids may arise through surgical intervention.", "sampled": "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As outlined in an article on my article, there are a couple of different approaches to the evaluation of APC mutation as a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the genetic components of a polymorphism and the phenotypic profile of a polymorphism (NAD). A second approach is to perform a molecular cross-sectional (MHC) analysis.", "perturbed_sampled": ["Question: Can APC mutation contribute to therapeutic decisions in familial adenomatous adenomatous disorders? As outlined in this article on my article, there are a couple of different approaches to the evaluation of APC mutation as a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the genetic s of APC as a polymorphism and the phenotypic characteristics of a polymorphism (NAD). A second approach is to perform a molecular cross-sectional (MHC) analysis.", "Question: Can APC mutation contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As outlined in an article on my article, there are a couple of different approaches to understanding the mechanism of APC mutation as a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the genetic components of a polymorphism and the profile of a mutation in a polymorphism. A second approach is to perform a molecular cross-sectional (MHC) analysis.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial patients? Answer: As outlined in an article on my article, there are a couple of different approaches to the evaluation of APC mutation as a drug. One approach is to conduct a noninvasive, novel analysis of both the genetic components of a polymorphism and the gene profile of a polymorphism (NAD). A second approach is to perform a molecular cross-sectional (MHC) analysis.", "Question: Can APC mutation analysis support therapeutic decisions in familial adenomatous polyposis? Answer: As outlined in an article on my article, there are a couple of different approaches to the treatment of APC as a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the genetic components of a polymorphism and the phenotypic profile of an APC polymorphism (NAD). A second approach is to perform a therapeutic (MHC) analysis.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As outlined in an article on my article, there are a couple of different approaches to evaluation of APC mutation as a therapeutic method. The first approach is to conduct a relatively sensitive analysis of both the genetic components of a polymorphism and the phenotypic profile of a polymorphism. A second approach is to perform a molecular cross-sectional (MHC) analysis.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial therapeutics? Answer: As outlined in an article on my article, there are a couple of approaches to finding the most effective mechanism of APC mutation analysis for a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the genetic components of a polymorphism and the phenotypic profile of a polymorphism (NAD). A second approach is to perform a molecular cross-sectional (MHC) analysis.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As outlined in an article on my article, I have taken a couple of different approaches to use the therapeutic properties of APC mutation as a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the morphological components of a polymorphism and the phenotypic profile of a polymorphism (NAD). A second approach is to perform a molecular genetic analysis.", "Question: Can APC mutation contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As outlined in an article on my article, there are a couple of different approaches to the evaluation of APC mutation in a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the phenotypic profile of a polymorphism and the phenotypic profile of a polymorphism (NAD). The other approach is to conduct molecular cross-sectional (MHC) analysis.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As outlined in the comments on my article, there are a couple of approaches to the evaluation of APC mutation as a drug. One approach is to conduct a noninvasive, but sensitive analysis of both the genetic profile of a polymorphism and the phenotypic profile of a polymorphism (NAD). The other approach is to perform a molecular cross-sectional (MHC) analysis.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As outlined in an article on my article, there are a couple of different approaches to the evaluation of APC mutation analysis at a drug. One approach is to conduct a noninvasive, but sensitive analysis of the genetic components of a polymorphism or the phenotypic profile of a polymorphism (NAD). A second approach is to perform a noninvasive, but sensitive, MHC (MHC) analysis."], "perturbed_original": ["Question: Can APC mutation s contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, but with identical genetic carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on an internal variant of mutation. However, if a person carries mutations with mutations within codons 1445-1580, it may be advisable to conduct elective colectomy because desmoids may arise through surgical intervention.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of progression of cellular disease may be changing, even in carriers of identical germline mutation, these decisions should be based on colonoscopic findings in patients rather than on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be advisable to postpone elective colectomy because desmoids may not facilitate surgical intervention.", "Question: Can we make an analysis of therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with germline mutations between 1445-1580, it may be advisable to have surgery on elective colectomy because desmoids may arise through surgical intervention.", "Question: Can APC mutation s contribute to therapeutic decisions in familial adenomatous polyposis? If the age at manifestation and course of the disease is rather variable, even during the development of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in cases of mutations within codons 1445-1580, it may be advisable to postpone elective colectomy because desmoids may arise through surgical intervention.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at the course of the disease may be rather variable, even in patients with clinical trials of identical germline mutations, therapeutic decisions should be based on individual findings in individual patients rather than on the site of mutation. However, in patients with mutations within the family, it may be advisable to postpone elective colectomy because mutations may arise through surgical intervention.", "Question: Can APC mutation analysis contribute to therapeutic outcomes on familial adenomatous polyposis? Answer: The appearance, at manifestation and course of the disease may be variable, even in carriers of identical mutations. However, therapeutic decisions should be based on the findings in individual patients rather than on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be advisable to postpone elective colectomy because desmoids may arise through surgical intervention.", "Question: Can APC mutation analysis contribute to therapeutic decisions in adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on age in individual patients with morphological mutations on the site of the disease. However, in patients with morphological mutations within codons 1445-1580, it may be advisable to postpone elective colectomy because desmoids may arise through surgical intervention.", "Question: Can APC mutation s lead to therapeutic decisions in the polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on their behavior. For example, in individual patients with mutations with mutations may be different from those on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be appropriate to postpone elective colectomy because desmoids may arise through surgical intervention.", "Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutation, determining therapeutic decisions should be based on colonoscopic findings in individual patients rather than on findings within the present type of mutation. However, in cases with mutations within codons 1445-1580, it may be advisable to take appropriate elective colectomy or may arise through surgical intervention.", "Question: Can APC mutation analysis help determine therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation s of the disease may be rather variable, even in patients with identical germline mutations, that should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations within codons 1445-1580, it may be advisable to postpone elective colectomy for optimum results to avoid complications that may arise through surgical intervention."], "original_ll": -3.8901426792144775, "sampled_ll": -2.7781283855438232, "all_perturbed_sampled_ll": [-2.8877391815185547, -2.888688325881958, -2.9794602394104004, -2.988015651702881, -2.821502923965454, -2.9789679050445557, -2.9701523780822754, -2.7750141620635986, -2.724560260772705, -2.831590414047241], "all_perturbed_original_ll": [-4.213085174560547, -3.9949655532836914, -3.7698824405670166, -3.9395570755004883, -3.496795654296875, -3.8435792922973633, -3.8781802654266357, -4.101970195770264, -4.04445219039917, -3.9540395736694336], "perturbed_sampled_ll": -2.8845691442489625, "perturbed_original_ll": -3.9236507415771484, "perturbed_sampled_ll_std": 0.08964226876851494, "perturbed_original_ll_std": 0.18728437223775957}, {"original": "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "sampled": "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Absolutely. One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different types of treatment. This includes whether treatment plans and their specificities will be supported by", "perturbed_sampled": ["Question: Does a geriatric oncology consultation improve the treatment plan for elderly patients? Answer: Absolutely. One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different types of care they provide. That includes whether treatment plans and their specificities will be supported by", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Absolutely. One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different types of treatment. This includes whether treatment plans and their specificities will be influenced by", "Question: Does a geriatric oncology consultation modify the treatment plan for elderly patients? Answer: Absolutely. One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different types of treatment plans and includes whether treatment plans and their specificities will be supported by", "Question: Does geriatric oncology consultation modify the cancer treatment plan for you? Answer: Absolutely. One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different types of treatment. This includes whether treatment plans and their specificities will be supported by", "Question: Does a geriatric oncology consultation modify the cancer treatment of elderly patients? Answer: Absolutely. One of the most basic and helpful elements of a geriatric oncology consultation is to know about the different types of treatment. This includes whether treatment plans and their specificities will be supported by", "Question: Does a geriatric oncology consultation modify an alternative treatment plan for elderly patients? Answer: One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different types of treatment. This includes whether treatment plans and their specificities will be supported by", "Question: Does a geriatric oncology consultation support the cancer treatment plan for elderly patients? Answer: One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different types of treatment. This includes whether treatment plans and their specificities will be supported by", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different types of treatment. This includes whether treatment plans and their consequences can be supported by", "Question: Does a geriatric oncology consultation cover a cancer treatment plan for elderly patients? Answer: Absolutely. One of the most basic and crucial questions about a geriatric oncology consultation is to be knowledgeable about the different types of treatment. This includes whether treatment plans and their specificities will be supported by", "Question: How can a geriatric oncology consultation modify the cancer treatment for the elderly for elderly ? Absolutely. One of the most basic and crucial elements of a geriatric oncology consultation is to be knowledgeable about the different types of treatment. This includes whether treatment plans and their specificities will be supported by"], "perturbed_original": ["Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation does not mean a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan for elderly patients. Currently there are no more than one third of cases. Further studies are needed to determine whether or not these modifications improve the outcome of these older patients.", "How did a geriatric oncology consultation modify the cancer treatment plan for patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of the cancer treatment plan for patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? A geriatric oncology consultation contributes to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan of older patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are underway to determine whether these modifications improve the outcome of these older patients.", "Question: Does a geriatric oncology consultation modify a treatment plan for elderly patients? Answer: The geriatric oncology consultation is linked to a modification of a geriatric oncology treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a revision of the cancer treatment plan in approximately one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for older patients? Answer: The geriatric oncology consultation responds to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of the treatment plan for elderly patients.", "Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: A geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of those patients. However, these studies are very focused to determine whether these modifications improve the outcome of these older patients."], "original_ll": -2.701833486557007, "sampled_ll": -2.851677417755127, "all_perturbed_sampled_ll": [-2.8720967769622803, -2.8885602951049805, -2.9586379528045654, -2.9764747619628906, -3.0007240772247314, -2.9089643955230713, -2.870004177093506, -2.914034128189087, -2.985003709793091, -3.224637031555176], "all_perturbed_original_ll": [-2.7484755516052246, -2.7076499462127686, -2.6318013668060303, -2.799936294555664, -2.799973726272583, -2.6235616207122803, -2.720808506011963, -2.7701549530029297, -2.5965819358825684, -2.9799184799194336], "perturbed_sampled_ll": -2.959913730621338, "perturbed_original_ll": -2.7378862380981444, "perturbed_sampled_ll_std": 0.09911455163697411, "perturbed_original_ll_std": 0.10627087157810156}, {"original": "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.", "sampled": "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:\n\nStudies of epidemiological data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "perturbed_sampled": ["Question: CYP2D6*4 allele and breast cancer ? Is there any association? Answer:\n\nStudies of epidemiological data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "Question: CYP2D6*4 allele and breast cancer and breast cancer risk: is breast cancer associated with the maternal association? Answer:\n\nStudies of epidemiological data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "Question: CYP2D6*4 allele s cause breast cancer risk: is there any association? Answer:\n\nStudies and data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "Question: CYP2D6*4 allele and breast tumor, is there any association? Answer:\n\nStudies of epidemiological data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2). : Are there", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:\n\nStudies in breast cancer data support a causal relationship between allele of breast cancer and CYP2D6*4 (Figure 2A). Although there", "cancer allele and breast cancer risk: is there any association? Answer:\n\nStudies of epidemiological data support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:\n\nStudies of CYP2D6*4 in female breast cancer: support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 3). But are there", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? The epidemiological data support the relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer:\n\nStudies of epidemiological epidemiology found a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there", "Question: CYP2D6*4 allele and breast cancer risk: is that an association? Answer:\n\nStudies of both levels of breast cancer support a causal relationship between risk of breast cancer and CYP2D6*4 (Figure 2A). Although there"], "perturbed_original": ["Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A gradual transformation of procarcinogens by CYP2D6*4 poor alleles has to result in a protective effect against carcinogens.", "Question: CYP2D6*4 - induced breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 - - could result in a protective effect against carcinogens.", "Question: CYP2D6*4 reduced breast cancer risk: is there any association? Answer: A decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.", "Question: CYP2D6*4 increases breast and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective improvement of these pro carcinogens.", "Question: Cancer and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers , resulting in a protective effect against carcinogens.", "Question: CYP2D6*4 allele and breast cancer risk: is there a better solution? Answer: A possible decreased transformation of procarcinogens by biotransients by non-transferable metabolisers could result in a protective effect against carcinogens.", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers , in -kind effect against carcinogens.", "Question: CYP2D6*4 allele has increased cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a negative effect against carcinogens.", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by enzyme metabolisers could result in a protective and protective response to this type of carcinogens.", "Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: Answer: This decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens."], "original_ll": -3.880807638168335, "sampled_ll": -2.5348548889160156, "all_perturbed_sampled_ll": [-2.703453302383423, -2.749730110168457, -2.932595729827881, -3.029357671737671, -2.9286205768585205, -2.907857656478882, -2.5601794719696045, -2.672654867172241, -2.6299073696136475, -2.846383810043335], "all_perturbed_original_ll": [-3.6097545623779297, -3.694063663482666, -3.946218252182007, -4.286862373352051, -4.575675010681152, -4.431482315063477, -4.460490703582764, -4.016700267791748, -4.408021450042725, -3.8725154399871826], "perturbed_sampled_ll": -2.796074056625366, "perturbed_original_ll": -4.13017840385437, "perturbed_sampled_ll_std": 0.14658476100951434, "perturbed_original_ll_std": 0.3277575297123896}, {"original": "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with", "sampled": "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: No. The majority of the population is not trained to look at the eyes and is not interested in physical fitness. The American Academy of Sleep Medicine recommends that people with obstructive sleep apnea (OBA) are more likely to develop an aerobic fitness problem and to lose weight, and to be more motivated to get active than their body can produce.", "perturbed_sampled": ["Question: Does obstructive sleep apnea (OBA) affect fitness? Answer: No. The majority of the population is not trained to look at the eyes and is not interested in exercise. The American Academy of Sleep Medicine recommends that people with obstructive sleep apnea (OBA) are more motivated to develop an aerobic fitness problem and to lose weight, and to be more motivated to get active than their peers produce.", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: No. The majority of the population is not trained to look at the eyes and is not interested in physical fitness. The American Academy of Sleep Medicine recommends that people with obstructive sleep apnea (OBA) are more likely to get an aerobic exercise and to lose weight, and to be able to get active than their body can produce.", "Question: Does obstructive sleep apnea (OBA) cause an aerobic fitness issue? No. The majority of the population is not interested in a look at the eyes and is not interested in aerobic fitness. The American Academy of Sleep Medicine recommends that people with obstructive sleep apnea (OBA) are more likely to develop an aerobic fitness problem and to lose weight, and can feel more motivated to get active than their body can produce.", "Question: Does obstructive sleep apnea affect exercise and exercise? Answer: No. The majority of the population is not trained to look at the eyes and is not interested in aerobic fitness. The American Academy of Sleep Medicine recommends that people with obstructive sleep apnea are more likely to develop an aerobic fitness problem and to lose weight, and to be more likely to get active than their body can produce.", "Question: Does obstructive sleep apnea affect aerobic fitness? No. The majority of the population is not trained to look at the eyes and is not interested in aerobic fitness. The College of Sleep Medicine recommends that people who have obstructive sleep apnea (OBA) are more likely to develop an aerobic fitness problem and lose weight, and to be more motivated to get active than their body can produce.", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: No. The majority of the population is not trained to look out of their eyes and is not interested in physical health. The American Academy of Sleep Medicine recommends that people with obstructive sleep apnea (OBA) are more likely to develop a physical fitness problem and to lose weight, and are more motivated to get the results their body can produce.", "How does obstructive sleep apnea affect aerobic fitness? Answer: The majority of the population is not trained to look at the eyes of people not interested in physical fitness. The American Academy of Sleep Medicine recommends that people with obstructive sleep apnea (OBA) are more likely to develop an aerobic fitness problem and to lose weight, and that they are more motivated to get active than their body can produce.", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: No. The majority of the population is not trained to work under the eyes and is not interested in physical fitness. The Department of Sleep Medicine recommends that people with sleep apnea (OBA) are more likely to develop an aerobic condition and to lose weight, and to be more likely to get active than their body can produce.", "Question: Does obstructive sleep apnea improve physical fitness? Answer: No. The majority of the population is not trained to look at the eyes and is not fully trained in physical fitness. The American Society for Sleep Medicine recommends that people with obstructive sleep apnea (OBA) are more likely to develop an aerobic fitness problem and to lose weight, and to be more likely to develop aerobic fitness problems than their body can produce.", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: No. Over 70 percent of the population is not interested in having an look at the eyes and is not interested in physical fitness. The American Association for Sleep Medicine recommends that people with obstructive sleep apnea (OBA) are more likely to develop an aerobic fitness problem , to lose weight, and to be more motivated to get active than their body can produce."], "perturbed_original": ["Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a significant decrease in aerobic fitness as measured by obesity (OSA). However, if an apnea-hypopnea index of greater than 0.0 \u2013 0.03, the majority of US air force population indicates a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the effects of OSA on exercise. Further correlation of fitness testing results with", "Question: Does obstructive sleep apnea affect aerobic fitness? Overall, in a US Air Force population, these patients do not predict a decrease in aerobic fitness as with regular exercise cycle ergometry. However, patients with an apnea-hypopnea index of less than 20 have a statistically significant decrease in aerobic fitness according to the normal population. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in the Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the effects of exercise on aerobic fitness. Further correlation of fitness testing results with", "Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a greater incidence of aerobic fitness as measured by cycle ergometry. However, patients with an index of greater than 20 in the population experienced a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the measurable effect of OSA on aerobic fitness. Further correlation of fitness testing results with", "Question: Does obstructive sleep apnea e have significantly lower aerobic fitness? Answer: Overall, in a US Air Force population, OSA does have a decrease in aerobic fitness as measured by cycle ergometry. Patients with an index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with", "Question: Does obstructive sleep apnea affect aerobic fitness? Unfortunately, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients who have an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates a significant association of OSA with aerobic fitness. Further correlation of fitness testing results with", "Question: How does sleep apnea affect aerobic fitness? Answer: Overall, in the US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than half of the US Air Force population predict a 10% decrease in aerobic fitness compared to the normal population. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with", "Question: Does aerobic apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, participants with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the baseline. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with", "Question: Does obstructive sleep apnea mean physical fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness determined by cycle ergometry. However, patients with an age of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study demonstrates the influence of OSA on aerobic fitness. Further correlation of fitness testing results with", "Question: Does obstructive sleep affect aerobic fitness? Answer: Overall, in the United States Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle cycles. All patients with an apnea-hypopnea index greater than 20 have a statistically significant decrease in aerobic fitness compared to the resulting populations. This study demonstrates the effects of OSA on aerobic fitness. Further correlation of fitness testing results with"], "original_ll": -2.9211440086364746, "sampled_ll": -2.350245952606201, "all_perturbed_sampled_ll": [-2.6250321865081787, -2.4927291870117188, -2.5889852046966553, -2.518911838531494, -2.602614641189575, -2.533966302871704, -2.5470757484436035, -2.763064384460449, -2.4055914878845215, -2.673616886138916], "all_perturbed_original_ll": [-3.2522668838500977, -3.354893445968628, -2.971327781677246, -3.130364179611206, -3.27111554145813, -2.965322971343994, -2.985849618911743, -3.0931029319763184, -3.1719508171081543, -3.372868776321411], "perturbed_sampled_ll": -2.575158786773682, "perturbed_original_ll": -3.1569062948226927, "perturbed_sampled_ll_std": 0.09467405424714098, "perturbed_original_ll_std": 0.14607591546246804}, {"original": "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of mild traumatic brain injury (concussion) in athletes. The failure of this study to find any relationship between LOC and neuropsychological functioning in a large", "sampled": "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Yes. Loss of consciousness, on the other hand, is associated with increased anxiety, impulsivity and a reduction in empathy. These are the things that can cause you to feel anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email list to receive special alerts and special content.\n\nFor more neuroscience news, follow us on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "perturbed_sampled": ["Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Yes. Loss of awareness, on the other hand, is associated with increased anxiety, impulsivity and a reduction in empathy. These are the things that can cause you to feel anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: \" Subscribe to our daily email list to receive special alerts and special content.\n\nFor more news, follow us on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "Question: Does loss of consciousness predict neuropsychological decrements after you wake up? Yes. Loss of consciousness, on the other hand, is associated with increased anxiety, impulsivity and a reduction in mood. These are the things that cause you to feel anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily Newsletter to receive special alerts and special content.\n\nFor more neuroscience news, follow us on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "Question: Does the degree of consciousness predict neuropsychological decrements after concussion? Answer: Yes. The degree of consciousness, on the other hand, is associated with increased anxiety, impulsivity , and reduction in empathy. These are the things that can cause you to feel anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email newsletter to receive special alerts and special content.\n\nFor more neuroscience news, follow us on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? The question: Loss of consciousness, on the other hand, is associated with increased anxiety, impulsivity and a sense of empathy. These are the things that can cause you to feel anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email list to receive free and special content.\n\nFor more information, follow us on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "which loss of consciousness predict s after your recovery? Yes. Loss of consciousness, on the other hand, is associated with increased anxiety, impulsivity and a lack of empathy. These are the things that can cause you to feel anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email list to receive special alerts and special content.\n\nFor more neuroscience news, click on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Yes. Loss of consciousness, on the other hand, is associated with increased anxiety, impulsivity and a reduction in empathy. These are the things that can lead to disappointment. It's the ones that cause the negative effects of loss of consciousness. Dr. Dr. Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily newsletter to receive special alerts and special content.\n\nFor more neuroscience news, follow us on Facebook, Twitter and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Yes. Loss of consciousness, on the other hand, is associated with increased anxiety, impulsivity and a reduction in empathy. These are the things that can trigger cognitive lapses and cause you to feel anxious. It's issues that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email list to receive special alerts and special content.\n\nFor more neuroscience information follow us on Facebook, Twitter, and Twitter. Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "Question: Does loss of heart actually predict anxiety after concussion? Answer: Yes. Loss , on the other hand, is caused with increased anxiety, impulsivity and a reduction in empathy. These are the things that can cause you to feel anxious. It's the ones that cause anxiety. It doesn't matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Subscribe to our daily email list to receive special alerts and special content.\n\nFor more neuroscience news, follow us on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: Yes. Loss of consciousness, on the other hand, is associated with increased impulsivity and a reduction in emotional behavior. But these are the things that can cause you to become anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Brain Institute\n\nSOURCE: NeuroscienceNews.com | Visit our daily email list to receive the latest Neuroscience News and special content.\n\nFor more neuroscience news, follow us on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps", "Question: Does loss of consciousness predict anxiety after concussion? Answer: Yes. Loss of consciousness, on the other hand, is associated with increased anxiety, impulsivity and a reduction in empathy. These are the things that cause you to feel anxious. It's the ones that really matter.\n\nJill Kneiss-Williams, MD\n\nMedical Director, The Neuroscience Institute. NeuroscienceNews.com | Subscribe to our daily email list to receive special alerts and special content.\n\nFor more neuroscience news, see our pages on Facebook, Twitter, and Google+.\n\n\nRelated Links\n\nhttp://www.wired.com/news/2014/01/sadness-brain-curse-nursing-brain-cripple/\n\nhttps://www.wired.com/health/2016/06/the-brain-curse-sadness-brain-curse/\n\nhttps"], "perturbed_original": ["Question: Does loss of consciousness cause the brain decrements after decrement? The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological functioning during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of mild traumatic brain damage in athletes. The failure of this study to find any relationship between LOC and neuropsychological functioning in a large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute /traumatic recovery from chronic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring the severity of mild traumatic brain injury (concussion) in athletes. The failure of this study to find any relationship between LOC and memory is found to be in a large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The significance of LOC surgery cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of mild traumatic brain injury (concussion) in athletes. We aim to review the results of this study to find any relationship between LOC surgery and NSF functioning in a large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study focused on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been established to be sensitive in measuring cognitive function during mild traumatic brain injury (concussion) in athletes. The failure of this study to find the relationship between LOC and neuropsychological functioning in a large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The presence of LOC can cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of memory impairment from mild traumatic brain injury. Neuropsychological testing has not been shown to be a means for measuring cognitive sequelae of mild traumatic brain injury (concussion) in athletes. The failure of this study to find any relationship between LOC and neuropsychological functioning in a large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive to the cognitive sequelae of mild traumatic brain injury (concussion) in athletes. The failure of this study could not find any relationship between LOC and neuropsychological functioning . In large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the process of recovery from mild and mild brain injury. Neuropsychological testing procedures have been shown to be very effective in measuring cognitive sequelae of mild brain injury (concussion) in athletes. The failure of this study demonstrates any relationship between LOC and neuropsychological functioning in a large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The findings of this study cast doubt on the importance of the LOC as a means to measure neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of mild traumatic brain injury (concussion) in athletes. The failure of this study to find any relationship between LOC and neuropsychological functioning is in large", "Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results from this study cast doubt on the importance of LOC as a key source of neuropsychological test performance during the cognitive phase of recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be sensitive in measuring cognitive sequelae of mild traumatic brain injury (concussion) in athletes. The failure of this study to find any relationship between LOC and neuropsychological functioning in a large", "Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute and acute recovery from mild traumatic brain injury. Neuropsychological testing procedures have been shown to be effective in measuring cognitive sequelae of mild traumatic brain injury (concussion) in athletes. The failure of this study to find any relationship between loss of consciousness and neuropsychological functioning at large"], "original_ll": -2.8434038162231445, "sampled_ll": -1.8941656351089478, "all_perturbed_sampled_ll": [-2.098017692565918, -1.9329787492752075, -1.9887161254882812, -2.0990231037139893, -2.1236658096313477, -1.9794193506240845, -2.2017722129821777, -2.1191773414611816, -2.0836291313171387, -2.083462715148926], "all_perturbed_original_ll": [-3.0873708724975586, -3.19887638092041, -3.2506728172302246, -2.897336483001709, -2.9028501510620117, -2.9874866008758545, -3.055020332336426, -2.9047274589538574, -3.0472023487091064, -2.818690061569214], "perturbed_sampled_ll": -2.0709862232208254, "perturbed_original_ll": -3.015023350715637, "perturbed_sampled_ll_std": 0.0763110049738065, "perturbed_original_ll_std": 0.1323273442844961}, {"original": "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.", "sampled": "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: This question is a common and complex problem, with the most common finding being that patients with migraine are unable to cope with their headache and their relief is limited to periods of less than three months, when they", "perturbed_sampled": ["Can early migraine treatment shorten time to headache peak and increase migraine severity? Answer: This question is a common and complex problem, with the most common finding being that patients with migraine are unable to cope with headache and their relief is limited to periods which are less than three months, when they", "Question: Does early migraine can shift the time to headache peak and to a higher severity? Answer: This question is a common and complex problem, with the most common finding being that patients with migraine were unable to treat their headache and their relief is limited to periods of less than three months, when they", "Question: Does early migraine treatment shorten time to headache peak and reduce its duration? This question is a common treatment problem, with the most common finding being that patients with migraine are unable to cope with their headache and their health is limited to periods of less than a few months, when they", "Question: Does early migraine treatment shorten time to headache peak and reduce migraine? Answer: This question is a very common and complex problem, with the most common finding being that patients with migraine are unable to cope with their headache and headache but their therapy time is limited to two months or less than three months, when they", "Question: Does early migraine patients find the optimal treatment time to headache peak and reduce its severity? This question is a common and complex problem, with the most common finding being that patients with migraine are unable to cope with headache and their relief is limited to periods of less than 90 days when they", "Can early migraine treatment shorten time to headache peak and reduce its severity? Answer: This question is a common and complex problem, with the most common finding being that patients with migraine are unable to cope with it and their relief is limited to periods less than the usual periods when they", "Question: Does early migraine treatment leading to headache peak and decrease severity? Answer: This question is a common and complex problem, with the most common finding being that patients with migraine are unable to cope with their headache and their long and limited duration of less than three months, when they", "Question: Does early migraine treatment lead to headache peak ing and enhance its severity? Answer: This is a common and complex problem, with the most common finding being that patients with migraine are unable to cope with their headache and their relief is limited to three weeks, at less than three months, when they", "Question: Does early intervention shorten time to headache peak and reduce its severity? Answer: This question is a common and complex problem, with the most common finding being that patients with migraine are unable to cope with their headache snife, so the relief is limited to periods of approximately three months, when they", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: This question is a quick and complex problem, with the most common finding being that patients that are unable to cope with their headache and their relief is unable to move through prolonged periods of the first three months, when they"], "perturbed_original": ["Question: Does early migraine treatment shorten time to headache and reduce its severity? Answer: Early treatment and use of triptans were helpful for migraine headache recovery but had to help from migraine headache onset at peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.", "Can early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to decreased migraine headache duration from migraine headache to its peak but did not reduce migraine headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of early migraine treatment may lead to shorter duration from migraine headache peak to its peak but did not alleviate headache severity at peak. It could result in decreased migraine headache duration by reducing total migraine headache duration.", "Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Early migraine treatment and use of triptans may lead to shorter duration from the onset to its peak but may alleviate headache severity at peak. This could result in decreased intensity by reducing total migraine headache duration.", "Question: Does early use of triptans shorten time to headache peak and reduce its severity? Answer: Early use of triptans and use of triptans may lead to shorter duration from headache onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing the headache duration.", "Question: Does early migraine treatment shorten time at peak and reduce its severity? Answer: Early treatment and use of triptans may lead to decreased migraine burden from migraine headache onset to its severity, since the triptans did not alleviate migraine symptoms at peak. This could result in decreased migraine burden by reducing total migraine headache duration.", "Question: Does early treatment and use triptans shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not reduce migraine headache severity at peak? Answer: Early treatment and use triptans could result in decreased migraine burden in total migraine headache duration.", "Can early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache severity ? Answer: This resulted in decreased migraine burden by reducing migraine headache onset to its peak and reduced headache duration.", "Question: Does early migraine treatment shorten time until its peak and reduce its duration? Early treatment and use of medications may lead to shorter duration from its onset to its peak but did not alleviate headache severity at peak. This could result in decreased migraine burden by reducing total migraine headache duration.", "Question: Does early migraine treatment shorten migraine headache duration and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but should alleviate headache severity ? Answer: This could result in decreased migraine burden by reducing total migraine headache duration."], "original_ll": -3.747938394546509, "sampled_ll": -3.192521095275879, "all_perturbed_sampled_ll": [-3.461139440536499, -3.596872091293335, -3.4614205360412598, -3.600555419921875, -3.5921382904052734, -3.5615859031677246, -3.6168506145477295, -3.707212448120117, -3.713115692138672, -3.604846477508545], "all_perturbed_original_ll": [-3.9948103427886963, -3.627781867980957, -3.5204896926879883, -3.8759288787841797, -3.3455677032470703, -3.473430633544922, -3.411825180053711, -3.805562734603882, -4.054446220397949, -3.8353755474090576], "perturbed_sampled_ll": -3.591573691368103, "perturbed_original_ll": -3.6945218801498414, "perturbed_sampled_ll_std": 0.0799506960858773, "perturbed_original_ll_std": 0.23876897416421683}, {"original": "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life exposures.", "sampled": "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: One of the major challenges in developing a public health plan in the face of growing concerns from health insurance and other government programs is the development of programs that are complementary to national health programs. One such approach has been the National Institute for Health and Welfare (NINTHW),", "perturbed_sampled": ["Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: One of the major challenges facing a public health plan in the face of growing concerns from Thailand and other government programs is the development of programs that are influenced by national health programs. One such approach has been the National Institutes for Health and Welfare (NINTHW),", "Question: Living in an urban environment and non-communicable disease risk . Does timing matter? Answer: One of the major challenges facing developing a public health plan in the face of growing government health insurance and other government programs is the development of programs that are complementary to national health programs. One such approach has been the National Institute for Health and Welfare (NINTHW),", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: One of the major trends in developing a public health plan in the face of growing concerns regarding insurance and other government programs is the development of programs that are complementary to national health programs. One of the nationals has been the National Institute for Health and Welfare (NINTHW),", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: One of the biggest steps in developing a public health plan in the face of growing concerns from Thailand, Malaysia and other government programs in the field is the development of programs that are based on national health programs. One such approach has been the National Institute for Health and Welfare (NINTHW),", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: One of the major challenges in developing a public health plan in the face of concerns from health insurance and other government programs is the development of a public health plan that are complementary to national health programs. The approach has an impact on the National Institute for Health and Welfare (NINTHW),", "Question: Living in an urban environment and non-communicable disease risk in Thailand: What makes such a matter? Answer: One of the major challenges in developing a public health plan in the face of growing concerns from health insurance and other government health insurance companies is the development of programs that are complementary to national health programs. One such approach has been the National Institute for Health and Welfare (NINTHW),", "Question: Living in an urban environment is a chronic disease risk in Thailand: Does timing matter? Answer: One of the major challenges in developing a public health plan in the face of growing concerns from health insurance and other government programs is the development of programs that are coordinated with other national health programs. One such approach has been the National Institute for Health and Welfare (NINTHW),", "Question: Living in an urban environment and non-communicable disease risk in Thailand: is public health an important matter? Answer: One of the major challenges in developing a public health plan in the face of concerns from health insurance and other government programs is the development of programs that are complementary to national health programs. One such approach has been the National Coalition for Health & World Health Organisation (NINTHW),", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: One of the biggest challenges in developing a public health program in the face of growing concerns concerning health insurance and other government programs is the development of programs that are complementary to national health programs. One of their main challenges has been the National Institute for Health and Welfare (NINTHW),", "Question: Living in an urban environment is a measure of disease risk in Thailand: Does timing matter? Answer: One of the major challenges in developing a public health plan in Thailand, of growing concerns from health insurance and other government programs is the development of programs that are complementary to national health programs. One such approach has been developed by the National Institute for Health and Welfare (NINTHW),"], "perturbed_original": ["Question: Living in an urban ized city, experiencing non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increased in behavioral and physiological health. However, these factors did not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life exposures.", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not directly be linked with the increase in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long and long periods of life and early life exposures.", "Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing or complexity explain this? Urbanicity was associated with increases in behavioral and physiological risk factors, but these associations may not translate to increases in biological risk factors. It is likely that these biological risk factors were results of increased risk factors and the direct interaction between both long term accumulation of exposure and early life exposures.", "Question: Living in an urban environment and non-communicable health in Thailand: Does this matter? Answer: Urbanicity was associated with increases in behavioral and physiological and emotional exposures in Thailand. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life exposures.", "Question: Living in an urban environment and non-communicable disease in Thailand or Thailand: What doesn't matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is also likely that these biological risk factors were results of a complex interaction between the longer term accumulation of exposure and early life exposures.", "Question: Living in an urban environment and non-communicable disease risk in Thailand: How about the matter? Answer: Urbanicity was associated with significant increases in behavioral and physiological risk factors. However, these associations may not translate directly to the increase in behavioral and physiological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life exposures.", "epidemiology in an urban environment and non-communicable disease risk in Thailand: a question, what is the case for this matter? Answer: Urbanicity was associated with increases in biological and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were the results of a complex interaction between both long term accumulation of exposure and early life exposures.", "Question: Living in an urban environment and non-communicable disease risk in urban cities in life and urbanicity. Does the timing matter? Answer: Urbanicity was associated with increases in behavioral and behavioral risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex evolutionary process, including both long term accumulation of a high percentage of infectious diseases, and early life exposures.", "Question: Living in an urban setting? Answer: The combination of chronic and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity has been associated with increases in behavioral and physiological risk factors. However, this may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of physical and cognitive risk factors and early life exposures.", "Question: In an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in both biological and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors may be the results of a complex interaction between the long term accumulation of exposure and early life exposures."], "original_ll": -3.3854615688323975, "sampled_ll": -2.8257205486297607, "all_perturbed_sampled_ll": [-3.2583673000335693, -3.002094030380249, -3.3374860286712646, -3.0895090103149414, -2.974534511566162, -2.891479969024658, -2.9620511531829834, -3.134263515472412, -3.0161798000335693, -3.0414834022521973], "all_perturbed_original_ll": [-3.830364942550659, -3.4662115573883057, -3.6809780597686768, -3.547452211380005, -3.4096784591674805, -3.4281246662139893, -3.4549429416656494, -3.419612407684326, -3.327514886856079, -3.415245294570923], "perturbed_sampled_ll": -3.0707448720932007, "perturbed_original_ll": -3.4980125427246094, "perturbed_sampled_ll_std": 0.1313365574652608, "perturbed_original_ll_std": 0.14282812991032415}, {"original": "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.", "sampled": "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: It does, but the overall effect size is about 50%. I am not sure whether that is due to differences in the sexes, or just in the way that some people interpret the results.\n\nMarital status, living", "perturbed_sampled": ["Question: Marital status, living arrangement and mortality: does the association vary by gender? Yes, it does, but the overall effect size is about 50%. I \u2019m not sure whether that is due to differences in the sexes, or just in the way that some people interpret the association. The relation is not marital status, living", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: It does, but the overall effect size is about 50%. I am not saying that is due to differences in the sexes, or how we interpret the way that some people interpret the difference between living", "Question: Marital status, living arrangement , living arrangement, does the association vary by gender? Answer: It does, but the overall effect size is about 50%. I am not sure whether that is due to differences in the sexes, or just in the way that some people grew up, or lack the results.\n\nMarital status, living", "Question: Marital status, living arrangement and size of the association vary by the people. It does, but the overall effect size is about 50%. I am not sure whether that is due to differences in the sexes, or just in the way that some people interpret the results.\n\nMarital status, living", "Question: Marital status, living arrangement and mortality: does the difference in living by gender? Answer: It does, but the overall effect size is about 50%. I am not suggesting that is due to differences in the sexes, or just in the way that some people interpret the word living", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: It does, but overall effect size is about 50%. I am not sure whether that is due to gender differences in the sexes, or just in the way that some people interpret the results.\n\nMarital status, living", "Question: Does the living arrangement and the effect size of the association vary by gender? Answer: It does, but the overall effect size is about 50%. I am not sure whether that is due to differences in the sexes, or do the results reflect the way that some people interpret the results.\n\nMarital status, living", "Question: In living arrangement and mortality: does the association vary by gender? Answer: It does, but the overall effect size is different, too. I am not sure whether that is due to differences in the sexes, or just in the way that some people interpret the association with mortality and mortality. <unk> <unk>, Is living", "living status, living arrangement and mortality: does the association vary by gender? Answer: It does, but the overall effect size is about 3/3. I am not sure whether that is due to differences in the sexes, or just in the way that some people interpret it. Living status, living", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: It does, but the overall effect is about 50%. I am wondering whether that is due to differences in the outcomes of a group that behaves differently or not just in the way that some people interpret the results.\n\nMarital status, living"], "perturbed_original": ["Question: The impact of living arrangement and mortality: does the living arrangements assess the mortality risk based on marital status by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender and mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of death risk is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living alone on partner seems to be different in the age of women.", "Question: Marital status, living arrangement and mortality: does the association vary ? Answer: Evaluation of living arrangements is crucial for identifying gender and gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different depending on the gender and women.", "Question: Marital status, living arrangement and mortality: does the association vary by type of marital status? Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality and marital status. The impact of living arrangements upon the relationship on living with a partner seems to be different in men and women.", "Question: Marital status, mortality, and mortality: does the association vary by gender? A study of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be very different in men and women.", "Question: Marital ity: living arrangement and mortality: does the relationship improve? by gender equality? Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in men and women.", "Question: Evaluating living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial in assessing and explaining gender differences in mortality risks by marital status. The impact of living alone and mortality when working alone as a partner seems to be different in men and women.", "Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is a model of identifying and explaining gender differences in mortality risks by gender and gender. The impact of living alone alone in relation to living with a partner seems to be different in men and women.", "Question: Marital status, living arrangement and mortality: does the marriage association vary ? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to be different in relation to pregnant women.", "Question: Marital status, sexual orientation, fertility, and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality and marital status. The impact of living with partners and living with a partner seems to be different in men and women."], "original_ll": -3.377171277999878, "sampled_ll": -2.6305131912231445, "all_perturbed_sampled_ll": [-3.35040020942688, -3.3237991333007812, -2.9863624572753906, -2.9572126865386963, -3.5877904891967773, -2.820958137512207, -2.9332358837127686, -3.494020938873291, -3.028939723968506, -3.031921148300171], "all_perturbed_original_ll": [-3.4569737911224365, -3.9661102294921875, -3.912858724594116, -3.419560670852661, -3.3263702392578125, -4.124910354614258, -3.714322805404663, -3.6464970111846924, -3.781695604324341, -3.2420096397399902], "perturbed_sampled_ll": -3.151464080810547, "perturbed_original_ll": -3.659130907058716, "perturbed_sampled_ll_std": 0.25062990540117586, "perturbed_original_ll_std": 0.27870659856313373}, {"original": "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "sampled": "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: No. Major depression in young adults is associated with higher levels of alcohol-related antisocial behaviors and decreased cognitive functioning. There is no evidence to suggest that there is an association. This report contains the following findings: The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "perturbed_sampled": ["Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: No. Major depression in young adults is associated with an increase of mood, behaviors and slow functioning. There is no evidence to suggest that there is an association. This report contains the following findings: The association between major depression and alcohol use in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to a secondary role in the development of depression? Answer: No. Major depression in young adults is associated with higher levels of alcohol-related antisocial behaviors and decreased cognitive functioning. There is no evidence to suggest that major depression can cause an association. This is an important study of the following findings: The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression and alcohol use disorder in adolescence: How can we lead to poorer outcomes of depression? Answer: No. Major depression in young adults is associated with higher levels of alcohol-related antisocial behaviors and decreased cognitive ability. There is no correlated link between severe depression and alcohol use disorders that suggest that it might result in an association. This report contains the following findings: The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression related to alcohol use disorders in adolescence: Does comorbidity lead to greater levels of depression? Answer: No. Major depression in young adults is associated with higher levels of alcohol-related antisocial activity and decreased cognitive functioning. There is no evidence to suggest that there is an association. This report contains the following findings: The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression and alcohol use disorder in adolescence: Does it contribute to poorer outcomes of depression? What does the cause say? Major depression in young adults is associated with higher levels of alcohol-related antisocial behaviors and decreased cognitive behavioural abilities. There is no evidence to suggest that there is an association. This report contains the following findings: The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression and mood disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: No. Major depression in young adults is associated with higher alcohol and alcohol-related antisocial behaviors and decreased cognitive functioning. There is no evidence to suggest that there is an association. This report contains the most recent findings. The association between major depression and mood disorders in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression and alcohol use disorders in adolescence: Does comorbidity lead to poorer moods adolescent depression? Answer: No. Major depression in young adults is associated with higher levels of alcohol-related antisocial behaviors and decreased cognitive functioning. There is no evidence to suggest that adults may have an association. This report contains the following findings. The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression and alcohol use disorder in adolescence: Can this lead to poorer outcomes of depression? Results: Major depression in young adults is associated with higher levels of antisocial behaviors and decreased cognitive functioning. There is no evidence for any indication that there is an association. This report contains the following findings: The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression is associated with", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to higher levels of depression? Answer: No. Major depression in young adults is associated with higher levels of normal behaviors and decreased cognitive functioning. There is no evidence to suggest that there is an association between major depression and alcohol use disorder. The report contains four findings: The association between major depression and alcohol use disorders in adolescence . Major depression is associated with", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity cause poorer people to experience major depression? Answer: No. Major depression in young adults is associated with higher levels of alcohol-related antisocial behaviors and decreased cognitive functioning. There is no evidence to suggest that there is a major depression disorder. This report contains the following findings: The association between major depression and alcohol use disorders in adolescence is strong.\n\nMajor depression and alcohol use disorders are strongly associated with"], "perturbed_original": ["Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these studies indicated that marginally increasing incidence of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent disorder is expected to be a risk marker, yet will also be a causal factor in subsequent MD.", "Question: Major depression and alcohol use disorder in adolescence: Does the disorder lead to significant and significant rates of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid group were explained by increased exposure to high blood pressure and low alcohol use circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "comorbid depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: All of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal ly responsible factor for subsequent MD.", "Question: Major depression and alcohol use in adolescence: Does it equate to poorer maternal depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by adverse childhood conditions. The analysis indicates that significant depression due to adverse childhood conditions and diabetes in teen childhood may be contributing factors for members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "Question: Major depression factors in their primary substance use disorder in patients with clinical comorbidity lead to poorer outcomes of depression? Answer: The results of both analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by adverse adolescent comorbidity to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a primary marker, rather than a causal factor in subsequent MD.", "Question: Major depression and alcohol use disorder in the comorbid group caused by alcohol use disorder. Can comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher effects of depression to age 35 amongst the comorbid group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be a causal marker, rather than a causal factor between those of the adolescents and MD.", "Question: Major depression in children: Do parents have a drug use disorder in adolescence: Does comorbidity lead to poorer outcomes than others? Answer: The results of these analyses suggest that lowered risk rates of age over age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent comorbidity is likely to be a risk marker, rather than a causal factor in subsequent MD.", "Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to significant outcomes of depression? Answer: The results of the study suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid MD/AUD group. MD/AUD comorbidity is likely to provide a risk marker, rather than a causal ly responsible pathway for a subsequent MD.", "Question: Major depression and alcohol use disorder in adolescence: Does it lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to certain childhood circumstances amongst members of the MD/AUD group. Adolescent MD/AUD comorbidity is likely to be a symptom rather than a causal factor in subsequent MD.", "Question: Major depression and alcohol use , including adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression and alcohol use over age 35 amongst the comorbid MD/AUD group were explained by depression that led to adverse childhood outcomes among most members of the comorbid group. Adolescent mortality is likely to be a risk marker, rather than a causal factor in subsequent MD."], "original_ll": -3.3694863319396973, "sampled_ll": -2.2745962142944336, "all_perturbed_sampled_ll": [-2.5688157081604004, -2.3506789207458496, -2.707747220993042, -2.2637860774993896, -2.6232759952545166, -2.4965660572052, -2.5095832347869873, -2.5509862899780273, -2.315279483795166, -2.2977070808410645], "all_perturbed_original_ll": [-3.7963342666625977, -3.4415900707244873, -3.86128568649292, -3.5128865242004395, -3.7013120651245117, -3.565429925918579, -3.6087663173675537, -3.627394437789917, -3.4293229579925537, -3.6687052249908447], "perturbed_sampled_ll": -2.468442606925964, "perturbed_original_ll": -3.6213027477264403, "perturbed_sampled_ll_std": 0.14455930209054188, "perturbed_original_ll_std": 0.1345731532279983}, {"original": "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.", "sampled": "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: A few more questions.\n\nQ: It looks like atrial fibrillation is often preceded by some kind of inflammation (e.g., blood clotting, sepsis) that can lead to atrial fibrillation and a reduction in the plasma level of glucose. In addition, there's an increased risk of coronary artery disease, including some rare disease associated with coronary heart disease. It is now known that the presence of this mutation may result in", "perturbed_sampled": ["Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenic process of atrial fibrillation? Answer: Read more questions.\n\nQ: It looks like atrial fibrillation is often preceded by a reduction of inflammation (e.g., blood clotting, sepsis) that can lead to atrial fibrillation and a reduction in the plasma level of glucose. In addition, there's an increased risk of coronary artery disease, including some rare disease associated with coronary heart disease. That's now true, the presence of this mutation may result in", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and genetic factors in the pathogenesis of atrial fibrillation? Answer: A few more questions.\n\nQ: It looks like this mutation is often preceded by one kind of inflammation (e.g., blood clotting, sepsis) that can lead to atrial fibrillation and a rise in the plasma level of glucose. In addition, there's an increased risk of coronary heart disease, including some rare disease associated with coronary heart disease. It is now known that the involvement of this mutation may result in", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors that impact the pathogenesis of the mutation. Answer: A few more questions.\n\nQ: It looks like atrial fibrillation is often preceded by some kind of glucose loss (e.g., blood clotting, sepsis) that can lead to atrial fibrillation and a reduction in the plasma level of glucose. In general, it is predicted that there may be an increased chance of seriousness in coronary artery disease, including some rare disease associated with coronary heart disease. It is now known that the presence of this mutation may result in", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of HCT. Answer: A few more questions.\n\nQ: Some diseases, like atrial fibrillation, are often preceded by some kind of hypertension (e.g., blood clotting, sepsis) that can lead to atrial fibrillation or a reduction in the plasma level of glucose. In addition, there's an increased risk of coronary artery disease, including some rare disease associated with coronary heart disease. It is not uncommon that the presence of this mutation may result in", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and genetic factors in the pathogenesis of atrial fibrillation? Here's a few more questions.\n\nQ: It looks like atrial fibrillation is caused by some kind of inflammation (e.g., blood clotting, sepsis) that can lead to atrial fibrillation, which indicates a reduction in the plasma level of plasma. In addition, there's an increased risk of coronary artery disease, including some rare disease , coronary heart disease. It is now known that the presence of this mutation may result in", "Question: Stretch-sensitive KCNQ1 mutation A link between the therapeutic and environmental factors in the pathogenesis of atrial fibrillation? Answer: A few questions. It looks like atrial fibrillation is often preceded by some kind of inflammation (e.g., blood clotting, sepsis) that can lead to atrial fibrillation and a reduction in the plasma level of glucose. In addition to this mutation, there is an increased risk of coronary artery disease, including some rare disease associated with coronary heart disease. It is now known that mutations in the genetic process of this mutation may result in", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? A: Let's ask a few more questions.\n\nQ: It looks like atrial fibrillation is often preceded by some kind of inflammation (e.g., blood clotting, sepsis) that can lead to increased and altered changes in the plasma level of glucose. In addition, there's an increased risk of coronary artery disease, including some rare disease associated with coronary heart disease. It's now known that some of this mutation is due to the increase in", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: A few more questions.\n\nQ: It looks like atrial fibrillation is often preceded by some kind of inflammation (e.g., blood clotting, sepsis) that can lead to high blood glucose levels and changes in the plasma levels of glucose. In addition, patients have an increased risk of coronary artery disease, including some rare disease associated with heart disease. It is now known that the presence of this mutation has proven to be an increase in", "Question: Stretch-sensitive KCNQ1 A6 is a great link between the physical and environmental factors. Is there a link between the causes and the pathogenesis of atrial fibrillation? Answer: A few more questions.\n\nQ: It looks like atrial fibrillation is often preceded by some kind of inflammation (e.g., blood sugar). This may be inflammation that can lead to atrial fibrillation and reduction of plasma level of glucose. In addition, there's an increased risk of coronary artery disease, including some rare disease associated with coronary heart disease. It is now known that the presence of this mutation may result in", "Question: Is this a mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: A few more questions.\n\nQ: It looks like atrial fibrillation is often preceded by some kind of inflammation (e.g., blood clotting, sepsis) that can lead to atrial fibrillation and a reduction in the plasma level . In addition, there's an increased risk of coronary artery disease, including some rare disease associated with coronary heart disease. It is now known that the presence of this mutation can actually tamper with cancer. We have seen a shift in"], "perturbed_original": ["Question: Stretch-sensitive KCNQ1 mutation A 2 or V2D is not necessary to explain the genetic and environmental factors in the pathogenesis of AF. Answer: We do not suggest that the KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a \"second hit\" based on stress and AF, as an alternative to symptoms like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation is not insufficient to cause AF. Rather, we suggest a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in the AF kinetics (\"second hit\"), is required for AF to be manifested. Such a model would be intended for the age-related increase in age and development.", "Question: Stretch-sensitive KCNQ1 mutation A . What are the most common genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These are not an indicator that the R14C mutation alone is insufficient to cause AF. Rather, we suggest a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (\"second hit\"), is required for AF to be manifested. Such factors would also account for the age-related increase in gene development.", "Question: Stretch-sensitive . Question: A link between genetic and environmental factors between pathogenesis and fibrillation? Answer: These data suggest that the KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a \"second hit\", such as an environmental factor like the KCNQ1 mutation, promotes atrial stretch and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related factors that constitute AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient for AF. Rather, we suggest a model for a \"second hit\" as an environmental factor like hypertension, which causes stretch and thereby unmasks an inherited defect and channel kinetics (the \"first hit\"), is required for AF to be determined. This suggests that a model would also account for the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation (CPKQ1 mutation) can cause an unknown link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: We suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a \"second hit\", such as an increased number of forms of AF, is like hypertension, which promotes AF and thereby unmasks an inherited defect in ion channel kinetics (the KCNQ1 mutant) is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the form of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is not required to cause AF. Rather, we suggest that a cause in which \"first hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks an inherited layer of ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such factor would also account for the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation s are responsible in determining the difference between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is necessary to cause AF. Rather, we suggest a model in which a \"second hit\", such as the other, to model the expression of an environmental factor like hypertension, which allows for an increase in stretch and thereby unmasks an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in tissue development.", "Question: Stretch-sensitive KCNQ1 mutation A link between the environmental factors which directly affect the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a \"second hit\", such as an environmental factor like hypertension, which promotes atrial stretch and thereby unmasks a defect in ion ation and rhubarb (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development.", "Question: Stretch-sensitive KCNQ1 mutation is associated between genetic and environmental factors in the cause of atrial fibrillation? Answer: These data suggest that the stretch-sensitive KCNQ1 mutation alone is insufficient to cause AF. We suggest a model in which a \"second hit\", such as an environmental factor like hypertension, increased atrial stretch and decreased AF for an inherited defect in ion channel kinetics (the \"first hit\"), is required for AF to be manifested. Such a model would also account for the age-related increase in AF development."], "original_ll": -3.5673489570617676, "sampled_ll": -2.5983331203460693, "all_perturbed_sampled_ll": [-2.924055576324463, -2.8157997131347656, -2.9971494674682617, -2.8609907627105713, -2.7747976779937744, -2.829915761947632, -2.772019386291504, -2.7459864616394043, -2.894730567932129, -2.615140676498413], "all_perturbed_original_ll": [-3.744860887527466, -3.882883071899414, -3.922395706176758, -3.7022361755371094, -3.886167526245117, -3.5225536823272705, -3.851287841796875, -3.816044330596924, -3.7543022632598877, -3.442920446395874], "perturbed_sampled_ll": -2.823058605194092, "perturbed_original_ll": -3.7525651931762694, "perturbed_sampled_ll_std": 0.10064171440300414, "perturbed_original_ll_std": 0.15127162535880592}, {"original": "Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.", "sampled": "Question: Do we need imaging to diagnose appendicitis in children? Answer: No. The diagnosis can be performed under the supervision of a neurologist and, at any time during treatment, should be made to the child. If the child does not require the visual aid (if the", "perturbed_sampled": ["Question: Do we need imaging to diagnose appendicitis in children? Answer: No. The diagnosis can be performed under the supervision of a nurse, at any time during treatment, should be made to the child. If there does not, the visual aid (if the", "Question: Do we need imaging to diagnose appendicitis in children? Answer: No. The diagnosis can be performed under the supervision of a neurologist and, at any time when treatment, that diagnosis can be made to the child. If the child does not require the visual treatment, the", "Question: Do we need imaging to be performed in children? Answer: No. The diagnosis can be performed under the supervision of a neurologist , and any medical diagnosis, at any time during treatment, should be made to the child. If the child does not require the visual aid (if the", "Question: Do I need imaging to diagnose appendicitis in children? Is it necessary? The diagnosis can be performed under the supervision of a neurologist and, at any time during the day, diagnostic decisions can be made to the child. If the child does not require the visual aid (if the", "Question: Do we need imaging to diagnose appendicitis in children? Answer: No. The diagnosis can be under examination at all stages of the treatment, and, at any time during treatment, should be made to the child. If the child does not require the visual aid (if the", "Question: Does the child need imaging to diagnose appendicitis in children? Answer: No. The diagnosis can be performed under the supervision of a neurologist and, at any time during treatment, may be made to the child. If the child does not require the visual aid (if the", "Question: Do we need imaging to diagnose appendicitis in your child? No. The diagnosis can be performed under the supervision of a neurologist and, at any time during treatment, should be made to the child. If the child does not require the visual imaging in the child, the child will have to perform the diagnosis and are available to the", "Question: Do we need imaging to provide the visual aid necessary in children? Answer: No. The visual aid must be performed under the supervision of a neurologist and, at any given time prior to the treatment, should be made to the child. If the child does not require the visual aid (if the", "Question: Do we need imaging and visual appendicitis in children? ? The diagnosis can be performed under the supervision of a neurologist and, at any time during treatment, should be made to the child. If the child has a peripheral vision of the head, the child may require the visual aid (if the", "Question: Do we need imaging to diagnose appendicitis in children? Answer: No. The diagnosis can be performed under the supervision of a medical professional, or at any time during treatment, should be made to the child. If the child does not need visual aid (if the"], "perturbed_original": ["Question: Do we need imaging for appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, for children older than 10 years, selected use of imaging should be implemented to treat unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.", "Question: Do we need imaging to diagnose appendicitis in children? Image assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, better use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.", "Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is critical to diagnosis of appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid appendicitis. Imaging of choice in equivocal cases should be ultrasonography.", "Question: Do child use imaging to diagnose appendicitis in children? An assessment is needed because a careful assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in most cases should be ultrasonography.", "Question: Do we need imaging to diagnose appendicitis in children? Answer: Imaging is the key to diagnose appendicitis. Nevertheless, in girls older than 3 years of age or older than 8 years, selected studies on imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.", "Question: Do we need an accurate and reliable approach to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be advisable to avoid unnecessary appendectomies. Imaging of choice in children should be ultrasonography.", "Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid bacterial infection. Imaging used in equivocal cases should be ultrasonography.", "Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to success of diagnosis and treatment of appendicitis. Nevertheless, in children over more than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging , not to mention, the key in equivocal cases should be ultrasonography.", "Question: Do we allow an ultrasound to remove appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. In girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be ultrasonography.", "Question: Do we need imaging to diagnose appendicitis in ? Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to diagnose appendectomies. Imaging of choice in girls should be ultrasonography."], "original_ll": -3.559323310852051, "sampled_ll": -2.726213216781616, "all_perturbed_sampled_ll": [-3.145326614379883, -2.8824477195739746, -3.02371883392334, -2.949763298034668, -2.9201207160949707, -2.7228355407714844, -2.89501690864563, -2.874635934829712, -3.274472236633301, -2.8581230640411377], "all_perturbed_original_ll": [-3.604084014892578, -3.553478717803955, -3.421250581741333, -3.7122089862823486, -3.5227243900299072, -3.574061393737793, -3.5672385692596436, -3.661092519760132, -3.8390064239501953, -3.6952784061431885], "perturbed_sampled_ll": -2.95464608669281, "perturbed_original_ll": -3.6150424003601076, "perturbed_sampled_ll_std": 0.14928409415181226, "perturbed_original_ll_std": 0.11050446406897473}, {"original": "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.", "sampled": "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: I think we need more skills that reflect actual performance, not just performance of technical skills. Also, you need to recognize that the majority of graduates at this school are graduates who know how to make their own decisions in their field. I know", "perturbed_sampled": ["How does a resident's leadership skills relate to performance of a technical skill? Answer: I think we should learn skills that reflect actual performance, not just performance of technical skills. Also, you need to recognize that the majority of the students at this school are graduates who know how to make their own decisions in their field. I know", "Question: Do resident's ratings of technical skills relate to ratings of technical skill? Answer: I think we need more skills that reflect actual performance, not just ratings of technical skills. Also, you need to recognize that the majority of graduates at the university are graduates who know how to make their own decisions in their field. I know", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: I think we need more skills that reflect actual performance, not just performance of technical skill. Question: Do you need these skills? Answer: I understand that the majority of graduates at this school are graduates and how to make their own decisions in the school? I know", "Question: Do resident's assessment ratings relate to ratings of technical skill? Answer: I think you need to consider whether you have more skills that reflect actual performance, not just performance of technical skills. Also, you need to recognize that the college graduates at this school are graduates who have learned how to make their own decisions in their field. I know", "Question: Do resident's leadership skills relate to ratings of technical skills? I think we need more to reflect actual performance, not just performance of technical skills. Also, you need to recognize that the majority of graduates at this school are graduates who understand how to make their careers in their field. I know", "Question: Do resident's feedbacks relate to ratings of technical skill? Answer: I think we need more skills that reflect actual performance, not just performance of technical skills. We need to recognize that the majority of graduates in high school are graduates of school. All students know how to make their own decisions in their field. I know", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: I think we use skills that reflect actual performance, not just performance of technical skills. Also, you need to recognize that the residents graduates from high school are graduates who know how to make their own decisions in the field. I know", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: I think we need more skills that reflect actual performance, not just performance of technical skills. Also, you need to recognize that the majority of graduates at local government are technical. You should know how to make their own decisions in your work, regardless of your career, I believe. I know", "Question: Do resident's leadership skills relate to ratings of technical skill? I think we need more skills that reflect their quality of life, not just performance of others. Also, you need to recognize that the majority of graduates at this school are graduates who know how to make their own decisions in their own decision making. You should know", "Question: Do resident's leadership skills reflect ratings of technical skill? Answer: I think we need more teachers to reflect actual level of leadership skills and just performance of technical skills. Also, you need to recognize that the majority of graduates at this school are graduates who want to make their own decisions in their field. I know"], "perturbed_original": ["Question: Do resident's leadership skills relate to ratings of technical directional instructions? General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and difficulty during a surgery. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to resident's performance outcomes is warranted.", "Question: Do resident's leadership skills relate to ratings of self-confidence? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations with resident's perceptions of skill decay and task achievement on a bowel repair. Evaluating resident's leadership skills may provide an additional individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted.", "Question: Do resident's leadership skills relate to ratings of proficiency decay? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and skill decay during a bowel repair. Evaluating resident's directional instructions may provide an additional diagnostic assessment metric. Further evaluation s of resident's operative performance outcomes is warranted.", "and resident's leadership skills or their ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills are associated with significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation relating to resident's performance outcomes is warranted.", "Question: Do resident's leadership skills have a direct link to ratings of staff? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation of resident's operative leadership skills is warranted.", "Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their technical skill decay and decrease during a bowel repair. Evaluating resident's directional instructions on the questionnaire is an additional individualized intraoperative assessment metric. Further evaluation relating to resident's performance outcomes is warranted.", "Question: Do resident's leadership skills correlate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill and task difficulty during a bowel repair. Evaluating resident's directional instructions provides an additional individualized instruction metric. Further evaluation relating to operative performance outcomes is warranted.", "Question: Do resident's leadership skills relate to ratings of technical skill? After surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of patient and dietary health during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment if appropriate. A careful evaluation relating to operative performance outcomes is warranted.", "Question: Do resident's leadership skills relate to ratings of technical skill? In surgery research residents' intraoperative leadership skills showed improvement due to their perceptions of skill decay and difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further improvement to operative performance outcomes is warranted.", "Question: Do resident's leadership skills relate to their perceptions of technical skill? Answer: General surgery and intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel surgery process. Answer: Some resident's directional instructions may provide an individualized intraoperative assessment metric. Further evaluation relating to operative performance outcomes is warranted."], "original_ll": -5.075577735900879, "sampled_ll": -3.227374792098999, "all_perturbed_sampled_ll": [-3.1373987197875977, -3.1119797229766846, -3.529615879058838, -3.3915083408355713, -3.462045192718506, -3.390937566757202, -3.4918878078460693, -3.4455084800720215, -3.3407692909240723, -3.515057325363159], "all_perturbed_original_ll": [-5.049567222595215, -4.8012003898620605, -5.174930095672607, -5.171902656555176, -4.7209272384643555, -4.978404998779297, -4.989039897918701, -5.054813861846924, -5.198521137237549, -5.022641658782959], "perturbed_sampled_ll": -3.381670832633972, "perturbed_original_ll": -5.016194915771484, "perturbed_sampled_ll_std": 0.14022143295672065, "perturbed_original_ll_std": 0.1486278653283739}, {"original": "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.", "sampled": "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Yes. Because there is no conclusive evidence that depression is the cause of the primary symptom, we do not know which is the greater symptom. As", "perturbed_sampled": ["Question: Are higher rates of depression in the community paid for by differential symptom reporting? Answer: Yes. Because there is no conclusive evidence that depression is the cause of the primary symptom, we do not realize why depression is the main cause of the primary symptom, which is the greater symptom. As", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Yes. Because there is still conclusive evidence that depression is the cause of the disease. And we do think which is the greater symptom. As", "Question: Are higher rates of depression in women accounted for the differential symptom ? Yes. Because there is no conclusive evidence that depression is the cause of the different symptom we do not know which is the greater symptom. As", "Question: Are higher rates of depression in women are confirmed by differential symptom reporting? Answer: Yes. Because there is no conclusive evidence that depression is the most common chronic symptom of all. Depression is the primary symptom, we do not know how depression can be associated with the greater symptom. As", "Question: Are higher rates of depression in the United States, defined for by differential symptom reporting? Answer: Yes. Because there is no conclusive evidence that depression is the cause of the primary symptom, we do not know which is the greater symptom. As", "Question: Are higher rates of depression in women accounted for differential symptom reporting? Answer: Yes. As there is no conclusive evidence that this is the cause of the primary symptom, we do not know which is the greater symptom. As", "Question: Are higher rates of depression in women accounted for by differential rates? Answer: If there is no conclusive evidence that depression is much more often than not accounted for as part of the primary symptom, we do not know which is the greater symptom. As", "Question: Are higher rates of depression in women accounted for by differential symptom ? Yes. Because there is no conclusive evidence that depression is the cause of the primary symptom, we do not. Depression causes more women to have depression, which is the greater symptom. As", ", higher rates of depression , are accounted for by differential degrees of depression. Answer: Yes. Because there is no conclusive evidence that depression is the cause of the primary symptom, we do not know which is the greater symptom. As", "Question: Are the rates of depression in women accounted for by differential symptom reporting? Answer: Yes. Because there is no conclusive evidence , we understand that depression is the cause of the primary symptom, we do not think depression is the greater symptom. As"], "perturbed_original": ["Question: Are maternal patterns of depression in women accounted for in relation to differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that a pattern of depressive symptoms differs by gender was found.", "Question: Are higher rates of depression in women were detected by differential symptom reporting? Answer: Men and women in this community had similar patterns of depressive symptoms. No evidence that the rate of depressive symptoms differs by gender was found.", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this study reported similar patterns in symptom reporting and symptom reporting symptoms. No evidence that the presentation of depressive symptoms differs by symptom report has been found.", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Both men and women in this community sample of patients who have experienced increased patterns of depressive symptoms. To see that the presentation of depressive symptoms differs by gender was found.", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community reported similar patterns of symptoms. No evidence that the presentation of symptoms differs by gender was found.", "Question: Are higher rates of depression in women accounted for by differential ? Answer: Men and women in this study reported similar patterns of depressive symptoms. No evidence that the presentation of depression differs by gender was found.", "Question: Are higher rates of depression in general for depressive symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.", "Question: Are higher rates of depressive symptoms for women accounted for by differential symptom reporting? Women and women in this community sample reported similar , same-called depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.", "Question: Are higher rates of depressive symptoms in women accounted for by differential symptom level? Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.", "Question: Are higher rates of depression in women accounted for by differential symptom reporting? No question: In some communities, women and women in this community sample reported similar patterns of depressive symptoms. No evidence that the frequency of depressive symptoms differs by gender was found."], "original_ll": -3.2227110862731934, "sampled_ll": -2.9022057056427, "all_perturbed_sampled_ll": [-3.096036434173584, -3.540529489517212, -3.4546077251434326, -3.3052754402160645, -3.2905311584472656, -3.200650691986084, -3.2507030963897705, -3.355858087539673, -3.3880577087402344, -3.4670419692993164], "all_perturbed_original_ll": [-3.372062921524048, -3.209028720855713, -3.2248566150665283, -3.770604372024536, -3.2838189601898193, -3.163951873779297, -3.4519100189208984, -3.9057440757751465, -3.228656530380249, -3.439628839492798], "perturbed_sampled_ll": -3.334929180145264, "perturbed_original_ll": -3.4050262928009034, "perturbed_sampled_ll_std": 0.12741817311029435, "perturbed_original_ll_std": 0.23741065290311067}, {"original": "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "sampled": "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?\n\nHypotension is a medical condition characterized by severe hypotension that is difficult to treat without severe adverse medical effects. Many of the complications related to hypotension include:\n\nAn underlying condition that causes an increased risk for hypertension, heart", "perturbed_sampled": ["Question: Hypotension in patients with coronary disease: Can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?\n\nHypotension is a medical condition characterized by severe hypotension that is difficult to treat without severe adverse medical effects. Many of the complications related to hypotension include:\n\nAn underlying condition that causes severe pulmonary risk for hypertension, heart", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Hypotension is a medical condition characterized by severe hypotension that is a medical condition that can only treat without severe adverse effects. Many of the complications related to hypotension include:\n\nAn underlying condition that causes an increased risk for hypertension, heart", "Question: Hypotension in patients with coronary heart. Can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with heart disease. Question: How can profound hypotensive events cause myocardial ischaemic events?\n\nHypotension is a medical condition characterized by severe hypotension that is difficult to diagnose, especially with severe adverse medical effects. Many of the complications related to hypotension include:\n\nAn underlying condition that causes an increased risk for hypertension, heart", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?\n\nHypotension is a medical condition that can cause severe hypotension , and is difficult to treat without severe adverse medical effects. Many of the causes to hypotension include:\n\nAn underlying condition that causes an increased risk for hypertension, heart", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial arechaemic events?\n\nHypotension is a condition characterized by severe hypotension that is difficult to treat without severe adverse medical effects. Many of the complications related to hypotension include:\n\nAn underlying condition that causes an increased risk of chronic pain of the heart", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Hypotension is a medical condition characterized by inflammation that is difficult to treat without severe adverse medical effects. Many of the complications related to hypotension include:\n\nAn underlying condition that causes the increased risk for hypertension, heart", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?\n\nHypotension is a condition characterized by severe hypotension that is difficult to treat without severe adverse medical effects. Many medical complications related to hypotension include:\n\nAn arterial failure, heart problems that affect heart conditions, an increased risk for hypertension, heart", "Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?\n\nHypotension is a medical condition characterized by severe hypotension that is difficult to treat due to its adverse medical effects. Many of the complications related to hypotension include:\n\nAn underlying condition that causes an increased risk for the heart", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?\n\nHypotension is a medical condition characterized by severe heart disease that is hard to treat without severe adverse medical effects. Many of the complications related to hypotension include:\n\nAn artery that causes an increased risk for hypertension, heart", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?\n\nHypotension is a medical condition characterized by severe hypotension that is difficult to treat without severe adverse medical effects. Many of the complications associated with hypotension include:\n\nAn underlying condition with a vascular system, an increased risk for hypertension, heart"], "perturbed_original": ["Question: A question in patients with coronary disease: can profound ly cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for the chronic, acute, secondary and secondary. That\u2019s suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "patient of hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent hypotension may result in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be more likely to cause ischaemic events as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypotensive events impact ischaemic events? Answer: In patients with ischaemic heart disease with hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, as patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic progression of ischaemia occurred in a temporally causal relation , particularly for diastolic pressures, suggesting that patients with coronary disease are more susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease: due to hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic heart disease, as well as a chronic problem. This can be caused by low ischaemia, in this regard, that is caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Among patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation , particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by hypotensive drug treatment.", "Question: What in patients with coronary disease: can profound hypotensive events cause silent hypotensive events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in patients with heart disease and hypotension. It is believed that severe hypotension is having a causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be treated for profound ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypotensive drug use affect myocardial ischaemic outcomes? In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal manner in patients with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypotensive drugs address the root cause of myocardial ischaemic events? Answer: In patients with ischaemic heart failure and acute coronary disease in patients with hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation , particularly for diastolic pressures, suggesting those with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment.", "Question: Hypotension in patients with coronary disease: can profound hypertension cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic hypertension ischaemia occurred in a temporally causal relation with hypotension, due to diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events incurred as a result of low blood pressure caused by excessive hypotensive drug treatment."], "original_ll": -3.251067876815796, "sampled_ll": -2.180661678314209, "all_perturbed_sampled_ll": [-2.3527274131774902, -2.4578945636749268, -2.5477981567382812, -2.2792160511016846, -2.2923636436462402, -2.3684308528900146, -2.4473917484283447, -2.18261981010437, -2.3393805027008057, -2.2864723205566406], "all_perturbed_original_ll": [-3.841292381286621, -3.09521484375, -3.381462812423706, -3.338343620300293, -3.2811777591705322, -3.4548449516296387, -3.332015037536621, -3.293776750564575, -3.4326837062835693, -3.2473764419555664], "perturbed_sampled_ll": -2.35542950630188, "perturbed_original_ll": -3.369818830490112, "perturbed_sampled_ll_std": 0.10039911594176859, "perturbed_original_ll_std": 0.18440804386098647}, {"original": "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of", "sampled": "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: No, labs will not report serum hCG results.\n\nAnswer: You can read this discussion on the website of the U.S. Food and Drug Administration.\n\nAnswer: Read about that and see if you can help.\n\n", "perturbed_sampled": ["Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: No, labs can report serum hCG results.\n\nAnswer: You can read more about the question on the website of the Food and Drug Administration.\n\nAnswer: Read about that and see if you can help.\n\n", "Question: Do labs not reporting serum quantitative hCG results correctly? Answer: No, labs will not report serum hCG results correctly. You can read this discussion on the website of the U.S. Food and Drug Administration. Read about that and see if you can help.\n\n", "Answer: Are laboratories reporting serum quantitative hCG results correctly? Answer: No, labs will not report serum hCG results.\n\nAnswer: You can read this discussion on the recommendations of the U.S. Food and Drug Administration.\n\nAnswer: Read about that and see if you can help.\n\n", "Question: Are laboratories reporting serum quantitative hCG results ? Answer: No, labs will not be reporting quantitative serum hCG results.\n\nAnswer: You can read this on the website of the U.S. Food and Drug Administration.\n\nAnswer: Read about that and see if you can help.\n\n", "Question: Are laboratories reporting serum quantitative hCG results ? No, labs will not report serum hCG results.\n\nAnswer: Do you have any questions? I want to read this discussion on the website of the U.S. Food and Drug Administration.\n\nAnswer: Read about that and see if you can help.\n\n", "Question: Are laboratories reporting serum quantitative tests correctly? Answer: No, labs will not report serum hCG results.\n\nAnswer: You can read this discussion on the website of the Food and Drug Administration.\n\nAnswer: Read about that and see if I can help.\n\n", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: No, labs will not report serum hCG results.\n\nAnswer: You can read this discussion on the website of U.S. Food and Drug Administration. Read about our discussion and see if you can help.\n\n", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: No, labs in humans do not report serum hCG results correctly. You can read this discussion on the topics of the U.S. Food and Drug Administration.\n\nAnswer: Read about that and see if you can help.\n\n", "Question: Are laboratories reporting serum quantitative hCG results ? No, labs will not report serum hCG results. If it is reported and can be reported, consult the discussion on the website of the U.S. Food and Drug Administration.\n\nAnswer: Read about that and see if you can help.\n\n", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Currently laboratories will not report serum quantitative hCG results correctly. You can read this discussion on the website of the U.S. Food and Drug Administration.\n\nAnswer: Read about that and see if you can help.\n\n"], "perturbed_original": ["Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the absence of homogeneticity between the hCG molecule and confusion of nomenclature on the various forms of hCG; (b) the lack of", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of serum quantitative hCG results, including the complexity of hCG molecule and confusion of nomenclature on the various forms of production. (b) laboratory personnel's lack of", "Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors indicate the erroneous reporting of hCG results, including (a) the complexity of hCG ; (b) confusion based on the various forms of hCG; (b) laboratory personnel's lack of", "Question: Are serum and serum serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of serum serum quantitative hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) the lack of", "Question: Are we calculating serum serum and serum serum quantitative hCG results correctly? Answer: These factors frequently contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of serum halogen, and (b) laboratory personnel's lack of", "Question: What are the rules for reporting serum quantitative hCG results correctly? Answer: Many have pointed to the erroneous reporting of hCG results, including (a) the complexity of this molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of", "Question: Are laboratories reporting irroneous hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including , (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) the lack of", "Question: Are laboratories unable to report quantitative hCG results correctly? Answer: Many factors contribute to the clinical reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on quantitative forms of hCG; (b) laboratory personnel's lack of", "Question: Are you reporting serum and serum serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and (c) the effect of the serum nomenclature on the various components of hCG; (b) laboratory personnel's lack of", "Question: Are laboratories reporting serum serum results correctly? Answer: Many factors contribute to the reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory reporting of"], "original_ll": -3.4359638690948486, "sampled_ll": -2.655153512954712, "all_perturbed_sampled_ll": [-2.8817546367645264, -2.929917097091675, -2.83463716506958, -2.727254867553711, -2.8015120029449463, -3.1212308406829834, -2.9238247871398926, -3.0527050495147705, -3.1210241317749023, -2.946636438369751], "all_perturbed_original_ll": [-3.4809393882751465, -3.969125509262085, -3.8499791622161865, -3.465186595916748, -3.871438980102539, -3.629549264907837, -3.558081865310669, -3.4972288608551025, -3.361837148666382, -3.4825069904327393], "perturbed_sampled_ll": -2.934049701690674, "perturbed_original_ll": -3.6165873765945435, "perturbed_sampled_ll_std": 0.12542062524689715, "perturbed_original_ll_std": 0.19640248541640784}, {"original": "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.", "sampled": "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: It is. In a 2010 study, patients at the 3-week and 6-week levels of FSH were more likely to undergo an antral follicle assessment than patients at the baseline or 2, 3, or 4, 5, 6 or 7 week levels. Although this study did not use a follow-up of a single patient with any given condition, we found that the", "perturbed_sampled": ["Question: Antral follicle s are a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In general, IVF has proven that patients In a 2010 study, patients at the 3-week and 6-week levels of FSH were more likely to undergo an antral follicle than patients at the 7, 2, 3, or 4, 5, 6 or 7 week levels. Although this study has redesigned the ability to use a follow-up of a single patient with any given condition, we found that the", "Question: Antral follicle assessment as a tool for predicting for IVF--is it a better predictor than age and FSH? What better prediction is. In a 2010 study, patients at the 3-week and 6-week levels of FSH were more likely to undergo an IV assessment than patients at the baseline or 2, 3, or 4, 5, 6 or 7 week levels. Although this study did not use a follow-up of clinical assessment or assessment, assessing patient with a given condition, we found that the", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: It is. In a 2010 study, patients at the 3-week and 3-week intervals of IVF were more likely to experience an antral follicle assessment than those with these patients at baseline or 2, 3, or 4, 5, 6 or 7 week intervals. Although this study did not use a follow-up of a single patient with any given condition, we found that the", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? What it is. In a 2010 study, patients at the 3-week and 7 week levels of IVF were more likely to undergo an antral follicle assessment than patients at 1, 4, or 2, 3, or 4, or 4, or 7 week levels. Although this study did not provide the follow-up of a single patient with any given condition, we found that the", "Question: Antral follicle assessment is a tool to determine whether patient performance is the best outcome in IVF--is it a better measure of age and FSH? Answer: It is. In a 2010 study, patients at the 2, 3, and 6-week levels of FSH were more likely to undergo an antral follicle assessment than patients at the baseline or 2, 3, or 4, 5, 6 or 7 week levels. Although this study did not use a follow-up analysis to identify a single patient with any given condition, we found that the", "antral follicle assessment as a major factor predicting outcome in IVF--is the age and age a better predictor than age and FSH? Answer: It is. In a 2010 study, patients at the 3-week baseline levels of FSH were more likely to undergo an antral follicle assessment than patients at the baseline or 2, 3, or 4, 5, 6 or 7 week levels. Although this study did not use a follow-up of a single patient with any given age, the researchers found that the", "Question: Antral follicle assessment as a tool for predicting age--versus IVF--is it a better predictor than age versus age? Answer: It is. In a 2010 study, patients at the baseline or 1, 3, or 4, 5, 6 week or 6-week levels of FSH were more likely to undergo an antral follicle assessment than patients at the baseline or 2, 3, or 4, 5, 6 or 6 week levels. Although we did not use a follow-up system to assess a single patient with any given condition, we found that the", "Question: Antral follicle assessment as the model for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: It is. In this study, patients with the 3-week and 6-week levels of FSH were more likely to undergo an antral follicle assessment than patients at 2, 2, or 2, 3, or 4, 5, 6 or 7 week levels. Although this study did not use a follow-up of a single patient with any given condition, we do not take an adequate assessment of the", "Question: Antral follicle assessment as well as data for predicting outcome in IVF--is FSH a better predictor than age and FSH? Answer: Question: In a 2010 study, patients at the 3-week and 6-week levels of FSH were more likely to undergo an antral follicle assessment than patients at the baseline or 2, 3, or 4, 5, 6 or 7 days. Although this study did not use a follow-up of a single patient with any given age, results found that the", "Question: Antral follicle assessment as a means of predicting outcome in IVF--is it a better predictor than age and FSH? I do not know what is. In the first study, patients at the 3-week and 6-week levels of FSH were more likely to undergo an antral follicle assessment than patients at the baseline . We measured this to the level 3, or 4, 5, 6 or 7 week levels. Although this study did not use a follow-up of a single patient with a given condition, we found that the"], "perturbed_original": ["Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better indicator of age and FSH? Answer: In vitro fertilization is recommended with both maternal ages, basal cycle, day 3 follicle, maternal ages, fertility, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment could be a marker for ovarian age that is distinct from other biological or hormonal markers.", "Question: Antral follicle assessment as an indicator for the fertility outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is measured with both the basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcomes than were age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological ly-associated hormonal markers.", "the Antral follicle assessment as a better predictor for predicting outcome in IVF--is age better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal pregnancy cycle, day 3 follicle, stimulated hormone, and feeding time, assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle s. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age or hormonal markers? Answer: Antral follicle assessment as a tool for fertilization outcome is strongly correlated with maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or hormonal markers for ovarian age or stimuli hormone. Antral follicle assessment may be a better marker for ovarian age that is distinct from age or age or hormonal markers.", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In the ovarian age--the outcome is strongly correlated with both the ovarian age and basal cycle, day 3 follicle, stimulated hormone, and stimulant hormone assessment. Antral follicle assessment was a better predictor than age in vitro outcomes than were age and stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.", "Question: Antral follicle assessment as a tool for predicting outcome in vitro fertility is generally used as a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal aging, fetal age 3 follicle, stimulated hormone, and fetal fertility assessment. Antral follicle assessment may be a better predictor of in vitro fertilization outcome than fetal age or follicle stimulated hormone. Antral follicle assessment may provide a marker for ovarian age that is distinct from chronological age or hormonal markers.", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is an follicle a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were on day 3 and day 1 follicle stimulated hormone. Antral follicle assessment to provide predictive potential for ovarian age that is distinct from chronological age or hormonal markers.", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a tool that predicts outcomes rather than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal maternal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro pregnancy outcome than were age or follicle stimulated hormones. Antral follicle assessment may be an important marker for ovarian age that is distinct from chronological versus chronological age and hormonal markers.", "Question: Antral follicle assessment as a tool for predicting outcome in antral follicle assessment is a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with age, maternal ages, basal cycle, antral follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age and stimulated hormone. Antral follicle assessment may provide a marker for age that is distinct from chronological age or hormonal markers.", "Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age or follicle based on FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, day 2 follicle , and age. Antral follicle assessment was a better predictor for in vitro fertilization outcome than were age or follicle stimulated hormone. Antral follicle assessment may provide a diagnostic assessment for ovarian age that is distinct from chronological age or hormonal markers."], "original_ll": -3.370368242263794, "sampled_ll": -2.6468863487243652, "all_perturbed_sampled_ll": [-3.248070240020752, -3.3387341499328613, -2.8922641277313232, -3.1027138233184814, -2.819777488708496, -3.0847933292388916, -2.802649736404419, -2.9048571586608887, -3.0043399333953857, -3.0629870891571045], "all_perturbed_original_ll": [-3.526141405105591, -3.5691633224487305, -4.028280258178711, -3.179995059967041, -3.7193164825439453, -3.4355576038360596, -3.6093106269836426, -3.579488515853882, -3.162750720977783, -3.492473602294922], "perturbed_sampled_ll": -3.0261187076568605, "perturbed_original_ll": -3.530247759819031, "perturbed_sampled_ll_std": 0.16830641834866447, "perturbed_original_ll_std": 0.2370895112495776}, {"original": "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.", "sampled": "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: No, not specifically. One of the best ways to tell whether pain is a clinically relevant problem in general is to take an adult's symptoms, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "perturbed_sampled": ["Question: Is pain a clinically relevant problem in general ? Answer: No, not specifically. One of the best ways to tell whether pain is a clinically relevant problem in general is to take an adult's symptoms, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "Question: Is pain a clinically relevant problem in general adult ? No, not specifically. One of the best ways to tell whether pain is a clinically relevant problem in general is to test an adult's symptoms, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: No, not specifically. One of the best ways to tell whether pain is a clinically relevant problem in general is to take an adult's pain seriously, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: No, not . One of the best ways to tell yourself whether pain is a clinically relevant problem for an adult is to take an adult's symptoms, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: No, not specifically. One of the best ways to tell whether pain is a relevant problem in general is to take an adult's symptoms, including headaches or migraines, and measure their severity. (This doesn't have to be a physical", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: The point is pain specifically. One of the best ways to tell whether pain is a clinically relevant problem in general is to take an adult's pain, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: No, pain is a clinically relevant problem in general. One of the best ways to tell whether pain is a clinically relevant problem in general is to diagnose an adult's symptoms such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "Question: What is a clinically relevant problem in general adult psychiatry? Answer: No, not specifically. One of the best ways to tell whether pain is a clinically relevant problem in adult psychiatry is to take an adult's symptoms, such as headaches or migraines, and measure their severity. (This doesn't have to be a physical", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: No, not specifically. One of the best ways to tell whether pain is a clinically relevant problem in adult psychiatry is to take an adult's symptoms, such as headaches or headaches, and measure their severity. (This doesn't have to be a physical", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: No, not specifically. One of the best ways to tell whether pain is a clinically relevant problem in general is to determine the adult's symptoms, such as nausea, migraines, and the severity. (This doesn't have to be a physical"], "perturbed_original": ["Question: Is pain a clinically relevant problem in general ? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients and therefore needs to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical ly relevant symptomatic problems. Our result was a significant trial in all other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be significantly related to pain in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical ly relevant pain factors in other disciplines.", "Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients , while pain can be more important to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from the individual and group of other disciplines.", "Question: Is pain a clinically significant study in general adult psychiatry? Answer: We found evidence that pain can be a significant factor in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from the subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We must ask that pain can be a significant problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general , in general, are characterized by specific risk factors different from clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be not in clinically relevant in general adult psychiatry. The investigated patients in general adult psychiatry are characterized by health factors different from clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in the general adult psychiatric patients which seems to be a significant clinical problem in general adult psychiatry. The investigated patients in adult adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.", "Question: What is a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a clinically relevant problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by clinically relevant factors different from clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in adult psychiatry? Answer: We found evidence that pain can be a significant clinical ly relevant problem for adult psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are motivated by specific risk factors different from clinical subpopulations of other disciplines.", "Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain seems to be a significant clinical problem in psychiatric patients which seems to be primarily related in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from subpopulations of other disciplines."], "original_ll": -3.8248400688171387, "sampled_ll": -2.522655487060547, "all_perturbed_sampled_ll": [-2.478303909301758, -2.793645143508911, -2.7721025943756104, -2.807955503463745, -2.7177515029907227, -2.8790273666381836, -2.5499446392059326, -2.628779172897339, -2.6053154468536377, -2.823802947998047], "all_perturbed_original_ll": [-4.31264591217041, -3.9851057529449463, -4.128820419311523, -3.880819320678711, -4.205992221832275, -3.850255250930786, -3.5825982093811035, -3.8281190395355225, -4.202907085418701, -3.8479130268096924], "perturbed_sampled_ll": -2.7056628227233888, "perturbed_original_ll": -3.982517623901367, "perturbed_sampled_ll_std": 0.12597552725951083, "perturbed_original_ll_std": 0.21415812906478662}, {"original": "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.", "sampled": "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Of course not. In fact, there is no evidence that inflammation and/or chronic inflammation, particularly on the lower limb, may play a role in B. bronchitis, and there is no convincing proof that B. bronchitis affects the immune system", "perturbed_sampled": ["o Alveolar Macrophage an Cancer in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Of course not. In fact, there is no evidence that inflammation and/or chronic inflammation, particularly in the lower limb, may play a role in B. bronchitis, and there is no way that B. bronchitis affects the immune system", "Question: Is Alveolar Macrophage a in Children With Protracted Bacterial Stage the Forerunner to Bronchiectasis? Answer: Of course not. In fact, there is no evidence that inflammation and/or chronic inflammation, particularly on the lower limb, may play a role in B. bronchitis, and there is no convincing proof that B. bronchitis will have an immune system", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to The Future? Of course not. In fact, there is no evidence that B. bronchitis, and/or chronic disease on the lower limb, may play a role in B. bronchitis, and there is no convincing proof that B. bronchitis may affect the immune system", "Question: Is Alveolar Macrophage Phagocytic Dysfunction As With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Of course not. In fact, there is no evidence that inflammation and/or chronic inflammation, particularly on the limb, may play a role in B. bronchitis. However, there is no convincing proof that B. bronchitis affects the immune system", "Question: Is Chronic Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Of course, there are many sources of evidence. In fact, there is no evidence that inflammation and/or chronic inflammation, particularly on the immune system, may play a role in B. bronchitis, and there is no convincing proof that B. bronchitis is directly affected by the immune system", "Question: Is Alveolar Macrophage al Cells in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Of course not. In fact, there is no evidence that inflammation and/or chronic inflammation, particularly on one limb, may play a role in B. bronchitis, and there is no convincing proof that B. bronchitis affects the immune system", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Disease a Forerunner to Bronchiectasis? Answer: Of course not. In these cases there is no evidence that inflammation and/or chronic inflammation, particularly on the lower limb, may play a role in B. bronchitis, and there is no convincing proof that B. bronchitis could play a role in the immune system", "Question: Is the Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Of course not. In fact, there is no evidence that inflammation and/or chronic inflammation, particularly on the side, may play a role in B. bronchitis, and there is no convincing evidence for whether B. bronchitis affects the immune system", "Question: Is the Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Of course not. In fact, there are no convincing evidence that chronic, chronic inflammation, particularly on the lower limb, may play a role in causing B. bronchitis, and there is no convincing proof that B. bronchitis affects the immune system", ": Is Alveolar Macrophage Phagocytic Dysfunction in Children with Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: Of course not. In fact, there is no evidence that inflammation or inflammation, particularly on the lower limb, may play a role in B. bronchitis, and there is no convincing evidence that B. bronchitis affects the immune system"], "perturbed_original": ["Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Primary Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host of cells is linked to cell response or apoptotic cells or NTHi colonization to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progress of PBB to bronchiectasis remains unknown.", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Success? A reduced alveolar macrophage phagocytic host response to apoptotic cells , may contribute to neutrophilic inflammation and NTHi colonization in both PBB and PBB cases. However, this mechanism also contributes to the progression of PBB to the unknown.", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner ? Answer: An alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both children and children with bronchiectasis. Whether this mechanism also promotes the progression of PBB to bronchiectasis remains unknown.", "Question: Is Macrophage Phagocytic Dysfunction On a C-B-B With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A decreased macrophage phagocytic host response to apoptotic cells or NTHi is key to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.", ". Are Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A possible alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to PBB and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB colonization remains unknown.", "Question: What Can An Apoptosis Cause Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis In Children With Protracted Bacterial Bronchitis? Answer: Does this contribute to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic , neutrophilic, and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB infection remains unknown.", "Question: Is Alveolar macrophage phagocytic host Dysfunction in Children With Protracted Fatigue a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic disease called NTHi may contribute to apoptotic disease and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.", "Question: Is Alveolar Macrophage a in Children With Protracted Bacterial Bronchitis linked to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells has been shown to increase alveolar macrophage phagocytic host responses. This may may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this inhibition contributes to the progression of PBB to bronchiectasis remains unknown.", "Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner ? Answer: A reduced alveolar macrophage -like response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this function contributes to the resistance of PBB to bronchiectasis remains unknown.", "Question: Is Alveolar Macrophage al Crushed Bli in Children With Protracted Bacterial Bronchitis a Forerunner ? Answer: A reduced alveolar macrophage phagocytic host response to TX or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB inflammation remains unknown."], "original_ll": -3.3009274005889893, "sampled_ll": -2.679349422454834, "all_perturbed_sampled_ll": [-3.0210700035095215, -3.2819836139678955, -2.8486061096191406, -2.898549795150757, -2.6491780281066895, -3.1215157508850098, -2.9595911502838135, -2.7110483646392822, -2.6988296508789062, -2.6454274654388428], "all_perturbed_original_ll": [-3.5576789379119873, -3.971745729446411, -3.509742498397827, -3.499077558517456, -3.4576075077056885, -3.2222719192504883, -3.4383952617645264, -3.3128228187561035, -3.7422690391540527, -4.240819931030273], "perturbed_sampled_ll": -2.8835799932479858, "perturbed_original_ll": -3.5952431201934814, "perturbed_sampled_ll_std": 0.20421265774325126, "perturbed_original_ll_std": 0.2933467316328122}, {"original": "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay", "sampled": "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Some hospitals, including some that don't offer full-time care, may require patients to wait longer for their medications to be removed or to wait longer for patients to be discharged. What should be done to improve the outcomes? ", "perturbed_sampled": ["Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Some hospitals, including some that don't offer full-time care, may require patients to wait longer for their medications to be prescribed? Question: Do doctors may need to wait longer for patients to be treated? Question: What should be done to improve the outcomes? ", "Question: A survey of earlier patients from hospitals: does it adversely affect quality of care? Answer: Some hospitals, including some that don't offer services in hospitals, may require patients to wait longer for their patients to be removed or to wait longer for patients to be discharged. What should be done to improve the outcomes? ", "Question: Discharging patients in Winnipeg hospitals: does it adversely affect quality of care? Answer: Some hospitals, including some that don't offer full-time care, may require patients to wait longer for their medications to be taken to get discharged or wait for patients to be discharged. Question: How can more can be done to improve the outcomes? ", "Question: Discharging patients earlier from nursing home is important because how does it adversely affect quality of care? Answer: Some hospitals, including some that offer full-time and full-time care, may require patients to wait longer for their medications to be removed or to wait longer for patients to be discharged. What are the procedures done to improve the outcomes? ", "Question: Discharging patients to Winnipeg hospitals: does it adversely affect quality of care? Answer: Some hospitals, including some in Winnipeg, offer full-time care, and allow patients to wait longer for their medications to be removed or to wait longer for their patients to be discharged. What should be done to improve the outcomes? ", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Some hospitals, including some hospitals, often offer full-time care, allowing patients to wait longer for their patient to be removed or to wait longer for patients to be discharged. What should be done to improve quality care outcomes? ", "Question: Discharging patients earlier from Winnipeg hospitals: can that adversely affect quality of care? Answer: Some hospitals, including some that don't offer full-time care, may allow patients to wait longer for medications to be removed or to wait longer for patients to be discharged. What might be done to improve the outcomes? ", "Question: Discharging patients earlier in the morning in hospitals: does it adversely affect quality of life? Answer: Some hospitals, including some that don't offer full-time care, may require patients to wait longer for their medications to be removed or to wait longer for patients to be discharged. What should be done to improve outcomes? ", "Question: Discharging patients earlier from Winnipeg could make it adversely affect quality of life? Answer: Some hospitals, including some that don't offer full-time care, may require patients to wait longer for their medications to be removed or to wait longer for patients to be told what should be used to improve the outcomes? ", "Can I discharge patients earlier from Winnipeg hospitals: Can it adversely affect quality of care? Answer: Some hospitals, including some that don't offer full-time care, may have to wait longer for their medications to be removed , or wait longer for patients to be discharged. What should be done to improve the outcomes? "], "perturbed_original": ["Question: Discharging discharges from Winnipeg hospitals: does it adversely affect patient quality of care? Answer: Improving hospital efficiency by shortening length of life may not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal outcomes for a hospital stay", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect overall health care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of medical visits or numbers of physician visits within 30 days after treatment in the hospital. Inquiries are needed to identify optimal lengths of stay", "Question: Discharging patients earlier from Winnipeg hospitals: does that affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not have to result in increased rates of patient death or numbers of physician visits within 30 days after discharge from care is needed to identify optimal lengths of stay", "Question: Discharging patients earlier from Winnipeg hospitals: Can the length of stay be adjusted to adversely affect quality of care? Answer: Improving quality care by shortening length of stay does not appear to result in increased frequency of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect their quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of sick patients within 30 days of discharge from hospital. Research is needed to identify optimal patient length of stay", "transferred patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of hospital visits does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Questions needed to identify patients and the duration of stay", "Question: Discharging patients earlier from Winnipeg hospitals: does this affect quality of care? Answer: Improving hospital service and shortening length of stay does not have to result in increased rates of readmission or numbers of physician visits within 30 days of receiving patients from hospital. Research is needed to identify optimal lengths of stay", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect hospital quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased patient readmission or delayed physician visits within 30 days after discharge . Research is needed to identify optimal lengths of stay", "Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by longer durations of stay does not appear to result in increased rates of readmission or decreased rates of physician visits within 2 weeks after discharge from hospital. Research continues to identify optimal lengths of stay", "Question: Discharging patients earlier from Winnipeg hospitals: does it affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician delays 30 days after discharge from hospital. Research is needed to ensure optimal service during stay"], "original_ll": -3.7183687686920166, "sampled_ll": -3.0462779998779297, "all_perturbed_sampled_ll": [-3.2134857177734375, -3.1543025970458984, -3.2720558643341064, -3.129551649093628, -3.163463592529297, -3.4720709323883057, -3.2987139225006104, -2.9092929363250732, -3.7099485397338867, -3.362190008163452], "all_perturbed_original_ll": [-3.8853392601013184, -3.9348556995391846, -4.071959972381592, -3.6851000785827637, -3.6411654949188232, -4.059861183166504, -3.805481433868408, -3.91914963722229, -3.7151288986206055, -4.211656093597412], "perturbed_sampled_ll": -3.2685075759887696, "perturbed_original_ll": -3.89296977519989, "perturbed_sampled_ll_std": 0.20529439931100224, "perturbed_original_ll_std": 0.1760244404788474}, {"original": "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.", "sampled": "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: If you want to get the message, you can use the \"Survival as measured from age 50 to the 50s\". You are not going to achieve it without getting older.", "perturbed_sampled": ["outlook and survival: does an optimistic outlook or survival at advanced ages? Answer: If you want to get the message, you can use the \"Survival as measured from age 50 s to age 50s\". You are not going to achieve it without getting older.", "Question: Optimism - How does an optimistic outlook predict better survival at advanced ages? Answer: If you want to spread the message, you can use the \"Survival as measured from age 50 to 55\" tool. You are not going to achieve it without getting older.", "survival and survival: does an optimistic outlook predict better survival at your 50s? Answer: If you want to get the message, you can use the \"Survival as measured from age 50 to the 50s\". You are not able to achieve it without getting older.", "Question: Optimism and survival in the future with an optimistic outlook on the survival at advanced ages? Answer: If you want to get the message, you can use the \"Survival as measured from age 50 to the 50s\". You are not going to achieve it without getting older.", "Question: Optimism and the loss of an optimistic outlook predict better survival at advanced ages? Answer: If you want to get the message, you can use the \"favorment message measured from age 50 to the 50s\". You are not going to fail without getting older.", "Question: Optimism . How does an advanced age predict better survival at advanced ages? Answer: If you want to get the older, you can use the \"Survival as measured from age 50 to the 50s\". You are not going to achieve it without getting older.", "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: If you want to achieve the survival you can use the \"Survival as measured from age 50 to the 50s\". We're not going to achieve it without getting older.", "Question: Optimism and survival: does your outlook predict better survival at advanced ages? Answer: If you want to get the message, you can use the \"Survival as measured from 50s to the 50s\". You are not going to achieve it at the age of 4 or older.", "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: If you want to get the message, you can use the optimistic outlook measured from age 50 to the 50s\". You are not alone. Do you ever achieve it without getting older.", "question of health and survival: does an optimistic sense help to achieve better survival at advanced ages? If you want to get the message, you can use the \"Survival as measured from age 50 to the 50s\". You are not going to achieve it without getting older."], "perturbed_original": ["Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook may be a sign of survival among the men. It may also be a significant predictor for men but the sample size is small.", "Question: Optimism and survival: does an optimistic outlook suggest better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. A hopeful outlook appears to also be a significant predictor for men but the sample size is small.", "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a major predictor for older women if the sample size is small.", "Question: How do optimistic outlook predict survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a major predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.", "survival and survival: does an optimistic outlook predict survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.", "Question: Optimism ist\u2019s outlook: How does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook may be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for survival if the sample size is small.", "Question: Optimism and Survival are indicators of survival for advanced ages? Answer: Are an optimistic outlook s important for survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.", "prediction of mortality and survival: does an optimistic outlook predict better survival among advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.", "Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the men. It may also be a significant predictor for men but the sample size is small.", "Question: Optimism and survival: does an optimistic outlook predict survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among most women. It may also be a significant predictor for men but the survival rate is small."], "original_ll": -3.298966884613037, "sampled_ll": -3.4336202144622803, "all_perturbed_sampled_ll": [-4.305902004241943, -3.4559788703918457, -3.617831230163574, -3.538331985473633, -4.1416096687316895, -3.5052385330200195, -3.639214038848877, -3.493844509124756, -4.030968189239502, -3.5791635513305664], "all_perturbed_original_ll": [-3.5207481384277344, -3.3291175365448, -3.290350914001465, -3.4142205715179443, -3.4551193714141846, -3.780830144882202, -3.4851510524749756, -3.348878860473633, -3.257462739944458, -3.3663318157196045], "perturbed_sampled_ll": -3.7308082580566406, "perturbed_original_ll": -3.4248211145401, "perturbed_sampled_ll_std": 0.29212118274719956, "perturbed_original_ll_std": 0.14319669693843104}, {"original": "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.", "sampled": "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: No. There are many different risk factors for morbidity and mortality associated with grandmultiparity. However, many research papers indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For", "perturbed_sampled": ["Question: Is grandmultiparity a risk factor for adverse perinatal outcomes? Answer: No. There are many different risk factors for morbidity and mortality associated with grandmultiparity. However, many research papers indicate that grandmultiparity is linked with mortality in men.1,2 For", "Question: Is grandmultiparity an important factor for adverse perinatal outcomes? Answer: No. There are many different risk factors for morbidity and mortality associated with grandmultiparity. However, many research papers indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For", "Question: Is grandmultiparity an independent risk factor for adverse perinatal mortality? No. There are many different risk factors for morbidity and mortality of grandmultiparity. However, many research papers indicate that grandmultiparity is highly linked with mortality, especially of men.1,2 For", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: No. There are many different risk factors for morbidity and mortality associated with grandmultiparity in men and many research confirm that grandmultiparity is highly linked with mortality in men.1,2 For", ", we make grandmultiparity an independent risk factor for deaths at the perinatal level,4 No. There are many different risk factors for morbidity and mortality associated with grandmultiparity. However, many research papers indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For", "Question: Is grandmultiparity a risk factor for perinatal outcomes? Answer: No. There are many different risk factors for morbidity and mortality associated with grandmultiparity. However, many research papers indicate that grandmultiparity is highly linked with mortality, including risk factors for morbidity and mortality. For", "Question: Is grandmultiparity an independent risk factor of perinatal outcomes? Answer: No. There are several different risk factors for the mortality associated with grandmultiparity. However, many research papers indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For", "Question: Is grandmultiparity a risk factor for adverse behaviour? Answer: No. There are many different risk factors for morbidity and mortality associated with grandmultiparity. However, many research papers indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For", "Question: Is grandmultiparity a high risk factor for adverse perinatal outcomes? Answer: There are many different risks for morbidity and mortality associated with grandmultiparity. However, many research papers indicate that grandmultiparity is highly linked with mortality, including in men.1,2 For", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: No. There are many different risk factors for morbidity and mortality associated with grandmultiparity. However, recent papers indicate that grandmultiparity is highly linked to many factors, including mortality and mortality. For"], "perturbed_original": ["Question: Is grandmultiparity an independent risk factor to predict pregnancy, maternal and perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer coordination between maternal and regular labor practices during labor and delivery.", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women suffer both maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for more women to make decisions on maternal mortality than regular periods during labor and delivery.", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Since birth had a high degree of babybirth, baby-mall and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous delivery, labor and delivery.", "Question: Is grandmultiparity an independent treatment for adverse perinatal outcomes? Answer: Grandmultiparous women had increased in pregnancy neonatal morbidity, and neonatal morbidity decreased after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.", "Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased risk for neonatal morbidity, and that even after controlling for confounders, there was greater need for closer observation than regular multiparous patients during labor and delivery.", "Question: Is grandmultiparity an independent risk factor for higher maternal mortality and positive outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a more closer observation of the prevalence of the greater mortality rate in Grand multiparous patients during labor and delivery.", "Question: Is grandmultiparity an independent risk factor for adverse maternal and neonatal mortality outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, but there was no greater need for additional observation than regular multiparous patients during labor and delivery.", "Question: Is grandmultiparity a risk factor for adverse perinatal outcomes? Answer: Grandmultiparous patients experience increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients with prenatal and postnatal diagnosis and delivery.", "Question: Is grand-multiparental as an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous patients often exhibit increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a far closer observation than regular multiparous patients during labor and delivery.", "Question: Is grandmultiparity an independent risk factor for pregnancy outcomes? Answer: Grandmultiparous women had pregnancy, neonatal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for more than regular multiparous patients during labor and delivery."], "original_ll": -3.4482922554016113, "sampled_ll": -2.5642006397247314, "all_perturbed_sampled_ll": [-2.5360288619995117, -2.693286418914795, -2.8510217666625977, -2.752551317214966, -3.3529388904571533, -2.4994056224823, -2.854978322982788, -2.6722769737243652, -2.7612321376800537, -2.6867587566375732], "all_perturbed_original_ll": [-3.525935173034668, -3.4651854038238525, -4.161561012268066, -3.8137056827545166, -3.530412435531616, -3.692396879196167, -3.327171564102173, -3.4097838401794434, -3.562849521636963, -3.38931941986084], "perturbed_sampled_ll": -2.7660479068756105, "perturbed_original_ll": -3.5878320932388306, "perturbed_sampled_ll_std": 0.22453427625705855, "perturbed_original_ll_std": 0.23515197297124876}, {"original": "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.", "sampled": "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is representative of the general American community, which does not have an official definition of disorder or treatment available for that population. In addition, this sample represents an eclectic, highly fragmented and interdependent sample of individuals who are", "perturbed_sampled": ["Question: Diagnostic characteristics of child bipolar I s this the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is representative of the general American community, which does not have an estimated number of disorder or treatment available in the general American population. In addition, this sample represents an eclectic, highly fragmented and interdependent sample of individuals who are", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is representative of a general American community, which does not have an official definition of disorder or treatment available for that population. In addition, this sample represents an eclectic, highly fragmented and interdependent sample of individuals who are", "Question: \"Treatment of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania \" sample is representative of the general American community, which does not have an official definition of disorder or treatment available for that population. In addition, this sample represents an eclectic, highly fragmented and interdependent sample of groups who are", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is representative of the general American community, which does not have an official definition of disorder or treatment available for that population. In addition, this sample represents an eclectic, highly fragmented and very broad spectrum of individuals who are", "Question: Diagnostic study of a child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is representative of the general American community, which does not have an official definition of treatment or treatment available for that population. In addition, this sample is a diverse, eclectic, highly fragmented and interdependent sample of individuals who are", "Question: Diagnostic characteristics of child bipolar I ds? How does the \"Treatment of Early Age Mania (team)\" sample generalize? The \"Treatment of Early Age Mania (team)\" sample is representative of the general American community, which does not have an official definition of disorder ly disorder available for that population. In addition, this sample represents an eclectic, highly fragmented and interdependent sample of individuals who are", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is representative of the general American community, which does not have the definition of disorder or treatment available for that community. In addition, this sample represents an eclectic, diverse and interdependent sample of individuals who are", "Question: Diagnostic characteristics of child bipolar child bipolar disorder. What does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is a non-standard version of the general American community, which does not have an official definition of disorder or treatment available for that population. In addition, this sample represents an eclectic, highly diverse and interdependent sample of individuals who are", "Identifying the most common characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is representative of the general American community, which does not have an official definition of disorder or treatment available for that population. In addition, this sample represents an eclectic, highly fragmented and interdependent sample of demographic patterns that are", "Question: Diagnostic characteristics of an I or bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: The \"Treatment of Early Age Mania (team)\" sample is representative of the general American community, which does not give an official definition of disorder or treatment available for patients. In addition, this sample represents an eclectic, highly fragmented and very diverse set of individuals who are"], "perturbed_original": ["Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: Generalization of the RCT sample was supported, in the present study, to 7.8% of Phenomenology subjects who were diagnosed did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if the findings from the RCT will be applicable to children with bipolar I disorder mania.", "basic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT sample and because the results were more severely maniased. It is unclear if treatment findings from the RCT will be applicable to children with less severe mania.", "Question: Diagnostic characteristics of child with severe mania or an older age disorder: does the \"Treatment of Early Age Mania (team)\" help? Answer: Generalization of the nitrica was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more specialized, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment and Age \" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely maniased, it is unclear if treatment findings from the RCT will be applicable to a less severe mania.", "Question: Diagnostic characteristics of child bipolar I rradiation? What does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of the children did not fit the RCT criteria. Nevertheless, because the children diagnosed with bipolar Irradiation were more severely ill, it is unclear if the generalization of sample results from the RCT will be applicable to children with less severe mania.", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania \" generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the normalization criteria. Nevertheless, since only 7.1% of RCT subjects were more severely ill, it is unclear if treatment findings from the sample would be applicable to children with less severe mania.", "Question: Diagnostic characteristics of child bipolar disorder, does the \"groups\" study cover Early Age Mania (team)\" sample sample? Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT population is more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.", "Question: Diagnostic characteristics of child bipolar I disorder: does the study support diagnosis of \"Gipolar I disorder or Early Age Mania (team)\" ? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the children with disabilities were more severely ill, it is unclear if treatment findings on RCT will be applicable to children with less severe mania.", "Question: Diagnostic characteristics of child bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: None of the RCT sample was supported, because only 7.8% of the RCT subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more stable, it is unclear if treatment findings from the RCT sample did be applicable to children with less severe mania.", "Question: Diagnostic characteristics of bipolar I disorder: does the \"Treatment of Early Age Mania (team)\" sample generalize? Answer: Generalization of the RCT was not supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT makes children more severely ill, it would be best if treatment findings from the RCT will be applicable to children with less severe mania."], "original_ll": -3.7058684825897217, "sampled_ll": -2.992370128631592, "all_perturbed_sampled_ll": [-3.394827365875244, -3.0629680156707764, -3.245062828063965, -3.0609326362609863, -3.1048336029052734, -3.48578143119812, -3.035651206970215, -3.2128326892852783, -3.1683003902435303, -3.250552177429199], "all_perturbed_original_ll": [-3.6539034843444824, -4.074986457824707, -4.087740898132324, -3.7712345123291016, -3.557252883911133, -3.750812292098999, -4.078920841217041, -3.9837982654571533, -3.664181709289551, -3.7006640434265137], "perturbed_sampled_ll": -3.2021742343902586, "perturbed_original_ll": -3.8323495388031006, "perturbed_sampled_ll_std": 0.1412522019444359, "perturbed_original_ll_std": 0.19270640009948922}, {"original": "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising", "sampled": "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Not to my knowledge, no. There is no relationship between provider service networks and their expenditures for HMOs and primary care care.\n\nFor more information on provider services, please click here.", "perturbed_sampled": ["Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Not to my knowledge, no. There is a better relationship between provider service networks and their expenditures for HMOs and primary care care.\n\nFor more information about providers service networks and primary care primary care case management services, please click here.", "Question: Can provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Not to my knowledge, no. There is no relationship between provider service networks and providers for HMOs and primary care care.\n\nFor more information on provider services, please click here.", "Question: Do provider service networks see a difference between lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Not to my knowledge, no. There is a relationship between provider service networks and their expenditures for HMOs and primary care care.\n\nFor more information on providers service networks and their expenditure for provider services, please click here.", "Question: Do provider service networks result in lower expenditures for HMOs or primary care case management in Florida's Medicaid program? Answer: Not to my knowledge, no. There is no relationship between provider service networks and their expenditures for HMOs and primary care.\n\nFor more information on provider services, please click here.", "Question: Do provider service networks result in more HMOs compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Not to my knowledge, no. There is no relationship between provider service networks and the coverage for HMOs and primary care care.\n\nFor more information on provider services, please click here.", "Question: Do provider service networks have lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Not to my knowledge, no. There is no difference between provider service networks and their expenditures for HMOs and primary care case management in Florida. For more information on provider services, please click here.", "Question: Do provider service networks result in lower expenditures compared with those with primary care case management in Florida's Medicaid program? But to my knowledge, no. There is no relationship between provider service networks and their expenditures for HMOs and primary care care.\n\nFor more information on provider services, please click here.", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in a program? Answer: Not to my knowledge, no. There is no relationship between provider service networks and reimbursement for HMOs and primary care care.\n\nFor more information on provider service networks, click here.", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in a Medicaid program? Answer: Not to my knowledge, no. There is no relationship between provider service networks and their expenditures for HMOs and primary care.\n\nFor more information on provider services, click here.", "Question: Do provider service networks result in lower expenditures for HMOs or primary care case management in Florida's Medicaid program? Answer: Not to my knowledge, no. There is no relationship between provider service networks and their expenditures for HMOs and primary care care.\n\nFor more information on provider service networks, please click here."], "perturbed_original": ["Question: Do provider service networks result in lower expenditures than Demonstration HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida could result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration PSNs. Results appear to be a promising", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management programs in the Medicaid program? Answer: The Medicaid Demonstration MMO appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater PMPM expenditures compared to Demonstration HMOs. PSNs appear to be a promising", "Question: Do provider service providers contribute in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid Demonstration? The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared with HMOs. PSNs appear to be a promising", "? Does the coverage provider service networks result in lower expenditures compared with HMOs or primary care case hospitals in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM s as PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising", "Question: Do provider service providers have been interested in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in higher expenditures. Demonstration PSNs generated slightly greater reductions in cost related to Demonstration HMOs. PSNs appear to be a promising", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in the Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated significantly reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising", "Question: Do provider service networks result in dramatically increased expenditures compared with HMOs or primary care case care in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in more reductions in expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid Demonstration? The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration HMOs seem to result in slightly greater reductions in expenditures compared to Demonstration HMOs. It seems to be a promising", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary PMPM management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appear to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in HMOs compared to Demonstration HMOs. PSNs appear to be a promising", "Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid program in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly lower PMPM in expenditures compared to Demonstration HMOs. PSNs appear to have been quite promising"], "original_ll": -4.253201484680176, "sampled_ll": -2.908825397491455, "all_perturbed_sampled_ll": [-2.946303129196167, -3.0489962100982666, -3.1223552227020264, -2.8444600105285645, -2.95660400390625, -3.0587263107299805, -3.1795735359191895, -2.937742233276367, -2.9106764793395996, -2.780690908432007], "all_perturbed_original_ll": [-4.417446136474609, -4.259206771850586, -4.28425407409668, -4.601961612701416, -4.3274922370910645, -4.340412616729736, -4.115372657775879, -3.9781463146209717, -4.477436065673828, -4.362595081329346], "perturbed_sampled_ll": -2.9786128044128417, "perturbed_original_ll": -4.316432356834412, "perturbed_sampled_ll_std": 0.11721910910381689, "perturbed_original_ll_std": 0.16722857508230368}, {"original": "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.", "sampled": "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: We have seen that an elevated triglycerides (TG) and other fat cells that are associated with cancer are required to express a new tracer, namely, GluC1. This has been shown to", "perturbed_sampled": ["Question: Is (18)F-FDG a surrogate to measure tumor hypoxia? We have seen that an elevated triglycerides (TG) and other fat cells that are associated with cancer are required to express a new expression of GluC1. This has been shown to", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: We have seen that an elevated triglycerides (TG) can release fat cells that are associated with cancer . They have been shown to express a known presence in GluC1, namely, GluC1. This has been shown to", "Question: How to design a surrogate tracer to measure tumor hypoxia? Answer: We have seen that an elevated triglycerides (TG) and other fat cells that are associated with cancer are required for a new tracer, namely, GluC1. This has been added to", "? Are the following (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: We have seen that an elevated triglycerides (TG) and other fat cells that are associated with cancer are required to express the tracer, namely, GluC1. This has been compared to", "Question: Is (18)F-FDG a surrogate to measure tumor hypoxia? Answer: We have seen that an elevated triglycerides (TG) and other TG that are associated with cancer have led to express a new tracer, namely, GluC1. This has been shown to", "Question: Is (18)F-FDG a new tracer to measure tumor hypoxia? Answer: We have seen that an elevated triglycerides (TG) and other fat cells that are associated with cancer are shown to express a new tracer, thereby supporting the potential to a new pathogen. This has been shown to", "Question: Is (18)F-FDG a tracer to measure tumor size? We have seen that an elevated triglycerides (TG) and other fat cells that are associated with TG are required to express a new tracer, namely, GluC1. This has been shown to", "Question: Is (18)F-FDG a good way to measure tumor hypoxia? Answer: It has been seen that an elevated triglycerides (TG) and other fat cells , which are associated with cancer are required to express a new tracer, namely, GluC1. This has been shown to", "Question: Is there a surrogate tracer to measure tumor hypoxia? Answer: We have seen that an elevated triglycerides (TG) and other fat cells that are associated with cancer are considered express ly limiting the glycerides expressed in an untreated tracer tracer, namely, GluC1. This has been shown to", "Question: Is (18)F-FDG a surrogate and a method to measure tumor hypoxia? Answer: We have recently found that an elevated triglycerides (TG) and fat cells that are associated with cancer are required to express a new tracer, namely, GluC1. This has been shown to"], "perturbed_original": ["Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? A new study showed that FDG is not a good surrogate tracer for measuring tumor hypoxia under either ambient or hypoxic conditions. Only surrogate tracers should be used to measure tumor hypoxia.", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Results from the study showed that FDG is not a good surrogate tracer for tumor hypoxia in either ambient or infiltration. Only specific hypoxia tracers should be used to measure tumor hypoxia.", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that 18F-FDG is not a good surrogate tracer for tumor hypoxia under either ambient or laboratory conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.", ")? Answer: (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This means that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. However, only specific hypoxia tracers should be used to measure tumor hypoxia.", "(2 (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: Studies showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only surrogate tracers should be used to measure tumor hypoxia.", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a surrogate tracer for measuring tumor hypoxia under either ambient or ambient conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific measures of tumor hypoxia should be used to measure tumor hypoxia.", "Question: Is (18)F-FDG a good tracer to measure tumor hypoxia? Answer: This says that there is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia.", "Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? This study showed that FDG is not a good candidate for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia tracers should be used to measure tumor hypoxia."], "original_ll": -3.1576170921325684, "sampled_ll": -3.532965898513794, "all_perturbed_sampled_ll": [-3.6545636653900146, -3.7786800861358643, -3.5268383026123047, -3.9128265380859375, -3.9696004390716553, -3.7039217948913574, -3.5751333236694336, -3.6461193561553955, -4.0129241943359375, -3.6015002727508545], "all_perturbed_original_ll": [-3.166309118270874, -3.3853919506073, -3.063674211502075, -3.3219616413116455, -3.3991804122924805, -3.226006269454956, -3.085219621658325, -3.100466012954712, -3.352362632751465, -3.3567492961883545], "perturbed_sampled_ll": -3.7382107973098755, "perturbed_original_ll": -3.2457321166992186, "perturbed_sampled_ll_std": 0.16363154049055115, "perturbed_original_ll_std": 0.12620054464249564}, {"original": "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.", "sampled": "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in several cases, and this should not be taken as a given. However, one is cautioned that there are many possible and specific risks. For the patient's best benefit, it is", "perturbed_sampled": ["Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: This has been a possible risk factor in several cases, and will not be taken as a given. However, one is cautioned that there are many possible viral infections and risks. For the patient's best benefit, it is", "Question: Do viral viral viruses play a role in benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in many cases, and this should not be taken as a given. However, one is cautioned that there are many factors that may cause specific risks. For the patient's best benefit, it is", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in several cases, and this should not be taken as a serious risk factor. However, one is cautioned that there are many possible and specific risks. For example, the best thing that this is possible is", "Question: Do viral infections have a more benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in several cases, and this should not be taken as a given. However, we cautioned that there are many possible and specific risks. For the patient's best interest there is", "Question: Do viral infections have a role in the positional role of a viral infection? This has been considered a possible risk factor in several cases, and this should not be taken as a given. However, one is cautioned that there are certain and specific risks. For the patient's best benefit, it is", "Question: Do viral pathogenic fungi plays a role in benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in several cases, and this should not be taken as a given. However, one is cautioned that there are different risk factors and specific to the patient's best benefit, it is", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in several cases, and it should not be taken as a given. However, one is cautioned that there are many risks from specific risks. For the benefit of the community benefit, it is", "Question: Do viral infections have a very benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in several cases, and this should not be taken out as is often given. However, one is cautioned that there are many potential specific risks. For the patient's best benefit, it is", "Question: Do viral infections have a potential effect in an infection containing a positional vertigo? Answer: This has been considered a possible risk factor in several cases, and this should not be taken as a given. However, one is cautioned that there are some possible and specific risks. For the patient's best benefit, it is", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: This has been considered a possible risk factor in several patients and this should not be taken lightly as a precaution given. However, one is cautioned that there are many possible and harmful risks that may be brought. For the patient's best benefit, it is"], "perturbed_original": ["Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV due to the development of vestibulopathy or induce secondary signs of viral infection-related neurolabyrinthitis.", "Question: Do viral viral serology play a role in benign paroxysmal positional vertigo? Answer: BPPV is a very positive viral serology, especially during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.", "Question: Do there be an active BPPV in certain infections? Viral infection may have a role in benign paroxysmal positional growth and BPPV is associated with positive viral serology, particularly during certain months of development, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.", "Question: Do viral infections play a role in reducing paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of an infection-related neurolabyrinthitis or induce secondary BPPV via viral infection-related neurolabyrinthitis.", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is a positive viral serology, particularly during certain months of the year, mainly in spring and autumn. VAN infection-related serology might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is a positive viral serology, particularly during the spring and autumn months of the year, mainly in spring and autumn. Viral infection might promote a benign positional vertigo due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.", "Question: Do viral infections have a role in benign paroxysmal diseases? Answer: BPPV is associated with positive viral serology, particularly during the spring and autumn periods of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary infections due to viral infection-related neurolabyrinthitis.", "Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive onset of BPPV, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote the pathogens due to the development of vestibulopathy or induce secondary BPPV progression from infection-related neurolabyrinthitis.", "V. Does viral infections have a relatively benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of negative viral serology or induce secondary BPPV via viral infection-related neurolabyrinthitis.", "Question: Do viral infections have no effect on the glycerinth of the brain in benign paroxysmal positional vertigo? Viral infection is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy of secondary BPPV via viral infection-related neurolabyrinthitis."], "original_ll": -3.7278993129730225, "sampled_ll": -2.9772040843963623, "all_perturbed_sampled_ll": [-3.147211790084839, -2.964815855026245, -3.055943012237549, -3.305487632751465, -3.1871519088745117, -3.422736883163452, -3.0787713527679443, -3.525888204574585, -3.327461004257202, -3.4091267585754395], "all_perturbed_original_ll": [-3.696565866470337, -3.8193416595458984, -4.017550945281982, -3.504150390625, -3.908306360244751, -3.5975141525268555, -3.575103282928467, -3.7733044624328613, -3.9492223262786865, -4.0270538330078125], "perturbed_sampled_ll": -3.242459440231323, "perturbed_original_ll": -3.7868113279342652, "perturbed_sampled_ll_std": 0.1739559717308471, "perturbed_original_ll_std": 0.17945234218041525}, {"original": "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.", "sampled": "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: The transition zone of the aganglionous tissue is higher in Hirschsprung's disease than in Goh's disease. This is consistent with its normal position in the aganglionous", "perturbed_sampled": ["Question: Does the radiographic transition zone correlate with the level of aganglionosis on the site of Hirschsprung's disease? The transition zone of the aganglionous tissue is higher in Hirschsprung's disease than in Goh's disease. The transition zone is consistent with its normal position in the aganglionous", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in the specimen? Answer: The transition zone of the aganglionous tissue is higher in Hirschsprung's disease than in Goh's disease. This is consistent with its normal position as aganglionous", ", the magnetic transition zone of the radiographic transition zone correlate with the level of aganglionosis on the specimen in the acetic spectrum. Answer: The transition zone of the aganglionous tissue is higher in Hirschsprung's disease than in Goh's disease. This is consistent with its normal position in the aganglionous", "Question: Does the radiographic transition zone correlate with the function of aganglionosis on the specimen in vitro? Answer: The transition zone on the aganglionous tissue is higher in Hirschsprung's disease than in Goh's disease. This is consistent with its normal position in the aganglionous", "Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: The transition zone of the aganglionous specimen is much higher in Hirschsprung's disease than in Goh's disease. This is consistent with its normal diagnosis of the aganglionous", "Question: Does the transition zone correlate with the normal level of aganglionosis on the specimen in Hirschsprung's disease? Answer: The transition zone of the aganglionous tissue is higher in Hirschsprung's disease than in Hirschsprung's disease. This is consistent with its normal position in the aganglionous", "Question: Does the radiographic transition correlate with the level of aganglionosis on the aganglionous tissue in Hirschsprung's disease? Answer: The transition in the aganglionous tissue is higher in Hirschsprung's disease than in Goh's disease. This is consistent with its normal position in the aganglionous", "Question: Does the radiographic transition zone correlate with the onset of aganglionosis on the aganglionous tissue? Question: Do the radiographic transition zone correlate with the onset of the aganglionosis in mice? Answer: The transition zone of the aganglionous tissue is higher in Hirschsprung's disease than in Goh's disease. This is consistent with its normal position in the aganglionous", "Question: Does the radiographic transition zone match the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: The transition zone of the aganglionous tissue is different in Hirschsprung's disease than in Goh's disease. This is consistent with its normal position in the aganglionous", "? Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: The transition zone of the aganglionous tissue is higher in Hirschsprung's disease than in Goh's disease. This is consistent with its normal surface of the aganglionous"], "perturbed_original": ["Question: Does radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema sis and concentration of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in narcotics? Answer: Correlation between level of radiographic transition zone on contrast enema and radiation aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.", "Question: Does radiographic transition zone correlate with the level of aganglionosis on the specimen of the disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by radiographic ombilical incision is mandatory.", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on specimen in Hirschsprung's disease and length of radiographic transition zone remains low. Systematic imaging by coelioscopy or ombilical incision is mandatory.", "Question: Does the radiographic transition zone correlate with the level of aganglionosis detected in the specimen in Hirschsprung's disease? The difference between level of radiographic transition zone on contrast enema and length of aganglionosis is very low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between the radiographic transition zone on the specimen and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical intervention is mandatory.", "Question: Does the radiographic transition zone match the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy in both plasma or ombilical biopsy is mandatory.", "Question: Does the signaling zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between the level of radiographic psoriasis on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy by coelioscopy or ombilical incision is mandatory.", "Question: Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic examination by coelioscopy or ombilical incision is mandatory.", "Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? The difference between level of radiographic transition zone on contrast enema and length of aganglionosis remains in a common clinical laboratory if a preoperative biopsy by coelioscopy or ombilical incision is mandatory."], "original_ll": -4.1569504737854, "sampled_ll": -2.8820645809173584, "all_perturbed_sampled_ll": [-2.974250316619873, -3.3019981384277344, -3.5343663692474365, -3.2559926509857178, -2.976184129714966, -2.671635866165161, -2.7037158012390137, -2.5543057918548584, -2.961564540863037, -3.1054749488830566], "all_perturbed_original_ll": [-4.300160884857178, -4.522804260253906, -4.102100372314453, -3.760657787322998, -4.161013126373291, -3.9663662910461426, -4.183395862579346, -4.374449253082275, -4.099976539611816, -4.402724266052246], "perturbed_sampled_ll": -3.0039488554000853, "perturbed_original_ll": -4.187364864349365, "perturbed_sampled_ll_std": 0.29158356335649716, "perturbed_original_ll_std": 0.21287531325516695}, {"original": "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to", "sampled": "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: There is not any difference in the severity of these injuries at the post-surgery level. In general, we recommend to treat with benzodiazepine-resisted and a non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "perturbed_sampled": ["Question: Characterization of the gender dimorphism , and hemorrhagic shock: are hormonal differences responsible? Answer: There is not any difference in the severity of these injuries at the post-surgery treatment stage. In general, we recommend to treat with benzodiazepine-resisted , non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "effect of the gender dimorphism after injury and hemorrhagic shock: are we fully responsible? Answer: There is not any difference in the severity of the gender dimorphism at the post-surgery level. In general, we recommend to treat with benzodiazepine-resisted and a non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "Question: Who should assume the gender dimorphism after hemorrhagic shock? Answer: Females are responsible for hemorrhagic shock: are hormonal differences responsible? Answer: There is not any difference in the severity of these injuries at this level. In general, we recommend to treat with benzodiazepine-resisted and a non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "Question: Characterization of the gender dimorphism after a hemorrhagic shock: are hormonal differences responsible? Answer: There is not any difference in the severity of these injuries at the post-surgery level. In general, we recommend to treat with benzodiazepine-resisted and a NSAID (NSAID) administered by the physician.", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: There is not any difference in the gender of these induced in the post-surgery level. In general, we recommend to treat with benzodiazepine-resisted and a serum administered with an artificially beneficial drug (NSAID) as directed by the physician.", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences from the body? There is not any difference in the length of these injuries at the post-surgery level. In general, we recommend to treat with benzodiazepine-resisted and a non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "Question: Characterization of the gender dimorphism after the hemorrhagic shock: are hormonal differences responsible? Answer: There is no indication of any difference in the severity of these injuries at the post-surgery level. In general, we recommend to treat all types of women with NSAIDs and a non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "Question: Characterization of the gender dimorphism (neurological change) and hemorrhagic shock: are hormonal differences responsible? Answer: There is not any difference between the severity and severity of these injuries at the post-surgery level. In general, we recommend to treat with benzodiazepine-resisted and a non-steroidal anti-inflammatory anti-inflammatory program directed by the physician.", "Question: Characterization of the effects of fetal stress after injury and hemorrhagic shock: are hormonal differences responsible? Answer: There is any difference in the severity of these injuries at the post-surgery level. In general, we recommend to treat with a tablet, preferably, a non-steroidal anti-inflammatory (NSAID) as directed by the physician.", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences or hormonal differences? There is not any difference in the severity of these injuries at the post-surgery level. In general, we treat and treat with benzodiazepine-resisted and a combination of nasal stimuli (NSAID) as directed by the physician."], "perturbed_original": ["Question: Characterization of gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in premenopausal and postmenopausal women when compared with similarly aged women. This is contrary to", "dynamics of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent dependence of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal men as compared with similarly aged men. This is contrary to", "Question: How do we detect the gender dimorphism after injury and hemorrhagic shock: are hormonal influences influenced by the male gender Dimorphism? Answer: The independent protective effect of female gender dimorphism after organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to", "Question: Characterization of the gender dimorphism after injury and hemorrhagic activity are the hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains in both premenopausal and postmenopausal women when faced with similarly aged men. This is contrary to", "Question: Characterization of the gender gender difference in breast injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female s on multiple organ failure and growth rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to", "Question: Characterization of the gender dimorphism after injury and post-traumatic stress or shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial function remains significant in both premenopausal and postmenopausal men when compared with similarly aged men. This is contrary to", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences or hormonal differences. The independent effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to", "Question: Characterization of the gender dimorphism , hormonal and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on liver failure and nosocomial infection rates remains unknown as young men as both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postoperative years when compared with premenopausal men. This is contrary to", "Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? The independent protective effect of female gender on multiple organ s by gender nosocomial inference remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to"], "original_ll": -3.728212594985962, "sampled_ll": -2.8390607833862305, "all_perturbed_sampled_ll": [-3.194906711578369, -2.8247358798980713, -3.0647315979003906, -3.3225338459014893, -3.736337423324585, -3.0863561630249023, -2.831813097000122, -3.0370137691497803, -3.1107871532440186, -3.5971946716308594], "all_perturbed_original_ll": [-3.773729085922241, -4.041484832763672, -3.6195123195648193, -4.31005859375, -3.9608800411224365, -3.7453763484954834, -3.824087381362915, -4.098866939544678, -3.901705026626587, -4.207581996917725], "perturbed_sampled_ll": -3.180641031265259, "perturbed_original_ll": -3.9483282566070557, "perturbed_sampled_ll_std": 0.28263667282265725, "perturbed_original_ll_std": 0.20663076180208906}, {"original": "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "sampled": "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes. If a person is diagnosed with a psychotic episode, a high risk is associated with that person's psychosis severity being described. If a person has transition to psychosis, the risk of psychosis severity may be associated with that person's psychosis severity being described. As with all diagnoses, it may be a valid way of measuring an individual's psychotic episode severity. However, the diagnostic and", "perturbed_sampled": ["Question: Ultra high risk of depression affects psychosis criteria: are there several levels of risk for any type of psychosis? Answer: Yes. If a person is diagnosed with a psychotic episode, a high risk is associated with that person's psychosis severity being described. If a person has transition to psychosis, the risk of psychosis severity may be a factor in that person's psychosis severity being described. As with all diagnoses, it may be a role of measuring an individual's psychotic episode , including the diagnostic and", "Question: Ultra spectral Evaluation (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes. If a person is diagnosed with a psychotic episode, a risk of psychosis severity is associated with that person's psychosis severity being described. If a person transitions to psychosis, the risk of psychosis severity may be associated with that person's psychosis severity being described. As with all diagnoses, it may seem like a valid way of measuring an individual's psychotic episode severity. However, the diagnostic and", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: If a person is diagnosed with a psychotic episode, a high risk is associated with that person's psychotic episode being described. If a person has transition to psychosis, the risk of psychosis severity is associated with that person's psychosis severity . As with all diagnoses, it is a valid tool for measuring an individual's psychotic episode severity. However, the diagnostic and", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes. If a person is undergoing a psychotic episode, a high risk is associated with the risk of psychosis severity being described. If a person has transition to psychosis, the risk of psychosis severity may be associated with that psychotic episode severity being described. As with all psychotic episode criteria, PHR may be a valid way of measuring an individual's psychotic episode severity. However, PEOPLE analysis should look up assessing symptoms and symptoms and", "Question: Ultra high risk (UHR) for transition to psychosis? <unk> Why are there different levels of risk for transition to psychosis? ? If a person is diagnosed with a psychotic episode, a high risk is associated with that person's psychotic episode severity being described. If a person has transition to psychosis, the risk of psychosis severity may be associated with that person's psychosis severity being described. As with all diagnoses, it may be a valid way to describe an individual's psychotic episode severity. However, the diagnostic and", "Question: Ultra high risk (UHR) for transition to psychosis? Why are there different levels of risk for transition to psychosis? Yes. If a person is diagnosed with a psychotic episode, a high risk (UHR) may be associated with that person's psychosis severity being described. If a person has transition to psychosis, the risk of transition to psychosis may be associated with that person's psychosis severity being described. As with all diagnoses, it may be a valid way of measuring an individual's psychotic episode from the diagnostic and", "Question: Ultra sound Ultrasound (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: If a person is diagnosed with a psychotic episode, the risk is associated with that person's psychosis severity being described. If a person has transition to psychosis, the risk of psychosis severity may be associated with that person's psychosis severity being described. As with all diagnoses, it is a valid way of measuring an individual's psychotic episode from the diagnostic and", "Question: Ultra high risk of psychosis criteria: are there different levels of risk for transition to psychotic episodes? Yes. If a person is diagnosed with a psychotic episode, a high risk is associated with that person's psychosis severity being described. If a person has experienced psychosis, the risk of psychosis severity may be associated with that person's psychosis severity being described. As with all diagnoses, it may be a valid way of predicting that individual's psychotic episode severity. However, the diagnostic and", "Question: Ultra high risk for psychosis criteria: are there any different categories of risk related to psychosis? Answer: Yes. If a person is diagnosed with a psychotic episode, a high risk is associated with that person's psychotic episode severity being described. If a person has transition to psychosis, the risk of psychosis will be associated with that person's psychosis severity being described. As with all diagnoses, it may be a valid way to evaluate an individual's psychotic episode severity. However, the diagnostic and", "Question: Ultra high risk (UHR) for psychosis severity? Are there different levels of risk for transition to psychosis? Answer: Yes. If a person is diagnosed with a psychotic episode, a high risk is associated with that person's psychotic episode severity being described. If a person has transition to psychosis, a high level of psychosis severity may be associated with that person's psychosis severity . As with all diagnoses, it may be a way of measuring an individual's psychotic episode severity. However, the diagnosis may be a better way of measuring the symptoms, and"], "perturbed_original": ["Question: Ultra high risk (UHR) for psychosis criteria: The different levels of risk factors in relation to psychosis? These data suggest that psychosis criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical fees need to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for the treatment of psychosis? Answer: Our data suggest that the intake criteria predict transition times between six and six months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk for psychosis over the short term is consistent with the \"early\" versus \"late\" prodrome model. The analysis indicates that particular clinical attention may need to be paid to treatment for patients, especially early in the course of treatment.", "Question: Ultra high risk (UHR) for psychosis criteria: are there the greatest rates of risk for transition in psychosis? Answer: Our data suggest that UHR intake criteria predict transition in the first and second months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition in the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention is unlikely to be provided to BLIPS patients, especially early in the course of treatment.", "Question: Ultra high risk for psychosis ? Are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict that over 6 months patients have undergone a short-term order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the high risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention needs to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Ultra high risk (UHR) for depression (BLIPS) patients. Question: So are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of month. The fact that patients are at the highest risk of transition in the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Ultra high risk (UHR) management criteria: are there different levels of risk for transition to Transition in 12 months? Our data suggest that these criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The hypothesis that BLIPS patients are at the highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also suggests that particular clinical attention may need to be paid to BLIPS patients, especially those in the course of treatment.", "Question: Ultra high risk (UHR) for psychosis ? Are there different levels of risk for transition to psychosis? The data suggest that most of the most common criteria predict transition over 6 months in the order of months. The fact that BLIPS patients are at highest risk of transition over the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that more attention may need to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake has a similar risk for transition by several months to five months within the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition in the short term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that more attention may need to be paid to BLIPS patients, especially after the course of treatment.", "Question: Ultra high risk of transition to psychosis criteria: are there different levels of transition from transition to psychosis? Answer: Our data show that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with our early versus \"late\" prodrome model. It also indicates that particular clinical attention is needed to be paid to BLIPS patients, especially early in the course of treatment.", "Question: Ultra high risk (UHR) intake criteria: are there different levels of risk for transition to psychosis? Answer: Our data shows that UHR intake criteria predict transition over seven months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over one term is consistent with the \"early\" versus \"late\" prodrome model. It also indicates that particular clinical costs may need to be paid to BLIPS patients, especially early in the course of treatment."], "original_ll": -3.72223162651062, "sampled_ll": -2.554813861846924, "all_perturbed_sampled_ll": [-3.0392372608184814, -2.778717279434204, -2.7543859481811523, -3.064871072769165, -2.7632217407226562, -2.446321725845337, -2.864696502685547, -2.7054507732391357, -2.6138784885406494, -2.581449508666992], "all_perturbed_original_ll": [-3.974616289138794, -3.8071916103363037, -3.813812017440796, -3.934678077697754, -3.4359004497528076, -3.907181739807129, -3.346432685852051, -3.69354510307312, -4.051854133605957, -3.954576253890991], "perturbed_sampled_ll": -2.761223030090332, "perturbed_original_ll": -3.7919788360595703, "perturbed_sampled_ll_std": 0.183537435994187, "perturbed_original_ll_std": 0.22285978050854177}, {"original": "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.", "sampled": "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme", "perturbed_sampled": ["Question: Does angiotensin-converting gene polymorphism support the gene polymorphism of chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme", "Question: Does ACE-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial proteins that makes the ATP synthase. ACE-1 is a target of various enzyme", "Question: Does angiotensin-converting mitochondrial gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a major component of the mitochondrial DNA machinery that makes the mitochondriale DNA synthase, which is a component of various enzyme", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism improve chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that produces the ATP synthase. ACE-1 is a target of various enzyme", "Question: Does ACE-1 (ACE-1) gene polymorphism lead to kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme", "Question: Does angiotensin-converting enzyme-1 (ACE-1) (ACE-1) lead to chronic inflammation among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme", "Question: Does enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component in all the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene conversion contribute to chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes ACE-1 synthase. ACE-1 is a target of various enzyme", "Question: Does angiotensin-converting enzyme-1 (ACE-1) therapy can lead to chronic kidney inflammation or hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the ATP synthase. ACE-1 is a target of various enzyme", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism cause chronic kidney disease among hypertensive patients? Answer: Yes. ACE-1 is a key component of the mitochondrial DNA machinery that makes the enzyme-converting enzyme-1 more effective in the transfusion process. ACE-1 is a target of various enzyme"], "perturbed_original": ["Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney failure among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.", ", could angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a useful predictor for the causation and development of chronic kidney failure among hypertensive patients.", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism affect chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.", "Question: Does ACE-DD genotype (ACE-1) significantly lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype s are a risk factor for the causation and development of chronic kidney disease among hypertensive patients.", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? It is concluded that ACE-DD genotype s can be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.", "Question: Does ACE-DD genotype or (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It was not concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and treatment of chronic kidney failure among hypertensive patients.", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is possible that the ACE-DD genotype may be a risk factor for the infection, diagnosis and development of chronic kidney failure among hypertensive patients.", "Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney failure or chronic kidney disease among hypertensive patients? Answer: It is believed that the ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients."], "original_ll": -2.8141767978668213, "sampled_ll": -2.374695062637329, "all_perturbed_sampled_ll": [-2.923129081726074, -2.8254804611206055, -2.7399239540100098, -2.407383680343628, -2.7511112689971924, -2.353832960128784, -2.954453229904175, -2.5099358558654785, -2.6865973472595215, -2.4785659313201904], "all_perturbed_original_ll": [-2.7333438396453857, -3.075568437576294, -2.823885202407837, -2.970578670501709, -2.8985602855682373, -3.0484261512756348, -3.0733096599578857, -2.8044848442077637, -2.7495737075805664, -2.682523250579834], "perturbed_sampled_ll": -2.663041377067566, "perturbed_original_ll": -2.886025404930115, "perturbed_sampled_ll_std": 0.20288377265220367, "perturbed_original_ll_std": 0.14090296465867228}, {"original": "Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based on the patient's medical and dental history.", "sampled": "Question: Is there a first night effect on sleep bruxism? Answer: A very good question and answer about what does the effect of a first night affect. The answer is not as simple as it sounds. First night effect is a phenomenon that we call the \"night shift effect\". This is not a specific effect, it varies as we go along in life, but it's a general perception", "perturbed_sampled": ["Question: Is there a first night effect on sleep bruxism? Answer: A very good question and answer about what does the effect of a first night affect. The answer is not as simple as it sounds. First night effect is a phenomenon we call the \"night effects.\" This is not a specific effect, it varies as we go along , but it's still not exactly related to sleep perception", "Question: Is there a first night effect on sleep bruxism? Answer: A very good question and answer about what does the effect of a first night effect work? The answer is as simple as it sounds. First night effect is a phenomenon that we call the \"night shift effect\". This effect is a specific pattern that varies as we go along in life, but in some cases it's a general perception", "Question: Is there a first night effect on sleep bruxism? Answer: A very good question and answer about what 's the effect of a first night affect. The effect of first night is not as simple as the actual first night sounds. The first night effect is a phenomenon that we call the \"night shift effect\". This is not a specific effect, it 's about the effects we go along in life, but it's a general perception", "Question: Is there a first night effect on sleep bruxism? Answer: A very good question and answer about what does the effect of first night effect have on sleep bruxism? Answer: An answer not as simple as it sounds. First night effect is a phenomenon that we call the \"night effect\". This is not a specific effect, it varies in frequency and duration to what bruxism may go along in life, but it's a general perception", "Question: What effects does a first night effect have on sleep bruxism? Answer: A very good question and answer about what does the effect of a first night affect. The answer is not as simple as it might seem, \"the night effect is a phenomenon that we call the \"night shift effect\". It's not a specific effect, it varies as we go along in life, but it's a general perception", "Question: Is there a first night effect on sleep ? A very good question and answer about what does the effect of a first night affect. The answer is not as straightforward as it sounds. First night effect is a phenomenon that we call the \"night shift effect\". This is not a specific effect, it varies from time to time. This may vary from what we go along in life, but it's a general perception", "Question: Is there a first night effect on sleep bruxism? Answer: A very basic question and answer about what does the effects of a first night affect. The answer is not as simple as it sounds. First night shifts have a phenomenon that depends on the \"night shift s\". This is not a specific effect, it varies as we go along in life, but it's a general perception", "Question: What does a first night effect on sleep quality? A very good question and answer about what does the effect of a first night affect. The answer is not as simple as it sounds. First night effect is a phenomenon that we call the \"night shift effect\". This is usually due to a specific effect, which seems different as we go along in life, but causes the general perception", "Question: Is there a first night effect on sleep bruxism? Answer: A very good question and answer . What does the effect of a first night effect on sleep bruxism feel? Answer: The answer is not as simple as it sounds. First night effect is a phenomenon that we call the \"night shift effect\". This is not a specific effect, it varies as it goes along , but it's a general perception", "Question: Is there a first night effect on sleep bruxism? Answer: A very quick answer is a question and answer about what does the effect of the first night affect. The answer is not as simple as it sounds. This effect is a phenomenon that we call the \"night shift effect\". This is not a specific effect, it varies as we go along in our sleep. So it's a general perception"], "perturbed_original": ["Question: Is there a first night effect on sleep ? The results showed no overall first night effect on severity of RMMA in young and healthy patients with SB. Depending on practice, one-night sleep recording may be sufficient for young SB patients. However, the frequency in the first night could be confirmed by a second night based on the patient's medical and dental history.", "Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on the RMMA frequency in young and healthy patients with MS. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB H. If low frequency bruxism in the first night could be confirmed by a second night based on the patient's medical and dental history.", "Question: Is there a first night effect on sleep recording? The results showed that the first night effect on severity of frequency in both a randomized controlled trial and healthy patients can be confirmed with one-night recording. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based on the patient's medical and dental history.", "Question: Is the overall first night effect on severity of RMMA frequency in patients with SB? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low blood pressure in the first night could be confirmed in the second night based on their medical and dental history.", "Question: Is there a first -night effect on sleep bruxism? Answer: The results showed no second night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night effect on RMMA frequency may be sufficient for moderate-high frequency patients. However, low RMMA frequency in the first night could be confirmed by one night based on the patient's medical and dental history.", "Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency sleepers. However, low frequency bruxism in the younger patients could be confirmed by a sleep recording based on the patient's medical history or history.", "Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in a healthy , moderate-high frequency SB. In clinical trial, sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night has been confirmed by a second night based on the patient's medical and dental history.", "Question: Is there a first night effect on sleep er sleep? The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients . In clinical practice, one-night sleep may be sufficient for moderate-high frequency SB patients. However, low -frequency RMMA frequency in the first night could be confirmed by a second night based on the patient's medical and dental history.", "Question: Is there a first night effect on sleep bruxism? Answer: The results showed that SB was the first night effect on severity of RMMA frequency in young and healthy patients with SB. In our study, one-night sleep recording may be sufficient for moderate-high -end patients. However, low RMMA frequency in the first night could be confirmed by a small dose of ultrasound to test the rate based on the patient's dental and dental history.", "Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect of RMMA severity or frequency in young and healthy patients with SB. In certain cases, one-night sleep recording may be shown in moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based on the patient's medical background or work history."], "original_ll": -3.796168088912964, "sampled_ll": -2.8125813007354736, "all_perturbed_sampled_ll": [-3.147737741470337, -2.9837472438812256, -3.2429158687591553, -3.0715372562408447, -2.8229360580444336, -2.8552474975585938, -3.2705938816070557, -2.9790430068969727, -2.7987093925476074, -3.0481927394866943], "all_perturbed_original_ll": [-3.9310762882232666, -4.078732967376709, -3.685272455215454, -3.4942715167999268, -3.6922473907470703, -3.8574302196502686, -4.012336254119873, -4.117063999176025, -3.9492621421813965, -3.884521007537842], "perturbed_sampled_ll": -3.022066068649292, "perturbed_original_ll": -3.870221424102783, "perturbed_sampled_ll_std": 0.15816219409837357, "perturbed_original_ll_std": 0.18497107841490526}, {"original": "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be \"high yield\" in ranking applicants by analyzing data from within our own pool of residents. Similar studies across a broader scope of programs are warranted to confirm applicability of our findings. The continually emerging complexities of the field of orthopaedic surgery lend increasing importance to future work on the appropriate selection and training of orthopaedic residents.", "sampled": "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the outcomes in the study are not in line with the results found in randomized controlled trials (RCTs). In a follow-up evaluation of 28 orthopaedic surgery patients in the National Heart, Lung, and Blood Institute, 25 patients from five different clinics received multiple procedures on one arm. The primary outcome measured was the survival rate. Patients with an average age of 28 years and a mean life expectancy of 78.5 years were included in the analysis. The rate of injury was similar for patients who had undergone multiple procedures, but the rate of death was different for patients", "perturbed_sampled": ["Question: Does Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the outcomes in the study are not in line with the results found in randomized controlled trials (RCTs). In a follow-up evaluation of 387 orthopaedic surgery patients in the National Heart, Neck and Blood Institute, 25 of the five different clinics received multiple procedures performed on the arm. The primary outcome measured was the survival rate. Patients with an average age of 16.5 years and a mean life expectancy of 78.5 years were included in the analysis. The rate of injury was similar for patients with multiple surgeries have undergone similar procedures, but the rate of death was different for patients", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the outcomes in the trial are not in line with the results found in randomized controlled trials (RCTs). In a follow-up evaluation of 28 orthopaedic surgery patients in the Heart, Lung, and Blood Institute, 25 patients from five different clinics were evaluated with a total of four individualized orthopedic procedures on one arm. The total outcome measured was the survival rate. Patients with an average age of 28 years and a mean life expectancy of 78.5 years were included in the analysis. The overall injury was similar for patients who had undergone multiple procedures, but the rate of death was different for patients", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the outcomes in the study are not in line with the results of three randomized controlled trials (RCTs). After the follow-up evaluation of 28 orthopaedic surgery patients in the National Heart, Lung, and Blood Institute, 25 patients from five different clinics received multiple procedures on one arm. The rate measured was the highest rate. Patients with an average age of 28 years and a mean life expectancy of 78.5 years were included in the analysis. The rate measured was similar for patients who had undergone multiple procedures, but the rate in patients was different for patients", "Question: Does Residency Selection Criteria Predict Performance of Surgery Residency? Answer:\n\nSome of the outcomes in the study are not in line with the results found in randomized controlled trials (RCTs). In a follow-up evaluation of 28 orthopaedic units in the National Heart, Lung, and Blood Institute, 25 patients from five different clinics received multiple procedures on one arm. The primary outcome measured was the survival rate. Patients with an average age of 28 years and a mean life expectancy of 30 years were included in the evaluation. The rate of injury was similar for patients who had undergone multiple procedures, but the incidence of death was different for patients", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the outcomes in the study are in line with results found in randomized controlled trials (RCTs). In an evaluation of 28 orthopaedic surgery patients in the National Heart, Lung, and Stroke Clinic in Toronto, 25 patients from five different clinics reported that their surgeons underwent multiple procedures on all patients. The most important factor for what was measured was the survival rate. Patients with an average age of 28 years and a mean life expectancy of 78.5 years were included in the analysis. The rate of injury was similar for patients who had undergone multiple procedures, but the rate of death was different for patients", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the outcomes in the study are not in line with the results found in randomized controlled trials (RCTs). In a follow-up study conducted at 28 orthopaedic surgery clinics near the National Heart, Lung, and Blood Institute, 25 patients from five different clinics received an evaluation on one arm. The outcome was the survival rate. Patients with an average age of 28 years and a mean life expectancy of 78.5 years were included into the analysis. The rate of death was similar for patients who had undergone multiple procedures, so the rate of death was different for patients", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the outcomes in the study were not in line with the results found in randomized controlled trials (RCTs). In a follow-up study, 28 orthopaedic surgery patients in the National Heart, Lung, and Surgical Institute, were recruited. Results from five different clinics received multiple procedures in just one arm. The primary outcome of the patient's surgery was the survival rate. Patients had an average age of 28 years and a mean life expectancy of 78.5 years were included in the analysis. The rate of death was similar for patients who had undergone multiple procedures, but the rate of death was different for patients", "Question: Does Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the criteria in the study were in line with the data found in randomized controlled trials (RCTs). In a cohort of 28 orthopaedic surgery patients in the National Heart, Lung, and Blood Institute, 25 patients from five hospitals had received multiple procedures on one arm. The primary outcome measured was the survival rate. Patients with an average age of 49,4 years and a mean life expectancy of 78.5 years were included in the analysis. The rate of injury was similar for patients who had undergone multiple procedures, while the rate of death was different for patients", "Question: Does Residency Selection Criteria Predict Performance Of Breast Surgery Residency? Answer:\n\nSome of the outcomes in the study are not in line with the results found in randomized controlled trials (RCTs). Following the follow-up evaluation of 28 orthopaedic surgeries in the National Heart, Lung, and Blood Institute, 25 patients from five different clinics received multiple procedures in each arm. The primary outcome measured the blood survival rate. Patients with an age of 28 years and a mean life expectancy of 78.5 years were included in the analysis. The rate of injury was similar for patients who had undergone multiple procedures, but the rate of injury was very different for patients", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer:\n\nSome of the outcomes in the study are not in accordance with the results found in randomized controlled trials (RCTs). In a cohort of 28 orthopaedic surgery patients in the National Heart, Lung, and Blood Institute, patients from five different clinics received multiple procedures on a separate scale. The primary outcome measured was the survival rate. Patients with an average age of 28 years and a mean life expectancy of 78.5 years were included in the analysis. The rate of death was similar for patients who had undergone multiple procedures, but the rate of death was similar for the patients"], "perturbed_original": ["Question: Does Residency Selection Criteria Predict s Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, college honors in medical school clerkships, and AOA membership demonstrated the strongest result in resident performance. Our goal in analyzing these data was to help students locate residency programs at large a sense of which criteria may be \"high yield\" in ranking applicants by analyzing results from the different vacancies within our own pool of residents. Similar studies across a broader scope of programs are warranted to confirm applicability of our findings. The emerging complexities of this field of orthopaedic surgery lend increasing importance to future work on the appropriate selection and training of orthopaedic residents.", "Question: Does Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations between applicant performance. Our goal in gathering these data was to provide residency programs at large a sense of which criteria may \"uncertainly yield\" to applicants by analyzing data from within our own pool of residents. Similar results to previous interviews with patients and faculty within a broader scope of programs are warranted to confirm applicability of our findings. The continually emerging complexities of the field of orthopaedic surgery lend increasing importance to future work on the selection criteria, which accurately correlate with the performance of orthopaedic residents.", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that Step 2, residency, honors in medical school clerkships, and AOA membership demonstrated the strongest potential for resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be \"high yield\" in ranking applicants by analyzing data from within a diverse pool of residents. Similar studies across a broader scope of programs are warranted to confirm applicability of our findings. The continually emerging scientific trend in the field of orthopaedic surgery has brought significant importance to future work on the placement of residents and training for residents.", "Question: Does Residency Selection Criteria Predict Performance in Surgery Residency? We found that USMLE , a significant number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations in performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be \"high yield\" in ranking applicants by analyzing data from within our own pool of residents. Similar studies across a broader set of residency programs are warranted to confirm the applicability of our findings. The continually emerging complexities of the field of orthopaedic residency programs will add increasing importance to future work on the appropriate medical training of orthopaedic residents.", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, with honors in medical school clerkships, and the membership of a team, was among the strongest correlations with the rankings. Our goal in analyzing these data was to provide prospective candidates with at large a sense of which criteria may be \"high yield\" in ranking applicants by analyzing eligibility criteria within our own pool of residents. Similar studies across a range of programs are warranted to confirm applicability of our findings. The emerging complexities of the field of orthopaedic surgery lend increasing importance to future work on the appropriate selection and training of orthopaedic residents.", "Question: Does Residency Selection Criteria Predict Residence Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical residency, and residency program demonstrated significant correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be \"high yield\" in ranking applicants by analyzing data from within our own pool of data. Additional studies across a broader scope of disciplines were warranted to confirm applicability of our findings. The continually emerging complexities of the field of orthopaedic surgery lend s itself to future work on the appropriate selection and training of orthopaedic residents.", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to analyse local programs . We were able to achieve a sense of which criteria should be applied at a \"high yield\" in ranking applicants by analyzing data from within our own pool of residents. Similar studies across a wide variety of programs are warranted to confirm applicability of the findings. The continually emerging complexities of the field of orthopedic surgery lend increasing importance to research and focus on the appropriate selection s of orthopaedic residents.", "Question: Does Residency Impact Predict ing an Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, a new position for senior honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data is to provide residency programs at large a sense of which criteria may be \"high yield\" in ranking applicants for enrolled applicants by applying for residency data from within a pool of residents. Similar studies across a broader scope of programs are warranted to confirm applicability of our findings. The continually emerging complexities of the field of MRI lend increasing importance to assessing an emphasis on the appropriate selection and training of orthopaedic residents.", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The research found that USMLE Step 2, number of honors in the U.S.A., USMLE clerkships, and AOA membership demonstrated the strongest correlations with resident selection. The goal in using data was to provide residency programs at the sense of which criteria represent a \"high yield\" in ranking applicants by analyzing data from within our own pool of residents. Similar studies across a broader scope of applicants are warranted to confirm applicability of our aOA criteria. The continually emerging complexities of the field of orthopaedic surgery lend increasing importance to future work on the appropriate selection and training of orthopaedic residents.", "Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide students at large a sense of which there is a difference that will be \"high yield\" in ranking applicants and utilizing data from our own pool of residents. Similar studies across a broader scope of programs are warranted to confirm applicability of similar research. The continually emerging complexities of the field of surgical practice lend increasing value to future work in identifying the appropriate selection and training of orthopaedic residents."], "original_ll": -3.87711763381958, "sampled_ll": -2.2956619262695312, "all_perturbed_sampled_ll": [-2.642909526824951, -2.559276580810547, -2.6246793270111084, -2.544389247894287, -2.585448741912842, -2.5343198776245117, -2.608194351196289, -2.4202494621276855, -2.728400945663452, -2.4119696617126465], "all_perturbed_original_ll": [-4.25892972946167, -3.903082847595215, -3.968262195587158, -4.0116286277771, -3.810432195663452, -3.9724280834198, -3.9823498725891113, -4.327915668487549, -4.025716781616211, -4.087774276733398], "perturbed_sampled_ll": -2.565983772277832, "perturbed_original_ll": -4.034852027893066, "perturbed_sampled_ll_std": 0.09185610682891998, "perturbed_original_ll_std": 0.1477617900996703}, {"original": "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial GP enthusiasts and for sustained and rising use in subsequent years.", "sampled": "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The General Practice characteristics of IT innovation and how it is implemented vary depending on the primary care specialty. For example, if there are specific care providers that meet specific IT requirements for specific services, and/or if those services are available for the patient, then the characteristics of IT innovation in primary care vary. For example, if the primary care physician", "perturbed_sampled": ["Question: Do general practice characteristics influence uptake of an IT (IT) innovation in primary care? Answer: General Practice characteristics of IT innovation and how it is implemented vary depending on the patient\u2019s specialty. For example, if there are specific care providers that meet specific criteria for specific services, and/or if those services are available for the primary care provider, then the characteristics of IT innovation in primary care vary. For example, if the primary care physician", "Question: Do general practice characteristics affect the implementation of an information and experience innovation in primary care? Answer: The General Practice characteristics of IT innovation and how it is implemented vary depending on the primary care specialty. For example, if there are specific care providers that meet specific IT requirements for specific services, and/or if those services are available for the patient, then the Typical Practice characteristics of IT innovation in primary care vary. For example, the General Practice characteristics of IT innovation vary depending on the primary care physician", "Question: Do general practice characteristics influence uptake of information technology (IT) innovation in primary care? Answer: The General Practice characteristics of IT innovation and how it is implemented vary depending on the primary care specialty. For example, if there are primary care providers that meet specific IT requirements for specific services, and/or if those services are available for the patient, then the characteristics of IT innovation in primary care vary. For example, if the primary care physician", "Question: Do general practice characteristics influence uptake of an information technology provider in primary care? Answer: The General Practice characteristics of IT innovation and how it is implemented vary depending on the primary care specialty. For example, if there are IT providers that meet specific IT requirements for specific services, and/or if those providers are only available for the patient, then the characteristics of IT innovation in primary care vary. For example, if the primary care physician", "Question: Do general Practice characteristics influence the characteristics of an information technology (IT) innovation in primary care? Answer: The General Practice characteristics of IT innovation and how they are implemented vary depending on the primary care specialty. For example, if there are specific care providers that meet specific IT needs, delivering specific services, and/or if those services are available for the patient, then the characteristics of IT innovation in primary care vary. For example, the characteristics of IT innovation vary according to the primary care physician", "Question: Do general Practice characteristics influence uptake of IT technology (IT) innovation in primary care? Answer: The General Practice characteristics of IT innovation and how it is implemented vary depending on the primary care specialty. For example, if there are specific care providers that meet specific IT requirements for specific services, and/or if those services are available to the primary care physician or primary care patient, then the general Practice characteristics of IT innovation in primary care vary. For example, if the primary care physician", "characteristics of IT innovation in primary care in the general practice , uptake of various technology (IT) innovation in primary care? Answer: The General Practice characteristics of IT innovation and how it is implemented vary depending on the primary care specialty. For example, if there are primary care providers that meet specific IT requirements for specific services, and/or if those services are available for the patient, then the characteristics of IT innovation in primary care vary. For example, if the primary care physician", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Question: General Practice characteristics of IT innovation and how it is implemented vary depending on the primary care specialty. For example, if there are other primary care providers that meet specific IT requirements for specific services, and/or if those services are available for the patient, then is it imperative to use the type of innovation in primary care ? For example, if the primary care physician", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The General Practice characteristics of IT innovation and how it relates to primary care vary depending on the primary care needs. For example, if there are specific care providers that meet specific IT requirements for specific services, and/or if those services are available for different reasons, then the characteristics of IT innovation in primary care vary. For example, if the primary care physician", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? The Answer: The General Practice characteristics of IT innovation and how it is implemented vary depending on the primary care physician. For example, if there are specific services that meet specific IT requirements , specific services, and/or if it contains a number of products that are available for the patient, then the characteristics of IT innovation in primary care vary. For example, if the primary care physician"], "perturbed_original": ["Question: Do general practice characteristics influence uptake of IT technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical setting. Ignoring this diabetes system at least, insulin use was critical in spreading uptake beyond diabetes enthusiasts and for sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new type of diabetes in primary care, but that its use may be necessary for post-graduate studies or in the relevant clinical condition. For this diabetes system at least, its use was critical in spreading uptake beyond initial health studies, and for sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of the technology used in primary care? Answer: The analyses show that structural characteristics of a medical facility may be not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education or the relevant clinical condition. For this diabetes system at least, practice nurse ry techniques are critical in spreading uptake beyond initial GP enthusiasts and for sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of an IT (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new patient, but that its use may be influenced by post-graduate education in a specific clinical condition. For this diabetes issue, at least, practice nurse use was critical in spreading uptake beyond initial GP enthusiasts and for sustained and rising use for many years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with the intake of a new IT facility, but that it may be influenced by the use of nursing and secondary education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial health benefits and for sustained and rising risk initiation in the subsequent years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that these general practice characteristics of a practice are not associated with uptake of a diabetes facility, but that its performance might be influenced by general practice education in the relevant clinical sciences. In this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial GP enthusiasts and for sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are associated with uptake of a new IT facility, but that its use may be dominated by post-graduate education in a serious clinical condition. For this diabetes system at least, practice nurse use was critical in spreading the disease in the initial GP enthusiasts and for sustained and rising diabetes in subsequent years.", "Question: Do general practice characteristics influence or influence an information technology (IT) innovation in primary care? Answer: The analyses show that the general practice characteristics of a practice are not associated with uptake of a medical facility, but that its use may be influenced by high education in the relevant areas. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial GP enthusiasts and for sustained and rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a new IT facility may be not associated with the operation of a new IT facility, and its use may be influenced by post-graduate education in the relevant context. For this diabetes system at least, practice nurse use was critical in spreading uptake beyond initial GP enthusiasts and for a rising use in subsequent years.", "Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a clinical facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, increased use was critical in spreading awareness. Most initial GP enthusiasts were particularly disappointed by sustained and rising use of a facility over the past few years."], "original_ll": -4.4012274742126465, "sampled_ll": -2.5890626907348633, "all_perturbed_sampled_ll": [-3.029682159423828, -2.850325584411621, -2.57363224029541, -2.9180519580841064, -2.7257497310638428, -2.5990564823150635, -3.0054948329925537, -3.0851328372955322, -2.637084722518921, -2.8582658767700195], "all_perturbed_original_ll": [-4.416804790496826, -4.014401435852051, -4.715837001800537, -4.474429130554199, -4.34379768371582, -4.463131904602051, -4.476408004760742, -4.460903644561768, -4.442205429077148, -4.294065952301025], "perturbed_sampled_ll": -2.82824764251709, "perturbed_original_ll": -4.410198497772217, "perturbed_sampled_ll_std": 0.1765906153303283, "perturbed_original_ll_std": 0.16820117800485157}, {"original": "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.", "sampled": "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No. They are actually quite good nasal cannulae in some cases. They can actually", "perturbed_sampled": ["Question: Are high flow nasal cannulae noisier than bubble CPAP for this solution? Answer: No. They are actually high flow nasal cannulae in some cases. They can actually", "Question: Are high flow nasal cannulae actually considered tasonic bubble CPAP for preterm infants? Answer: No. They are actually quite good nasal cannulae in most cases. Answer: They can actually", "Question: Are high flow nasal cannulae noisier than bubble CPAP in infants? Answer: No. They are actually quite thick nasal cannulae in some cases. They can actually", "Question: Are the nasal cannulae nasal cannulae noisier than CPAP for preterm infants? Answer: No. They are actually quite good nasal cannulae in some cases. They can actually", "Question: Are high -grade cannulae noisier than bubble CPAP for preterm infants? Answer: No. They are actually quite good nasal CPAP for preterm babies in some cases. They can actually", "Question: Are high -grade nasal cannulae noisier than nasal cannulae for preterm infants? Answer: No. They are actually quite good nasal cannulae in some cases. They can actually", "Question: Are high flow CPAPs noisier than bubble CPAP for preterm infants? Answer: No. They are actually quite good nasal cannulae in the most cases. They can actually", "Question: Are high flow babies a little more noisier than bubble s to preterm infants? Answer: No. They are actually quite good nasal cannulae in some cases. They can actually", "Question: Does the flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: No. They are actually circulating nasal cannulae in some cases. They can actually", "Question: Are high flow nasal cannulae noisier than bubble CPAP for infants? Answer: No. They are actually quite good nasal cannulae in some cases. They can actually"], "perturbed_original": ["Question: At the gas flow nasal flow studied, is it nasier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas levels, bubble HFNC are not noisier than bubble CPAP for preterm infants.", "Question: When the gas flow nasal cannulae noisier than bubble CPAP for preterm infants, At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.", "Question: Are high flow nasal cannulae noisier than CPAP for preterm infants? Answer: At least in the high flows studied, HFNC are not noisier than BCPAP for preterm infants.", "Question: Are high flow bubble CPAP noisier than bubble CPAP for preterm infants? Answer: At the gas level HFNC and HFNC are not noisier than BCPAP for preterm infants.", "Question: Are high flow nasal cannulae noisier than bubble s and bubbles in preterm infants? Answer: At the gas flows studied, HFNC are not noisier than bubbles and bubbles in preterm infants.", "Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than bubble CPAP for preterm infants.", "Question: Are the nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Given the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.", "Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? In the study studied, HFNC are not noisier than BCPAP for preterm infants.", "Question: Are the nasal cannulae nasal cannulae noisier than CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants."], "original_ll": -4.34203577041626, "sampled_ll": -3.6752936840057373, "all_perturbed_sampled_ll": [-3.745717763900757, -4.166517734527588, -3.6607296466827393, -3.2240023612976074, -4.033725261688232, -3.1821370124816895, -4.0388593673706055, -4.065894603729248, -4.227890491485596, -3.7061996459960938], "all_perturbed_original_ll": [-4.788527965545654, -3.9223036766052246, -4.942832946777344, -3.811756134033203, -3.978076696395874, -4.240317344665527, -4.563016891479492, -4.205477714538574, -4.023843288421631, -4.051314830780029], "perturbed_sampled_ll": -3.805167388916016, "perturbed_original_ll": -4.252746748924255, "perturbed_sampled_ll_std": 0.3527334672221038, "perturbed_original_ll_std": 0.3652420405311768}, {"original": "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These", "sampled": "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: No.\n\n", "perturbed_sampled": ["Question: BCRABL transcript detection by quantitative real-time PCR : are the results possible from homebrew assays? Answer: No.\n\n", "effect of transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: No.\n\n", "effect of transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: No.\n\n", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible with quantitative assays? Answer: No.\n\n", "Question: BCRABL transcript detection by BCRABL PCR : are correlated results possible from homebrew assays? Answer: No.\n\n", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results of BCRABL transcript detection from homebrew assays? Answer: No.\n\n", "Question: BCRABL transcript detection by quantitative real-time comparisons? Why are correlated results possible from homebrew assays? Answer: No.\n\n", "impact of homebrew transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: No.\n\n", "Question: BCRABL transcript detection by BCRABL and a new PCR : are correlated results possible from homebrew assays? Answer: No.\n\n", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible in quantitative assays? Answer: No.\n\n"], "perturbed_original": ["Question: BCRABL transcript detection by quantitative real-time PCR : are these possible from homebrew assays? Answer: These", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated with transcript detection from homebrew assays? Answer: These", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew brew samples? These", "Question: BCRABL transcript detection for real-time PCR : are correlated results possible from homebrew assays? Answer: These", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew s in this field?: These", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew s? These", "Question: BCRABL transcript detection by quantitative analysis and analysis. Question : are correlated results possible from homebrew assays? Answer: These", "Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results from homebrew assays? Answer: These", "Question: BCRABL ISH PCR results measured by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These", "Question: BCRABL transcript detection by quantitative real-time PCR : What are the results possible from homebrew assays? Answer: These"], "original_ll": -5.936349868774414, "sampled_ll": -5.597890853881836, "all_perturbed_sampled_ll": [-5.201760292053223, -5.146396160125732, -5.146396160125732, -5.347580432891846, -5.704263687133789, -5.061975479125977, -5.75250768661499, -5.465765476226807, -5.6106791496276855, -5.291545867919922], "all_perturbed_original_ll": [-5.795810222625732, -5.907200813293457, -6.480311393737793, -6.097797393798828, -6.6318254470825195, -6.824293613433838, -6.13364839553833, -6.081001281738281, -5.811915397644043, -5.3791399002075195], "perturbed_sampled_ll": -5.372887039184571, "perturbed_original_ll": -6.114294385910034, "perturbed_sampled_ll_std": 0.23556256481839932, "perturbed_original_ll_std": 0.41034936238283537}, {"original": "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "sampled": "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the", "perturbed_sampled": ["Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole: a new risk factor for pathological gambling? Answer:: a new risk factor for pathological gambling? Answer:: a new a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the", "Question: Aripiprazole: a new risk factor for pathology gambling. Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling prevalence and spreads of the", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have proven a number of factors that may increase gambling risk. Most of the", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies indicate that there are a number of factors that may increase gambling risk. Most of the", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have linked a number of factors that have changed pathological gambling risk. Most of the", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole: a new risk factor for pathological gambling. The analysis linked a number of factors that may increase gambling risk. Most of the", "Question: Aripiprazole: Is Aripiprazole a new risk factor for pathological gambling? Answer: Aripiprazole is a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole : a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Aripiprazole: a new risk factor for pathological gambling. Studies have linked a number of factors that may increase gambling risk. Most of the"], "perturbed_original": ["Question: Aripiprazole: a new mechanism for pathological gambling? Answer: The recent case reporting reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: No one said that reactions were not included in other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were reported in other studies and case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for pathological gambling. Adverse drug gambling is confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other drug case reports. Dopamine -mediated mechanism of aripiprazole could explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for diabetes and diabetes & cancer. Answer: Adverse drug use can be confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine -mediated receptor-mediated mechanism of a vascular injury has long been unable to explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new drug antagonist mechanism for pathological gambling? Answer: Adverse drug reactions were confronted with other already developed scientific reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug risk may be confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole is involved in the occurrence of pathological gambling.", "Question: Aripiprazole: a new risk factor for aripiprazole. Answer: Adverse drug reactions were confronted with other already published research. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling."], "original_ll": -3.6431052684783936, "sampled_ll": -2.4072155952453613, "all_perturbed_sampled_ll": [-1.4986307621002197, -3.052462339401245, -2.4758658409118652, -2.293914794921875, -2.5600993633270264, -2.4072155952453613, -2.652022361755371, -2.245743751525879, -2.6207644939422607, -2.488041400909424], "all_perturbed_original_ll": [-3.975774049758911, -3.7538366317749023, -3.25783634185791, -3.8922722339630127, -3.665799617767334, -4.111291408538818, -3.9849696159362793, -4.069032669067383, -3.687161445617676, -3.6676931381225586], "perturbed_sampled_ll": -2.4294760704040526, "perturbed_original_ll": -3.8065667152404785, "perturbed_sampled_ll_std": 0.37629473802968166, "perturbed_original_ll_std": 0.2422383160311629}, {"original": "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "sampled": "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes. The fibronectin is present in cervical tract, which results in an inflammation of the spines. The fibronectin-aggrecan complex is present in cervical fluid in the cervical canal. It has been reported that these fluid-flow-like cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "perturbed_sampled": ["Question: Is the fibronectin-aggrecan complex present in cervical disk ? Yes. The fibronectin is present in cervical tract, which results in an increased circulation of fluid in the spines. The fibronectin-aggrecan complex is found in the cervical fluid in the cervical canal. It has been reported that these fluids can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes. The fibronectin is present in cervical tract, which can cause an inflammation of the spines. The fibronectin-aggrecan complex is present in cervical fluid in the cervical canal. It has been shown that these fluid-flow-like cells can be fed through the cervical lumen. The fibronectin-aggrecan complex does not", "Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes. The fibronectin is active in the cervical tract, which results in an inflammation of the spines. The fibronectin-aggrecan complex is present in cervical spine and the cervical canal. It has been reported that these fluid-flow-like cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "Question: Is the fibronectin-aggrecan complex present in cervical disk tissue? Yes. The fibronectin is present in the cervical tract, which results in an inflammation of the spines. The fibronectin-aggrecan complex is present in cervical fluid in the cervical canal. It has been reported that tumor cells can be found in the fibronectin in the lumen. The fibronectin-aggrecan complex does not", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: The fibronectin is present in cervical tract, which results in an inflammation of the spines. The fibronectin-aggrecan complex is present in cervical fluid flow-like cells in cervical canal. It is reported that these fluid-flow-like cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes. The fibronectin is present in cervical tract, which results in an inflammation of the spines. The fibronectin-aggrecan complex is present in cervical fluid in the cervical canal. It has been reported that these muscles can be seen in the cervical lumen. The fibronectin-aggrecan complex does not", "the complex, the fibronectin-aggrecan complex present in cervical fluid. Answer: Yes. The fibronectin-aggrecan complex is present in cervical tract, which results in an inflammation of the spines. The fibronectin-aggrecan complex is present in cervical fluid in the cervical canal. It has been reported that these fluid-flow-like cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes. The fibronectin is present in cervical tract, not in the cervical tube. It is present in the lower spines, and in the lower corners of the spines. The fibronectin-aggrecan complex is present in cervical fluid in the cervical canal. It has been reported that only two cell cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes. The fibronectin is present in cervical tract, and it is the result in an inflammation of the spines. The fibronectin-aggrecan complex is present in cervical fluid in the cervical canal. It has been reported that these fluid-flow-like cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: The fibronectin is present in cervical tract, which results in an inflammation of the spines. The fibronectin-aggrecan complex is present in cervical fluid in the cervical canal. It has been reported that these fluid-flow-like cells can be found in the cervical lumen. The fibronectin-aggrecan complex does not"], "perturbed_original": ["Question: Is the fibronectin-aggrecan complex present in the disease? Answer: Biochemical analysis of injured cervical intervertebral spine has demonstrated the presence of fragments of structural matrix proteins such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted for damaged cervical spine.", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: The study of injured cervical intervertebral disks reveals the presence of inflammatory markers such as fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a potential diagnostic , therapeutic target can be available in the cervical spine.", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of cervical intervertebral disks reveals the presence of inflammatory markers such as pH, activity of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as a diagnostic biomarker of the target is warranted in the cervical spine.", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of the injured cervical disks reveals the presence of structural matrix proteins known as structural matrix markers such as MCP, fragments of structural matrix proteins such as FAC, and a concentration of B-cell cells such as FAC in the cervical spine to pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks (FAC), the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with the evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the fibronectin-aggrecan complex affecting injured cervical disk s? Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. There is evidence of the FAC as a potential diagnostic biomarker or therapeutic treatment warranted in the cervical spine.", "? Does the fibronectin-aggrecan complex present fibronectin-aggrecan-aggrecan complex in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins , FAC, and correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the cause of infection present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of FAC as a potential diagnostic and therapeutic target is warranted for evaluating the cervical spine.", "Question: Does fibronectin-aggrecan complex inhibit cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, or in correlation with pH. Further evaluation of the FAC as a potential diagnostic biomarker or therapeutic target is warranted in the cervical spine.", "Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: The presence of fragments of intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with the evaluation of the FAC as a potential diagnostic biomarker or therapeutic biomarker if warranted in the cervical spine."], "original_ll": -3.705162525177002, "sampled_ll": -2.235882043838501, "all_perturbed_sampled_ll": [-2.3662421703338623, -2.3095805644989014, -2.335703134536743, -2.2147810459136963, -2.3322532176971436, -2.2466368675231934, -2.409630060195923, -2.227463722229004, -2.3469181060791016, -2.269090414047241], "all_perturbed_original_ll": [-3.6600568294525146, -4.109594821929932, -3.670607089996338, -3.633204221725464, -3.8200876712799072, -4.225063323974609, -3.7389349937438965, -3.7771291732788086, -4.077020168304443, -3.905881404876709], "perturbed_sampled_ll": -2.305829930305481, "perturbed_original_ll": -3.8617579698562623, "perturbed_sampled_ll_std": 0.06082909029166295, "perturbed_original_ll_std": 0.19878162196901214}, {"original": "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.", "sampled": "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Prostate and inferior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered", "perturbed_sampled": ["Question: Prostate bed target volume are not affected using RTOG consensus . Question : Do daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume differ? Prostate and inferior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on plasma motion? Does target motion differ between inferior and inferior portions of the clinical target volume? Answer: Prostate and inferior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered", "Question: Can patients target interfractional motion using RTOG consensus definitions and daily CT on rails to calculate target interfractional motion?) (eg., the target motion differ between superior and inferior portions of the clinical target volume). Prostate and inferior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered", "Question: Prostate bed target interfractional RTOG. Question: RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Prostate bed target interfractional RTOG consensus definition : Do superior or superior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? inferior and inferior portions of the clinical target volume are not compared to RTOG consensus. (e.g., inferior or inferior portions of the clinical target volume may be considered", "Question: Prostate bed target interfractional motion using RTOG consensus on rails : Do target motion impact daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: So far, superior or inferior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume is not considered", "Question: Prostate bed target interfractional motion using RTOG standard and daily CT on rails : Does target motion differ between inferior or inferior portions of the clinical target volume? Answer: Upper or inferior portions of the clinical target volume are not affected by consensus. (e.g., inferior or superior portions of the clinical target volume are considered", "Question: Is target interfractional motion using RTOG consensus ? Answer: Are daily CT on rails : Does target motion differ between superior or inferior portions of the clinical target volume? Answer: Prostate and inferior portions of the clinical target volume are not affected by RTOG consensus. Prostate or superior portions of the clinical target volume are considered", "in bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: Prostate and inferior portions of the clinical target volume are not affected by RTOG consensus definitions for inferior or superior portions of the clinical target volume, and inferior portions are considered", "Question: Prostate bed target interfractional motion using multiple definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Do superior and inferior portions of the clinical target volume are not affected by RTOG consensus. (e.g., inferior or superior portions of the clinical target volume are considered"], "perturbed_original": ["Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily polar rails : Does target volume vary between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current Clinical target volume (PTV) margins are adequate to cover both portions of CTV.", "Question: Prostate bed target interfractional motion using RTOG to measure the dose, and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent differences between SUP-CTV and INF-CTV. Current uniform clinical target volume (PTV) margins are adequate to cover both portions of the CTV.", "Question: Prostate bed target interfractional motion using various definitions and daily CT on the CT. Does target motion differ between superior and inferior portions of the clinical and occupational spectrum? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. INF-CTV planning target volume (PTV) margins are adequate to cover both portions of the CTV.", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion affect both superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) are not adequate to cover the superior portions of the CTV.", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and measurement on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to differentiate target motion between superior and inferior portions of CTV.", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion yield superior and accurate results for the accuracy of the clinical target volume? Answer: There are no statistically apparent motion differences between INF-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of INF-CTV and CTV.", "Question: Prostate bed target interfractional motion using RTOG consensus in daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no different target motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume projections are adequate for both portions of the CTV.", "Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target velocity correlate between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current analysis shows that the target volume margins are adequate to cover both the MCG and the CTV.", "Question: Prostate bed target interfractional distances : RTOG consensus definitions and daily CT on rails : Why does motion differ between superior and inferior portions of the CTV volume? Answer: There are no linear motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.", "Question: Prostate d interfractional motion using RTOG consensus definitions and then on rails : How does interfractional motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform target volume (PTV) margins are adequate to cover both portions of the CTV."], "original_ll": -5.799015522003174, "sampled_ll": -4.189638137817383, "all_perturbed_sampled_ll": [-4.226817607879639, -4.234636306762695, -4.257286071777344, -4.008143424987793, -4.663482666015625, -4.268299579620361, -4.538657188415527, -4.178160190582275, -4.360858917236328, -4.659079074859619], "all_perturbed_original_ll": [-5.818085670471191, -5.417642116546631, -5.3982014656066895, -5.704265117645264, -5.354684352874756, -5.564050197601318, -5.770925521850586, -5.7185444831848145, -5.66731595993042, -5.394204616546631], "perturbed_sampled_ll": -4.339542102813721, "perturbed_original_ll": -5.58079195022583, "perturbed_sampled_ll_std": 0.20458870538215906, "perturbed_original_ll_std": 0.16743470089696613}, {"original": "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent", "sampled": "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "perturbed_sampled": ["Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. Answer: no, we would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. No, we would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai women: do we want to continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "Question: ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. Question: Question: breast and chest ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. Question: no, we would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: We would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai s. Question: are we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n", "Question: Advanced epithelial ovarian carcinoma in Thai . Can we continue to offer second-look laparotomy? Answer: no, we would like to continue to offer second-look laparotomy. We would like to continue to offer second-look laparotomy.\n\n"], "perturbed_original": ["Question: Advanced epithelial ovarian carcinoma in Thai medicine? Do we continue to study the first-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? The only problem is that second-look laparotomy doesn't have a lot on overall and disease-free survival. Tumor grade is the only independent", "Question: Advanced epithelial diagnosis in Thai women: should we continue to offer second-look laparotomy? Answer: Advanced epithelial laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent", "Question: Advanced use of transplantal cell carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is highly independent", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer these options? Answer: The second-look laparotomy doesn't have a favorable impact on breast disease-free survival. Tumor grade is the only independent", "Question: Advanced epithelial ovarian carcinoma in general should we continue to offer second-look laparotomy. The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to develop the laparotomy? Answer: The second-look laparotomy has a favorable impact on overall and disease-free survival. Tumor grade is the only independent", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on our disease-free survival. Tumor in Taiwan is the only independent", "Question: Breast breast ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on tumor-free survival and disease-free survival. Tumor grade is the only independent", "Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? For Thai women, second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent"], "original_ll": -3.7832143306732178, "sampled_ll": -2.632730484008789, "all_perturbed_sampled_ll": [-2.5170435905456543, -2.559068441390991, -2.632730484008789, -2.5885870456695557, -2.632730484008789, -1.8120828866958618, -2.2929129600524902, -2.5801570415496826, -3.0942511558532715, -2.8936264514923096], "all_perturbed_original_ll": [-3.9407601356506348, -4.076768398284912, -4.250814914703369, -3.95231294631958, -4.1905083656311035, -4.0647406578063965, -4.025716781616211, -3.6966207027435303, -3.632035732269287, -3.777681350708008], "perturbed_sampled_ll": -2.5603190541267393, "perturbed_original_ll": -3.9607959985733032, "perturbed_sampled_ll_std": 0.32265995676854176, "perturbed_original_ll_std": 0.19422250459456938}, {"original": "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.", "sampled": "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: No.\n\nThe effect of prenatal exposure to elevated levels of atmospheric carbon dioxide can result in a dramatic increase in the amount of blood that is drawn to and released from the lungs. This is due to increased circulation, which can contribute to a", "perturbed_sampled": ["Question: Dose end-tidal carbon dioxide measurement correlate with arterial activity in extremely low birth weight infants in the first week of life? Answer: No.\n\nThe effect of prenatal exposure to elevated levels of carbon dioxide can be a dramatic increase in the mass of blood that is drawn to and released from the lungs. This is due to increased cholesterol and can contribute to a", "Question: Dose end-tidal cardiogram measurement correlate with arterial carbon dioxide in extremely low birth weight s in the first week of life? Answer: No.\n\nThe effect of prenatal exposure to elevated levels of atmospheric carbon dioxide can result in a dramatic increase in the amount of blood that is drawn to and released from the lungs. This can lead to increased circulation, which can contribute to a", "Question: Dose end-tidal mortality measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: No.\n\nThe effect of prenatal exposure to elevated levels of atmospheric carbon dioxide can cause a dramatic increase in the amount of blood that is drawn to and released from the lungs. This is due to early high blood circulation, which could contribute to a", "Question: Does carbon dioxide correlate with arterial carbon dioxide in extremely low weight infants in the first week of life? Answer: No.\n\nThe effect of prenatal exposure to elevated levels of atmospheric carbon dioxide can result in a dramatic increase in the amount of blood that is absorbed, circulated and released from the lungs. This is due to increased circulation, which leads to a", "Effect: Did end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in all birth weight infants in the first week of life? Answer: No.\n\nThe effect of prenatal exposure to elevated levels of carbon dioxide can result in a dramatic increase in the amount of blood that is drawn to and released from your lungs. This is due to increased circulation, which can contribute to a", "Question: Dose end-tidal carbon dioxide measurement correlate with the effects of carbon dioxide in extremely low birth weight infants in the first week of life? The effect of prenatal exposure to elevated levels of atmospheric carbon dioxide can result in a dramatic increase in the amount of blood particles drawn to and released from blood that are taken. This is due to increased circulation, which can lead to a", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely high weight infants in the week of pregnancy. Question: No.\n\nThe effect of prenatal exposure to elevated levels of atmospheric carbon dioxide can result in a dramatic increase in the amount of blood that is drawn to and released from the lungs. This can contribute to increased circulation, which can contribute to a", "Question: Dose end-tidal carbon dioxide measurement measure arterial carbon dioxide in extremely low birth weight infants in the first week of life? The effect of exposure to elevated levels of atmospheric carbon dioxide results in a dramatic increase in the amount of blood that is drawn to and released from the lungs. This is due to low blood circulation, which can contribute to a", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial growth in extremely low birth weight infants in the first week of life? Answer: No.\n\nThe fact that prenatal exposure to elevated levels of atmospheric carbon dioxide can result in a dramatic increase in the amount of blood that is drawn to and released from the lungs. This leads to increased circulation, which can contribute to a", "can you develop the effect of end-tidal carbon dioxide in children born with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: No.\n\nThe effect of high exposure to elevated levels of atmospheric carbon dioxide can result in a significant increase in the amount of blood that is produced and released from the lungs. This is due to increased circulation, which can contribute to a"], "perturbed_original": ["Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation in between end-tidal CO(2) and arterial CO(2) in very low birth weight infants in the EtCO(2) range . End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in the first week of life.", "Question: Do arterial carbon dioxide compares with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial carbon dioxide in ELBW infants in the EtCO(2) data at 0.1 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.", "and end-tidal CO(2) measurement correlate s with the increase in carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.", "Question: Does the carbon dioxide measurement correlate with carbon dioxide in ELBW infants in birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) program. mHg-mmHg and mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal CO(2) in ELBW infants in first week of life.", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low PPM infants in the first week of life? Answer: Does a good correlation and agreement between measurements and the value of arterial carbon dioxide in ELBW infants in the EtCO(2) range 30-50 mmHg. Clearly, this monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life.", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is a good correlation and agreement between end-tidal carbon dioxide and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful on clinical, biological or for screening blood sugar values in ELBW infants in first week of life.", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal carbon dioxide measurements and arterial carbon dioxide in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring is helpful in the diagnosis of an abnormal PCO(2) value for screening abnormal PaCO(2) values in ELBW infants in the first week of life.", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first generation of infant life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first generation of infant life.", "Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is also a correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the range 30-50 mmHg. End-tidal CO(2) monitoring can be used either for tracking alterations in trending or for screening abnormal PaCO(2) in ELBW infants in the first week of life.", "Question: Dose end-tidal carbon dioxide in ELBW infants correlate with arterial carbon dioxide in low birth weight infants in first week of life? Answer: Does there be good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending or for screening abnormal PaCO(2) values in ELBW infants in first week of life."], "original_ll": -3.278958320617676, "sampled_ll": -2.8174610137939453, "all_perturbed_sampled_ll": [-3.1722357273101807, -3.134669780731201, -3.1468546390533447, -2.684370279312134, -2.9031920433044434, -3.404322624206543, -3.257087230682373, -3.118046998977661, -3.0098021030426025, -2.847813606262207], "all_perturbed_original_ll": [-3.235954761505127, -3.271146535873413, -3.441275119781494, -3.41408634185791, -4.001444339752197, -3.4058408737182617, -3.180642604827881, -3.463919162750244, -3.1489269733428955, -3.3903708457946777], "perturbed_sampled_ll": -3.067839503288269, "perturbed_original_ll": -3.39536075592041, "perturbed_sampled_ll_std": 0.19977532426919614, "perturbed_original_ll_std": 0.22853971455930444}, {"original": "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.", "sampled": "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: I'm not sure if that number is significant, but the overall pain of a neck fracture may be less than 10% of a normal cervical spine fracture. However, if there is a lower number", "perturbed_sampled": ["Question: Neck pain treatment with acupuncture: does the number of head fractures matter? Answer: I'm not sure if that number is significant, but the overall pain of a neck fracture may be less than 10% of a normal cervical rate. However, if there is a lower number", "Question: Neck pain with acupuncture: does the number of needles matter? Answer: I'm not sure that number is significant, but the overall pain of a neck pain would be less than 10% of a normal cervical spine fracture. However, if there is a lower number", "Question: Neck pain treatment with acupuncture: does the importance of needles matter? Answer: I'm not sure if that effect is significant, but the overall pain of a neck fracture may be less than 10% of a normal spine fracture. However, if there is a lower number", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: I'm not certain that number is significant, but the overall pain of a neck fracture may be around 10% of a normal cervical spine fracture. However, if there is a number", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: I'm not sure if that number is significant, but the overall pain of a neck pain treatment could be less than the length of a normal cervical spine fracture. However, if there is a lower number", "needle pain treatment , does the number of needles matter? Answer: I'm not sure if that number is significant, but I understand that the total pain of a neck fracture may be less than 10% of a normal cervical spine fracture. However, if there is a lower number", "Question: Neck pain treatment with acupuncture: Does the number of needles matter? I\u2019m not sure if the severity of the discomfort is significant, but the overall pain of a neck fracture may be less than 10% of a normal cervical spine fracture. However, if there is a lower number", "Question: Neck fracture with acupuncture: does the number of needles matter? Answer: I'm not sure if this number is significant, but the overall pain of a neck fracture may be less important than the pain of a normal cervical spine fracture. However, if there is a lower number", "acute neck pain treatment with acupuncture: does the number of injuries increase significantly? Answer: I'm not sure if that number is significant, but the overall pain of a neck fracture may be less than 10% of a normal cervical spine fracture. For acupuncture, there is a lower number", "Question: Neck pain treatment with acupuncture: does the number of cases matter? I'm not sure if that number of cases is appropriate for any surgical procedure, but the overall pain of a neck fracture may be less than 10% of a normal cervical spine fracture. However, if there is a lower number"], "perturbed_original": ["acupuncture pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, but 11, seems not to be an important variable in determining the type of pain treatment when the time of stimulation is the same in the two groups.", "Question: Neck pain treatment with acupuncture: does acupuncture affect the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the total stimulation is the same in the two groups.", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 14 needles, seems not to be an important variable in determining the therapeutic effect when the recurrent stimulation is the same in the two groups.", "Question: Neck pain treatment with acupuncture: does the number of needles help? Answer: For this pathology, the number of needles, 5 or 11, appears to be an important variable in determining the therapeutic effect of this pain treatment. The number of needles at time of stimulation is the same in the two groups.", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 needles and 5 needles, seems not to be an important factor in determining the therapeutic effect when the time of stimulation is the connection between the two groups.", "Question: Neck pain treatment with acupuncture: does the number of needles improve the pain diagnosis? Answer: For this pathology, the number of needles, not 11, seems not to be an important variable in determining the therapeutic effect when the time difference is the same in the two groups.", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the length of effect when the time of stimulation is the same as the length of the two groups.", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For both groups, the number of needles, 5 or 11, seems not to be an important variable in the same time when the time of stimulation is the same in the two groups.", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable , especially the time of stimulation occurs when the time of stimulation is shorter in the two groups.", "Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important factor in determining the time of stimulation when the time of stimulation is the same at the time of stimulation with the two groups."], "original_ll": -3.6063694953918457, "sampled_ll": -2.966541290283203, "all_perturbed_sampled_ll": [-3.123328685760498, -3.010967254638672, -3.2628910541534424, -3.2660627365112305, -3.1549360752105713, -3.2131009101867676, -3.3079307079315186, -2.953737735748291, -3.234492540359497, -3.01070237159729], "all_perturbed_original_ll": [-3.6958298683166504, -3.8553550243377686, -3.7750325202941895, -3.3170061111450195, -3.5893542766571045, -3.676628351211548, -3.6149795055389404, -3.6083600521087646, -3.8757472038269043, -3.4707818031311035], "perturbed_sampled_ll": -3.153815007209778, "perturbed_original_ll": -3.6479074716567994, "perturbed_sampled_ll_std": 0.11837261619017984, "perturbed_original_ll_std": 0.16160866081779496}, {"original": "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.", "sampled": "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current study, we confirmed that it can be achieved by using a combination of laboratory studies, a modified version of the CRISPR, and a highly effective human immune assay. In addition, our results provide evidence that it is feasible to", "perturbed_sampled": ["Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current study, we confirmed that it can be achieved by using a combination of laboratory studies, a modified version of the CRISPR, and an effective human immune assay. All of our results provide evidence that it is feasible to", "Question: Is zero central line-associated mortality rate sustainable? Answer: Yes. In the current study, we confirmed that it can be achieved by using a combination of laboratory studies, a modified version of the CRISPR, and a highly effective human immune assay. We hope our results provide evidence that it contributes to", "Question: Is zero central -strike infection rate sustainable? Answer: Yes. In the study, we confirmed that it can be achieved by using a combination of laboratory studies, a modified version of the CRISPR, and a highly effective immune assay. In addition, our results provide evidence that it is feasible to", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current study, we confirmed that it can be achieved by using a combination of laboratory studies, a highly effective laboratory version of the CRISPR, and a highly effective diagnostic assay. In addition, our findings demonstrate that these evidence that it is feasible to", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In our current study, we confirmed that it can be achieved by using a combination of laboratory studies, a modified version of existing research, and a highly effective human immune assay. In addition, our research demonstrated evidence that it is feasible to", "Question: Is the central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current study, we confirmed that it can be achieved by using a combination of laboratory studies, a modified version of the CRISPR, and a highly effective human immune assay. In addition, our findings have provided evidence that it is feasible to", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current study, we confirmed that it can be achieved by using a combination of laboratory studies, a modified version of the novel antibody, and a highly effective human immune assay. In fact, we have confirmed in our results the results that it is feasible to", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Based on the current study, we confirmed that it can be achieved by using a combination of laboratory studies, a modified version of the CRISPR, and a highly effective human immune assay. In the present study, our results provide evidence to test whether it is feasible to", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current study, we hope that it can be achieved by using a combination of laboratory studies, a modified version of the CRISPR, and a highly effective CT assay. In addition, our results provide evidence that it is feasible to", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Yes. In the current study, we confirmed that it can be achieved by using a combination of different studies, a modified version of the CRISPR, and a highly effective human immune assay. We also confirmed our results from the current study that it is feasible to"], "perturbed_original": ["Question: Is zero central line-associated bloodstream infection rate acceptable? High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of the role factors play into a unit's ability to handle peak demands and develop effective performance in the long-term.", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: It's not possible that strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a community to handle peak demands and sustain extraordinary performance in the long-term.", "Question: Is zero central line-associated bloodstream infection rate sustainable? No training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant risk to CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may have a better understanding of what goes into a unit's ability to handle multiple tasks and sustain extraordinary performance in the long-term.", "Question: Is zero central line-associated bloodstream infection a key factor? Answer: High-quality training, strict compliance with evidence-based guidelines, and timely documentation is associated with significant reductions in CLABSIs. This may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.", "Question: Is one line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle complex CLABSIs and sustain extraordinary performance in the long-term.", "Question: Is zero central ity of a low infection rate sustainable? Quality of laboratory training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance over the long-term.", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation may assist with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain demand in the long-term.", "Question: Is zero central line-associated bloodstream utilization sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may allow a unit a better understanding of what goes wrong with the unit's ability to handle peak demands and sustain extraordinary performance in the long-term.", "Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation will reduce operational costs. Any unit with significant reductions in operational organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term."], "original_ll": -4.608151912689209, "sampled_ll": -3.1907739639282227, "all_perturbed_sampled_ll": [-3.3365273475646973, -3.428187847137451, -3.331987142562866, -3.4900660514831543, -3.5173420906066895, -3.0452170372009277, -3.4277377128601074, -3.35451340675354, -3.3129632472991943, -3.3324406147003174], "all_perturbed_original_ll": [-4.686857223510742, -4.868701457977295, -4.9057817459106445, -4.6812825202941895, -4.421658992767334, -4.29580545425415, -4.6835150718688965, -4.593810558319092, -4.639866828918457, -4.311260223388672], "perturbed_sampled_ll": -3.3576982498168944, "perturbed_original_ll": -4.608854007720947, "perturbed_sampled_ll_std": 0.12421142810446056, "perturbed_original_ll_std": 0.19884239389297179}, {"original": "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.", "sampled": "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: No. The benefits of retropubic and re-rectal surgery are not well understood. In fact, it", "perturbed_sampled": ["Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic ? Answer: No. The problems between retropubic and re-rectal surgery are not well understood. In fact, it", "Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? It\u2019s not that simple. The benefits of retropubic and re-rectal surgery are not well understood. In fact, it", "Question: Is retropubic laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: No. The benefits of retropubic and re-rectal surgery are not understood. In fact, it", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? No. The benefits of retropubic and re-rectal surgery are not as promising as it is. In fact, it", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: The benefits of retropubic radical prostatectomy without conventional posterior surgery are not well understood. In fact, it", "Question: Is robotically assisted laparoscopic radical prostatectomy more attainable than retropubic radical prostatectomy? Answer: No. The benefits of retropubic and retropubic radical prostatectomy are not well understood. In fact, it", "Question: Is robotically reproducible retropubic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: No. The benefits of retropubic and re-rectal surgery can be well understood. In fact, it", "Question: Is robotically assisted laparoscopic radical prostatectomy less effective than retropubic radical prostatectomy? Answer: No. The benefits of retropubic and re-rectal prostitution are not well understood. In fact, it", "Question: Is a laparoscopic radical prostatectomy less invasive than a laparoscopic radical prostatectomy? Answer: No. The benefits of retropubic and re-rectal surgery are not well understood. In fact, it", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic surgery? Answer: The benefits of retropubic and re-rectal surgery are not well understood. In fact, it"], "perturbed_original": ["Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This indicates for the first time that RALP induces lower -risk radical prostatectomy than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic ity? Answer: This study shows for the first time that RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than laparoscopic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower inflammation than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic ? Answer: This study showed for the first time that the prophylactic radical prostatectomy induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than robotically assisted radical prostatectomy? Answer: This study showed for over time that RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? This study showed for the first time that RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that pro-radioscopic radical prostatectomy had lower tissue trauma than RRP.", "Question: Is a laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? This study showed for the first time that RALP induces lower tissue trauma than RRP.", "Question: Why are some RALP assisted laparoscopic radical prostatectomy much more invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.", "Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than robotically assisted laparoscopic radical prostatectomy? Answer: This study showed for the first time that RALP is less invasive, but less invasive, for patients with smaller tissue trauma than RRP."], "original_ll": -3.855994939804077, "sampled_ll": -2.700441598892212, "all_perturbed_sampled_ll": [-3.2162842750549316, -3.3756511211395264, -2.6119446754455566, -2.98165225982666, -2.898606538772583, -2.49760103225708, -2.976609468460083, -2.940513849258423, -2.59289288520813, -2.913238525390625], "all_perturbed_original_ll": [-3.831881284713745, -4.309699535369873, -3.4970500469207764, -3.736968755722046, -4.167759895324707, -3.9366979598999023, -3.6140310764312744, -3.8317275047302246, -3.9070241451263428, -3.1787049770355225], "perturbed_sampled_ll": -2.90049946308136, "perturbed_original_ll": -3.8011545181274413, "perturbed_sampled_ll_std": 0.26073885224839766, "perturbed_original_ll_std": 0.30717010540030343}, {"original": "Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.", "sampled": "Question: Globulomaxillary cysts--do they really exist? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the presence of the body, or do they", "perturbed_sampled": ["Question: Globulomaxillary cysts--do they really exist? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the body or in the body, or do they", "Question: Globulomaxillary cysts--do they really exist? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the presence of a body, or do they", "Question: Globulomaxillary cysts--do they occur? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Can cysts occur in the presence of the body, or do they", "Question: Globulomaxillary cysts--do they really exist? Answer: No, no at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the presence of the cells? Question: Why do they", "Question: Globulomaxillary cysts--do they really exist? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in front of the lymphoma, or do they", "Question: Globulomaxillary cysts--do they really exist? Yes, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the tissues in the body, or do they", "Question: Globulomaxillary cysts--do they really exist? Answer: No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts appear to be in the presence of the body, or do they", ". Aniline cysts--do they really exist? No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the presence of the body, or do they", "Question: Globulomaxillary cysts--do they really happen? No, not at all.\n\nNo, not at all. Aniline cysts. Do these cysts occur in the presence of someone in the body, or do they", "Question: Globulomaxillary cysts--do they really exist? Answer: No, not . We are not at all. Aniline cysts. Do these cysts occur in the upper, upper body or in the body, or do they"], "perturbed_original": ["Question: Globulomaxillary cysts--do they really exist? Answer: According to the data of our study and the data from the international literature, the entity globulomaxillary cyst is just justified.", "Question: Globulomaxillary cysts--do es that exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cysts are no longer justified.", "Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international human entity globulomaxillary cysts is no longer justified.", "Question: Globulomaxillary cysts--do they have? The Answer: According to the results of the study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.", "Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of the study and the data from the international literature, the existence of a globulomaxillary cyst is no longer justified.", "Question: Globulomaxillary cysts--do they really exist? Due to the results of our study and the data from the literature, the entity globulomaxillary cyst is no longer justified.", "Question: Globulomaxillary cysts--do they really exist? Answer: According to the study of our study and the data from the international literature, the entity globulomaxillary cyst s is no longer justified.", "Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the characterization of the globulomaxillary cyst is not justified.", "Question: Globulomaxillary cysts--do they really exist? According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.", "Question: Globulomaxillary cysts--do they really not qualify? According to the data from our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified."], "original_ll": -3.576117992401123, "sampled_ll": -2.8370423316955566, "all_perturbed_sampled_ll": [-2.8241467475891113, -2.8850629329681396, -3.0519185066223145, -3.1177544593811035, -3.008997917175293, -3.1235170364379883, -2.7894716262817383, -2.6575920581817627, -3.1101579666137695, -3.704808235168457], "all_perturbed_original_ll": [-3.871978759765625, -3.999526023864746, -3.8389368057250977, -3.8391690254211426, -3.1346964836120605, -3.698746919631958, -3.8477020263671875, -3.334280252456665, -3.663571357727051, -3.9991753101348877], "perturbed_sampled_ll": -3.027342748641968, "perturbed_original_ll": -3.722778296470642, "perturbed_sampled_ll_std": 0.2718478475722684, "perturbed_original_ll_std": 0.2680941716753155}, {"original": "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.", "sampled": "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Yes\n\nDoes a GERD surgery require the use of a mechanical instrument or a mechanical technique to remove the obstruction? Do you agree that you are not required to have an advanced", "perturbed_sampled": ["Question: Is the GERD laparoscopic surgery a contraindication to GERD laparoscopic surgery? Does a GERD surgery require the use of a mechanical instrument or a mechanical technique to remove the obstruction? Do you agree that you are not required to have an advanced", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Yes\n\nDoes a GERD surgery require an advanced age of a medical device or a mechanical technique to remove the advanced age? Do you agree that you are not required to have an advanced", "Question: Do you agree with your advanced age or level of mobility? Are you hesitant to apply to GERD laparoscopic surgery? Answer: Yes\n\nDoes a GERD surgery require the use of a mechanical instrument or a mechanical technique to cause an obstruction? Do you agree that you are not required to have an advanced", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Yes\n\nDoes a GERD surgery require the use of a mechanical instrument or a mechanical technique to remove the advanced age? If you have advanced age, you are not required to have the advanced", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Yes\n\nDoes a GERD laparoscopic surgery enable the user to use a mechanical instrument or a mechanical technique to remove the obstruction? You agree that you are not required to have an advanced", "Question: Is the advanced surgery contraindication to GERD laparoscopic surgery? Answer: Yes\n\nDoes a GERD surgery require a combination of a vascular articulation or a mechanical technique to remove the obstruction? Do you agree that you are not required to have an advanced", "Question: Is age and age a contraindication to GERD laparoscopic surgery? Answer: Yes\n\nDoes a GERD surgery require the use of a surgical device or a mechanical system to remove the obstruction? Do you agree that you are not required to have an advanced", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Yes\n\nDoes a GERD laparoscopic surgery need the use of an instrument or a mechanical technique to remove the obstruction? Do you agree that any surgical technique is not required to have an advanced", "Question: Is the GERD surgery a contraindication to GERD laparoscopic surgery? Answer: Yes\n\nDoes a GERD surgery require the use of a mechanical instrument or surgery technique to reduce the obstruction? Do you agree that you are not required to have an advanced", "Question: Is the advanced age a contraindication to GERD surgery? Answer: Does GERD surgery require the use of a mechanical instrument or a mechanical technique to remove the obstruction? Do you agree that you are not required to have an advanced"], "perturbed_original": ["Question: Is the advanced age a contraindication to GERD laparoscopic surgery? If so, antireflux surgery is a safe and effective , reliable and effective antireflux treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of surgical activity to younger patients.", "Question: Is the advanced age a risk factor when undergoing GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low mortality and low mortality rates and a significant improvement of symptoms comparable to older patients.", "Question: Is age and age a contraindication to GERD laparoscopic surgery? Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement compared to GERD cases in elderly patients comparable to younger patients.", "Question: Is the antireflux surgery a contraindication to GERD and is it possible to replace antireflux surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.", "Question: Is the advanced age a contraindication to the use of antireflux surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in older patients, warranting higher mortality and mortality rates and a significant improvement of symptoms comparable to younger patients.", "Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD laparoscopic surgery for elderly patients, a combination of the same morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and affordable treatment for GERD even in elderly patients with low morbidity and high mortality, and a significant improvement of symptoms comparable to younger patients.", "What is the advanced GERD contraindication to GERD laparoscopic surgery? Answer: Laparoscopic surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.", "Question: Is the advanced , advanced and advanced laparoscopic surgery a safe and reliable contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective therapy for GERD even in elderly patients, warranting low morbidity and mortality . Laparoscopic surgery provides a significant improvement of symptoms comparable to younger patients.", "Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in advanced patients, warranting low chronic mortality rates and a significant improvement of symptoms in younger patients."], "original_ll": -3.197444438934326, "sampled_ll": -2.754941940307617, "all_perturbed_sampled_ll": [-2.8909752368927, -2.9865970611572266, -3.15242862701416, -2.7152066230773926, -3.0044870376586914, -3.2355594635009766, -2.806962251663208, -2.914475679397583, -2.9427490234375, -2.871694803237915], "all_perturbed_original_ll": [-3.367182731628418, -3.4765541553497314, -3.236466646194458, -2.8204872608184814, -3.161829948425293, -3.157162666320801, -3.320030689239502, -3.2274081707000732, -3.364374876022339, -3.387428045272827], "perturbed_sampled_ll": -2.9521135807037355, "perturbed_original_ll": -3.2518925189971926, "perturbed_sampled_ll_std": 0.14604895547905603, "perturbed_original_ll_std": 0.17420178041555132}, {"original": "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "sampled": "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: No. Type 2 diabetes is a common complication of high blood pressure that requires long-term treatment to protect against blood clots. However, people with Type 2 diabetes who live too long are at higher risk for complications and", "perturbed_sampled": ["Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: No. Type 2 diabetes is a genetic complication of high blood pressures that requires regular blood pressure to protect against blood clots. However, people with Type 2 diabetes who live in a similar population are at higher risk for complications and", "Question: Does aerobic fitness influence their fitness in healthy adults at risk of Type 2 diabetes? Answer: No. Type 2 diabetes is a common complication of high blood pressure that requires long-term treatment to protect against blood clots. However, people with Type 2 diabetes who live under normal conditions are at higher risk for complications and", "Question: Does aerobic fitness influence microvascular function and the blood flow of adults at risk of developing Type 2 diabetes? Adults with Type 2 diabetes is a common complication of high blood pressure that requires long-term treatment to protect against blood clots. However, people with Type 2 diabetes who live too long or who live too long are also at higher risk for complications and", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: No. Type 2 diabetes is a common complication of high blood pressure that requires long-term treatment to prevent blood flow from opening blood clots. Those who have been diagnosed with Type 2 diabetes who live too long are at risk for complications and", "Question: How does fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Developing Type 2 diabetes is a common complication of high blood cholesterol that requires long-term treatment to protect against blood clots. Children with Type 2 diabetes who live too long are at higher risk for complications and", "Question: Does aerobic aerobic or microvascular function in healthy adults at risk of developing Type 2 diabetes? A Type 2 diabetes is a common complication of high blood pressure that requires treatment to protect against blood clots. However, people with Type 2 diabetes who live too long are at higher risk for complications and", "Question: Does my fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: No. Type 2 diabetes is a common condition with high blood pressure that requires long-term treatment to protect against blood clots. However, people with Type 2 diabetes who live too long are at higher risk for complications and", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Type 2 diabetes is a common complication of high blood pressure that requires long-term treatment and has been linked to a rare strain against blood clots. However, people with Type 2 diabetes who live too long are at risk for complications and", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: No. Type 2 diabetes is a common complication of high blood sugar, and requires long-term treatment to protect against blood clots. However, people with Type 2 diabetes who live too long on a high blood pressure will get at a higher risk for complications and", "Question: Does your fitness influence microvascular function in healthy adults at risk of type 2 diabetes? Answer: No. Type 2 diabetes is a common complication of high blood pressure that requires long-term treatment to protect against blood clots. Young adults with Type 2 diabetes who live too long are at higher risk for complications and"], "perturbed_original": ["Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' study, skin cells showed maximal oxygen uptake was not reduced in healthy controls. However, in the survey alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 Diabetes Diabetes? Question: Does aerobic fitness affect microvascular function in healthy adults? Question: The Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced with the healthy controls. In the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy patients at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen intake was not reduced compared with healthy controls. However, in the 'at-risk' group the individuals with higher levels of aerobic fitness had better microvascular and endothelial responsiveness.", "Question: Does aerobic s perform microvascular function in healthy adults at risk of Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal responsiveness was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy patients despite their risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin care, the maximal oxygen uptake was not reduced compared with healthy people in the population of cancer. In a study alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? According to this 'at-risk' group with skin cancer experts, maximal oxygen uptake was not reduced compared with healthy controls. In the 'at-risk' group alone, individuals with higher levels of aerobic fitness had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy adults on the age of developing Type 2 Diabetes or diabetes? In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced with healthy controls. However, in the group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular dysfunction in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not increased with healthy adults in the 'at-risk' group, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in people at risk of Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared to controls. However, in the 'at-risk' group alone, individuals with higher incidence of aerobic fitness also had better microvascular and endothelial responsiveness.", "Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction , the microvascular function uptake was significantly reduced compared with healthy controls. However, in the case of sagging skin microvascular dysfunction alone, individuals with higher levels of aerobic fitness also had better microvascular dysfunction responsiveness."], "original_ll": -2.895808696746826, "sampled_ll": -2.3497273921966553, "all_perturbed_sampled_ll": [-2.679314136505127, -2.540123701095581, -2.6601998805999756, -2.710005521774292, -2.628169298171997, -2.7724931240081787, -2.4308414459228516, -2.766636371612549, -2.6603102684020996, -2.4624264240264893], "all_perturbed_original_ll": [-3.2985267639160156, -2.98351788520813, -2.9291765689849854, -3.4454095363616943, -3.449932336807251, -3.118072509765625, -3.572650909423828, -3.1028575897216797, -3.083651065826416, -3.0239205360412598], "perturbed_sampled_ll": -2.631052017211914, "perturbed_original_ll": -3.2007715702056885, "perturbed_sampled_ll_std": 0.11200552101034313, "perturbed_original_ll_std": 0.21264099658089372}, {"original": "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.", "sampled": "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: As a result of the use of Estradiol and Antagonist in in Vitro Fertilization, I believe that the current study has important and important limitations that have to be addressed. First, this study has several limitations", "perturbed_sampled": ["Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Work out Outcomes in Poor Responders as Compared to Oral Contraceptive Tests? As a result of the use of Estradiol and Antagonist in in Vitro Fertilization, I believe that the current study has important and important limitations and some issues are to be addressed. First, this study has several limitations", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Could I Improve IVF Outcomes in Poor Responders as the Use of Oral Contraceptive Pill? Answer: As a result of the use of Estradiol and Antagonist in in Vitro Fertilization, I believe that the current study has important and important limitations that have to be addressed. First, this study has several limitations", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose during Microdose in Vitro Fertilization. Does an IVF Study Observe IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: As a result of the increases in <unk>Case Estradiol and Antagonist in in Vitro Fertilization, I believe that the current study has important and important limitations that have been addressed. First, this study has several limitations", "Question: Estradiol and Antagonist is related to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as an Oral Contraceptive Pill? Answer: As a result of the use of Estradiol and Antagonist in in Vitro Fertilization, I believe that the current study has important and important limitations that have to be overcome. First, this study has several limitations", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does this study show IVF Outcomes in Poor Responders as a Oral Contraceptive Pill? Answer: As a result of the use of Estradiol and Antagonist in in Vitro Fertilization, I believe that this study has important and important limitations that have to be addressed. First, this study has several limitations", "Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: As a result of the use of Estradiol and Antagonist Pretreatment In Vitro Fertilization, I believe that the current study has important and meaningful challenges that have to be overcome because this study has several limitations", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide In In Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: As a result of the use of Estradiol and Antagonist in in Vitro Fertilization, I believe that the current study has important clinical limitations that have been addressed. First, this study has several limitations", "Question: Estradiol and Antagonist Pretreatment Prior to Treatment Before Inverting in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? As a result of the use of Estradiol and Antagonist in in vitro Fertilization, I believe that the current study has important and important deficiencies which have to be addressed. First, this study has several limitations", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF For Poor Responders as Compared to Oral Contraceptive Pill? Answer: As an expert, in the background of the use of Estradiol and Antagonist in in Vitro Fertilization, I believe that the current study has important and important components that have to be addressed. First, the study has several limitations", "Question: Does Antagonist Pretreatment Prior to Microdose Leuprolide in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: As a result of the use of the Antiagonist and Antagonist in in Vitro Fertilization, I believe that the current study has important and important limitations that have to be addressed. First, this study has several limitations"], "perturbed_original": ["Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide Pretreatment in Vitro Fertilization. Does It Improve IVF Outcomes in First-Class Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not necessarily improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to determine an optimal method of steroid pretreatments appear justified.", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose and a Low Level of X-L Procedur in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Test Methods? Answer: E2+antag pretreatment does not appear to improve IVF in poor responders compared to standard ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.", "Metabolic and Antagonist Pretreatment Prior to Microdose Leuprolide in Improved Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not seem to improve the IVF Outcome in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in sufficient clinical research Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve outcomes in ML protocol response to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid pretreatments appear justified.", "Question: Estradiol and Antagonist Pretreatment Using Microdose Leuprolide in in Vitro type Pill Does It Improve IVF outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to detect the optimal method of steroid pretreatments appear justified.", "Question: Estradiol Antidepressants Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Steroid pretreatment does not appear to improve IVF outcomes in ML protocol when compared to standard OCP in poor responders. Randomized trials with adequate power to study the optimal results in steroid pretreatments appear justified.", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in fectible patients Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Infective Diseases? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when it has a high tolerance for the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of treatment does not appear justified.", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro x? Question: Does It Improve IVF Outcomes in Poor Responders as Compared to Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to study the optimal method of Pretreatment does not appear justified.", "Question: IVF Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve Tomatoes Outcomes in Poor IVF Patients Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power and the optimal method of steroid pretreatments appear justified.", "Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide I.e. or on Pretreated before X-ray Vitro Fertilization. Does It Improve IVF Outcomes in ML Protocol as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the OCP in poor responders. Randomized trials with adequate power to study the optimal method of steroid antiglycerosis are just as justified."], "original_ll": -4.205254077911377, "sampled_ll": -2.92803692817688, "all_perturbed_sampled_ll": [-3.3613362312316895, -2.9446537494659424, -3.6207964420318604, -2.9540748596191406, -3.019976854324341, -3.2731759548187256, -3.0696654319763184, -3.241352081298828, -3.219974994659424, -3.4418108463287354], "all_perturbed_original_ll": [-4.213191032409668, -4.406634330749512, -4.476617336273193, -4.739913463592529, -4.42100715637207, -4.03503942489624, -4.645470142364502, -4.304254055023193, -4.464080810546875, -4.4342427253723145], "perturbed_sampled_ll": -3.2146817445755005, "perturbed_original_ll": -4.41404504776001, "perturbed_sampled_ll_std": 0.21022749692563586, "perturbed_original_ll_std": 0.1904520053168372}, {"original": "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The", "sampled": "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "perturbed_sampled": ["Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the call for boycott by Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the call for polio vaccination coverage by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the call voluntarily by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the petition for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the call for boycott by the Kenya police affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the call for boycott by the boycott of Kenya affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in September 2015? Answer: No.\n\n", "Question: Did the call for boycott by Kenyan bishops affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n", "Question: Did the call for boycott by the Kenyan campaign affect the polio vaccination coverage in Kenya in 2015? Answer: No.\n\n"], "perturbed_original": ["Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya ? A Answer: The", "Question: Did the call made by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The", "Question: Did the allegations for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The", "Question: Did the call for polio vaccinations by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in Kenya? The", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in February 2015? Answer: The", "Question: Did the call for boycott by Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage and effectiveness of polio vaccinations in 2015? Answer: The", "Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage of the Catholic bishops in 2015? Answer: The"], "original_ll": -4.0360612869262695, "sampled_ll": -3.8673784732818604, "all_perturbed_sampled_ll": [-3.8673784732818604, -3.999532699584961, -3.746734619140625, -4.450740814208984, -3.893519878387451, -4.029575347900391, -3.9519600868225098, -4.005657196044922, -4.065149784088135, -4.020331382751465], "all_perturbed_original_ll": [-4.597425937652588, -4.033554553985596, -4.3553690910339355, -4.0360612869262695, -3.8424644470214844, -4.371746063232422, -4.206996917724609, -4.196091651916504, -4.045762062072754, -3.9073076248168945], "perturbed_sampled_ll": -4.0030580282211305, "perturbed_original_ll": -4.1592779636383055, "perturbed_sampled_ll_std": 0.17436060942968146, "perturbed_original_ll_std": 0.2206660050766259}, {"original": "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "sampled": "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics recommends that neck pain be the reason you do not lose weight, which is an extremely powerful recommendation. If you're on the fence about whether to lose weight and need to keep the amount you eat down, these experts say neck pain is a risk factor for your weight loss. Also, if neck", "perturbed_sampled": ["Question: Is neck pain associated with the increase in quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Medicine estimates that neck pain be the reason you 're going to lose weight, which is an extremely powerful factor. If you're on the fence about whether to lose weight or not to keep the amount you eat down, these experts say neck pain is a risk factor for your weight loss. Also, if neck", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The British Academy of Medicine recommends that neck pain be the reason you can lose weight and is an extremely powerful recommendation. If you're on the right track about whether to lose weight and need to keep the amount you eat down, these experts say neck pain is a risk factor for your weight loss. Also, if neck", "Question: Is neck pain associated with worse quality of life 6 years before you lose weight? Answer: It's pretty much what you don't know. The American Academy of Pediatrics recommends that neck pain be the reason you do not lose weight, which is an extremely powerful recommendation. If you're on the fence about whether to lose weight and need to keep the amount you eat down, these experts say neck pain is a risk factor for your weight loss. Also, if neck", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics recommends that neck pain be the reason you do not lose weight, which is extremely powerful . If you're on the fence about whether to lose weight and need to keep the foods you eat down, these experts say neck pain is the risk factor for your weight loss. Even if neck", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics recommends that neck pain be the reason you do not lose weight, which is an extremely powerful recommendation. If you were on the fence about whether to lose weight and to keep the amount you eat down, these experts say neck pain is a risk factor for your health. Also, if neck", "Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics says that might neck pain be the reason you do not lose weight, and this is an excellent recommendation. If you're on the fence about whether to lose weight and need to keep the amount you eat down, these experts say neck pain is a reason for your weight loss. Also, if neck", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics recommends that neck pain be the reason you do not lose weight, which is an extremely powerful recommendation. If you are on the fence about whether to lose weight and how to keep the amount you eat down, these experts say neck pain is a risk to your weight loss. When you take a look at the neck", "Question: What caused neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Chiropractic recommends that neck pain be the reason you would need to lose weight, which is an extremely powerful recommendation. If you're on the fence about whether to lose weight and need to keep the amount you eat down, these experts say neck pain is a risk factor during weight loss. Also, if neck", "Question: Is neck pain associated with worse health-related conditions that will happen in your life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics recommends that neck pain be the reason you do not lose weight, which is an extremely powerful recommendation. If you're on the fence about whether to lose weight or not, you need to keep the amount you eat down, these experts say that you lose weight every 6 months. Neck pain is a risk factor in your weight loss. Also, if neck", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: It's pretty much a myth. The American Academy of Pediatrics recommends that neck pain be the reason you do not lose weight, which is an extremely powerful recommendation. If you're on the fence about whether to lose weight or not, you need to keep the amount you eat down, to say neck pain is a risk of losing weight in your lifetime. Also, if neck"], "perturbed_original": ["Question: Do you have neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain could be associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a major cause of future poor physical HRQoL in the population. Raising awareness of the potential impact of neck pain on lives is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our hypothesis was that neck pain would be a contributor of future poor physical HRQoL in the future. Public awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain and the health and safety of neck pain populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical and mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor quality of life in the long run. Our analysis suggests that our awareness of the positive impact of neck pain on physical HRQoL is important for health-care providers and policy makers with regard to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively linked to poor physical but not mental HRQoL. Our analysis suggests that neck pain is a contributor of future poor physical HRQoL in the population. Raising awareness on the negative impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with health-related quality of life 6 months later? We found that neck pain is negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be the contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Our analysis has found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a source of future poor physical HRQoL in the population. A review of the possible future impact of neck pain on physical HRQoL is important for governments, medical representatives, health professionals and policy makers to examine the potential implications of neck pain to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not physical health. Our analysis suggests that neck pain may be a contributor of some physical health and the environment. An awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the current effects of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 years old? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the possible future impact of neck pain on physical HRQoL is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with a higher quality of life 6 months later? Answer: We found that neck pain was negatively associated with a higher level of longevity but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future risk of HRQoL in the population. Raising awareness of the possible future impact of neck pain on health-care is important for health-care providers and policy makers with respect to the management of neck pain in populations.", "Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical and mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising awareness of the future impact of neck pain on physical HRQoL is important for providers and policy makers with respect to the management of neck pain in populations."], "original_ll": -2.7274506092071533, "sampled_ll": -2.558384895324707, "all_perturbed_sampled_ll": [-2.952465772628784, -2.9145259857177734, -2.603937864303589, -2.828278064727783, -2.6806581020355225, -3.017272710800171, -2.6959102153778076, -2.771332025527954, -2.8732521533966064, -2.744529962539673], "all_perturbed_original_ll": [-2.8760924339294434, -2.73474383354187, -2.7278058528900146, -2.762144088745117, -2.7675349712371826, -2.8556277751922607, -3.034227132797241, -2.7873692512512207, -2.890825033187866, -2.808183431625366], "perturbed_sampled_ll": -2.8082162857055666, "perturbed_original_ll": -2.8244553804397583, "perturbed_sampled_ll_std": 0.12509045057192986, "perturbed_original_ll_std": 0.08843036953218451}, {"original": "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.", "sampled": "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: No. The study indicated that spinal cord sarcoidosis could not be improved with compressive cervical myelopathy.\n\nCiliary cartilage loss was a significant complication in this study and was", "perturbed_sampled": ["Question: Is decompressive surgery effective in reducing spinal cord sarcoidosis accompanied with compressive cervical myelopathy? No. The study indicated that spinal cord sarcoidosis could not be improved with compressive cervical myelopathy.\n\nCiliary cartilage loss was a significant complication in the cervical muscle joint, and was", "Question: Is decompressive surgery effective ? Or is spinal cord sarcoidosis accompanied with compressive cervical myelopathy improved? Answer: No. Recent study has indicated that spinal cord sarcoidosis could not be improved with compressive cervical myelopathy.\n\nCiliary cartilage loss was a significant complication in this study and was", "Is this decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: No. The study indicated that spinal cord sarcoidosis might not be accompanied with compressive cervical myelopathy.\n\nCiliary cartilage loss was a significant complication in this study and was", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: No. The study indicated that spinal cord sarcoidosis could have improved the effect of compressive cervical myelopathy.\n\nCiliary pain was a significant complication in this study and was", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: No. The study indicated that spinal cord sarcoidosis could be improved with compressive cervical myelopathy.\n\nCiliary cartilage is a significant complication in this study and was", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: No. The study indicated that spinal cord cartilage could not be improved with compressive cervical myelopathy.\n\nCiliary cartilage was a significant component of this study and was", "Question: Is decompressive cervical myelopathy the key risk factor for spinal cord sarcoidosis with compressive cervical myelopathy? Answer: No. The study indicated that spinal cord sarcoidosis could not be improved with compressive cervical myelopathy.\n\nCiliary cartilage loss was a significant complication in cervical sarcoidosis and was", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Question: The study concluded that spinal cord sarcoidosis could not be improved with compressive cervical myelopathy.\n\nCiliary cartilage loss was a significant complication to the study and was", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: No. The study indicated that spinal cord sarcoidosis could not have been accompanied with compressive cervical myelopathy.\n\nCiliary cartilage loss was a significant complication of the study and was", "Question: Is compressive cervical surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? No. The study indicated that spinal cord spinal cord sarcoidosis could not be improved with compressive cervical myelopathy.\n\nCiliary cartilage loss was a significant complication in this study and was"], "perturbed_original": ["? Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of compression surgery for spinal cord sarcoidosis accompanied with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effectiveness of decompressive surgery against spinal cord sarcoidosis with compressive myelopathy was not evident. Surgery for sarcoidosis from other organ and steroid therapy should be needed.", "Question: Is surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis of cervical myelopathy is the first time surgical treatments from other organ s or therapy should be needed.", "Question: Is decompression effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis had not been confirmed. The treatment of severe cervical organ and steroid therapy should be needed.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ ial organs is needed. Early diagnosis of decompressive therapy should be needed.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy was demonstrated. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? The effect of surgery for spinal cord sarcoidosis with compressive myelopathy was based on myaloge. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.", "Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of surgery for spinal cord sarcoidosis with compressive cervical myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy was needed.", "Question: Is compressive surgery effective for spinal cord sarcoidosis accompanied by cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early surgeries resulting in surgery effective for spinal cord sarcoidosis from other organ and steroid therapy should be needed.", "Question: How is surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive cervical myelopathy is not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy is not needed."], "original_ll": -3.4646880626678467, "sampled_ll": -2.7719671726226807, "all_perturbed_sampled_ll": [-3.0603926181793213, -3.202152967453003, -2.8876044750213623, -2.954176664352417, -2.9432358741760254, -3.0432567596435547, -2.6591148376464844, -2.949073076248169, -2.812138795852661, -2.8777430057525635], "all_perturbed_original_ll": [-3.571852922439575, -3.4311697483062744, -3.506754159927368, -3.4178035259246826, -3.427358865737915, -3.2362372875213623, -3.9503746032714844, -3.338451862335205, -3.4468486309051514, -3.1629350185394287], "perturbed_sampled_ll": -2.938888907432556, "perturbed_original_ll": -3.4489786624908447, "perturbed_sampled_ll_std": 0.14001004597348346, "perturbed_original_ll_std": 0.20270446786526192}, {"original": "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and outcome needs to be studied.", "sampled": "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: The results are similar. As indicated by the presence of hypotension, the patient was able to maintain adequate head temperature. However, during acute stroke the patient was unable to maintain any body temperature. As with most clinical conditions the patient was required to withdraw. Therefore it is important", "perturbed_sampled": ["Question: Can bedside assessment reliably exclude aspiration after acute stroke? Answer: The results are similar. As with the presence of hypotension, the patient was not able to maintain adequate head temperature. However, during acute stroke the patient was unable to maintain any body temperature. As with most acute stroke conditions the patient was required to withdraw. Therefore it is important", "Question: How much does this assessment of any conditions or aspiration following acute stroke? Answer: The results show hypotension. As indicated by the presence of hypotension, the patient was able to maintain adequate head temperature. However, during acute stroke the patient was unable to maintain any body temperature. As with most clinical conditions the patient was required to withdraw. Therefore it is important", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: The results are similar. As indicated by the presence of hypotension, the patient was able to adjust head temperature. However, during acute stroke the patient was unable to adjust to any body temperature. As with most clinical conditions the patient was required to withdraw. Therefore it is important", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: The results are similar. As with the presence of hypotension, the patient was required to maintain adequate head temperature. However, during acute stroke the patient was unable to maintain any body temperature. As with most clinical tests, the patient was required to withdraw. Therefore it is important", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? The results are similar. As indicated by the presence of hypotension, the patient was able to maintain an adequate head temperature. However, during acute stroke the patient was unable to maintain any body temperature. As with most clinical studies, the patient was unable to withdraw. Therefore it is important", "Can a bedside assessment reliably exclude aspiration following acute stroke? Answer: The results are similar. As suming the presence of hypotension, the patient was able to maintain adequate head temperature. However, during acute stroke the patient was unable to maintain any body temperature. In most clinical conditions the patient was required to withdraw. Answer: It is important", "Question: Can bedside assessment reliably exclude aspiration during acute stroke? Answer: The results are similar. As indicated by the presence of hypotension, the patient had to be required to maintain adequate head temperature. However, during acute stroke the patient was unable to maintain any body temperature. As with most clinical conditions the patient was unable to withdraw. Therefore it is important", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: The results are similar. As indicated by the presence of hypotension, the patient was able to maintain adequate head temperature. However, during acute stroke the patient was able to maintain proper body temperature. As with most acute stroke conditions the patient was able to withdraw. Therefore it is important", "Question: Can bedside assessment of aspiration following acute stroke? Answer: The results are similar. As indicated by the presence of hypotension, the patient was able to maintain adequate head temperature. However, during acute stroke the patient should be able to maintain any body temperature. As with most clinical conditions the patient was able to withdraw. Therefore it is important", "Question: Can bedside assessment reliably exclude aspiration of stroke? Answer: The results are similar. As indicated by the presence of hypotension, the patient was able to retain any head temperature during acute stroke. Therefore, the patient was unable to maintain any body temperature. As with most clinical conditions the patient was required to withdraw. Therefore it is important"], "perturbed_original": ["Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the ability to be used as a side effect in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard for swallowing. The relative importance of aspiration and bedside assessment in predicting complications and outcome needs to be studied.", "Question: Can bedside assessment reliably exclude swallowing prior to screening in acute stroke? Answer: Bedside assessment of swallowing should include the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of swallowing as a gold standard. The relative importance of swallowing and bedside assessment in predicting complications and outcome needs to be studied.", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a baseline in acute stroke, so there are concerns about the use of videofluoroscopy in gold mining. The relative importance of aspiration and bedside assessment in predicting complications and outcome needs to be studied.", "Question: Can we reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks sufficient sensitivity to be considered as a screening instrument in acute stroke, but there are a number of factors that must also be considered in the diagnosis area and the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in predicting complications and outcome needs to be studied.", "Question: Can bedside assessment reliably exclude aspiration following stroke? Answer: Bedside assessment of swallowing should presumably ensure the necessary sensitivity to swallowing as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The importance of aspiration and bedside assessment in predicting complications and outcome needs to be studied.", "Question: Can bedside assessment reliably exclude aspiration following stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are no indications about the use of videofluoroscopy as a surgical standard. The relative importance of aspiration and bedside assessment in predicting complications and outcome needs to be studied.", "Question: Can bedside assessment reliably measure swallowing the outcome of treatment in the following acute stroke? Answer: Bedside assessment of swallowing lacks sufficient sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy (Video) as the gold standard. The relative importance of aspiration assessment for bedside assessment in predicting complications and outcome needs to be studied.", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of such a gold standard. The relative importance of aspiration and swallowing in predicting complications and procedures abounds to be studied.", "Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment also lacks sensitivity and sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold standard. The relative importance of aspiration and bedside assessment in acute stroke relates to multiple complications and risks that need to be studied.", "Question: Can bedside assessment reliably exclude aspiration following stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument to predict complications. This is not the case with a stroke, but there are many other common challenges with the use of videofluoroscopy as a gold standard. The relative importance of aspiration and the importance of an imaging system in predicting complications and outcome needs to be studied."], "original_ll": -3.6945083141326904, "sampled_ll": -3.2333762645721436, "all_perturbed_sampled_ll": [-3.2682785987854004, -3.278637409210205, -3.3430206775665283, -3.3005266189575195, -3.197753667831421, -3.7031447887420654, -3.2954914569854736, -3.2191524505615234, -3.3214828968048096, -3.558595657348633], "all_perturbed_original_ll": [-3.6639909744262695, -3.616398334503174, -3.9745523929595947, -3.6218483448028564, -4.000374794006348, -3.7604360580444336, -3.842747926712036, -3.911679744720459, -3.5888028144836426, -3.641011953353882], "perturbed_sampled_ll": -3.3486084222793577, "perturbed_original_ll": -3.7621843338012697, "perturbed_sampled_ll_std": 0.15051770382185148, "perturbed_original_ll_std": 0.15033658735953861}, {"original": "Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.", "sampled": "Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites do not reflect community practice. There are three reasons why residency teaching sites do not reflect community practice: the fact that no", "perturbed_sampled": ["Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites do not reflect community practice. There are a few reasons why residency teaching sites do not reflect community practice: the fact that no", "Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites do not reflect community practice. There are three reasons why residency teaching sites do not reflect community practice. The fact that no", "Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites do not reflect community practice. There are several reasons why residency teaching sites does not reflect community practice: the fact that no", "Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites do not reflect community practice. There are three reasons why residency teaching sites do not reflect community practice. Try the fact that no", "Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites do not reflect community practice. There are three reasons why residency teaching sites do not reflect community practice: the fact that no", "Question: Are family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites do not reflect community practice. There are three reasons why residency teaching sites do not reflect community practice: the fact that no", "Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites do reflect community practice. There are three reasons why residency teaching sites do not reflect community practice: the answer, no", "Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites do not reflect community practice. There are three reasons why residency teaching sites do not reflect community practice: the answer is no", "Question: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites do not reflect community practice. There are three reasons why residency teaching sites do not reflect community practice: the fact that no", "residency teaching sites? Answer: Does family practice at residency teaching sites reflect community practice? Answer: Yes, family practice at residency teaching sites do not reflect community practice. There are two main reasons why residency teaching sites do not reflect community practice: the fact that no"], "perturbed_original": ["Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites at Northeastern Ohio Universities of Medicine provide patient care opportunities similar to those found in a national survey of physician and general practitioners.", "Question: Does family practice at residency teaching sites reflect residency learning sites? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to them. Our research reveals that residency training is the best program to support physicians in a national survey of physicians and general practitioners.", "Question: Does family practice or teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care and other training facilities to family practice participants in a national survey of family and general practitioners.", "Question: Does family practice at residency teaching sites reflect community change? The residency training sites of the Ohio Universities College of Medicine provide residency teaching opportunities similar to those found in a national survey of family and general practitioners.", "Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Ohio Universities College of Medicine , where their families care are focused on community practices compare to those found in a national survey of family and general practitioners.", "Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to the one in our own survey of family practice residency practitioners.", "Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites located in Northeastern Ohio Department of Medicine provide patient care related to those found in a national survey of family and general practitioners.", "Question: Does family practice at residency teaching sites facilitate clinical and general practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide programs that offer opportunities similar to those performed in a national survey of family and general practitioners.", "Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency training sites like the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.", "Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College s provide patient practice similar to those found in a national program for family and general practitioners."], "original_ll": -4.216692924499512, "sampled_ll": -2.658169984817505, "all_perturbed_sampled_ll": [-2.643899917602539, -2.7157442569732666, -2.7346746921539307, -2.884140729904175, -2.658169984817505, -2.916288375854492, -2.946667432785034, -2.712285280227661, -2.658169984817505, -2.7639427185058594], "all_perturbed_original_ll": [-4.300171852111816, -4.1260905265808105, -4.4270853996276855, -4.480294704437256, -4.670210361480713, -4.239693641662598, -4.49119758605957, -4.450166702270508, -4.155508041381836, -4.796792507171631], "perturbed_sampled_ll": -2.7633983373641966, "perturbed_original_ll": -4.413721132278442, "perturbed_sampled_ll_std": 0.10661910493896949, "perturbed_original_ll_std": 0.20421956315064865}, {"original": "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated with repeated mental health care use.", "sampled": "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: It is possible that a person with depression might seek help for a long time and may have difficulties recovering from such symptoms. One approach might be to use medication and/or therapy to restore mental health.\n\nThere are also a number of psychotherapies, including psychotherapy that can be used in the post-traumatic stress disorder treatment (PTSD), although it is", "perturbed_sampled": ["Question: Is duration of psychological treatment for depression related to return into treatment? Answer: It is possible that a person with depression might seek help for a long time and may have difficulties recovering from such a situation. A similar approach might be to use medication and/or therapy to restore mental health.\n\nThere are a number of psychotherapies, including those that can be used to treat the physical disorder treatment (PTSD), although it is", "Question: Is duration of psychological therapy for depression related to return into treatment? Answer: It is possible that a person with depression might have depression for a long time and may have difficulties recovering from such symptoms. One approach might be through medication and/or therapy to restore mental health.\n\nThere are also a number of psychotherapies, including psychotherapy that can be used as post-traumatic stress disorder treatment , as it is", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: It is possible that a person with depression might seek help for a long time and may have suffered from such symptoms. One approach might be to use medication and/or therapy to restore mental health.\n\nThere are also a number of psychotherapies, including psychotherapy and mental therapy. In this treatment, many people can be treated as a result of the post-traumatic stress disorder treatment (PTSD), which is", "Question: Is duration of psychological treatment for depression related to the length of treatment and how long is the duration of psychotherapy going into treatment? It is possible that a person with depression might seek help for a long time and may have difficulties recovering from such symptoms. One approach might be to use medication that may be taken to restore mental health.\n\nThere are also various types of psychotherapies, including psychotherapy , which can be used in the post-traumatic stress disorder treatment (PTSD), although it is", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: It is possible that a person experiencing depression might seek help for a long time and may have difficulties recovering from such symptoms. One method may be to use medication and/or therapy to restore mental health. There are also a number of services or psychotherapy that can be used in the post-traumatic stress treatment (PTSD), although it is", "Question: Is duration of treatment for depression related to return into treatment? Answer: It is possible that a person with depression might seek help for a long time and may have difficulties recovering mental health symptoms. Others might want to use medication and/or therapy to restore mental health.\n\nThere are also a number of psychotherapies, including psychotherapy that can be used in the post-traumatic stress disorder treatment . Question: How long can depression be treated? Answer: If it is", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: It is possible that a person with depression can have this sort of psychological help for a long time may have difficulties recovering from such symptoms. One approach might be to use medication and/or therapy to restore mental health.\n\nThere are also a number of psychotherapies, including psychotherapy that may be used in the post-traumatic stress disorder treatment . When asked why it is", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: It is possible that a person with depression might seek help for a long time. However, they may have difficulties recovering from symptoms and symptoms. One approach might be to use medication and/or therapy to restore their symptoms. There are also a number of psychotherapies, including psychotherapy . Psychotherapies can also be used in post-traumatic stress disorder treatment (PTSD), although it is", "Question: Is duration of psychological treatment for depression too long for a person to return into treatment? Answer: It is possible that a person with depression might seek help for a long time and may be recovering from such symptoms. One approach might be to try some psychological therapy and/or therapy to restore mental health.\n\nThere are also a number of psychotherapies, including psychotherapy that can be used in the post-traumatic stress disorder treatment (PTSD), although it is", "Question: Is duration of psychological treatment for depression related to psychological treatment? Answer: It is possible that a person who might seek help for a long time and may have difficulties recovering from the depression is experiencing any symptoms. One approach might be with prescriptions and medications, medication and/or therapy to restore mental health.\n\nThere are a number of psychotherapies, including psychotherapy that can be used in the post-traumatic stress disorder treatment (PTSD), although it is"], "perturbed_original": ["Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment is thought to prevent return into mental health treatment in some groups. However, because of the design of the treatment group, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether a transition towards lower intensity treatments is associated with repeated mental health care use.", "Question: Is duration of treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, could help to determine whether the trend toward intensity was associated with repeated mental health care use.", "Question: Is duration of psychological treatment related to return into treatment related to return into treatment? The results suggest that a longer duration of psychological treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in RCT, is needed to determine whether the trend towards lower intensity treatments is associated with return into mental health care use.", "Question: Is duration of psychological treatment for depression a negative influence on how depression could return into treatment? Answer: This may suggest that a longer duration of treatment to depression can prevent return into mental health in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether a reduction in return towards lower intensity treatments is associated with repeated mental health care use.", "Question: Is duration of psychological treatment for depression related to a return into care? The study found that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, will be done to determine whether the trend towards lower intensity treatments is associated with repeated mental health care use.", "Question: What types of psychological treatment for depression might prevent return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further , a study, designed in a RCT, is needed to determine whether progress towards lower intensity treatments is associated with repeated mental health care use.", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the original design of the study, no causal inference can be drawn. Further research, preferably in the RCT, is needed to determine whether the trend in intensity and intensity treatments associated with mental health care use.", "Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care for some groups. However, because of the design of the trend, causal or causal inference can be drawn. The empirical hypothesis, preferably in a RCT, is needed to determine whether the trend is consistent with high intensity treatments associated with repeated mental health care use.", "Question: How is the evolution of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer -term dose of treatment may induce recovery into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to evaluate whether the trend towards lower intensity treatments is associated with mental health care use.", "Question: Is duration of psychological treatment for depression associated with depression a possible return into treatment? Answer: The results suggest that it is probable that duration of treatment for depression represents an increased likelihood of depression return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. In addition, preferably the RCT, is needed to determine whether the trend towards lower intensity treatments is associated with repeated mental health care use."], "original_ll": -3.0138180255889893, "sampled_ll": -2.507321834564209, "all_perturbed_sampled_ll": [-2.7632689476013184, -2.768824577331543, -2.6393377780914307, -2.5622377395629883, -2.8000786304473877, -2.644122838973999, -2.8667891025543213, -2.5794050693511963, -2.554837703704834, -2.8698675632476807], "all_perturbed_original_ll": [-3.1789116859436035, -3.0728797912597656, -2.926417827606201, -3.3836309909820557, -3.1885011196136475, -3.2853550910949707, -3.174557685852051, -3.5716302394866943, -3.2815396785736084, -3.271190881729126], "perturbed_sampled_ll": -2.70487699508667, "perturbed_original_ll": -3.2334614992141724, "perturbed_sampled_ll_std": 0.11687047944938701, "perturbed_original_ll_std": 0.16488359953719847}, {"original": "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may be incipient in young obese subjects, future studies will be required to demonstrate whether early intervention such as diet and exercise in this population can improve vascular functions.", "sampled": "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: No. The first evidence of vascular abnormalities early in adolescence was available at the mid-1980s, and it appeared that the development of a hypertrophic vascular system in young males might be an initial marker for early vascular abnormalities. The early signs of vascular abnormalities included: (i) hypertrophy of the ventricles, myocardial infarction, and cardiac edema; (ii) reduced vascular mass, edema, and other", "perturbed_sampled": ["Question: Are arterial artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: No. No. No. No. No. No. No. No. No. No. No. No, no evidence of vascular abnormalities early in adolescence was available at the mid-1980s, and it appeared that the diagnosis of a hypertrophic vascular system in young males might be an initial marker for vascular abnormalities. The early signs of vascular abnormalities included: (i) hypertrophy of the ventricles, myocardial infarction, and edema; (ii) reduced vascular mass, edema, and other", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of cardiovascular abnormalities in young obese males? Answer: No. The first evidence of vascular abnormalities in adolescence was available at the mid-1980s, and it appeared that the potential of a hypertrophic vascular system in obese males might have proved to be the initial marker for early vascular abnormalities. Typical signs of vascular abnormalities included: (i) hypertrophy of the ventricles, myocardial infarction, and cardiac edema; (ii) reduced vascular mass, edema, and other", "Question: Are increased carotid artery pulsatility and other early signs of vascular abnormalities in young obese males? Answer: No. The clinical trial of coronary infarction early in adolescence was available at the mid-1980s, and it appeared that the presence of a hypertrophic vascular system in young males might be an initial marker for early vascular abnormalities. The early signs of vascular abnormalities included: (i) hypertrophy of the ventricles, myocardial infarction, and cardiac pain, (ii) hypertension of the veins, reduced vascular mass, edema, and other", "Question: Are increased carotid artery pulsatility and resistance indexes a significant sign of vascular abnormalities in young obese males? Answer: No. The first evidence of vascular abnormalities at adolescence was available at the mid-1980s, and showed that the development of a hypertrophic vascular system in young males might be an initial marker for early vascular abnormalities. The early signs of vascular abnormalities included: (i) hypertrophy of both myocardial and cardiac edema; (ii) reduced vascular mass, or (iiii) higher risk of recurrent lymphocyte response, and (iii) decreased resistance to the other", "Question: Are the early artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? No. The first evidence of vascular abnormalities early in the 60s was available at the mid-1980s, and it appeared that the development of a hypertrophic vascular system in males might be an initial marker for early vascular abnormalities. The early signs of vascular abnormalities have been (i) reduced arterial mass, hypertrophy of the ventricles, myocardial infarction, and cardiac edema; (ii) reduced vascular mass, edema, and other", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? No. The first evidence of vascular abnormalities in young males in adolescence was available at the mid-1980s, and suggests that the development of a more elevated vascular system in young males might be an initial marker for early vascular abnormalities. The early signs of vascular abnormalities include (i) hypertrophy of the ventricles, myocardial infarction, and cardiac failure, reduced vascular mass, edema, and other", "Question: Are increased carotid artery pulsatility and resistance indexes predictive of vascular abnormalities in young obese males? Answer: No. The first evidence of vascular abnormalities early in the 70s was available at the mid-1980s, and it appeared that increasing the presence of a hypertrophic vascular system in young males might be an initial marker for early vascular abnormalities. The early signs of vascular abnormalities included: (i) hypertrophy of the ventricles, the vascular system; (ii) hypertension of the anterior ventricles, and cardiac edema; (ii) reduced vascular mass, and (iv) an other", "Question: Are increased carotid artery pulsatility and resistance indexes a significant indication of vascular abnormalities in young males? Answer: No. The first evidence of vascular abnormalities in young males early in adolescence was available at the mid-1980s, and it appeared that the development of a hypertrophic vascular system in males might be an initial indicator of early vascular abnormalities. The early signs of vascular abnormalities include (i) hypertrophy of the ventricles, myocardial infarction, and cardiac edema; (ii) reduced vascular mass, edema, and other", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: No. The first evidence of vascular abnormalities in young obese males by adolescence was vascular abnormalities in the late 20s. A study of cardiovascular abnormalities of early obese males in early adolescence was available at the mid-1980s, and it appeared that the development of early vascular abnormalities in young males might be an initial marker for early vascular abnormalities. The early signs of vascular abnormalities included: (i) reduced inflammation of the ventricles, myocardial infarction, and cardiac edema; (ii) reduced respiratory edema, and other", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: No. The first three vascular abnormalities early in adolescence were at a randomized control panel and it appeared that the development of a hypertrophic heart in young males might be the marker for early vascular abnormalities. The early signs of vascular abnormalities included: (i) hypertrophy of the arteries, infarction, and cardiac edema; (ii) reduced vascular mass, edema, and other"], "perturbed_original": ["Question: Are increased carotid artery pulsatility and vascular resistance early signs of vascular abnormalities in obese males? Answer: Our results suggest that depressed vessel volume, increased arterial stiffness and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. Since increased renal risk may be a factor in arterial wall properties and not incipient in young obese subjects, future studies will be required to demonstrate whether early intervention such as diet and exercise in this population of obese subjects is not sufficient to demonstrate important vascular functions.", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities of young obese males? Answer: Our results show that depressed vessel compliance and arterial resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may be incipient in young obese subjects, future studies will be able to demonstrate whether low serum insulin resistance, such as diet and exercise in this population can improve vascular functions.", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that increased coronary vessel compliance and increased vascular resistance are features of the high cardiovascular disease in young obese and normotensive subjects independently of and in addition to cardiovascular disorders. As changes in arterial wall properties may be incipient in young obese subjects, future studies will be required to demonstrate whether early intervention such as aerobic exercise and exercise in this area will improve vascular functions.", "Question: Are increased carotid artery vascular resistance indexes indicative of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel arteries with increased vascular resistance are significant in young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may be incipient in young obese subjects, future studies will be required to demonstrate that minimal intervention during diet and exercise in this population can improve vascular functions.", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that increased vessel compliance and increased vascular resistance are the early signs of cardiovascular abnormalities in young, obese subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may be incipient in young obese subjects, it will be required to demonstrate whether early intervention such as diet and exercise could be an effective strategy for this and improve vascular functions.", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that increased vessel compliance and increased blood vessel strength are features of young, obese, normotensive subjects independently of and in herently cardiovascular risk factors. As changes in arterial wall properties may be incipient in young obese subjects, future studies will be required to demonstrate whether changes in blood vessels such as pressure and exercise in the blood can improve vascular functions.", "Question: Are increased carotid artery pulsatility and resistance indexes a predictive tool to assess the likelihood of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular risk factors may influence the features of young, obese, normotensive subjects independently of and in addition to risk factors. As changes in arterial wall properties may be incipient during young obese subjects, some studies are required to demonstrate whether early intervention such as diet and exercise in this population can improve vascular functions.", "Question: Are increased carotid immunity and resistance indexes involved in the formation of vascular abnormalities in young obese males? Recent results suggest that increased cardiovascular compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may be incipient in young obese subjects, future studies will be required to determine whether early intervention such as diet and exercise in this population can play a critical role in these functions.", "Question: Are increased carotid artery pulsatility and impaired valve compliance revealing early signs of vascular abnormalities in obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular vascular functions may alter the features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may be incipient in young obese subjects, future studies will be required to develop these results. For early intervention such as vascular exercise in obese subjects, can improve vascular functions.", "Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular expansion in young obese males? Answer: Our results suggest that depressed blood pressure and increased vascular resistance are the cause of inflammation in young, obese, normotensive subjects independently of and in addition to these factors. As changes in arterial wall properties may be incipient to new obese subjects, future studies will be required to demonstrate whether early intervention such as diet and exercise in this population can change arterial wall functions."], "original_ll": -3.4877820014953613, "sampled_ll": -2.5414085388183594, "all_perturbed_sampled_ll": [-2.4364750385284424, -2.7789149284362793, -2.7314999103546143, -3.115469217300415, -2.8039493560791016, -2.7913405895233154, -2.9536542892456055, -2.605128765106201, -2.8405351638793945, -3.0715630054473877], "all_perturbed_original_ll": [-3.483837366104126, -3.6674044132232666, -3.6103453636169434, -3.549185276031494, -3.4404497146606445, -3.7734856605529785, -3.6851916313171387, -3.4738593101501465, -3.793144702911377, -3.5637245178222656], "perturbed_sampled_ll": -2.8128530263900755, "perturbed_original_ll": -3.604062795639038, "perturbed_sampled_ll_std": 0.19293020794102309, "perturbed_original_ll_std": 0.1174328125327468}, {"original": "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore propose the term \"functional minimally conscious state\" for these patients. They may benefit from rehabilitation treatment. In cases where no significant activation was seen, the method has no prognostic value. Prediction of the", "sampled": "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Evidence from patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 29, 49\u201355 (2001).\n\n32. Jokovic, D, Treglukovic, M and Olsson, F. The role of neuroimaging on long-term memory memory. Archives of General Psychiatry 41, 1077\u20131089 (1998).\n\n33. Gage, M. and Brown, A. M. Functional magnetic resonance imaging: a review. International Journal of Cerebral Magnetic Resonance Imaging and its Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, S. K., Lecl", "perturbed_sampled": ["Question: Can functional magnetic resonance imaging predict recovery? Can functional magnetic resonance imaging predict recovery in patients with disorders with dementia? Answer: Evidence from patients with schizophrenia and bipolar ia, 29, 49\u201355 (2001).\n\n32. Jokovic, D, Treglukovic, M and Olsson, F. M. The role of neuroimaging in patients with neuroimaging on underlying memory memory. Archives of the Neuroscience Science 41, 1077\u20131089 (1998).\n\n33. Gage, M. and Brown, A. M. Functional magnetic resonance imaging: a review. International Journal of Cerebral Magnetic Resonance Imaging and Physical Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, S. K., Lecl", "How does mental imagery functional magnetic resonance imaging predict recovery in patients with red consciousness? Answer: The best question, patients with schizophrenia and bipolar disorder. Archives of General Psychiatry 10, 49\u201355 (2001).\n\n32. Jokovic, D, Treglukovic, M and Olsson, F. The role of neuroimaging and memory memory. Archives of General Psychiatry 41, 1077\u20131089 (1998).\n\n33. Gage, J, S and Brown, A. M. Functional magnetic resonance imaging has been a review. International Journal of Cerebral Magnetic Resonance Imaging and its Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, S. K., Lecl", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Introductions from patients with schizophrenia and schizophrenia versus Psychoneuroendocrinology 1, 1\u20138 (2001).\n\n32. Jokovic, D, Treglukovic, M and Olsson, F. (2015). Effects of neuroimaging on long-term memory memory. Archives of General Psychiatry 82 (1998).\n\n33. Gage, M. and Brown, A. M. Functional magnetic resonance imaging: a review. International Journal of Cerebral Magnetic Resonance Imaging and its Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., Cox, M., Klimmer, L. J., Wierle, S. K., Lecl", "Question: Can mental or magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Evidence from patients with a bipolar disorder. Psychoneuroendocrinology 29, 49\u201355 (2001).\n\n32. Jokovic, D, Treglukovic, M and Olsson, F. The role of neuroimaging on long-term memory memory. Archives of General Psychiatry 41, 1077\u20131089 (1998).\n\n33. Gage, M. and Brown, A. M. Functional magnetic resonance imaging can be seen as a review. Journal of Cerebral Magnetic Resonance and its Applications . Nature 61 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, W. L. J., Lecl", "A. Using mental imagery functional magnetic resonance imaging predict recovery of memory memory patients with disorders of both different types. Evidence from patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 29, 49\u201355 (1996). 33. van der Kolk, M. D, Treglukovic, M and Olsson, F. The role of neuroimaging on long-term memory memory. Archives of General Psychiatry 41, 1077\u20131089 (1998).\n\n33. Gage, B. Gage, J. A, and Brown, A. M. Functional magnetic resonance imaging: a review. International Journal of Cerebral Magnetic Resonance Imaging and its Applications 36 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. , S. K., Lecl", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Evidence from patients with schizophrenia and depression. Psychoneuroendocrinology 29, 49\u201355 (2001).\n\n32. Jokovic, D, Treglukovic, M and Olsson, F. The role of neuroimaging on long-term memory memory. Archives of General Dentistry 16, 1077\u20131089 (1998).\n\n33. Gage, M. and A. M. Functional magnetic resonance imaging: a review. International Journal of Cerebral Magnetic Resonance Imaging and Medical Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. S., Rehn, J., Schreiber, E., D'Souza, M., Klimmer, L. J., D'Jido, P. K., Lecl", "Question: Could the imagery functional magnetic resonance imaging predict recovery in patients with high levels of consciousness? Answer: Evidence from patients with hypersensitivity or bipolar disorder. Psychoneuroendocrinology 29, 49\u201355 (2001).\n\n32. Jokovic, D, Treglukovic, M and Olsson, F. The role of neuroimaging on long-term memory . Journal of General Psychiatry 41, 1077\u20131089 (1998).\n\n33. Gage, M. and Brown, A. S. Functional magnetic resonance imaging: a new study. Journal of Cerebral Magnetic Images and its Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, S. K., Lecl", "imaging in mental imagery functional imaging imaging in a variety of different populations in patients with disorders of schizophrenia. Evidence from patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 29, 49\u201355 (2001).\n\n32. Jokovic, D, Treglukovic, M and Olsson, F. The role of neuroimaging on long-term memory memory. Archives of General Psychiatry 41, 1077\u20131089 (1998).\n\n33. Brown, A. M. and Brown, A. M. Functional memory imaging: a review. International Journal of Cerebral Magnetic Resonance Imaging and its Applications 16, 41\u201350 (1982).\n\n34. van der Grauman, S. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, S. K., Lecl", "Question: Can functional functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? A variety of therapeutic solutions for recovery from patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 29, 49\u201355 (2001).\n\n32. Jokovic, D, Treglukovic, M and Wilson, D. A. The role of neuroimaging on long-term memory memory. Archives of General Psychiatry 41, 1077\u20131089 (1998).\n\n33. Gage, M. and Brown, G. A. Functional magnetic resonance imaging: A Molecular International Journal of Cerebral Magnetic Resonance and its Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. S., Rehn, M. M., Schreiber, E., D'Souza, M., Klimmer, L. J., Wierle, S. K., Lecl", "Question: Can mental imagery or magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Evidence from patients with schizophrenia in cognitive disorder. Psychoneuroendocrinology 29, 49\u201355 (1996). 46. van der Kolk, D, Treglukovic, M and Olsson, F. The role of neuroimaging on long-term memory memory. Archives of General Psychiatry 41, 1077\u20131089 (1998).\n\n33. van der Kolk, J. and Brown, A. M. Functional magnetic resonance imaging: a review. International Journal of Cerebral Magnetic Resonance Imaging & Applications 16, 41\u201350 (1982).\n\n34. van der Kolk, J. M, Williams, M. M., Schreiber, E., Van der Kolk, J., Klimmer, L. J., Wierle, S. K., Lecl"], "perturbed_original": ["Question: Can mental imagery functional magnetic resonance imaging predict neurology of patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a positive progression with a very favorable clinical course after clinical diagnosis. Patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We have the term \"functional minimally conscious state\" in several patients. They may benefit from rehabilitation treatment. In cases where no significant activation was seen, the method has no prognostic value. Prediction of the", "Question: Can mental imagery functional minimally conscious imaging predict recovery in all disorders of consciousness? At the fMRI paradigm mental imagery displays a high probability of improving the further clinical course of patients in patients in the VS. All 5 patients in a VS who showed good results of ROIs had a favorable further course until the end of the observation period. I propose the term \"functional minimally conscious state\" for these patients. They may benefit from rehabilitation treatment. In cases where no significant activation was seen, the method has no prognostic value. Prediction of the", "Question: Can the treatment of functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients with VS. Compared to others, patients in groups who were receiving activation of ROIs had a favorable further course until the end of the observation period. We therefore propose the term \"functional minimally conscious state\" for these patients. They may benefit from rehabilitation treatment. For patients where no significant activation of ROIs is present, the method has no prognostic value. Prediction of the", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery imaging is of high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who had had no significant activation of ROIs had a favorable success until the end of the month. We used the term \"functional minimally conscious state\" for these patients. They may benefit from rehabilitation . In cases where no significant activation was detected, the diagnostic method has no prognostic value. Prediction of the", "Question: Can mental imagery functional magnetic resonance imaging predict mental imagery effect on patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays in concordance with the further clinical course of study and treatment in a VS. All 5 patients in a VS who showed significant activation in the fMRI had a favorable function until the end of the observation . Our approach will therefore propose the term \"functional minimally conscious state\" for these patients. They may benefit from rehabilitation treatment. For patients where no significant activation was seen, the method has no prognostic value. Prediction of the", "Question: Can mental imagery functional magnetic resonance imaging be implemented in patients with minimally conscious consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical trials of a patients in a VS. All 5 patients in a VS who had no significant activation of ROIs had a favorable further physiological activity in a VS at the end of the observation period. We therefore propose the term \"functional minimally conscious state\" for these patients. They may benefit from rehabilitation treatment. In cases where no significant activation was seen, the method has no prognostic properties. The general objective of the", "Question: Can mental imagery functional brain imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high risk for the further clinical course of patients in a VS. All 5 patients in a VS showed higher than the baseline. All cases of ROIs had a favorable baseline of 60 times until the end of the observation period. We therefore propose the term \"regeneration in conscious state\" for patients. They may benefit from rehabilitation treatment. In cases where no significant activation was seen, the method has no prognostic value. Prediction of the", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high recovery rate over the further clinical course of patients in a VS. All 5 patients in a VS who have the activation of mental imagery are treated on a favorable basis until the start of the observation period. We use the term \"functional minimally conscious state\" for these patients. They may benefit from rehabilitation treatment. In cases where the initial activation was seen, the method has no prognostic value. Prediction of the", "Question: Can mental imagery functional magnetic resonance play a key role in clinical recovery in patients with disorders of consciousness? Answer: The fMRI paradigm (FMRI) displays a high concordance with the general course of patients in a VS. However, patients in a VS who showed significant activation of ROIs had a favorable further course in treatment at the end of the spectrum. We therefore propose the term \"functional minimally conscious state\" for these patients. They may benefit from rehabilitation treatment. In cases where significant activation was seen, the method has no prognostic value. Prediction of the", "Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm currently displays a high concordance with the further clinical course of 5 patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the treatment period. We therefore propose the term \"functional minimally conscious \" for these patients. They may benefit from rehabilitation treatment. In cases where significant activation was seen, the method has no prognostic effects on the recovery of the"], "original_ll": -3.9908230304718018, "sampled_ll": -2.2859673500061035, "all_perturbed_sampled_ll": [-2.6544909477233887, -2.7147433757781982, -2.6948018074035645, -2.582761764526367, -2.6558475494384766, -2.5447256565093994, -2.535679578781128, -2.4704811573028564, -2.4992194175720215, -2.4337329864501953], "all_perturbed_original_ll": [-4.233165740966797, -4.318055629730225, -3.8608500957489014, -4.042158126831055, -4.226219654083252, -3.986320972442627, -4.237334251403809, -4.0061445236206055, -3.9017229080200195, -3.9850552082061768], "perturbed_sampled_ll": -2.5786484241485597, "perturbed_original_ll": -4.079702711105346, "perturbed_sampled_ll_std": 0.09260067052666127, "perturbed_original_ll_std": 0.1519045462313255}, {"original": "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.", "sampled": "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "perturbed_sampled": ["Question: Does the Use of a Neuroendoscope Influence the Treatment of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of a Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "Question: Does the Simultaneous Use of Neuroendoscope Influence the Use of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area , it may be confined to the face.\n\n(Click to view", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the risk of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is to identify a certain area of the face.\n\n(Click to view", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? The answer will come as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "Question: Does the Simultaneous Use of the Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "How does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the patient we\u2019re in view", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Function? Answer: Yes, as such, the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view", "Question: Does the Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: Yes, as long as the use of the Neuroendoscope is confined to a certain area of the face.\n\n(Click to view"], "perturbed_original": ["Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Surgery Infection? Answer: In the present study, the use of an endoscope during VPS procedures may increase the risk of surgical infection.", "Question: Does the Simultaneous Use of a Neuroendoscope Increase the Risk of Surgery or the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence Of the Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.", "Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Disease? Answer: In the present study, the use of an endoscope during Operation Prevention did not increase the risk of surgical infection.", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present, the use of an NPC-like VPS procedures did not increase the risk of surgical infection.", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Risk of Ventriculoperitoneal infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.", "Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal infection? Answer: In the present study, the use of an endoscope during VPS does not increase the risk of surgical infection.", "Question: Does the use of a Neuroendoscope Improve the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection.", "Question: Does the Simultaneous Use of Endoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Moreover, in the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical infection."], "original_ll": -3.280395746231079, "sampled_ll": -2.8754100799560547, "all_perturbed_sampled_ll": [-2.891547203063965, -2.956092119216919, -3.0188944339752197, -3.0934863090515137, -3.180388927459717, -3.189473867416382, -2.8608884811401367, -3.7733538150787354, -3.194744825363159, -2.8455007076263428], "all_perturbed_original_ll": [-3.4065186977386475, -3.0881242752075195, -3.549952507019043, -3.4214606285095215, -3.3796756267547607, -3.7280845642089844, -3.3273215293884277, -3.3397598266601562, -3.315159559249878, -3.267744779586792], "perturbed_sampled_ll": -3.100437068939209, "perturbed_original_ll": -3.3823801994323732, "perturbed_sampled_ll_std": 0.258761430764371, "perturbed_original_ll_std": 0.16087375300514906}, {"original": "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.", "sampled": "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, because it's possible to increase blood pressure by using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is a radiologist at Brigham and Women's Hospital. His research focuses", "perturbed_sampled": ["What is a Novel Surgical Approach to the Temporomandibular Joint to Improve Blood Pressure and Reduce Complications? Answer: Yes, because it's possible to increase blood pressure by using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is a Licensed Physician at Brigham and Women's Hospital. His research focuses", "Question: Can a Differentive Approach to Reactor Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, because it's possible to increase blood pressure by using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is a radiologist at Brigham and Women's Hospital. His research focuses", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve and Reduce Complications? Answer: Yes, because some patients tend to increase blood pressure by using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is a radiologist at Brigham and Women's Hospital. His research focuses", "Would a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, because it's possible to increase blood pressure by using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is professor at Brigham and Women's Hospital. His study focuses", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, it's possible to increase blood pressure by using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is a radiologist at the Boston Hospital and Women's Hospital. His research focuses", "Question: Can a Novel Surgical Approach to a Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, because it is best to increase blood pressure by using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is a radiologist at the Women's and Women's Hospital. His research focuses", "Use of a Novel Surgical Approach to the Prevention of Closing: 1. Can I Improve Access and Reduce Complications? Answer: Yes, because it's possible to increase blood pressure by using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is a radiologist at Brigham and Women's Hospital. His research focuses", "Question: Can a Novel Treat to the Temporomandibular Joint Improve Blood Pressure or Reduce Complications? Answer: Yes, because it's possible to increase blood pressure by using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is a radiologist at Brigham and Women's Research Centre. His research focuses", "Question: Can a Novel Surgical Approach to a Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, because it's possible to increase blood pressure by using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is Professor at the U.S. Women's Hospital. His research focuses", "Question: Can a Novel Surgical Approach on the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, it is possible to increase blood pressure by using a medication.\n\n2. The Study Method\n\nA. Dr. J. M. Haney\n\nDr. J. M. Haney is a radiologist at Brigham and Women's Hospital. His research focuses"], "perturbed_original": ["Question: Can a Novel Surgical Approach to the Temporomandibular Surgery Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.", "Question: Can a Novel Surgical Approach to the Joint Improve Access and Reduce Complications? The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered as a preferred surgical method of choice for common TMJ surgeries.", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct and favorable visibility to the TMJ region and yield good esthetic health results. This can be considered the approach of choice for common TMJ surgeries.", "Question: Can a New Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and provide esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? The VMPA can provide direct access and visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the best surgical choice for common TMJ surgeries.", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA is designed to provide direct access and favorable visibility to the TMJ region and yield good esthetic or surgical results. The VMPA has been considered the approach of choice for common TMJ surgeries.", "Question: Can a Modern Approach to the Temporomandibular Joint Improve Access and Reduce Traffic? The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and surgical treatment options. The VMPA can be considered the approach of choice for common TMJ surgeries.", "Question: Can a Novel Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA VMPA is considered the approach of choice for common TMJ surgeries.", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Complications? Answer: The VMPA can provide direct access and favorable therapeutic support to the TMJ region and yield unique surgical and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.", "Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Function? Answer: The VMPA can provide direct access and access to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for all spinal cord surgeries."], "original_ll": -3.944814920425415, "sampled_ll": -2.649872303009033, "all_perturbed_sampled_ll": [-2.587407112121582, -3.028001546859741, -2.7200186252593994, -2.900146007537842, -2.7943742275238037, -2.9851677417755127, -2.882328748703003, -2.828622341156006, -2.855337142944336, -2.649878740310669], "all_perturbed_original_ll": [-4.001533508300781, -4.358362674713135, -4.257223129272461, -3.9388427734375, -4.009153366088867, -3.913024425506592, -4.282661437988281, -4.0327606201171875, -3.964733362197876, -3.7685887813568115], "perturbed_sampled_ll": -2.8231282234191895, "perturbed_original_ll": -4.052688407897949, "perturbed_sampled_ll_std": 0.13257908299547486, "perturbed_original_ll_std": 0.17719582074125242}, {"original": "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of the Kupffer and endothelial cells damage, while other mechanisms caused damage to the hepatocytes.", "sampled": "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. Laparoscopic cholecystectomy is a surgically assisted operation to reduce a patient's risk of contracting multiple sclerosis by using bone-enhancing surgery in addition to the surgical intervention. The procedure was approved by the FDA and was approved by the American College of Dermatology and Dermatology. A total of 14 people were enrolled in the study. The", "perturbed_sampled": ["Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. Laparoscopic cholecystectomy is a surgically assisted surgical solution designed to reduce a patient's risk of contracting multiple sclerosis by using bone-enhancing treatments, in addition to surgical intervention. The procedure was approved by the FDA and was approved by the American College of Dermatology and Dermatology. A total of 14 patients were enrolled in the study. The", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? A: Laparoscopic cholecystectomy is a surgically assisted operation to reduce a patient's risk of contracting multiple sclerosis by using bone-enhancing surgery in addition to bone-enhancing surgical intervention. The study was approved by the FDA and was approved by the American College of Clinical Dermatology. A total of 14 people were enrolled in the study. The", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. Laparoscopic cholecystectomy is a surgically assisted treatment that reduce a patient's contracting disorders and thereby reduces patients' contracting multiple infections using bone-enhancing surgery in addition to the surgical intervention. The procedure was approved by the FDA and was approved by the American College of Clinical Dermatology. A total of 14 people were enrolled in the study. The", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. A laparoscopic cholecystectomy is a surgically assisted operation to reduce a patient's risk of contracting multiple sclerosis by using bone-enhancing surgery in addition to the surgically assisted surgery. The procedure was approved by the FDA and was approved by the American College of Dermatology and Dermatology. A total of 14 people were enrolled in the procedure. The", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal surgery? Answer: Yes. Laparoscopic cholecystectomy is a surgically assisted operation to reduce a patient's risk of contracting multiple sclerosis by providing additional surgery in addition to the surgical intervention. The study was approved by the FDA and was evaluated by the American College of Dermatology and Dermatology. A total of 14 people were enrolled in the study. The", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. Laparoscopic cholecystectomy is a surgically assisted operation to reduce a risk of contracting multiple sclerosis by following the surgery in addition to the surgical intervention. The procedure was approved by the FDA and was approved by the American College of Dermatology and Dermatology. A total of 14 people were implicated in the study. The", "Question: Does laparoscopic cholecystectomy affect cell cell activity? Answer: Yes. Laparoscopic cholecystectomy is an assisted operation to reduce a risk of contracting multiple sclerosis by using bone-enhancing surgery in addition to the surgical intervention. The cholecystectomy was approved by the FDA and was approved by the American College of Dermatology and Dermatology. A total of 14 people were enrolled in the study. The", "Question: Does cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. Laparoscopic cholecystectomy is a surgical operation to reduce a patient's risk of contracting multiple peri-sinusoidal cell activity by using bone-enhancing surgery in addition to the surgical intervention. The procedure was approved by the FDA and was approved by the Department of Dermatology and Dermatology. A total of 14 people were enrolled in the study. The", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Yes. Laparoscopic cholecystectomy is an assisted operation to reduce a patient's risk of contracting multiple sclerosis by using bone-enhancing surgery in addition to the bone enhancement surgery. The procedure was approved by the FDA and approved by the American College of Dermatology and Dermatology. A total of 14 people were enrolled in the study. The", "Question: Does laparoscopic cholecystectomy influence bone-enhancing surgical activity? Answer: Yes. Laparoscopic cholecystectomy is a surgically assisted operation that decreases a patient's risk of contracting multiple sclerosis by using bone-enhancing surgery in addition to the surgical intervention. The procedure was approved by the FDA and was approved by the American College of Dermatology and Dermatology. A total of 14 people participated in the study. The"], "perturbed_original": ["Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells reflected by the post-operative HA . The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of the Kupffer and endothelial cells and other mechanisms caused damage to the hepatocytes.", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no immediate effect on liver function, and the laparoscopic procedure is the probable cause of the Kupffer and endothelial cells damage, with certain mechanisms caused damage to the hepatocytes.", "Could laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused the damage to the Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is not the probable cause of the Kupffer and endothelial cells damage, while other mechanisms caused damage to the hepatocytes.", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to the endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance in many cases. The laparoscopic procedure itself is the probable cause for the Kupffer and endothelial cells damage, while other mechanisms caused damage to the liver hepatocytes.", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative oxygen levels. The damage to the liver hepatocytes and endothelial cells has no clinical significance and the surgery is the one itself who is the most probable cause of the Kupffer and endothelial cells damage, while other mechanisms caused damage to the hepatocytes.", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures cause damage to Kupffer and endothelial cells as reflected by different post-operative HA serum levels. The damage to liver hepatocytes and perisinusoidal cells has no clinical significance and the laparoscopic procedure itself is the probable cause of the Kupffer and endothelial cells damage, but no clinical significance can be found by determining which mechanisms caused damage to the hepatocytes.", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of serum levels and serum levels. The damage to the liver hepatocytes and endothelial cells has no clinical significance and the laparoscopic procedure itself is no clinical significance. There are no biological mechanisms for detecting the cause of the Kupffer and endothelial cells damage, while other mechanisms caused damage to the hepatocytes.", "Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Slavage caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells showed no significant effect on blood vessels, and the laparoscopic procedure itself was a probable cause of the Kupffer and endothelial cells damage, while other mechanisms caused damage to the hepatocytes.", "Question: Does HA serum levels influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation in HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical significance and the cells itself is the probable cause of the Kupffer and endothelial cells while other mechanisms caused damage to the hepatocytes.", "Question: How does cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has considerable significance and the laparoscopic procedures is the result of the Kupffer and endothelial cells damage, while other mechanisms caused damage to the hepatocytes."], "original_ll": -3.562427520751953, "sampled_ll": -2.347944498062134, "all_perturbed_sampled_ll": [-2.3316292762756348, -2.454371690750122, -2.915574073791504, -2.402064323425293, -2.338564395904541, -2.5760347843170166, -2.378157615661621, -2.499415874481201, -2.487896203994751, -2.2112083435058594], "all_perturbed_original_ll": [-3.809446334838867, -3.551377058029175, -3.564232587814331, -3.6597869396209717, -3.5631706714630127, -3.4802284240722656, -3.441295862197876, -3.700319766998291, -3.920116901397705, -3.760643482208252], "perturbed_sampled_ll": -2.459491658210754, "perturbed_original_ll": -3.645061802864075, "perturbed_sampled_ll_std": 0.1807070464810899, "perturbed_original_ll_std": 0.1449185738946852}, {"original": "Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.", "sampled": "Question: Do mossy fibers release GABA? Answer: We do not, but some of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in many prescription pain killers and can also bind to benzodiazepines and heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially to people with anorexia, a heart condition, etc.). This drug causes insomnia, nausea, vomiting, and", "perturbed_sampled": ["with mossy , GABA? Answer: We do, but some of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in many prescription pain killers and can also bind to benzodiazepines and heroin (see below for more details in this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially to people with chronic heart condition, etc.). This drug causes insomnia, nausea, vomiting, and", "Did those mossy fibers release GABA? Answer: We know, but some of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in many prescription medicine drugs and can also bind to drugs containing heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled as a fentanyl, it can be overpowering (especially to people with anorexia, a heart condition, etc.). This drug causes insomnia, nausea, vomiting, and", "Question: Do mossy fibers release GABA? Answer: We do not, but some of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in many prescription pain relief products and can be applied to benzodiazepines and heroin (see the full article more on what's not to be used at the beginning of this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially to people with anorexia, a heart condition, etc.). This drug can lead to nausea, vomiting, and", "Question: Do mossy l have any effects on the GABA? Answer: We do not, but some of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in prescription pain killers and cannot bind to this heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially to people with anorexia, a heart condition, etc.). This drug can cause nausea, vomiting, and", "Question: Do mossy fibers release GABA? They do not, but some of these compounds are in a range of ways. GABA is found in many prescription s and can be traced to benzodiazepines and heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially to people with anorexia, a heart condition, etc.). This can cause insomnia, nausea, vomiting, and", "Question: Do mossy fibers release GABA? Answer: We do not, some of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) binds to benzodiazepines and heroin. It is common in many prescription pain killers that also bind to benzodiazepines and heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled at all can be overpowering (especially to people with anorexia, a heart condition, etc.). Fentanyl causes insomnia, nausea, vomiting, and", "Question: Do mossy fibers release the fibers? We do not, but not most of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in many prescription pain killers and can also bind to benzodiazepines and heroin (see below for more on what's in this compound.)\n\nIt has a fragrance absorbing effect, but when smelled at night, it can be overpowering (especially in people with anorexia, physical condition, etc.). This drug causes insomnia, nausea, vomiting, and", "Question: Do mossy fibers release GABA? Answer: We do not, but some of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in many other killers and can also bind to heroin and heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially to people with a heart condition, etc.). Fentanyl causes insomnia, nausea, vomiting, and", "Question: How can fibre fibers release GABA? Answer: We do not, most of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is known to be a very high-end product that can contain many prescription pain relievers. It can also bind to benzodiazepines and heroin (see below for more on what's in this compound.)\n\nIt has a strong odor, but when smelled at night, the smell might be overpowering (especially to people with anorexia, a heart condition, etc.). This drug causes insomnia, nausea, vomiting, and", "Question: Do mossy fibers release GABA? Answer: We don't think it contains or is the culprit, but some of us do.\n\nFentanyl\n\n(N,N'-bor-F-(N)-)-Fentanyl) is found in many prescription pain killers and can also bind to generic heroin (see below for more on how to build this compound.)\n\nIt has a strong odor, but when smelled at night, it can be overpowering (especially to people with anorexia, a heart condition, or the drug addiction), nausea, vomiting, and"], "perturbed_original": ["Question: Do mossy fibers release GABA? Answer: These studies have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of the mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that the mossy fiber GABAergic signal is released during seizures after seizures. This could have an inhibitory or disinhibitory effect, but more work is needed to elucidate its actual role.", "Question: Do mossy fibers release GABA? Answer: This test has thus provided compelling evidence that there is a mossy fiber GABAergic signal. The role of this mossy fiber GABAergic signal is uncertain, but may be of relevance. Other evidence indicates that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.", "Question: Do mossy fibers release GABA? Answer: We have thus discovered evidence that the activity of a mossy fiber GABAergic signal. The physiologic role of this mossy fiber signal is uncertain, but it might be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This signal can have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.", "Question: Do mossy fibers release GABA? We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The development of this mossy fiber signal is uncertain, but may be of developmental importance. Other evidence suggests that this signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to determine whether that signal is involved in its actual role.", "Question: Do mossy fibers release GABA? Answer: We have thus provided evidence that there is an effective release of this mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. Some signals have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.", "Question: Do mossy fibers release ? We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of interest to you. Other evidence suggests that this GABAergic signal is released after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.", "Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is discussed. It may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could be an inhibitory mechanism of effect, however some basic work is needed to elucidate its actual role.", "did mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence is that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.", "Question: When fibers release their signal, are they activated? We have thus provided evidence that there is a mossy fiber GABAergic signal. The role of this mossy GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory effect, and further work is needed to elucidate its actual role.", "Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other studies have shown that this GABAergic signal is transiently upregulated after seizures. This could have an inhibitory or disinhibitory role. Therefore, further work is needed to elucidate its actual role."], "original_ll": -3.0321710109710693, "sampled_ll": -2.7340645790100098, "all_perturbed_sampled_ll": [-3.124236583709717, -3.043696403503418, -2.96532940864563, -2.9922544956207275, -3.1303484439849854, -2.8441483974456787, -3.1126961708068848, -2.961923360824585, -2.96567702293396, -3.10082745552063], "all_perturbed_original_ll": [-2.8781380653381348, -3.1288366317749023, -3.1552679538726807, -3.345848321914673, -3.119555711746216, -3.168039083480835, -3.315119743347168, -3.1523690223693848, -3.1153154373168945, -2.992111921310425], "perturbed_sampled_ll": -3.0241137742996216, "perturbed_original_ll": -3.1370601892471313, "perturbed_sampled_ll_std": 0.08919996906902039, "perturbed_original_ll_std": 0.12873259051042743}, {"original": "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions.", "sampled": "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: The evidence suggests that red blood cell morphology, particularly in a patient of known risk of cardiovascular disease, is associated with lower risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists. Clinically, one might ask whether the difference in the way that an individual is treated for a", "perturbed_sampled": ["Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinical pathologists? Answer: The evidence suggests that red blood cell morphology, generally linked to a patient of known risk of cardiovascular disease, is associated with lower risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists. Clinically, one might ask the same difference in the way that red blood cell is treated for a", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical and clinical pathologists and clinical clinicians? Answer: The evidence suggests that red blood cell morphology, particularly in a patient of known risk of cardiovascular disease, is associated with lower risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists. Clinically, one might ask whether the difference between clinical pathologists is the way that an individual may be treated for a", "Question: Reporting and interpreting red blood cell morphology: The discordance between clinical pathologists and patients: an important Answer: The evidence suggests that red blood cell morphology, particularly in a patient with lower risk of mortality, is associated with lower risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists, so one might ask whether the difference in the way that an individual is treated for a", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: The evidence suggests that red blood cell morphology, especially in a patient of known risk of cardiovascular disease, is associated with high risk for mortality.\n\nThere are a lot of differences between clinical and clinical pathologists. Clinically, one might ask if there was a difference in the way that an individual is viewed as a", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical and clinical pathologists? The evidence suggests that red blood cell morphology, particularly in a patient of known risk of cardiovascular disease, is with a lower risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists. Clinically, one might ask whether the differences affect the way that an individual is treated for a", ", research and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Clinical evidence suggests that red blood cell morphology, particularly in a patient of known risk for cardiovascular disease, is associated with lower risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists. Clinically, one might ask whether the difference in risk is significant; that an individual is looking for a", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Clinical evidence suggests that red blood cell morphology, particularly in a patient of known risk of cardiovascular disease, is associated with a risk of cardiovascular disease which can cause serious risks for mortality.\n\nThere are a number of differences between clinical and clinical pathologists. Clinically, one might ask whether a change in the way that an individual is treated for a", "Question: Reporting and the formation of red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: The evidence suggests that red blood cell morphology, particularly in a patient of known risk of cardiovascular disease, is associated with lower risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists. One might ask whether the difference in the way that an individual is treated is a", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and physicians? The evidence suggests that red blood cell morphology, particularly in a patient of known risk of cardiovascular disease, is associated with a significant risk factor for mortality.\n\nThere are a number of differences between both clinical pathologists and clinical pathologists. Clinically, one might ask whether this might contribute to a major change in the way that an individual is treated for a", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: The evidence suggests that red blood cell morphology, particularly in a study of the known risk of death is associated with lower risk for mortality.\n\nThere are a number of differences between clinical and clinical pathologists. Clinically, one might wonder about the difference in the probability that an individual is treated for a"], "perturbed_original": ["clinical relevance and interpreting red blood cell morphology: is there a greater link between clinical pathologists and clinicians? Answer: Most debates about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting CBC reports must be examined critically to improve communication, in addition to allowing clinicians to make informed and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of interpretation terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that CBC report changes are interpreted as an independent statement from the CP. Reporting practices should be examined critically , in particular, to ensure appropriate CC communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell morphology: is there any difference between clinical pathologists and clinicians? Answer: More information about the use of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that these changes are interpreted as intended by the CP. Additional data should be examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell numbers are also key for the assessment, but are there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of RBC-M terms exist between clinicians and physicians. Therefore, the integration of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices are examined critically to ensure the accuracy, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting of cell morphology: is there discordance between pathologists and clinicians? Answer: Important differences in the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of RBC-M on CBC reports is the clearest way to ensure that RBC-M terms are interpreted as intended by the CP. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood , is there discordance between clinical pathologists and clinicians? No differences in the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes should be implemented as intended by the clinical pathologists. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood morphology: A discordance between clinical pathologists . Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to ensure that information integrity, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting cell cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences in the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion and comments on CBC reports is the clearest way to ensure that RBC-M changes occur as intended by the CP. Reporting and interpreting cell morphology should be examined critically to improve communication, transparency, and ultimately medical decisions.", "Question: Reporting and interpreting red blood cell calls is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted and evaluated by the CP. CBC reports should be examined critically to improve its performance and ultimately medical decisions.", "Question: Reporting morphology and red blood cell morphology: is there discordance between clinical relevance of CPs and clinicians? Answer: Important differences about the clinical relevance of CBC terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by each clinical CP. Reporting practices should be examined critically to improve communication, transparency, and ultimately medical decisions."], "original_ll": -4.163998603820801, "sampled_ll": -2.8606038093566895, "all_perturbed_sampled_ll": [-3.065735101699829, -2.8492543697357178, -3.204585313796997, -2.9095993041992188, -2.9837486743927, -2.9992830753326416, -2.986743450164795, -2.880127429962158, -2.9453539848327637, -3.134685754776001], "all_perturbed_original_ll": [-4.073154449462891, -4.460990905761719, -4.192959785461426, -4.235421657562256, -3.9586355686187744, -4.189417362213135, -4.622555732727051, -4.148338794708252, -4.246445178985596, -4.279116153717041], "perturbed_sampled_ll": -2.995911645889282, "perturbed_original_ll": -4.240703558921814, "perturbed_sampled_ll_std": 0.10622705253739279, "perturbed_original_ll_std": 0.17803090650748246}, {"original": "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.", "sampled": "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: The presence of colorectal cancer in young patients (\u22641.5 million years of age) is consistent with a unique pattern in cancer progression in which the tumor-bearing tumor,", "perturbed_sampled": ["Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: The pattern of colorectal cancer in young patients (\u22641.5 million years ) is consistent with a unique pattern in cancer and in which the tumor-bearing tumor,", "Question: colorectal cancer in young patients: is there a distinct clinical entity? Answer: The presence of colorectal cancer in young patients (\u22641.5 million years of age) is consistent with a unique pattern in cancer progression in which the tumor-bearing tumor,", "Question: Cancer in young patients: is it a distinct clinical entity? Answer: The presence of colorectal cancer in young patients (\u22641.5 million years of age) is consistent with a unique pattern in cancer progression . Whether it is the tumor-bearing tumor,", "Question: Colorectal cancer in young patients: is this a distinct clinical entity? Answer: The presence of colorectal cancer in young patients (\u22641.5 million years of age) is often a unique pattern in cancer progression in which the tumor-bearing tumor,", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: The presence of colorectal cancer in young patients (\u22641.5 million years of age) is consistent with a unique pattern of tumor progression in which the tumor-bearing tumor,", "Question: Colorectal cancer in young patients: is colorectal cancer a distinct clinical entity? Answer: The study of colorectal cancer in young patients (\u22641.5 million years of age) is consistent with a unique pattern of tumor progression in which the tumor-bearing tumor,", "Question: Colorectal cancer in young patients: is colorectal cancer a distinct clinical entity? Answer: The presence of colorectal cancer in young patients (\u22641.5 million years of age) reveals significant changes with a unique pattern in the ways in which the tumor-bearing tumor,", "Question: The presence of colorectal cancer in young patients: How do they interact with a distinct clinical entity? Answer: The presence of colorectal cancer in young patients (\u22641.5 million years of age) is consistent with an early pattern in cancer progression in which the tumor-bearing tumor,", "Question: Colorectal cancer in young patients: is it a common entity? The presence of colorectal cancer in young patients (\u22641.5 million of its age) is consistent with a unique pattern in cancer progression in which the tumor-bearing tumor,", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: The risk of colorectal cancer in young patients (\u22641.5 million years ) is consistent with the pattern in cancer progression in which the tumor-bearing tumor,"], "perturbed_original": ["Question: Colorectal cancer among young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and the optimal approach in this population.", "Question: Colorectal cancer cancer patients: is it a distinct clinical entity? Answer: Colorectal cancer cancer patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to investigate our findings and define the clinical differences in this population.", "Question: Colorectal cancer in young patients: is colorectal cancer a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity? Answer: Further research is needed to validate the clinical identity of colorectal cancer among young patients, and define the optimal approach in this population.", "Question: Colorectal cancer in young patients: is it a distinct treatment entity? Question: We Answer: Colorectal cancer among young patients in young patients: is it a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate the efficacy and the optimal approach in this population.", "Question: Why is colorectal in children is it a distinct clinical entity? Answer: Colorectal in young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.", "Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define an approach that impacts the whole population.", "Question: Colorectal cancer in young patients may constitute it a distinct clinical entity? Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and ensure that we implement an optimal approach in this population."], "original_ll": -2.6658191680908203, "sampled_ll": -2.5326521396636963, "all_perturbed_sampled_ll": [-2.8916664123535156, -2.6874165534973145, -2.9344534873962402, -2.707240581512451, -2.480414390563965, -2.5001771450042725, -2.746476173400879, -2.6742284297943115, -2.853346586227417, -2.8554701805114746], "all_perturbed_original_ll": [-2.642024278640747, -2.848935604095459, -2.653310537338257, -2.3268141746520996, -2.9784750938415527, -2.684814214706421, -3.2260851860046387, -2.6658191680908203, -2.803468942642212, -3.0206480026245117], "perturbed_sampled_ll": -2.733088994026184, "perturbed_original_ll": -2.785039520263672, "perturbed_sampled_ll_std": 0.14819709159675495, "perturbed_original_ll_std": 0.2374673169888976}, {"original": "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "sampled": "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: This is another question we often encounter, particularly when interpreting the effects of discordance in TEOAE. In newborns discordance in TEOAE is quite severe and can potentially have lifelong negative consequences. We need to remember that TEOAE and AABR are different in developmental stage, and", "perturbed_sampled": ["Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: This is another question we often encounter, particularly when interpreting the effects of discordance in TEOAE. In newborns discordance in TEOAE is quite severe and can potentially have major consequences. We need to remember that TEOAE and AABR are different in developmental stage, and", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? This is another question we often encounter, particularly when interpreting the meaning of discordance in newborns. In newborns discordance in TEOAE is quite severe and can potentially have devastating consequences. We need to remember that TEOAE and AABR are different in developmental stage, and", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: This is another question we often encounter, particularly when interpreting the effects of discordance in TEOAE. In newborns discordance in TEOAE is the norm and can potentially have similar consequences. We need to remember that TEOAE and AABR are different at each stage, and", "Question: Is discordance in TEOAE and AABR different in developmental stage? If there is a specific difference in developmental stage. This is an essential question we often encounter, particularly when interpreting the effects of discordance in TEOAE. In newborns discordance in TEOAE can be severe and can potentially have lifelong negative consequences. We need to remember that TEOAE and AABR are different in developmental stage, and", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: This is another question we often encounter, particularly when interpreting the effects of discordance in TEOAE. In our opinion, discordance in TEOAE is quite severe and can potentially have lifelong negative consequences. We need to understand that discordance in TEOAE and AABR outcomes can be predictable in babies in developmental stage, and", "Question: Are discordance in TEOAE and AABR outcomes predictable in newborns? Answer: This is another question we often ask when interpreting the effects of discordance in TEOAE. In newborns discordance in TEOAE is quite different and can potentially have lifelong negative consequences. We need to remember that TEOAE and AABR are different in babies and", "Question: Is discordance in TEOAE and AABR outcomes predictable ? Answer: This is another question we have to ask, particularly when interpreting the effects of discordance in TEOAE. In newborns discordance in TEOAE is quite severe and can potentially have lifelong negative consequences. It is important to remember that TEOAE and babys are different in developmental stage, and", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: This is another question we often encounter, particularly when interpreting the concept of discordance in TEOAE. In newborns discordance in TEOAE is quite severe and can potentially have lifelong negative impact. We need to remember that TEOAE and TEOAE are significantly different in developmental stage, and", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: This is another question we often encounter, particularly when it comes to the effects of discordance in TEOAE. In newborns discordance in TEOAE is quite serious, and can potentially lead to significant negative consequences. We need to remember that TEOAE and AABR are different in developmental stage, and", "Question: Is this one of the TEOAE and AABR outcomes predictable in newborns? Answer: This is another question we often encounter, particularly when interpreting the effects of discordance in newborns, and the perception of newborns discordance in TEOAE is quite severe and can potentially have lifelong negative consequences. We want to remember that TEOAE and AABR are different in developmental stage, and"], "perturbed_original": ["Question: Is discordance in TEOAE and AABR outcomes at the screening of newborns? Answer: Given the available screening technologies, TEOAE and AABR outcomes is inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received perinatal hearing loss. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes inevitable among healthy newborns? Answer: Given the use of other detection technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers are currently in intensive care. The potential limitations of perinatal morbidities as basis of hearing loss for such cases therefore merit further consideration.", "Question: What is the role of screening in TEOAE to better outcomes for newborns? Answer: Given the available screening technologies, discordant screening from AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some cases of hearing loss among apparently healthy newborns whose mothers lack medical care. The potential limitations of research and testing as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes affecting pregnant newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR outcomes may be inevitable for some categories such as loss of newborns or healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR discordance in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose hearing loss is not as likely as prenatal care. The potential limitations of these screening technologies as basis of targeted screening for such cases therefore merit further consideration.", "Question: How are factors in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available evidence, the discordant TEOAE and AABR may be inevitable for some of the reasons for hearing loss among apparently healthy newborns whose mothers received prenatal screening. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further consideration.", "Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of newborns with AABR and TEOAE among older newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of screening technologies for such cases therefore merit further consideration.", "of these outcomes in some perinatal babies with discordance , TEOAE, and AABR outcomes for healthy newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening in such cases therefore merit further consideration.", "Question: Is discordance with hearing loss and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and NAFAF outcomes can be inevitable for some categories of hearing loss among the newborns whose mothers received prenatal care. The potential limitations in hearing loss and hearing loss morbidities as basis of targeted screening for such cases therefore merit further consideration."], "original_ll": -4.206080436706543, "sampled_ll": -2.913886308670044, "all_perturbed_sampled_ll": [-2.9215283393859863, -3.0615272521972656, -3.035376787185669, -2.953352451324463, -2.888507604598999, -3.0319769382476807, -3.279963254928589, -3.145254135131836, -2.8165104389190674, -3.434735059738159], "all_perturbed_original_ll": [-4.1907958984375, -4.064218044281006, -4.382450580596924, -4.279787540435791, -4.214869499206543, -4.048830509185791, -4.133535861968994, -3.8183445930480957, -4.323367595672607, -4.5668721199035645], "perturbed_sampled_ll": -3.0568732261657714, "perturbed_original_ll": -4.202307224273682, "perturbed_sampled_ll_std": 0.17793806071010346, "perturbed_original_ll_std": 0.19521497186409367}, {"original": "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.", "sampled": "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: There may be some degree-granting applicants.\n\n\n[A student must obtain at least an AP college credit]\n\n[The student should be authorized to receive the degree after the college credits have", "perturbed_sampled": ["Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: There are some questions here: [The student must obtain at least an AP college credit]\n\n[The student should be aware that the student must receive the degree after the college credits have", "Does a student need to be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: There may be some degree-granting applicants.\n\n\n[A student must obtain at least an AP SE degree.] [A student should be authorized to receive the degree after the college credits have", "Question: May student receive reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: There may be some questions: [The student must obtain the degree as an AP college credit]\n\n[The student should be authorized to receive the degree after the college credits have", "Question: May student examiners be reasonable substitute examiners for faculty in the OSCE on medical emergencies? Answer: There may be some degree-granting applicants.\n\n\n[A student examiners need at least an AP college degree granting application] An applicant should be authorized to receive the degree after the college credits have", "Question: May student examiners be reasonable substitute examiners for a student who is an undergraduate OSCE on medical emergencies? Answer: There may be some degree-granting applicants.\n\n\n[A student must obtain at least AP college credit]\n\n[The student should be authorized to receive the degree ]. [AP college credits have", "Question: May there be reasonable substitute examiners for faculty in the OSCE on an application? Answer: There may be some degree-granting applicants.\n\n\n[A student must obtain at least an AP college credit]\n\n[The student should be authorized to receive the degree after the college credits have", "Question: May student examiners be substitute examiners for faculty of undergraduate OSCE on medical emergencies? Answer: There may be some degree-granting applicants.\n\n\n[A student must obtain at least one MA AP college credit]\n\n[The student should be authorized to receive the degree after the college credits have", "Question: May student examiners be reasonable substitute examiners ? Can I also be a AP student in an undergraduate OSCE on medical emergencies? Answer: There may be some degree-granting applicants.\n\n\n[A student must obtain at least an AP college credit]\n\n[The student should be authorized to obtain a degree after the degree]. [I have", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: There may be some degree-granting applicants.\n\n\n[A student must obtain an AP college credit without an AP college credit]\n\n[The student may be authorized to receive the AP college credit]. All the college credits have", "Question: May student examiners be reasonable substitute examiners for faculty members facing an undergraduate OSCE on medical emergencies? Answer: There are some degree-granting applicants.\n\n\n[A student must obtain at least an AP college credit]\n\n[The student should be in need] [Dent scholar is required to receive the degree after the college credits have"], "perturbed_original": ["Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on -site examination? Answer: It seems unfair and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative evaluation evaluations, but not necessarily in summative assessment evaluations.", "Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate or graduate degree of medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate or college medical emergencies. It might seem reasonable for OSCE formative testing, but not necessarily to require additional assessment evaluations.", "Question: May student examiners be substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible , however, to encourage medical students to be as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.", "Question: Could substitute examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible , to encourage medical students to officiate as examiners in undergraduate emergency medicine exam testing, but not necessarily in summative assessment evaluations.", "Question: Could substitute examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It is also admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine examination and testing, but not necessarily in summative assessment evaluations.", "Question: May student examiners be authorized as examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Would it be quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE ? Question: Any student examiners are accepted but not necessarily in summative assessment evaluations.", "Question: Could medical examiners be oniciate as examiners for faculty in an investigation on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.", "Question: May student examiners be reasonable substitute examiners for medical students in an undergraduate OSCE on medical emergencies? Answer: It is firmly admissible and justified to encourage medical students to use their medical records as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.", "Question: May student and faculty consider reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate , undergraduate and undergraduate OSCE formative testing, but not necessarily in standard medical evaluations.", "Question: May this be reasonable substitute examiners for faculty in undergraduate OSCE on medical emergencies? Answer: It seems reasonable and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations."], "original_ll": -4.896374702453613, "sampled_ll": -3.7494866847991943, "all_perturbed_sampled_ll": [-3.968376398086548, -3.823125123977661, -4.141364574432373, -4.061751842498779, -4.011008262634277, -3.420114278793335, -3.889901638031006, -3.9608523845672607, -3.7312779426574707, -4.131425380706787], "all_perturbed_original_ll": [-4.969342231750488, -4.485474109649658, -4.964503288269043, -4.7718939781188965, -4.525265693664551, -4.639858722686768, -4.854362964630127, -4.767087936401367, -4.6951069831848145, -4.798871040344238], "perturbed_sampled_ll": -3.91391978263855, "perturbed_original_ll": -4.747176694869995, "perturbed_sampled_ll_std": 0.20530732089154619, "perturbed_original_ll_std": 0.15611473824753713}, {"original": "Question: Amblyopia: is visual loss permanent? Answer: Older", "sampled": "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "perturbed_sampled": ["Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n", "Question: Amblyopia: is visual loss permanent? Answer: yes.\n\n"], "perturbed_original": ["Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older", "Question: Amblyopia: is visual loss permanent? Answer: Older"], "original_ll": -5.546280384063721, "sampled_ll": -4.514839172363281, "all_perturbed_sampled_ll": [-4.514839172363281, -4.514839172363281, -4.514839172363281, -4.514839172363281, -4.514839172363281, -4.514839172363281, -4.514839172363281, -4.514839172363281, -4.514839172363281, -4.514839172363281], "all_perturbed_original_ll": [-5.546280384063721, -5.546280384063721, -5.546280384063721, -5.546280384063721, -5.546280384063721, -5.546280384063721, -5.546280384063721, -5.546280384063721, -5.546280384063721, -5.546280384063721], "perturbed_sampled_ll": -4.514839172363281, "perturbed_original_ll": -5.546280384063721, "perturbed_sampled_ll_std": 0.0, "perturbed_original_ll_std": 0.0}, {"original": "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.", "sampled": "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Yes. There are two main findings that may be related to this, although they can be difficult to understand at first. First, it's possible that surgery", "perturbed_sampled": ["Question: Does prior benign prostatectomy predict outcome for patients treated with radical perineal prostatectomy? Answer: Yes. There are several main findings that may be related , although they can be difficult to understand at first. First, it's possible that surgery", "Question: Does prior benign prostate biopsy predict outcome for patients treated with perineal prostatectomy? Answer: There are two main findings that may be related to this, although they can be difficult to understand at first. First, it's possible that surgery", "Question: Does prior benign prostate biopsy work for patients treated with radical perineal prostatectomy? Answer: Yes. There are two main findings that may be related to this, although they can be difficult to diagnose. It's first. First, it's possible that surgery", "Question: Does a prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Yes. There are two main findings that may contribute to this, although they might be difficult to understand at first. First, it's possible that surgery", "Question: Does prior benign prostate biopsy predict outcome for patients treated with a benign prostate biopsy? Question: Is a prior benign prostate biopsy predictive of perineal prostatectomy? Answer: Yes. There are several main findings that may be related to this, but these findings can be difficult to understand at first. First, it's possible that surgery", "Question: Does prior benign benign surgery predict outcome when treated with radical perineal prostatectomy? Answer: Yes. There are two different reasons that may be related to this, although they can be difficult to understand at first. First, it's possible that surgery", "Question: Does prior benign treatment predict outcome for patients treated with radical perineal prostatectomy? Answer: Yes. There are two main findings that may be related to this, but this one can be difficult to understand at first. First, it's possible that surgery", "Question: Does prior benign prostate biopsy predict outcome of surgery when treated with radical perineal prostatectomy? Answer: Yes. There are two main findings that may lead to this, but it can be difficult to understand at first. First, it's possible that surgery", "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: Yes. There are two main findings that may be related to prostate biopsy, but they can be difficult to understand . First, find out that surgery", "Question: Does prior benign prostate biopsy predict outcome as you treated with a benign prostatectomy? Answer: Yes. There are two main findings that may be related to this, although they can be difficult to locate at first. First, it's possible that surgery"], "perturbed_original": ["Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable outcomes involving biochemical s such as radical perineal prostatectomy. Additional studies are required to confirm these findings.", "Question: Does prior benign prostate biopsy is the best outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes for patients treated with radical perineal prostatectomy. Additional studies are needed to examine these findings.", "Question: Does prior benign prostate biopsy predict outcome of prostate biopsy being treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical results for radical perineal prostatectomy. Additional studies are needed to make these findings.", "Question: Does benign prostate biopsy look good for patients treated with radical perineal prostatectomy? If successful, the prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.", "Question: Does a prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy was independently associated with more favorable clinical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.", "Question: Does prior benign prostate biopsy predict a determinant of renal proineal prostate biopsy in patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be associated with more natural and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.", "Question: Does prior benign prostate biopsy predict outcome after being treated with radical s? Answer: A prior benign prostate biopsy may be independently associated with the favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.", "Question: Does prior benign prostate biopsy work best for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with favorable surgical and biochemical outcomes . Additional studies are needed to confirm these findings.", "Question: Does prior benign prostate biopsy offer favorable therapeutic outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with favorable surgical and biochemical outcomes after prostatectomy. Additional biopsy is needed to confirm these findings.", "Question: Does prior benign prostate biopsy predict outcome for patients treated with radical s? Answer: Question: Could prior benign prostate biopsy predict outcome for patients treated with radicals? Answer: A prior benign prostate biopsy may be independently associated with favorable surgical and biochemical outcomes after prostatectomy. Additional studies may be necessary to confirm these findings."], "original_ll": -3.1973495483398438, "sampled_ll": -3.1437790393829346, "all_perturbed_sampled_ll": [-3.404046058654785, -3.104919195175171, -3.347266912460327, -3.0169034004211426, -2.728593587875366, -3.3155293464660645, -3.1895413398742676, -3.2799301147460938, -3.425611972808838, -3.2568283081054688], "all_perturbed_original_ll": [-3.387685775756836, -2.9205105304718018, -3.240558624267578, -3.4734373092651367, -3.099555730819702, -3.5355522632598877, -3.6382157802581787, -3.5717711448669434, -3.337899923324585, -3.0291576385498047], "perturbed_sampled_ll": -3.2069170236587525, "perturbed_original_ll": -3.3234344720840454, "perturbed_sampled_ll_std": 0.2004016144140414, "perturbed_original_ll_std": 0.2320619135585007}, {"original": "Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "sampled": "Question: Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I first saw her.\n\nI am concerned by her weight, and in particular how she does not feel", "perturbed_sampled": [". Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I saw her.\n\nI am concerned by her weight, and in particular how she does not feel", "Question: Does minimal access major surgery in the newborn hurt less? Answer: I\u2019m concerned at least when I am pregnant to her.\n\nI am concerned by her weight, and in particular how she does not feel", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I saw her.\n\nI am concerned about what she weight, and in particular how she does not feel", "Question: Does minimal access major surgery in the newborn hurt less? I started thinking about her as a baby, at least when I first saw her.\n\nI am concerned by her behaviour and in particular how she does not feel", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least until I first saw her.\n\nI am concerned by her weight, and in particular how she does not feel", "minimal access surgery or did minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I first saw she was very concerned by her weight, and in particular how she does not feel", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I first saw her.\n\nI am concerned by her weight, and in particular how I do not feel", "Question: Does minimal access ibility to blood in the newborn hurt less? Answer: Yes, at least when I first saw her.\n\nI am concerned by her weight, and in particular how she does not feel", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Yes, at least when I first asked myself, I am concerned by her weight, and also how she does not feel", "Question: Does minimal access major surgery in the next two months have made her feel less? Answer: Yes, at least when I first saw her.\n\nI am concerned by her weight, and am very concerned about how she does not feel"], "perturbed_original": ["Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is typically performed with low opioid doses.", "Question: Does the major ity of the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Major surgery for the newborn\u2019s esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "Question: Does minimal access major surgery in the newborn hurt less? Answer: MMM surgery for a type of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "Question: Does minimmal access surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery is not associated with severe bleeding, a minor injury, or the normal functioning of a shenia. The risk of decreased risk of the disease of a congenital, renal, or chronic fibromyalgia.: Is minimal access major surgery associated with minimal access major surgery less effective?: Ampicillin has a negative effect on the repair of the patient's nephrosis.(PDF): or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "Question: Why does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia . The diaphragmatic hernia is not associated with less cumulative opioid doses.", "Question: Does minimal access major surgery in the newborn are a possible and appropriate option? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with cumulative opioid doses.", "Question: Does minimal access major surgery in the patient perform less? Answer: Minimal access surgery for the patient has esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.", "Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery is associated with the repair of esophageal atresia and diaphragmatic hernia is not associated with less cumulative opioid doses."], "original_ll": -4.199948787689209, "sampled_ll": -3.8350327014923096, "all_perturbed_sampled_ll": [-4.126438617706299, -4.52074670791626, -4.074063777923584, -3.8630001544952393, -4.080952167510986, -4.753847599029541, -3.9488272666931152, -4.030167579650879, -4.485594272613525, -3.5666215419769287], "all_perturbed_original_ll": [-4.118296146392822, -4.4759697914123535, -4.518867015838623, -4.436048984527588, -4.345903396606445, -3.9900572299957275, -4.4100518226623535, -3.9783520698547363, -4.234567165374756, -4.197081089019775], "perturbed_sampled_ll": -4.145025968551636, "perturbed_original_ll": -4.270519471168518, "perturbed_sampled_ll_std": 0.3321264542512803, "perturbed_original_ll_std": 0.18716755438298535}, {"original": "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "sampled": "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: It is not.\n\nIn a 2014 study, two dozen patients with a common gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure that provides the usual means of screening for common gallbladder cancer. They received intraoperative therapy", "perturbed_sampled": ["Question: Is external palliative palliative therapy for common gallbladder carcinoma effective? Answer: It is unlikely to come through. In a 2014 study, two dozen patients with a common gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure that provides the usual means of chemotherapy for common gallbladder cancer. They received intraoperative therapy", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: It is not.\n\nIn a 2014 study, two dozen people with a common gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure that provides the usual treatment screening for common gallbladder cancer. They received intraoperative therapy", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: It is not.\n\nIn a 2014 study, two dozen patients with common gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure that provides the usual means of treatment for common gallbladder cancer. They received intraoperative therapy", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: It is not.\n\nIn this study, two dozen patients with a common gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure that provides the usual means of radiotherapy for common gallbladder cancer. They also used it as a therapy", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: It 's the same: In a 2014 study, two dozen patients with a common gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure which was the usual means of screening for common gallbladder carcinoma. They received intraoperative therapy", "Question: Is external palliative radiotherapy for gallbladder carcinoma ? It is not.\n\nIn a 2014 study, two dozen patients with a common gallbladder carcinoma underwent colonoscopy (conventional ) treatment, a procedure that provides the usual means of screening for common gallbladder cancer. They also utilized radiation therapy", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: It is not.\n\nIn a 2014 study, two dozen patients with a common gallbladder carcinoma underwent colonoscopy surgery, a procedure that included re-sectional therapy as well as the usual means of screening for common gallbladder carcinoma. They received intraoperative therapy", "Question: Is external palliative radiotherapy for common gallbladder cancer effective? Answer: It is not.\n\nIn a 2014 study, two dozen patients diagnosed with common gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure that provides a means of screening for common gallbladder cancer. They received intraoperative therapy", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: It is a 2014 study, and patients with a common gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure that provides the usual means of screening for gallbladder cancer. They received intraoperative therapy", "Question: Is external palliative therapy for a common gallbladder carcinoma effective? Answer: It is not.\n\nIn a 2014 study, two dozen people who have a common gallbladder carcinoma underwent colonoscopy (conventional radiotherapy), a procedure that provides the usual means of treating a common gallbladder cancer. They received intraoperative therapy"], "perturbed_original": ["Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the effectiveness of external palliative radiotherapy in palliative chemotherapy of gallbladder carcinoma. External radiotherapy is an effective treatment to palliative management of gallbladder carcinoma.", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: It seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further research is necessary to determine the role of radiotherapy in the adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy for palliative management effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further research is necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external radiotherapy receptive to palliative treatment for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. These studies are necessary to determine the effectiveness of external radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. Clinical studies are conducted to determine the effectiveness of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems effective as a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative and adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? The effectiveness of radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: There seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, the findings are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.", "Would external palliative radiotherapy for gallbladder carcinoma be safe and effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of internal radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma."], "original_ll": -2.2156364917755127, "sampled_ll": -2.721501588821411, "all_perturbed_sampled_ll": [-2.9171254634857178, -2.851469039916992, -2.675323009490967, -2.7450084686279297, -3.061263084411621, -3.2086174488067627, -3.046658754348755, -2.7135541439056396, -3.0297110080718994, -2.708120822906494], "all_perturbed_original_ll": [-2.0835893154144287, -2.2477831840515137, -2.394486665725708, -2.1366961002349854, -2.39048171043396, -2.3395819664001465, -2.3098390102386475, -2.3430697917938232, -2.472013473510742, -2.2566628456115723], "perturbed_sampled_ll": -2.8956851243972777, "perturbed_original_ll": -2.2974204063415526, "perturbed_sampled_ll_std": 0.17553586605981875, "perturbed_original_ll_std": 0.11325270858090078}, {"original": "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general", "sampled": "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Of course it is. But the poor, like the rich, have been doing this for thousands of years, and the most important thing is not to say \"it\" as we speak, but to show that it is the case.", "perturbed_sampled": ["Question: The use of audit to identify maternal mortality in different settings: What is just a difference between the rich and the poor? Answer: Of course it is. But the poor, like the rich, have been doing this for thousands of years, and the simplest thing is not to say \"it\" as we speak, but rather to say \"i do it\" just because we understand that it is the case.", "reducing the use of audit to identify the need for audit, which exists in different settings: is it just a difference between the rich and the poor? Answer: Of course it is. But the poor, like the rich, have been doing this in a couple of years, and the most important thing is not to say \"it\" as we speak, but to show that it is the case.", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the poor and the poor? Answer: Of course it is. But the people that go through maternal mortality, especially the rich, have been collecting maternal mortality for thousands of years, the most important thing is not to say \"it\" as we speak, but to show that it is the case.", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? And of course we cannot ask the question: But the poor, like the rich, have been doing this for thousands of years, so the most important thing is not to say \"it\" as we speak, but to show that it is the case.", "Question: The use of audit to identify maternal maternal maternal characteristics: Is it possible? Answer: The importance of audit in different settings: is it just a difference between the rich and the poor? Answer: Of course it is. But the poor, like the rich, have been doing this for many years, and the good thing is not to say \"it\" as we speak, but to show that this is the case.", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Of course it is. But the poor, like the rich, have been doing this for thousands of years, and the most important thing is not to say \"it\" so to speak, but to say that it is the case.", "Question: The use of the human resources can identify maternal mortality in different settings: what is the difference just the difference between the rich and the poor? Answer: Of course it is. But others, like the rich, have been doing this for thousands of years, and the most important thing is not to say \"it\" as we speak, but to show that it is the case.", "contexts in pregnancy? The use of audit to identify maternal mortality in different countries is it just a difference between the rich and the poor? Answer: Of course it is, the rich, the poor, the rich, have been doing this for thousands of years, and the most important thing is not to say \"it\" as we speak, but to show that it is the case.", "Question: The use of audit s and monitoring of maternal mortality. Question: The use of audits on maternal mortality in different settings: is it the same difference between the rich and the poor? Answer: Of course it is. But the poor, like the rich, have been doing this for 10 years, and the most important thing is not to say \"it\" as we speak, but to show that it is the case.", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Of course, there is. The poor, like the rich, have been doing this for thousands of years, and the most important thing is not to say \"it\" as we speak, but to show that it is the case."], "perturbed_original": ["Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Studies into maternal mortality are more than just between the rich and poor. The magnitude of maternal mortality and harnessing a strong political will to address the issues are important factors. However, there is no single, general", "Question: The use of tools to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and the poor; the use of the knowledge of maternal mortality and harnessing a strong political will to resolve the issues are important factors. However, there is no single, general", "Question: The use of data to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the significance of maternal mortality and harnessing a strong capacity to tackle the issues are important factors. However, there is no single, general", "Question: The use of audit to identify maternal mortality in different areas. Is it just a difference between the rich and the poor? Answer: Differences between maternal mortality and maternal mortality are more than just differences between the rich and the poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to address the issues are important factors. However, there is no single, general", "Question: The use of audit to identify the gaps in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than a matter of magnitude than the differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong effort to tackle the issues are important factors. There is no single, general", "Question: The use of both systems to identify maternal mortality in different settings: is there a difference between the rich and poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general", "Question: The use of audit to identify maternal mortality in different settings: is there a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general", "Question: The use of audit ing maternal mortality across rural settings: is it just a difference between the rich and the poor? Answer: The implications of auditing maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of this problem and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and the poor. Acknowledging the magnitude of maternal mortality and harnessing a strong will to address these issues are important factors. There is no single, general", "Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The results of maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important when there is a general"], "original_ll": -3.2243471145629883, "sampled_ll": -2.799184560775757, "all_perturbed_sampled_ll": [-3.0396976470947266, -3.090094804763794, -3.226785182952881, -3.084545373916626, -3.159651517868042, -2.8601155281066895, -3.1263341903686523, -3.052201747894287, -2.929992437362671, -2.9870760440826416], "all_perturbed_original_ll": [-3.4429261684417725, -3.1391797065734863, -3.1601221561431885, -3.1665396690368652, -3.658266544342041, -3.196540355682373, -3.1855263710021973, -3.4155964851379395, -3.240163564682007, -3.378380537033081], "perturbed_sampled_ll": -3.055649447441101, "perturbed_original_ll": -3.298324155807495, "perturbed_sampled_ll_std": 0.1030114152507836, "perturbed_original_ll_std": 0.16090056696448551}, {"original": "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "sampled": "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes.", "perturbed_sampled": ["Question: Transgastric endoscopic splenectomy: is there a Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with closed or open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a close, internal eye with multiple eye with a closed, external eye with multiple eye and closed, external eye with multiple, non-interlacing, or open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed internal eye with multiple, non-interlacing, or open, internal eyes.", "Question: Transgastric endoscopic splenectomy is feasible? Answer: Is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, closed, external and closed open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is there an alternative to this? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy involves a closed closed, external eye with multiple, non-interlacing, or open, internal eyes."], "perturbed_original": ["Question: Transgastric endoscopic splenectomy: is it possible? Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy appears technically feasible. Question: Is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears to be possible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it technically feasible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears possible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.", "Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy with a porcine model appears technically feasible. Additional long-term survival experiments are planned."], "original_ll": -3.3954811096191406, "sampled_ll": -3.0690927505493164, "all_perturbed_sampled_ll": [-3.505502462387085, -3.1429569721221924, -2.9663188457489014, -3.1995205879211426, -3.178928852081299, -3.0690927505493164, -3.2327256202697754, -3.0683884620666504, -3.0690927505493164, -3.0690927505493164], "all_perturbed_original_ll": [-3.5919289588928223, -2.8008553981781006, -3.5919289588928223, -3.228191614151001, -3.129382610321045, -3.3808414936065674, -3.3954811096191406, -3.326629877090454, -3.5919289588928223, -3.4264469146728516], "perturbed_sampled_ll": -3.1501620054244994, "perturbed_original_ll": -3.346361589431763, "perturbed_sampled_ll_std": 0.14021454863854066, "perturbed_original_ll_std": 0.23450706062039342}, {"original": "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "sampled": "Question: Are environmental factors important in primary systemic vasculitis? Answer: The two major components of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have severe vasculitis, it", "perturbed_sampled": ["Question: Are environmental factors important in primary systemic vasculitis? Answer: The two major components of vasculitis are vasculitis or the nervous system due to an increase in blood pressure. If you have vasculitis, you may want to do it", "Question: Are environmental factors important in primary systemic vasculitis? Answer: The major components of vasculitis are vasculitis or the acute vasculitis due to an increase in the amount of vasculitis caused by these factors. If you have severe vasculitis, it", "Question: Are environmental factors important in primary systemic vasculitis? Answer: The two main causes of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have a large blood pressure, it", "Question: Are environmental factors involved in primary systemic vasculitis? Answer: The two major components of vasculitis are vasculitis or the acute vasculitis due to an increase in vasculitis. If you have severe vasculitis, it", "Question: Are environmental factors important in primary systemic vasculitis? Answer: Most major components of vasculitis are vasculitis or the other causes due to an increase in blood pressure. If you have severe vasculitis, it", "Question: Are environmental factors important for systemic vasculitis? The two major components of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have severe vasculitis, it", "Question: Are environmental factors important in primary systemic vasculitis? Answer: The two major causes of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have severe vasculitis, it", "Question: Are environmental factors important in primary systemic vasculitis? Answer: The two major components of vasculitis are the acute vasculitis. This can trigger the acute vasculitis due to an increase in vasculitis. If you have severe vasculitis, it", "Question: Are environmental factors involved in primary systemic vasculitis? Answer: The two major components of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have severe vasculitis, it", "? Are the environmental factors important in primary systemic vasculitis? Answer: The two major components of vasculitis are vasculitis or the acute vasculitis due to an increase in blood pressure. If you have severe vasculitis, it"], "perturbed_original": ["Question: Are environmental health factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. This is to support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming agriculture and agricultural processes has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in preventing vasculitis? No significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are a significant association with PSV assays important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. A study to support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental environmental influences found in primary agriculture? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between EVA and PSV has been seen for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in preventing systemic vasculitis? Answer: A significant association between VSV and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between vsc and PSV has been reported for the first time. Results also support previously reported associations with silica, solvents, and allergy.", "Question: Are you most important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been reported for the first time. Results also support previously reported associations with silica, solvents, and allergy."], "original_ll": -3.712476968765259, "sampled_ll": -2.588107109069824, "all_perturbed_sampled_ll": [-2.8038551807403564, -2.5617849826812744, -2.669285774230957, -2.536545753479004, -2.9917948246002197, -2.5436296463012695, -2.561030149459839, -2.7217369079589844, -2.5419507026672363, -2.774378538131714], "all_perturbed_original_ll": [-3.774787187576294, -3.6734225749969482, -3.92132830619812, -3.7477867603302, -3.9552290439605713, -3.864000082015991, -3.766042709350586, -3.5062525272369385, -3.8414478302001953, -4.011947154998779], "perturbed_sampled_ll": -2.6705992460250854, "perturbed_original_ll": -3.8062244176864626, "perturbed_sampled_ll_std": 0.14449867391589924, "perturbed_original_ll_std": 0.13999612067031114}, {"original": "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "sampled": "Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in stable or elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "perturbed_sampled": ["Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile function: Are you near elevated or elevated resting states? Is there an effect on blood pressure? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "Question: Does the central venous pressure s impact the central venous responsiveness? Answer: Yes.\n\nErectile function: Are you in stable and in strong, resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "do you need the central venous fluid to respond to fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in stable or elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "Question: Does the central venous pressure predict function? Answer: Yes.\n\nErectile function: Are you in stable or elevated health? Answer: Yes. Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in stable or elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you pregnant or pregnant? Are you on a low-risk pregnancy?", "Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in your elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in an elevated resting state? Are you in a low-risk pregnancy?", "Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile pressure: Are you in stable or elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "Question: Does the central venous pressure predict fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in stable or elevated ? Answer: Yes. Is there an indication of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "Question: Does the central venous pressure predict these effects? Answer: Yes.\n\nErectile function: Are you in stable or elevated resting states? Does the central venous pressure predict an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?", "is the central venous function that affects fluid responsiveness? Answer: Yes.\n\nErectile function: Are you in stable or elevated resting states? Is there an effect of this? Answer: No.\n\nPregnancy: Are you in or near a low-risk pregnancy?"], "perturbed_original": ["Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no doubts to support the widespread practice of using central venous pressure to apply hydrolysis to fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure guide fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid therapy should be abandoned.", "Can the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid response, the traditional approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the idea of using central venous pressure to guide fluid responsiveness. The conventional approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data available for the widespread practice of using central venous pressure to provide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid resuscitation. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid therapy? There are no studies that support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the practice of using central venous pressure to guide fluid responsiveness. An approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? However, there are no data to support the widespread practice of using the central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.", "Question: Does the central venous pressure predict fluid responsiveness? Answer: There are some specific techniques to improve fluid therapy. The widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned."], "original_ll": -3.337890386581421, "sampled_ll": -2.6662752628326416, "all_perturbed_sampled_ll": [-2.8147103786468506, -2.8754477500915527, -2.797337293624878, -2.6424124240875244, -2.702519655227661, -2.659144878387451, -2.7672600746154785, -2.7726290225982666, -2.5500376224517822, -2.8729374408721924], "all_perturbed_original_ll": [-3.852879524230957, -3.256471872329712, -3.591451406478882, -3.2934768199920654, -3.530573606491089, -3.1445696353912354, -3.3786754608154297, -3.3632993698120117, -3.301863193511963, -3.7083067893981934], "perturbed_sampled_ll": -2.745443654060364, "perturbed_original_ll": -3.442156767845154, "perturbed_sampled_ll_std": 0.09997522692559462, "perturbed_original_ll_std": 0.2108811998142598}, {"original": "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "sampled": "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass", "perturbed_sampled": ["Question: How can preoperative statins reduce atrial fibrillation after coronary artery bypass ? Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be used to reduce atrial fibrillation after coronary artery bypass", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass", "Question: Do preoperative statins reduce atrial fibrillation after coronary bypass bypass grafting? Answer: Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass", "Can preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not have to reduce atrial fibrillation after coronary artery bypass", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass ? Preoperative statins may not be able to reduce atrial fibrillation after artery bypass", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be considered to reduce atrial fibrillation after coronary artery bypass", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass", "Question: Do you reduce atrial fibrillation after coronary artery bypass grafting? Answer: Preoperative statins may not be able to reduce atrial fibrillation after coronary artery bypass"], "perturbed_original": ["Question: Do preoperative statins have to be prevented from fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statins seems to reduce atrial fibrillation after CABG.", "Question: Can preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce AF development after coronary artery bypass grafting? Answer: Our findings suggest that preoperative statin therapy seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? A new study indicated that preoperative statin therapy seems to prevent AF development after CABG.", "Question: Do preoperative statin therapy stimulate the progression of atrial fibrillation after coronary artery bypass grafting? Answer: Our study reveals that preoperative statin therapy seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Studies have indicated that preoperative statins seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study found that preoperative statin therapy seems to reduce AF CL and CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery artery disease? Question: Are preoperative statins lower atrial fibrillation after CG? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.", "Question: Do preoperative statins reduce atrial fibrillation after coronary artery injury? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG."], "original_ll": -3.099543571472168, "sampled_ll": -2.1120846271514893, "all_perturbed_sampled_ll": [-2.642801523208618, -2.198324680328369, -2.1120846271514893, -2.5959219932556152, -2.2061684131622314, -2.71803879737854, -2.910729169845581, -2.1944899559020996, -2.1120846271514893, -2.3273403644561768], "all_perturbed_original_ll": [-3.484665632247925, -2.5614352226257324, -3.1703267097473145, -3.1220922470092773, -3.129486322402954, -3.115696907043457, -3.148756265640259, -3.3368124961853027, -3.084953784942627, -3.499028205871582], "perturbed_sampled_ll": -2.401798415184021, "perturbed_original_ll": -3.165325379371643, "perturbed_sampled_ll_std": 0.27401579681457416, "perturbed_original_ll_std": 0.2489583489660724}, {"original": "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.", "sampled": "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: yes. There are other conditions which do occur. Many may develop a complete lack of speech. For example, in people who do not speak clearly, they will often get the \"audible eye\"", "perturbed_sampled": ["Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: yes. There are other conditions which do occur. Many may develop a complete vision of your speech. For example, in people who do not speak properly, they will often get the \"audible eye\"", "Question: Prognosis of low-tone sudden deafness - does it inevitably aggravate the Meniere's afeal response? Again yes. There are other conditions which do occur. Many may develop a complete lack of speech. For example, in cases when people do not speak clearly, they will often get the \"audible eye\"", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's speech - yes. There are other conditions which do occur. Most people develop a complete lack of speech. For some people who do not speak clearly, they will often get the \"audible eye\"", "a symptom of low-tone sudden deafness - does it progress to Meniere's disease? Answer: yes. There are other conditions which do occur. Many may develop a complete lack of speech. For example, in people who do not speak clearly, they will often get \"in the eye\"", "causes of mental deafness - does it inevitably progress to Meniere's disease? Answer: yes. There are other conditions which do occur. Many may develop a complete lack of speech. For example, for those who do not speak clearly, they will often get the \"audible eye\"", "Question: Prognosis of speech impairment - deafness - does the poor people have the ability to make progress to Meniere's voice? Yes, yes. There are other conditions which do occur. Many may develop a complete lack of speech. For example, in people who do not speak clearly, they will often get the \"audible eye\"", "Question: Why i suffer from low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: yes. There are other conditions that may occur. In some cases, people can develop a complete lack of speech. For example, in people who do not speak clearly, they will often get the \"audible eye\"", "Question: Prognosis of low-tone sudden deafness to Meniere's disease: Does it inevitably progress to Meniere's disease? Answer: yes. There are other conditions which do occur. Many may develop a complete lack of speech. For example, in people who do not speak clearly, they will often develop an \"audible eye\"", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: yes. There are other conditions which do not affect the word, that may develop a complete lack of speech. People in people who do not speak clearly, they often get the \"audible eye\"", "Question: Prognosis of a patient is also related to the condition of deafness - does it inevitably progress towards the diagnosis of the disease? Answer: yes. There are other conditions which do occur. Many may develop a complete lack of speech. For example, in people who do not speak clearly, they will often get the \"audible eye\""], "perturbed_original": ["diagnosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic depression - as if they had vertigo attack at the beginning of the day and that electrocochleography (ECochG) was a useful prognostic tool.", "Question: Prognosis of low-tone sudden deafness - does it inevitably help predict the symptoms of Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even before they had vertigo attack at the onset and that electrocochleography (ECochG) could have a useful prognostic tool.", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that people with low-tone sudden deafness (SD) had decreased from endolymphatic hydrops even if they had vertigo attack from onset and that electrocochleography (ECochG) was a useful prognostic tool.", "Question: Prognosis of low-tone sudden deafness is very promising. Does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at all and that electrocochleography can be a useful prognostic tool.", "Question: Prognosis is not possible without an early detection of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that almost all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had an attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that almost all low-tone sudden deafness patients suffered from endolymphatic hydrops even if they had an attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.", "Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness victims suffered from endolymphatic hydrops ies and they were not out of attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.", "Question: Prognosis of sudden deafness - does it inevitably progress es to the diagnosis of the disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from sudden deafness even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.", "Question: Prognosis of low-tone sudden deafness - does it really contribute to Meniere's disease? Answer: We know that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.", "Question: Prognosis of sudden deafness - does it inevitably lead to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had deafness at the onset and that electrocochleography (ECochG) was a useful prognostic tool."], "original_ll": -3.970932722091675, "sampled_ll": -3.5817577838897705, "all_perturbed_sampled_ll": [-3.716505289077759, -4.1652445793151855, -3.957294464111328, -3.650966167449951, -3.6369545459747314, -3.6636993885040283, -3.4087257385253906, -3.396488904953003, -3.8534841537475586, -3.3156139850616455], "all_perturbed_original_ll": [-4.074883460998535, -4.083174705505371, -4.216341972351074, -3.9747507572174072, -3.9155032634735107, -3.9585397243499756, -4.147164821624756, -4.0031514167785645, -3.8280575275421143, -3.873195171356201], "perturbed_sampled_ll": -3.676497721672058, "perturbed_original_ll": -4.007476282119751, "perturbed_sampled_ll_std": 0.2516680885799348, "perturbed_original_ll_std": 0.11643785345840327}, {"original": "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.", "sampled": "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: No. I recommend that patients undergo primary angioplasty immediately. The primary angioplasty is one that is designed to treat multiple sclerosis, which is a serious condition that affects a significant percentage of the population.\n\nMyths", "perturbed_sampled": ["would make primary angioplasty an acceptable alternative ? Answer: No. I recommend that patients undergo primary angioplasty immediately. The primary angioplasty is one that is designed to treat multiple sclerosis, which is a serious illness that affects a significant percentage of the population.\n\nMyths", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: No. I recommend that patients have to start primary angioplasty immediately. The primary angioplasty is one that is designed to treat the root problem, which is a serious condition that affects a significant percentage of the population.\n\nMyths", "Question: Is primary angioplasty a not acceptable alternative to thrombolysis? Answer: No. I recommend that patients undergo primary angioplasty immediately. The primary angioplasty option is a therapy that is designed to relieve multiple sclerosis, which is a serious condition that affects a significant percentage of the population.\n\nMyths", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: No. I recommend that patients undergo primary angioplasty immediately. The primary angioplasty is recommended for anyone who is designed to treat multiple strokes. It is a serious condition that affects a significant part of the population.\n\nMyths", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: No. I recommend that anyone undergo primary angioplasty immediately. The primary angioplasty is one -sided. The treatment is designed to treat multiple sclerosis, which is a condition that affects a significant percentage of the population.\n\nMyths", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? If I can answer your question, I recommend that patients undergo primary angioplasty immediately. The primary angioplasty is one that is the best option to treat multiple sclerosis, which is a serious condition that affects a significant percentage of the population.\n\nMyths", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: No. I recommend that patients undergo primary angioplasty. The primary angioplasty is one procedure designed to treat multiple sclerosis, which is a serious condition that affects a significant percentage of the population.\n\nMyths", "Question: Is primary angioplasty an alternative to thrombolysis? Answer: No. I recommend that patients undergo primary angioplasty immediately. The first part of the treatment is one that is designed to treat multiple sclerosis, which is a serious chronic disease that affects a significant percentage of the population.\n\nMyths", "Question: Is primary angioplasty an acceptable treatment for thrombolysis? Myths - I recommend that patients undergo primary angioplasty immediately. The primary angioplasty is one that is designed to treat multiple sclerosis, which is a serious condition that affects a significant percentage of the population.\n\nMyths", "Is primary angioplasty an acceptable alternative to thrombolysis? Answer: No. I recommend that patients undergo primary angioplasty immediately. The primary angioplasty is one that is mainly used to treat multiple sclerosis, which is a serious condition that affects a significant part of the population.\n\nMyths"], "perturbed_original": ["Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to provide primary angioplasty service was acceptable to patients and their age levels were high regardless of the type of care received, with the exception of surgery and aftercare.", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was to make sure that the quality of care staffed by primary angioplasty patients and their discharge levels were high regardless of the type of services they received, with the exception of discharge and aftercare.", "Question: Is primary angioplasty an acceptable alternative to primary angioplasty? Answer: Reorganization of care : Reorganization of care to a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with respect for types of discharge and aftercare.", "Question: Was secondary angioplasty an acceptable alternative to thrombolysis? Answer: Preservative care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high depending on the type of care received, with the exception of discharge and aftercare.", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a different level of service was acceptable to patients and their carers. Satisfaction levels were highest regardless of the type of care received, with the patients providing excellent outcomes, including discharge and aftercare.", "Question: Is primary angioplasty an alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were acceptable to the patient, regardless of the type of treatment, with the exception of discharge and aftercare.", "Question: Is primary angioplasty an alternative to thrombolysis? Answer: Reorganization of the hospital to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.", "Question: Is primary angioplasty an acceptable alternative ? Answer: Reorganization of care to offer a primary angioplasty service was initiated by patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.", "Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Having provided primary angioplasty care to offer a primary angioplasty service was acceptable to all their carers. Satisfaction levels were generally higher, regardless of the type of care received, with the exception of discharge and aftercare.", "Question: Is this an example of surgery? Reorganization of care is unacceptable to thrombolysis? Answer: Reorganization of care to offer a functional angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare."], "original_ll": -3.2886338233947754, "sampled_ll": -2.195575475692749, "all_perturbed_sampled_ll": [-2.6659631729125977, -2.4433305263519287, -2.401547431945801, -2.5599570274353027, -2.6481146812438965, -2.3522627353668213, -2.1855947971343994, -2.421238422393799, -2.3649330139160156, -2.417499542236328], "all_perturbed_original_ll": [-3.533565044403076, -3.2216618061065674, -3.0755889415740967, -3.46490216255188, -3.632962703704834, -3.211683988571167, -3.1628575325012207, -3.4155781269073486, -3.2656426429748535, -3.5192511081695557], "perturbed_sampled_ll": -2.446044135093689, "perturbed_original_ll": -3.35036940574646, "perturbed_sampled_ll_std": 0.13740389217285964, "perturbed_original_ll_std": 0.17690491648188553}, {"original": "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.", "sampled": "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: Yes, this method may provide a high level of drainage. For patients who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "perturbed_sampled": ["Question: Is it necessary to insert a drainage tube and establish a endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: Yes, this method may provide a form of drainage. For patients who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "Question: Is it necessary to use a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: Yes, this method may provide a greater level of drainage. For patients who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct during patients with choledocholithiasis-induced cholangitis? Answer: Yes, this method may provide a high level of drainage. For patients who have certain forms of cholangitis, the use of a nasobiliary drainage tube, or an", "Question: Is it feasible to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with cholangitis. Answer: Yes, this method may provide a high level of drainage. For patients who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: Yes, this method may require a high level of drainage. For patients who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile tum? Why are patients with choledocholithiasis-induced choledocholithiasis not prescribed? Yes, this method may provide a high level of drainage. For patients who have acquired other forms of cholangitis, the use of a drainage tube or an", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the drainage duct in patients with choledocholithiasis-induced cholangitis? Answer: Yes, this method may provide a high level of confidence for patients who have all forms of cholangitis, the use of a nasobiliary drainage tube or an", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic analysis of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: Yes, this method may also cause a high level of drainage. For those who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "Question: Is it necessary to insert a nasobiliary drainage tube or an endoscopic tube to remove the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: Yes, this tube may provide a high level of drainage. For patients who have acquired other forms of cholangitis, the use of a nasobiliary drainage tube or an", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Yes, this method provides a high level of drainage. For patients who have acquired other forms of cholangitis, the use of an effective drainage tube or an"], "perturbed_original": ["Question: Is it necessary to insert an ENBD drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not affect the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.", "Question: Is it necessary for a nasobiliary drainage tube to provide endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and clinical course. An ENBD tube in patients with cholangitis inserted in the insertion would therefore be unnecessary.", "Question: Is it appropriate to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and even the insertion may be unnecessary.", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common EBDs in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD would not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.", "Question: Is it necessary to insert a ENBD tube routinely after endoscopic clearance of the lateral bile duct in the face of choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.", "Question: Is it the best practice to insert a nasobiliary drainage tube to improve the endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients who had to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after the insertion of the ENBD duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would not be unnecessary.", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD did not improve the clinical course, despite patients should endure increased procedure time and longer procedures, and the insertion would therefore be unnecessary.", "Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube may improve the clinical course, despite patients having to endure increased procedure and a little discomfort, and the procedure may therefore be unnecessary.", "Question: Is it necessary to insert a nasobiliary drainage tube at the end of clinical course after endoscopic clearance of the lateral bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to save procedure time and discomfort, and the insertion would therefore be unnecessary."], "original_ll": -4.165398597717285, "sampled_ll": -3.0467536449432373, "all_perturbed_sampled_ll": [-3.280613899230957, -3.026815891265869, -3.1766552925109863, -2.9443979263305664, -3.0737602710723877, -3.8462982177734375, -3.3002095222473145, -3.1674304008483887, -2.792006015777588, -3.3640401363372803], "all_perturbed_original_ll": [-4.06494665145874, -3.9791688919067383, -4.344751834869385, -4.331712245941162, -4.038456916809082, -4.0966644287109375, -4.051407337188721, -4.386563777923584, -4.212611675262451, -4.096632480621338], "perturbed_sampled_ll": -3.1972227573394774, "perturbed_original_ll": -4.160291624069214, "perturbed_sampled_ll_std": 0.27210300274292526, "perturbed_original_ll_std": 0.1392995235464115}, {"original": "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.", "sampled": "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Birth centers do not provide contraception during pregnancy because, because of the need to provide contraception for the newborn, most women who undergo birth control during pregnancy are not", "perturbed_sampled": ["Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Birth centers do not have contraception during pregnancy because, because of the need to be contraception centers for the newborn, most women who have control during pregnancy are not", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Most women who do not provide contraception for the newborn are not children, because, because most women need to provide contraception for the newborn, most women who undergo birth control during pregnancy are not", "Question: Does birth center care during a short period of pregnancy have any impact on reproductive reproduction? Answer: Birth centers do not carry their needs during pregnancy because, because of the need to provide contraception for the newborn, most women who undergo birth control during pregnancy are not", "Question: Does birth center care during a woman's first pregnancy have an impact on her future reproduction? Answer: Birth centers do not provide contraception during pregnancy because, because of the birth control a woman doesn't provide contraception for the future reproduction, the women who undergo birth control during pregnancy are not", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Birth centers do not provide contraception during pregnancy because, because of the need to provide contraception for pregnancy, most women with poor birth control during pregnancy are not", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Most pregnant women do not undergo birth control during pregnancy because, because of the need to provide contraception for the newborn, most women who undergo birth control during pregnancy are not", "Does birth control during a woman's first pregnancy have any impact on her future reproduction? Answer: Birth centers do not provide contraception during pregnancy because, because of the need to be a birth center for the newborn, most women who undergo birth control during pregnancy are not", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Should birth centers do more work on providing contraception during pregnancy because, because of the need to provide contraception for the newborn, women who undergo birth control during pregnancy are not", "Question: Does birth center care during a woman's pregnancy? Do birth centers have any control over her future reproduction? Answer: Birth centers do not provide contraception during pregnancy because, because birth centers need to provide contraception for the newborn, most women who undergo birth control during pregnancy are not", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: Birth centers do not provide contraception during pregnancy because, because of the need to provide contraception for females, most women who undergo birth control during pregnancy are not"], "perturbed_original": ["Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The model of a woman's birth center, rather than an adult model of pregnancy, as well as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect her future reproduction in Sweden.", "Question: Does birth center care during her first pregnancy have any impact on her future reproduction in Sweden? A woman's model of care, similar to her birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of pregnancy, also known as birth center care, during her first pregnancy, does not seem to be a sufficiently important factor to affect her future reproduction in Sweden.", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her second pregnancy, does not seem to be a sufficiently flexible model of care during the first pregnancy to affect subsequent reproductive reproduction in Sweden.", "Question: How can birth center care during a woman's first pregnancy have an impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to determine their subsequent reproduction in Sweden.", "Question: Does birth center care during a child's model pregnancy or a second pregnancy have any impact on her future reproduction? Answer: A woman's model pregnancy, such as birth center care, during a child's model pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.", "Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model , such as birth center care, during her first pregnancy does not appear to be a sufficiently important factor to influence her future reproduction in Sweden.", "Question: Does birth center care during a woman's first pregnancy have any impact on her reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to have a direct impact on reproduction in Sweden.", "Question: Does birth center care during a woman's first pregnancy have a significant impact on future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.", "Question: Does model of care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth , during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden."], "original_ll": -3.149041175842285, "sampled_ll": -2.7892401218414307, "all_perturbed_sampled_ll": [-3.392848491668701, -3.15384840965271, -3.2404708862304688, -3.196998119354248, -2.9289629459381104, -2.826216459274292, -2.9225502014160156, -3.2019667625427246, -3.0323402881622314, -2.8413376808166504], "all_perturbed_original_ll": [-3.0834929943084717, -3.3817098140716553, -3.0642306804656982, -3.232147216796875, -3.3348233699798584, -3.282391309738159, -3.1652328968048096, -2.981330394744873, -3.1590328216552734, -3.3161990642547607], "perturbed_sampled_ll": -3.0737540245056154, "perturbed_original_ll": -3.2000590562820435, "perturbed_sampled_ll_std": 0.18124372202136277, "perturbed_original_ll_std": 0.12459149436403484}, {"original": "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training and support. Appropriate service and education strategies should be implemented.", "sampled": "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Yes, as a result of a full and ongoing investigation conducted by the UK Department of Health. A full and complete analysis of the evidence is carried out by an independent medical expert. As part of that investigation, evidence has to be provided to ensure a proper and proportionate outcome for", "perturbed_sampled": ["Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Yes, as a result of a full and ongoing investigation conducted by the UK Department of Health. A full and complete analysis of the evidence is carried out by an independent medical expert. In the course of that investigation, evidence has to be assessed to ensure a proper and credible evidence analysis. required...: available for", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: Yes, as a result of a full and ongoing investigation conducted by the UK National Institutes of Health. A thorough and complete analysis of evidence and evidence is carried out by an independent medical expert. As part of that investigation, evidence has to be tested to ensure a proper and proportionate outcome for", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse cases? Yes, as part of a full and ongoing investigation conducted by the UK Department of Homeland Security. A full and complete analysis of the evidence is carried out by an independent inquiry based on the findings. As part of that investigation, evidence has to be provided to ensure a proper and proportionate outcome for", "Question: Are you satisfied with the training and support received in suspected child abuse? Answer: Yes, as a result of a full and ongoing investigation conducted by the UK Department of Health. A full and complete analysis of the evidence has to be carried out by a medical expert. As part of that an appropriate investigation has to be provided to ensure a proper and proportionate outcome for", "Question: Is radiologists satisfied with the training and support received in suspected child abuse? Answer: Yes, as part of a separate ongoing investigation conducted by the National Institute of Health. A full and complete analysis of the evidence is carried out by an independent medical expert. As part of that investigation, evidence has to be monitored to ensure a proper and proportionate outcome for", "Question: Are UK radiologists satisfied with the training and support received from child abuse? Answer: Yes, as a result of a full and ongoing investigation done by the UK Department of Health. A full and complete analysis of the evidence is carried out by an external expert. As part of that investigation, evidence to be provided to ensure a proper and proportionate outcome for", "Question: Are UK radiologists satisfied with the experience and support received in suspected child abuse? Answer: Yes, as a result of a full and ongoing investigation conducted by the UK Department of Health. A full and complete analysis of the evidence is supervised by a medical expert. As part of that investigation, evidence has to be provided to ensure a fully proportionate outcome for", "Question: Are UK radiologists satisfied with the training and training they provide in patients suffering from breast abuse? Answer: Yes, as a radiologists, there is a full and ongoing investigation conducted by the UK Department of Health. A full and complete analysis of evidence is carried out by an independent medical expert. As part of that investigation, evidence has to be provided to ensure a proper and proportionate outcome for", "Are UK radiologists satisfied with the training they received in suspected child abuse? Answer: Yes, as a result of a full and ongoing investigation conducted by the UK Department of Health. A thorough and complete analysis of the findings will be carried out by an independent medical expert. As part of that , extensive examination has to be provided to ensure a proper and proportionate outcome for", "Question: Are UK radiologists satisfied with the training and support received in connection with abuse and abuse? Answer: Yes, as a result of the new and ongoing investigation conducted by the UK Department of Health. A full and complete analysis of the evidence is carried out by an independent medical expert. As part of that analysis has to be provided to the proper medical team for the right outcome for"], "perturbed_original": ["Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with this service, and the low number of paediatric radiologists taking on this practice suggests the potential to increase numbers of child abuse experts by 27% if given training and support. Appropriate service and education strategies should be implemented.", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists and consultant radiologists insist on this work, and suggests the potential to increase numbers of child abuse experts by more given training and support. Their training and education strategies should be implemented.", "Are UK radiologists satisfied with the training and support received in children abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a recent survey found many members of paediatric radiologists taking on this work, and suggests the potential for increased numbers of radiology child abuse experts by 27% if given improved training and support before service and education strategies should be implemented.", "Question: Are the researchers satisfied with the training and support received in suspected radiologists? Answer: The survey shows a high number of expert radiologists amongst consultant radiologists with the most significant child abuse exposure. The survey confirms a low number of radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training and support. Appropriate service and education strategies should be implemented.", "Question: Are UK radiologists satisfied with the training and support received in suspected patients? Answer: The survey , which examined dissatisfaction amongst consultant radiologists with their service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by being given improved training and support. Appropriate service and education strategies should be implemented.", "Question: Are UK radiologists satisfied with the training and support received in suspected abuse cases? Answer: The survey of dissatisfaction amongst consultant radiologists with the current service, confirms the number of paediatric radiologists taking on this work, and provides the potential to increase numbers of radiology child abuse experts by 30 or more experts given improved training and support. Appropriate service and education strategies should be implemented.", "Question: Are radiologists satisfied with the training and support they suspected . Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on the work, and suggests the potential to increase the number of radiology child abuse experts by 27% if given improved training and support. Appropriate service and education strategies should be implemented.", "Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows that this study is particularly consistent amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and has the potential to increase numbers of radiology child abuse experts . Question: Will UK radiologists if given improved training and support, this service and education scheme be implemented.", "Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant number of consultant radiologists with the current service, confirms a low number of radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse practitioners by 27% if given improved training and support. Appropriate service and education needs to be implemented.", "Question: Are UK radiologists satisfied with the training and support they receive from suspected radiologists? Answer: The study of significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this service and suggests the potential to increase numbers of child abuse experts by 27% if given improved training and support. Appropriate service and education strategies should be implemented."], "original_ll": -3.8486931324005127, "sampled_ll": -2.779942274093628, "all_perturbed_sampled_ll": [-3.3679771423339844, -3.0628859996795654, -2.9865269660949707, -2.7275733947753906, -3.0049219131469727, -2.970656633377075, -3.059814214706421, -3.0636000633239746, -3.1936917304992676, -3.1854407787323], "all_perturbed_original_ll": [-3.858067750930786, -3.9624457359313965, -4.2588629722595215, -3.79164981842041, -4.082703113555908, -4.07474946975708, -3.9897964000701904, -4.083442687988281, -4.02090311050415, -3.9930195808410645], "perturbed_sampled_ll": -3.0623088836669923, "perturbed_original_ll": -4.011564064025879, "perturbed_sampled_ll_std": 0.15979623583949748, "perturbed_original_ll_std": 0.12272627958605355}, {"original": "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "sampled": "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: A.E.G.J.E. and the following other prospective clinical studies have reported significant decreases in postoperative colonic blood flow in patients with preoperative colitis, compared with a control group of healthy controls [38,39]. It has", "perturbed_sampled": ["Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: A.E.G.J.E. and the other prospective authors have reported significant decreases in colonic blood flow in patients with preoperative colitis, compared with a control group of healthy controls [38,39]. It has", "Question: Does preoperative anemia adversely affect colon and rectal blood flow? Answer: A.E.G.J.E. and the following other prospective clinical studies have reported significant effects on postoperative colonic blood flow in patients with preoperative colitis, compared with a group of healthy controls [38,39]. It has", "Question: Does preoperative anemia adversely affect preoperative rectal surgery outcomes? Answer: A.E.G.J.E. and the following other prospective clinical studies have reported significant decreases in postoperative colonic blood flow in patients with preoperative anemia compared with a control group of healthy controls and patients with renal surgery. Question: Preoperative anemia has", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: A.E.G.J.E. and the following other prospective clinical models reported significant decreases in postoperative colonic surgical outcomes in patients with preoperative colitis, compared with an individual group of healthy controls [38,39]. It has", "Question: Does postoperative anemia adversely affect colon and rectal surgery outcomes? Answer: A.E.G.J.E. and the following other prospective clinical studies have reported significant decreases in postoperative colonic blood flow in patients with preoperative colitis, making it a control of mortality in healthy controls [38,39]. It has", "Question: Does preoperative colonic blood flow affect colon and rectal surgery outcomes? Answer: A.E.G.J.E. and the following other prospective clinical studies have reported significant decreases in postoperative colonic blood flow in patients with preoperative colonic blood flow in patients with a healthy group of healthy controls [38,39]. It has", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: A.E.G.J.E. and the following other prospective clinical studies have reported significant improvements in postoperative colonic blood flow in patients with preoperative colitis, suggesting a control of both healthy controls [38,39]. It has", "Question: Does preoperative colitis affect colon and rectal surgery outcomes? Answer: A.E.G.J.E. and several other prospective clinical studies have reported significant decreases in postoperative colonic blood flow in patients with preoperative colitis, compared with the other group of healthy controls [38,39]. It has", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: A.E.G.J.E. and the authors of the prospective clinical studies have reported significant decreases in postoperative colonic blood flow in patients who have a colonic colitis, in a control group of healthy controls [38,39]. It has", "Question: Does preoperative anemia adversely affect colon and rectal cancer? Answer: A.E.G.J.E. and the following other prospective clinical studies have reported significant decreases in postoperative colonic blood in patients with preoperative colitis, compared with a control group of healthy patient. It has"], "perturbed_original": ["Question: Does preoperative anemia adversely affect patients with rectal surgery outcomes? Answer: This large retrospective analysis suggests that the presence of moderate and even mild and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "Can preoperative and preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: A multicenter database analysis suggests that the presence of severe and moderate and even moderate preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter study suggests that the presence of severe and moderate and even severe anemia is an independent risk factor for complications resulting from a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large -scale analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent basis for complications and a longer hospital cycle than standard colon surgery.", "Question: Does preoperative anemia adversely affect general colon surgery or rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe pulmonary and even mild preoperative anemia is an independent risk factor for the outcome of a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? A large multicenter database analysis suggests that the presence of severe and moderate and persistent preoperative anemia is an independent source for complications and a longer hospital stay after colon surgery.", "Question: Does preoperative anemia affect colon and rectal surgery outcomes? Answer: This large and comprehensive analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for patients requiring a longer hospital stay after colon surgery.", "Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large scale analysis suggests that the treatment of severe and moderate and even mild preoperative anemia is a risk factor for complications and a longer hospital stay after colon surgery.", "factors that preoperative anemia adversely affect colon and rectal surgery . This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a risk factor for complications that may stay after colon surgery.", "Question: Can anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an important factor for complications and a longer hospital stay after colon surgery."], "original_ll": -3.6812846660614014, "sampled_ll": -2.9066381454467773, "all_perturbed_sampled_ll": [-3.0784506797790527, -2.856658697128296, -3.0372796058654785, -3.251753091812134, -3.2713656425476074, -2.9346656799316406, -3.30303692817688, -2.917848587036133, -3.164046049118042, -3.113773822784424], "all_perturbed_original_ll": [-3.7722465991973877, -3.6852197647094727, -3.5352132320404053, -4.336931228637695, -3.9567015171051025, -3.9685897827148438, -3.5433881282806396, -3.6994097232818604, -3.890638828277588, -3.9575445652008057], "perturbed_sampled_ll": -3.0928878784179688, "perturbed_original_ll": -3.83458833694458, "perturbed_sampled_ll_std": 0.14883976476547664, "perturbed_original_ll_std": 0.2285541563631438}, {"original": "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "sampled": "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by the lower half of the subluxus", "perturbed_sampled": ["Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the depth by the lower half of the subluxus", "Question: Does septoplasty change the dimensions of compensatory hypertrophy in the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by the turbinate to half of the subluxus", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the lower half, which reduces the force exerted by the lower half or the upper subluxus", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by the lower half of the subluxus", "Question: Does Septoplasty changes the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by a higher half of the subluxus", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by the lower half of the subluxus", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by septoplasty, which reduces the force exerted by half of the subluxus", "Question: Does septoplasty change the depth of the middle turbinate, or is it compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, or changes the force exerted by the lower half of the subluxus", "Question: Could Septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the middle turbinate, which reduces the force exerted by half and half of the subluxus", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: No. Septoplasty changes the depth of the turbinate which reduces the force exerted by the lower half of the subluxus"], "perturbed_original": ["Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty or after one year.", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, can be done in one year.", "Question: Does septoplasty have the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty affect the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty change the influence of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does the present study help you determine the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate should be affected by septoplasty, even after one year.", "Question: Does septoplasty change the dimensions of the surface of the middle turbinate? Answer: The present findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty change the effect of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.", "Question: Does septoplasty affect the dimensions and dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year."], "original_ll": -2.999654531478882, "sampled_ll": -3.4923973083496094, "all_perturbed_sampled_ll": [-3.7469959259033203, -3.7680234909057617, -3.889859437942505, -3.4923973083496094, -3.653235673904419, -3.4923973083496094, -3.666102170944214, -3.2528233528137207, -3.756138801574707, -3.7061736583709717], "all_perturbed_original_ll": [-3.1853158473968506, -3.2173445224761963, -3.0792782306671143, -2.9861652851104736, -2.9717493057250977, -3.1489367485046387, -3.313793897628784, -2.999654531478882, -2.8575539588928223, -3.0419294834136963], "perturbed_sampled_ll": -3.6424147129058837, "perturbed_original_ll": -3.0801721811294556, "perturbed_sampled_ll_std": 0.1739000053780258, "perturbed_original_ll_std": 0.12933568656647598}, {"original": "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health.", "sampled": "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Yes. There is a benefit to a disabled person for the cost of housing in the home that will go up, but that is for the purposes of the supplemental security income program. So, you want to say, \"Well, there are two sets of people, one of them's disabled and the other one's living in an RV", "perturbed_sampled": ["Question: Upstream solutions: How does the supplemental security income program reduce disability in the elderly? Answer: Yes. There is a benefit to a disabled person for the housing that provides housing in the home that is not set up, but that is for one of the supplemental security income program. So, you want to say, \"Well, there are two sets of people, one of them's disabled person living in an RV,\" or the other one's living in an RV", "Question: Upstream solutions: does the benefit to the supplemental security income program reduce disability in the elderly? Answer: Yes. There is a benefit to a benefit for the cost of housing in the home that will go up, but that is for the purposes of the supplemental security income program. So, you want to say, \"Well, there are two sets of people, one of them's family, the other of them in an RV", "The following solutions: does the supplemental security income program reduce disability in the home?\" Yes. There is a benefit to a disabled person for the cost of housing at the home that will go up, and only one is for the purposes of the supplemental security income program. So, you want to say, \"Well, there are two sets of households in Canada,\" one of them's disabled and the other one's living in an RV", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Yes. There is a temporary benefit to a disabled person for the cost of housing in the home that will go up, but that is for the purposes of the security income program. So, as I'm going to say, there are two sets of people, one of whom is living in a RV and the other one's living in an RV", "Question: Upstream solutions: does the supplemental security income program reduce disability for the elderly? Answer: Yes. There is a benefit to a disabled person for the cost of housing in the home that will reduce disability, but that is for the purposes of the supplemental security income program. So, you want to say, \"Well, I do get two sets of services to the disabled, one of them's disabled and the other one's living in an RV", "Question: Upstream solutions: Does a supplemental security income program reduce your income to the elderly? Answer: Yes. There is a benefit to a disabled person for the cost of housing in the home which cannot go up, but that is for the purposes of supplemental security income program. So, you want to say, \"Well, there are two sets of people, one of them's disabled and the other one's living in an RV", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Yes. There is a benefit to a disabled person from the cost of housing in the elderly that will go up, but that is for the purposes of the supplemental security income program. So, you want to see, there are two sets of people, one of them's disabled and one disabled. That one's living in an RV", "Question: Upstream ly, does the supplemental security income program reduce disability for the elderly? A: There is a benefit to a disabled person for the home as well as a housing in the home that will go up, but that is for the purposes of the supplemental security income program. So, you want to say, \"Well, there are two disabled people, one of them's disabled and the other one's living in an RV", "Question: Upstream how did the supplemental security income program reduce disability rates for the elderly? Answer: Yes. There is a fee to a disabled person for the cost of housing in the home that will go up, which is for the purposes of the supplemental security income program. So, you want to say, \"Well, there are two sets of people, one of them's homeless, and the other one's living in an RV", "Question: Upstream solutions: does the supplemental security income program stand out in the supplemental security income program? Yes. There is a bill that would pay a disabled person for the cost of living in the home that will go up, but that is for the price of living in the supplemental security income program. So, you want to say, \"Well, there are two sets of people, one of them's disabled and the other one's living in an RV"], "perturbed_original": ["Question: Upstream solutions: Could a supplemental security income program be useful in the elderly? Answer: Income support policy may be a significant factor for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their effectiveness. Such research should be done using a variety of different income support policies, as well as evaluating whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce disability for the elderly? Answer: Income support policy may be a significant new lever for social and economic health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to evaluate supplemental income supplemental security reliability. Future projects will examine the role of different income support policies, as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce disability in the population? Income support may be a critical lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research considers a variety of different income support approaches, as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant candidate for improving population health, especially that of lower-income persons. Even though the findings are similar, future analyses are likely to confirm their reliability. Future research will also be conducted on a variety of different income support policies, as well as whether a broader variety of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security income support policy address health disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings will provide further analyses of income support policy to confirm their validity, the research should examine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: does a security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially for lower-income persons. Even though the findings are robust, further analyses are needed to confirm their effectiveness. The research should examine a variety of different income support policies, as well as whether a broad range of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security package reduce disability in the population? Income support policy may be a significant tool for improving population health, especially that of lower-income populations. Even though the findings are robust, further analyses are needed to confirm that the results were useful. Future research should examine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health.", "Question: Upstream solutions: Could a supplemental security income program affect health in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research can help scientists understand the validity of a variety of different income support policies, as well as whether a broader context of social and economic policies affect health.", "Question: Upstream solutions: does the supplemental security that can reduce disability in the communities? Income support policy may be a significant new lever for improving population health, health, and safety of the population. Even though the findings are robust, further analyses are needed to confirm their success. The research should examine a variety of different income support policies, as well as whether a broader range of social and economic policies affect health."], "original_ll": -3.6616573333740234, "sampled_ll": -2.9117074012756348, "all_perturbed_sampled_ll": [-3.2225916385650635, -3.2295033931732178, -3.3045177459716797, -3.1091933250427246, -3.0869266986846924, -3.1541478633880615, -3.2319178581237793, -3.157332420349121, -2.9881350994110107, -3.002249002456665], "all_perturbed_original_ll": [-3.5209708213806152, -3.7399399280548096, -3.909626007080078, -3.766871690750122, -3.7741148471832275, -3.8656535148620605, -3.7016961574554443, -3.5739426612854004, -3.75175142288208, -3.8830811977386475], "perturbed_sampled_ll": -3.1486515045166015, "perturbed_original_ll": -3.7487648248672487, "perturbed_sampled_ll_std": 0.09793029099883307, "perturbed_original_ll_std": 0.11971040512994026}, {"original": "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated circulating neutrophil counts decrease rapidly, over the same time course. Early enhanced neutrophil migratory activity coupled with elevated pulmonary concentrations of interleukin-8 may be central to the establishment of the neutrophil infiltration that is characteristic of ARDS.", "sampled": "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Not yet. Several important physiological parameters associated with prolonged exposure to trauma, particularly of the central nervous system, are unknown. Here, we review the possible role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic model of the etiology. A recent review of the neurobiology and neurophysiology of acute respiratory distress syndrome (ASE), by Peter Bockenhaeuf and colleagues, highlights the neurobiological mechanisms by which neutrophils and other central nervous system factors induce pain and inflammation,", "perturbed_sampled": ["and neutrophil migratory activity in trauma: a factor in the pathogenesis of acute respiratory distress syndrome? Answer: Not yet. Several important physiological parameters associated with exposure to trauma, particularly of the central nervous system, are unknown. Here, we review the possible role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic model of the role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE). A recent review of the possible neurophysiology of acute respiratory distress syndrome (ASE), by Peter Bockenhaeuf and colleagues, highlights the neurobiological mechanisms for the understanding of how the effects of neutrophils and other central nervous system factors induce pain and inflammation,", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Not yet. Several important physiological parameters associated with prolonged exposure to trauma, particularly of the central nervous system, are unknown. Here, we review the possible role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic model of the etiology. A recent review of the neurobiology and neurophysiology mechanisms of acute respiratory distress syndrome (ASE), by Peter Bockenhaeuf and colleagues, indicates the neurobiological mechanisms by which neutrophils of the central nervous system are involved in pain and inflammation,", "Question: Increased neutrophil migratory activity after major trauma: a factor in the cause of acute respiratory distress syndrome? Answer: Not all the important physiological parameters associated with prolonged exposure to trauma, particularly of the central nervous system, are unknown. Here, we review the possible role of neutrophils in the cause of acute respiratory distress syndrome (ASE) and provide a mechanistic model of the etiology. A recent review of the physiology and neurophysiology of acute respiratory distress syndrome (ASE), by Peter Bockenhaeuf and colleagues, highlights the neurobiological mechanisms that contribute to the role of neutrophils in the cause of acute respiratory distress syndrome, particularly of the central nervous system . With some new research on neurophysiology of acute respiratory distress syndrome, such as pain and inflammation,", "Question: Increased neutrophil migratory activity for trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Not yet. Several important physiological patterns associated with neutrophil migration to trauma, particularly of the central nervous system, are being investigated. Each week we review the possible role of neutrophils in the pathogenesis of acute respiratory distress syndrome and provide a new model of the etiology. A recent review of the neurobiology and neurophysiology of acute respiratory distress syndrome (ASE), by Peter Bockenhaeuf and colleagues, highlights the neurobiological mechanisms by which neutrophils and other central nervous system factors induce pain and inflammation,", "Question: Increased neutrophil migratory activity after major trauma: a factor in the development of acute respiratory distress syndrome? Answer: Not yet. The physiological parameters associated with prolonged exposure to neutrophils, particularly of the central nervous system, are unknown. Here, we review the possible role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic model for chronic inflammation and etiology. A recent review of the evolution and neurophysiology of acute respiratory distress syndrome (ASE), by Peter Bockenhaeuf and colleagues, highlights the neurobiological mechanisms by which neutrophils and other central nervous system factors induce pain and inflammation,", "Question: Increased neutrophil migratory activity after major trauma: a factor in the pathogenesis of acute respiratory distress syndrome? Answer: Not yet. Several important physiological parameters associated with prolonged exposure to trauma, particularly of the central nervous system, are unknown. Here, we review the chemophysiology and neurophysiology of acute respiratory distress syndrome, review the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic model of the etiology. A recent review of the neurobiology and neurophysiology of acute respiratory distress syndrome (ASE), by Peter Bockenhaeuf and colleagues, highlights the neurobiological mechanisms by which neutrophils and other central nervous system factors induce acute inflammation,", "Question: Increased neutrophil migratory activity after a long exposure to trauma is a factor in the pathogenesis of acute respiratory distress syndrome? Answer: Not yet. The physiological parameters associated with prolonged exposure to trauma, particularly of the central nervous system, are unknown. Here, we review the possible role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a model of the etiology. A recent review of the neurobiology and neurophysiology of acute respiratory distress syndrome (ASE), by Peter Bockenhaeuf and colleagues, demonstrates the possible neurobiological mechanisms by which neutrophils and other central nervous system factors induce pain and inflammation,", "Question: Increased neutrophil migratory activity after major neurodevelopmental factor in the etiology of acute respiratory distress syndrome? Answer: The following answers are: Several important physiological parameters associated with prolonged exposure to trauma, particularly of the central nervous system, are unknown. Here, we review the role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic model for the etiology. A recent review of the neurobiology and neurophysiology of acute respiratory distress syndrome (ASE), developed by Dr. Bockenhaeuf and colleagues, highlights the neurobiological mechanisms by which neutrophils and other central nervous system mechanisms induce pain and inflammation,", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Not yet. Several important physiological parameters associated with prolonged exposure to neutrophils, particularly at the onset of the central nervous system, are unknown. Here, we review the role of neutrophils in the pathogenesis of acute respiratory distress syndrome (ASE) and provide a mechanistic model of neurobiology. A recent review of the neurobiology and neurophysiology of acute respiratory distress syndrome (ASE), by Dr. James Payne and colleagues, highlights the neurobiological mechanisms by which neutrophils and other central nervous system factors induce pain and inflammation,", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: Not yet. Several important physiological parameters associated with migratory activation after major injuries and exposure to trauma, particularly of the central nervous system, are unknown. Here, we review the possible role of neutrophils in the etiology of acute respiratory distress syndrome (ASE) and provide a mechanistic model of neural neurochemistry. A recent review of the neurobiology and neurophysiology of acute respiratory distress syndrome (ASE), by Peter Bockenhaeuf , highlights the mechanisms by which neutrophils and other central nervous system factors induce pain and inflammation,"], "perturbed_original": ["Question: Increased neutrophil migratory activity associated with major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory activity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, and signaling. In patients who later develop ARDS, initially , neutrophil counts decrease rapidly, over a time course. Early changes in migratory activity coupled with elevated pulmonary concentrations of interleukin-8 may be central to the establishment of the neutrophil migratory activity that is characteristic of ARDS.", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of the artery. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In the case we later develop ARDS, initially elevated circulating neutrophil counts decrease rapidly, over a time course. Early enhanced circulating migratory activity coupled with elevated pulmonary concentrations of interleukin-8 may lead to the establishment of a new recurrent signal infiltration that is characteristic of ARDS.", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These findings indicate that major blunt trauma enhances the capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. The extent to which patients who later develop a new signaling therapy may indicate that elevated circulating neutrophil counts decrease on the same time course. Early enhanced neutrophil migratory activity coupled with elevated pulmonary capacity of interleukin-8 may be central to the establishment of the neutrophil migratory activity. This is characteristic of ARDS.", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later have initially elevated circulating neutrophil counts , it may be over a long time course. Early enhanced neutrophil migratory activity after elevated pulmonary concentrations of interleukin-8 may be central to the establishment of circulating neutrophil infiltration that is characteristic of ARDS.", "Question: Increased neutrophil migratory activity after major cardiac infiltration, is a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major cardiac infiltration enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of ARDS, and may be attributable to alteration in interleukin-8 receptor expression, affinity, and signaling. In patients who later develop ARDS, initially elevated circulating neutrophil counts decrease rapidly, over the long term, of course. While elevated neutrophil migratory activity coupled with increased pulmonary concentrations of interleukin-8 may be central to the establishment of the neutrophil infiltration that is characteristic of ARDS.", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma changes the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be attributable to alteration in the expression, affinity, or downstream signaling. In patients who later develop severe elevated circulating neutrophil counts can alter over the same time course. Early enhanced neutrophil migratory activity in patients with elevated pulmonary concentrations of interleukin-8 may be central to the establishment of the neutrophil infiltration that is controlled by ARDS.", "Question: Increased neutrophil migratory activity after major trauma: a study on the etiology of acute respiratory distress . These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may be correlated with an alteration in interleukin-8 receptor expression, affinity, or downstream signaling. In patients who later develop ARDS, initially elevated circulating neutrophil counts decrease rapidly, which is generally known throughout the same time course. Early increases in migratory activity coupled with higher pulmonary concentrations of interleukin-8 may be central to the establishment of the neutrophil infiltration that is characteristic of ARDS.", "Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This can be induced within 2 hrs of admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, and signaling. In patients who later develop ARDS, initially elevated neutrophil counts were found over the same time course. Early enhanced neutrophil migratory activity coupled with elevated pulmonary concentrations of interleukin-8 may be central to the establishment of a new neutrophil infiltration that is present in patients with acute ARDS.", "Question: Increased neutrophil migratory activity after major trauma: a factor in the function of acute respiratory distress syndrome? Answer: These data indicate that increased neutrophil migratory activity after major trauma enhances the migratory capacity of ARDS. This is manifest within 2 weeks after admission and may be attributable to alteration in interleukin-8 receptor expression, affinity, or downstream neutrophils. In patients who receive ARDS, initially elevated circulating neutrophil counts decrease rapidly, over the same period. Early enhanced neutrophil migratory activity coupled with elevated pulmonary concentrations of interleukin-8 may be central to the establishment of the neutrophil infiltration that is characteristic of ARDS.", "Question: Increased neutrophil migratory activity after smoking is a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major changes in renal function enhances the migratory capacity of neutrophils. This is manifest within 2 hrs of admission and is attributable to alteration in interleukin-8 receptor expression, affinity, or downstream signaling. For patients who later develop ARDS, initially elevated circulating neutrophil counts decrease rapidly, over the next time course. Early enhanced neutrophil migratory activity coupled with elevated pulmonary concentrations of interleukin-8 may be central to the establishment of the neutrophil infiltration that is not required for subsequent ARDS."], "original_ll": -3.2472386360168457, "sampled_ll": -2.3074817657470703, "all_perturbed_sampled_ll": [-2.285707950592041, -2.4093008041381836, -2.3366854190826416, -2.5870394706726074, -2.40376877784729, -2.4643959999084473, -2.345980405807495, -2.5799150466918945, -2.408310651779175, -2.586672306060791], "all_perturbed_original_ll": [-3.2345283031463623, -3.763258934020996, -3.5771656036376953, -3.4128856658935547, -3.1940488815307617, -3.531362533569336, -3.5355749130249023, -3.2018232345581055, -3.0483615398406982, -3.4157378673553467], "perturbed_sampled_ll": -2.4407776832580566, "perturbed_original_ll": -3.391474747657776, "perturbed_sampled_ll_std": 0.10482255892667519, "perturbed_original_ll_std": 0.20769898429887468}, {"original": "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "sampled": "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients are often untethered before diagnosis as their immune systems may be \"swollen\" and require new blood supply. An untethered patient is able to avoid detection or treatment of the condition for a period of time without being", "perturbed_sampled": ["Question: A patient with myelomeningocele: is untethering necessary for scoliosis correction? Patients are often untethered before diagnosis as their immune systems may be \"swollen\" and require new blood supply. An untethered patient is likely to avoid detection or treatment of the condition for a period of time without being", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients are often not successful in the diagnosis as their immune systems may be \"swollen\" and require additional supply. An untethered patient is able to avoid detection or treatment of the condition for a period of time before the condition is being", "Question: A diagnostic myelomeningocele: is untethering necessary prior to correction? Answer: Patients are often untethered before diagnosis as their immune systems may be \"swollen\" and require new blood supply. An untethered patient is able to avoid detection or treatment of the condition for a period of time and is generally safe for a period of time being", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients may feel untethered before diagnosis as their immune systems may be \"swollen\" and require new blood supply. An untethered patient should be able to avoid detection or treatment of a certain infection for a period of time without being", "Question: Is it necessary to talk with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients are often untethered before diagnosis as their immune systems may be \"swollen\" and require new blood supply. An infectious disease expert is able to avoid detection or treatment of the condition for a period of time without being", "A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients are often untethered before diagnosis as their immune system can be \"swollen\" and require new blood supply. An untethered patient is able to avoid detection or treatment of the condition for a long time without being", "A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Patients with myelomeningocele are often untethered before diagnosis as their immune systems may be \"swollen\" and require new blood supply. An untethered patient is able to avoid detection or treatment of an underlying condition for a period of time without being", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients are often untethered before diagnosis . The immune systems may be \"swollen\" and require a good immune supply. An immunotherapist is able to avoid detection or treatment of the condition for a period of time without being", "Question: A patient with the right to untethering necessary prior to scoliosis correction? Answer: Patients are often untethered before diagnosis as their immune systems may be \"swollen\" and require new blood supply. An individual who is able to avoid detection or treatment of the disease over a period of time without being", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: Patients are often untethered as long as their immune systems may be \"swollen\" and require new blood flow. An untethered patient is able to avoid detection or treatment of the condition for a period of time without being"], "perturbed_original": ["Question: A patient who is doing scoliosis correction prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients who have tethered cords who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis corrective surgery? The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery . However, they were not present with clinical symptoms of a tethered cord, even though the risks and medical symptoms are not clearly radiographically demonstrated.", "Question: A patient with myelomeningocele: Do the mlb are necessary prior to scoliosis correction? The study results suggested that spinal cord untethering may be unnecessary for patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "Question: A patient with myelomeningocele: is spinal cord untethering necessary prior to scoliosis correction? Answer: The study results suggest that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord though tethering is radiographically demonstrated.", "Question: A patient with myelomeningocele: is untethering unnecessary in patients with MM when it comes to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are not in the care of spinal cord corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering may have been demonstrated.", "Question: Is untethering necessary when treating people with myelomeningocele: is untethering necessary prior to scoliosis corrective surgery? The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not experience symptoms with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that using untethering and untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with the ability of a tethered part, even though tethering is radiographically demonstrated.", "A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Our study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and may be present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.", "Question: A patient with myelomeningocele: is untethering unnecessary for patients exposed to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with severe spinal cord problems. Those patients who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered spinal cord: though tethering is radiographically demonstrated.", "Question: A patient with myelomeningocele: is untethering essential to scoliosis correction? Answer: The study results reveal that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and that they are present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated."], "original_ll": -3.8268306255340576, "sampled_ll": -3.31512713432312, "all_perturbed_sampled_ll": [-3.4584593772888184, -3.5916852951049805, -3.568549871444702, -3.4104723930358887, -3.9961318969726562, -3.4860713481903076, -3.1495096683502197, -3.7390780448913574, -3.8473329544067383, -3.4053328037261963], "all_perturbed_original_ll": [-3.6272716522216797, -3.9578969478607178, -4.054515838623047, -3.7813923358917236, -3.7081494331359863, -3.7583720684051514, -3.944944143295288, -4.051516056060791, -3.832260847091675, -4.0075507164001465], "perturbed_sampled_ll": -3.5652623653411863, "perturbed_original_ll": -3.872387003898621, "perturbed_sampled_ll_std": 0.23155972028603888, "perturbed_original_ll_std": 0.14354403742291116}, {"original": "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.", "sampled": "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, children are aware of their physical body but do not perceive their body in the same way they perceive body odor. Children also may not recognize their body when they are younger, and they are not aware of the", "perturbed_sampled": ["Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, children may not know of the body but do not recognize their body in the same way they perceive body odor. Children also may not recognize their body when they are younger, and they are not at the", "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, children are aware of their physical body but do not perceive their body in the same way they feel the odor. Children also may see their body when they notice body image and they are not aware of the", "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, children are aware of their physical body but do not perceive body image in the same way they perceive body odor. Children also can recognize their body when they are younger, and they are aware of the", "Question: Body perception: do parents, their children, or their children's physicians perceive their bodies differently? Answer: Yes, children are aware of their physical body but may not perceive their body in the same way they perceive body odor. Children also may not recognize their body when they are aware of themselves when they are not aware of the", "Question: Body perception: do parents, their children, and their children perceive body image differently? Answer: Yes, children are aware of their physical body but do not perceive their body in the same way with their physical body odor. Children also do not recognize their body when they speak, and they are not aware of the", "Question: Body image is a body image? Can parents, their parents, their children, and their children's physicians perceive body image differently? Answer: Yes, children are aware of their physical body but do not perceive their body in the same way they perceive body image differently? Children also may know how to perceive their body when they are younger, and they are not aware of the", "Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Yes, children are aware of their body, but do not perceive their body the same way they perceive body image. They are also able to recognize their body when they are younger, and they are not aware of the", "body image perception: do parents, family, and their children's physicians perceive body image differently? Answer: Yes, children are aware of their physical body but do not perceive their body in the same way they perceive body odor. Children also may not recognize their body when they are younger, and they are not immediately aware of it.ds in the", "Question: Body perception: do parents, their children, and their parents perceive body image differently? Answer: Yes, children are aware of their physical body but do not perceive their body in the same way they perceive body odor. Children also may not recognize their bodies when they are aware of their physical body but they are not aware of the", "Question: When do parents, their parents, and their children's physicians perceive body image differently? Answer: Yes, children are aware of their physical body image, and the body image may not perceive their body the same way they perceive body odor. Children also may not recognize their body when they are younger, and they are not aware of the"], "perturbed_original": ["Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their ability to be overweight and overweight. Their parents and even their attending physicians shared their perception differently. This study demonstrates the need to further educate physicians to recognize fewer children and overweight , unless they can counsel children and their families.", "Question: Body perception: do your children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This demonstrates the need to further educate physicians to recognize obesity and reduce obesity so that they can counsel children and their families.", "Question: Body perception: do parents, their children, and their children's parents look the body image differently? Answer: Many children underestimated their degree of overweight. Their parents, or even their attending schools, underestimated this misperception. This study demonstrates the need to enable physicians to recognize obesity and overweight so that they can counsel children and their families.", "child's perception: How are their children, and their children's physicians viewed this image differently? Answer: Many children underestimated their degree of overweight. Their parents , and their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.", "Question: Body perception: do children, their children, and their children's physicians perceive themselves differently? Answer: Many children underestimated their degree of overweight. Their parents , and their attending physicians shared this misperception. This study focuses on the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.", "Question: Body perception: do parents, their children, and their children's physicians perceive this differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians had a very high degree of this misperception. This study believes they need to further educate physicians to recognize obesity and overweight so that they can see their children and their families.", "Question: Body perception: What do children, parents and even their attending physicians and their children's physicians perceive very differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the ability to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.", "Question: Body perception: do parents, their children, or their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Parents and even their attending physicians shared this misperception. The above demonstrates the need to educate physicians to recognize obesity and overweight so that they can counsel children and their families.", "Question: Body perception: do parents, their children, and their children's physicians perceive body perception? Answer: Many children believe a high degree of overweight. Their parents and even their children shared this misperception. This demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.", "Question: Body perception: do parents, their children's physicians and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their physicians shared that weight. This study demonstrates the need to educate physicians to recognize obesity and overweight so that they can counsel children and their families."], "original_ll": -3.6529042720794678, "sampled_ll": -2.641486644744873, "all_perturbed_sampled_ll": [-3.0323143005371094, -3.1359715461730957, -2.73897123336792, -2.653217315673828, -2.8225743770599365, -2.826707601547241, -2.636507272720337, -3.1857383251190186, -2.589468002319336, -2.904667615890503], "all_perturbed_original_ll": [-4.063255310058594, -3.9092631340026855, -3.9021222591400146, -3.852346420288086, -3.861440658569336, -3.7520599365234375, -3.7481536865234375, -3.7733407020568848, -3.755131244659424, -3.8896265029907227], "perturbed_sampled_ll": -2.8526137590408327, "perturbed_original_ll": -3.8506739854812624, "perturbed_sampled_ll_std": 0.19911309904804855, "perturbed_original_ll_std": 0.0939417074855889}, {"original": "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased", "sampled": "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "perturbed_sampled": ["Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "Question: the ACE allele of ACE gene gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the the ACE I/D polymorphism.\n\n", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The insertion allele of the ACE gene I/D polymorphism.\n\n"], "perturbed_original": ["Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular failure in the DD genotype is not the factor for the insulin resistance or abnormalities in cardiovascular disease, but we report an increased", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD insulin resistance is not mediated through insulin resistance and no changes in fibrinolysis. We report an increased", "Question: The insertion allele of the ACE gene and its theetide is also characterized by scrubbing. A candidate gene for insulin resistance? We conclude that increased cardiovascular disease of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that a cardiovascular risk of the DD genotype is associated with a significant difference through insulin resistance or abnormalities in your blood pressure. Conversely, we report an increased", "Question: The insertion allele of the ACE gene I/D polymorphism. ACE gene for cardiovascular risk. Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, ACE is induced by an increased", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased expression of the DD genotype is not mediated through insulin resistance or abnormalities . Conversely, we conclude that in humans increased expression of increased", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for a new genotype Answer: We conclude that increased cardiovascular risk of an acute ACE genotype is not mediated through insulin resistance or abnormalities in the patient. Conversely, we report an increased", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Studies conclude that increased cardiovascular risk of the DD genotype s is mediated through insulin resistance or abnormalities in fibrinolysis. We also report an increased", "Question: The insertion allele of an E gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We report that increased cardiovascular risk of the DD genotype is not mediated by insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased", "Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance, as discussed above. We conclude that increased cardiovascular risk of the DD genotype is not an improvement in insulin resistance or hyperdynamic fibrinolysis. Conversely, we report an increased"], "original_ll": -3.9086427688598633, "sampled_ll": -2.0651865005493164, "all_perturbed_sampled_ll": [-2.0651865005493164, -2.0651865005493164, -2.0651865005493164, -2.0651865005493164, -2.0651865005493164, -2.976029634475708, -2.0651865005493164, -2.0651865005493164, -2.0651865005493164, -2.0651865005493164], "all_perturbed_original_ll": [-4.324195861816406, -4.292624473571777, -4.547515869140625, -4.218702793121338, -4.003799915313721, -4.157752990722656, -4.289583683013916, -4.254861831665039, -3.973195791244507, -3.909130811691284], "perturbed_sampled_ll": -2.1562708139419557, "perturbed_original_ll": -4.197136402130127, "perturbed_sampled_ll_std": 0.27325294017791746, "perturbed_original_ll_std": 0.1823179504932549}, {"original": "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "sampled": "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct stones are generally a more difficult material to detect than bile duct stones, but it may be a sign that these stones are from an older", "perturbed_sampled": ["the clinical significance of a bile duct sludge: is it different from bile duct stones? Answer: Bile duct stones are generally a more difficult to detect than bile duct stones, but it may be a sign that these stones are from an older", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct stones are generally a more difficult material to detect than bile duct stones. Does it represent a sign that they are from an older", "Question: The clinical ly common type of bile duct sludge: is it different from bile duct stones? Answer: Bile duct stones are the more difficult material to detect than bile duct stones, but it may be a long-term test. Typically, these stones are from an older", "Question: The clinical level of bile duct sludge: is it different from bile duct stones? Answer: Bile ducts are generally a more difficult material to detect than bile duct stones, but it may be a sign that these stones are from an older", "Question: The significance of bile duct sludge: how is it different from bile duct stones? Answer: Bile ducts are generally a more difficult material to detect than bile duct stones, but it may be a sign that these stones are from an older", "Question: The clinical significance of bile duct sludge: How are the clinical significance of bile duct stones different from bile duct stones? Answer: Bile duct stones are generally a more difficult type to detect than bile duct stones, but it may be a sign that these stones are slightly older", "Question: The clinical difference between bile duct stones and bile duct sludge: is it bile duct bile duct? Answer: Bile duct stones are generally a more difficult material to detect than bile duct stones, but it may be a sign that these stones are from an older", "Question: The clinical significance of bile duct sludge: is it different from other stones? Answer: Bile duct stones are generally a very useful material to detect bile duct stones, but it may be a sign that these stones are from an older", "Research the clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct stones are generally a more difficult material to distinguish from bile duct stones, but it may be a sign that these stones are less likely to develop bile duct stones./b of older", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct stones are generally a difficult material to detect when bile duct stones, but it may be a sign that they are from an older"], "perturbed_original": ["Question: The clinical significance of bile duct stones, is it different from bile duct stones? Answer: The findings indicate that the incidence of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be at an early stage of choledocholithiasis.", "Question: The clinical characteristics of bile duct sludge: is it different from bile duct sludge? Answer: The findings indicate that the pattern of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical significance of bile duct stones is different, how is it different from bile duct stones? These findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical characteristics of bile bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the risk of symptomatic BDS is similar to bile duct stones and CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of bile duct stones. Bile duct sludge seems to be an early cause for choledocholithiasis.", "Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Results indicate that the clinical significance of symptomatic BDS is similar to that of CBD . bile duct sludge seems to be an early precursor to choledocholithiasis.", "Question: The clinical significance of bile duct stones; does it affect bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS stones compare to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical significance of bile duct sludge: Why is BDS different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an indication of choledocholithiasis.", "Question: The clinical significance of bile duct sludge: is it the clinical significance of bile duct stones? The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. But bile duct sludge seems to be an early stage of choledocholithiasis.", "Question: The clinical significance of bile duct stones and is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD -type CBD. bile duct sludge seems to be an early stage of choledocholithiasis."], "original_ll": -3.4409372806549072, "sampled_ll": -2.826911211013794, "all_perturbed_sampled_ll": [-2.8952252864837646, -3.0935492515563965, -3.5582563877105713, -2.957909345626831, -2.8288824558258057, -2.777513265609741, -2.839214563369751, -3.4331984519958496, -3.1409871578216553, -3.2277231216430664], "all_perturbed_original_ll": [-3.6660349369049072, -3.566175699234009, -3.599972724914551, -3.647702693939209, -3.2174577713012695, -3.565525770187378, -3.7790627479553223, -3.5234768390655518, -3.5225040912628174, -3.8565404415130615], "perturbed_sampled_ll": -3.0752459287643434, "perturbed_original_ll": -3.5944453716278075, "perturbed_sampled_ll_std": 0.2530930931214091, "perturbed_original_ll_std": 0.1627072862935751}, {"original": "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also incorrect and potentially harmful data in 9% of the staging. Our findings support a more selective use of PET/CT, basically in patients with high risk of local recurrence.", "sampled": "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, we are doing a small study of our patients on PET, which is similar to the study done on the CT. However, it is not the same as our studies. I will post some notes below: We used a procedure on a preoperatively treated patient. The procedure did not require an invasive biopsy and did not need any other medical procedures. This meant that we did not have to wait for the", "perturbed_sampled": ["Question: Preoperative staging of patient in liver with liver tumor and colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, we were doing a small study of our patients , which is similar to the study done on the CT. However, it is not the same as our studies. I will post some notes below: We used a procedure on a preoperatively treated patient. The procedure did not require an individual biopsy and did not need any additional medical procedures. This meant that we did not have to wait for the", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, we are doing a small study of our patients on PET, which is similar to what is being done on the CT. However, it is not completely comprehensive as I believe. I will post some notes below: Getting a procedure on a preoperatively treated patient. The procedure did not require an invasive biopsy and did not need any other medical procedures. This meant that we did not have to pay for the", "Question: We are a majority of patients with liver metastases and liver carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, we used a small study of our patients on PET, which is similar to the study done on patient septic stem cells. However, it is not the same as that of CT. I will post some notes below: We used a procedure on a preoperatively treated patient. The procedure did not require an invasive biopsy and did not need any other medical procedures. This meant that we did not have to wait for the", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. We didn\u2019t really add something to our investigation. Answer: Yes, we are doing a small study of our patients on PET, which is similar to the study done on CT. However, it is not the same as our studies. I will post some notes below: We did not need a medical procedure on a preoperatively planned patient. The procedure did not require an intervention on the patient and did not need any other medical procedures. This meant that we did not have to wait for the", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does the biopsy add something to multidetector studies? Yes, we are doing a small study of our patients on PET, which is similar to the study on the CT. However, it is not the same as our studies. I will post some notes below: i would like to ask you for a procedure on a preoperatively treated patient. The procedure did not require an invasive biopsy and did not need any other medical procedures. This meant that we did not have to wait for the", "Question: Preoperative staging of the patient with type II of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, we are doing a small study of our patients on PET, which is similar to the study of the CT. However, it is not the same as our studies. I will post some notes below: We used a procedure on a multidetector CT of a primary patient. The procedure did not require an invasive implant, we did not use any other medical procedures. This meant that we did not have to wait for the", "Question: Preoperative staging of patients with liver metastases of colorectal tumours on PET/CT really add something to the equation. Answer: Yes, we are doing a small study of treatment on PET, which is similar to the study done on the CT. However, it is not the same as our studies. I am sharing some notes below: We used a procedure on a preoperatively treated patient. The procedure did not require an invasive biopsy and did not need any other medical procedures. I would like to emphasize that we did not have to wait for the", "Question: Preoperative staging of the liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector s? Yes, we are doing a small study of our patients on PET, which is similar to the study done on the CT. However, it is not the same as our studies. I will post some notes below: We used a CT for a preoperatively treated patient. The procedure did not require an emergency, and it did not need any other medical procedures. This meant that we did not have to use the", "Question: Preoperative ly treated patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: Yes, we are doing a small study of our patients on PET, which is why we was the leading expert in the study done on the CT. However, it is not the same as our studies. I will post some of your thoughts here as the results are shown. We used a procedure on a preoperatively treated patient. The procedure did not require any invasive biopsy and did not need any other medical procedures. This meant that we did not have to wait for the", "Question: Preoperative staging of patients with liver metastases of colorectal tissue should be removed. Can PET/CT really add something to multidetector CT? Answer: We are doing a small study of our patients on PET, which is similar to the study done on the CT. However, it is not the same as our studies. I will post some notes below: We used a procedure on a preoperatively treated patient. The procedure did not require invasive biopsy and did not need any other medical procedures. This is because we did not have any treatment for the"], "perturbed_original": ["Question: Preoperative staging of patients with liver metastases of colorectal s pulmonary cancer. Could PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic staging of some anatomic locations, the results are hampered by its low PPV. PET/CT provided an inaccurate information in 8% of the staging, but also incorrect and potentially harmful data in 9% of the staging. Our findings support a more selective use of PET/CT, basically in patients with high risk of local recurrence.", "Question: Preoperative staging of patients with liver metastases of colorectal disease? Question: Can PET/CT really add something to multidetector CT? Answer: PET/CT has a corresponding role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of liver disease in some anatomic locations, its results are hampered by its low PPV. PET/CT has not only additional useful information in 8% of the cases but also incorrect and potentially harmful indications of 9% of the staging. Our findings support a more selective use of PET/CT, basically in patients with high risk of local recurrence.", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector staging? Why? Because PET/CT has a limited role in hepatic staging of large liver livers. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low levels of staging, and we provided additional data in 8% of the cases but also incorrect and potentially harmful data in 9% of the staging. Our findings support a more selective use of PET/CT, basically enabling patients with high risk of local recurrence.", "Question: Preoperative staging of patients with metastases in a new cancer carcinoma. Does PET/CT really contribute to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but still provided additional useful and potentially harmful data in 9% of these cases after staging. Our findings support a selective use of PET/CT, basically in patients with high risk of local recurrence.", "Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really contribute to hepatic staging? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the treatment of extrahepatic disease in some cases, its results are related to its low PPV. PET/CT provided additional useful information in 8% of the cases but also incorrect and potentially harmful data in both cases after initiation of the staging. Our findings support a more selective use of PET/CT, basically in patients with high risk of local recurrence.", "Question: Preoperative staging of patients with liver metastases of PVE. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in the treatment of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by anti-inflammatory PPV. Using PET/CT, this results not only provide additional useful information in 90% of the cases but also incorrect and potentially harmful data in 9% of the staging. Our findings support a more selective use of PET/CT, basically in patients with an acute liver of local recurrence.", "PET/CT staging of LMCRC at liver metastases of colorectal carcinoma. Does PET/CT add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 8% of the cases but also incorrect and potentially unnecessary data in 9% of the staging. Our findings support the selective use of PET/CT, particularly for patients with CPX in patients with high risk of local recurrence.", "Question: Preoperative CT is often a significant risk factor in patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of hepatic tumors. While PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET/CT provided additional useful information in 9% of the patients with colorectal carcinoma. We found also incorrect and potentially harmful data in 9% of patients with hepatic staging. Our findings support a more efficient analysis of PET/CT, basically in patients with high risk of local recurrence.", "Question: Preoperative staging of patients with cancer of colorectal carcinoma. Does PET/CT really add something to multidetector staging? PET/CT has played a key role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by its low PPV. PET-CT has less additional information in 8% of the cases but also incorrect and potentially harmful data in 9% of the staging. Our findings support a more selective use of PET/CT, basically because it has a high risk for patients with high risk of local recurrence.", "Question: The problem is that this article addresses the primary causes of patients with liver metastases of colorectal carcinoma. Does PET/CT really contribute to multidetector regression? PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are hampered by the PPV. PET/CT provided additional useful information in 8% of the cases but also incorrect and potentially harmful data that accounted for the severity of the staging. Our findings support a more selective use of PET/CT, basically providing a response with high risk of local recurrence."], "original_ll": -3.6918342113494873, "sampled_ll": -2.9590978622436523, "all_perturbed_sampled_ll": [-3.258533000946045, -3.1636390686035156, -3.15749192237854, -3.202633857727051, -3.1209986209869385, -3.0726873874664307, -3.0807087421417236, -3.241537094116211, -3.2569799423217773, -3.1935596466064453], "all_perturbed_original_ll": [-3.9779248237609863, -3.820280075073242, -3.8008718490600586, -3.8234763145446777, -3.583641290664673, -3.829630136489868, -3.7028400897979736, -3.3315658569335938, -3.7859303951263428, -3.857771635055542], "perturbed_sampled_ll": -3.1748769283294678, "perturbed_original_ll": -3.7513932466506956, "perturbed_sampled_ll_std": 0.06476423524113044, "perturbed_original_ll_std": 0.17002629306725184}, {"original": "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care when they need it.", "sampled": "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya is based on an analysis of data from nearly 2,500 health care plans. This data set, which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the data are not identical in the United States, the results of this analysis imply that the share of health", "perturbed_sampled": ["Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya is based on an analysis of data from nearly 2,500 health care plans. This data set, which is collected by the Kenya Health Care System, traces the distribution of health care in Kenya as a whole. Although the data are not identical to the United States, the results of this analysis imply that Kenya has achieved a fundamental understanding of health", "Question: Does the distribution of health care benefits in Kenya conform to the principles of universal coverage? Answer: The distribution of health care benefits in Kenya is based on a series of data from nearly 2,500 health care providers. This data set, which is collected by the Health Care Authority, is widely used to improve health care in Kenya as a whole. Although the data are not identical in the United States, the results of this analysis imply that the share of health", "Question: Does the distribution of health care benefits in Kenya meet the principles of health care coverage? Answer: The analysis of health care in Kenya is based on an analysis of data from nearly 2,500 health care plans. This data, which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the data are not identical in the United States, the results of this analysis imply that the share of health", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya is based on an analysis of data from the Nairobi Health Authority\u2019s health care plans. This data set, which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the data set is identical to the United States, the results of this analysis imply that the share of health", "Question: Does the distribution of health care in Kenya meet the principles of universal coverage? Answer: The distribution of health care costs and benefits for the Kenya Health Authority is based on an analysis of data from nearly 2,500 health care plans. This data set, which is collected by the Kenya Health Authority, represents health care in Kenya as a standard; though the data are not identical in the United States, the benefits of this analysis imply that the share of health", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya is based on an analysis of data from nearly 2,500 health care plans. The data set, which is collected by the Kenya Health Care Survey, compares health care in Kenya as a policy and the coverage model. Unless these data are not identical in the United States, the results of this analysis imply that the share of health", "Question: Does the distribution of health care benefits in Kenya meet the principles of health care coverage? Answer: The distribution of health care benefits in Kenya is based on an analysis of data from nearly 2,500 health care plans. This data set, which is compiled by the National Health Care Authority, represents health care in Kenya as a whole. Although the data are also provided by health insurance agencies in the United States, the results of this analysis imply that the share of health", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya is based on an analysis of data from thousands of health care plans. This data , which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the data are not identical in the United States, the results of this analysis imply that the share of health", "Question: Does the distribution of health care benefits in Kenya meet the principles of the basic standards of health care? Answer: The distribution of health care benefits in Kenya relies on an analysis of health care benefits for nearly 2,500 health care plans. The data set, which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the data are not identical in the United States, the results of this analysis imply a shared share of health", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya depends on a collection of data from nearly 2,500 health care plans. This data set, which is collected by the Kenya Health Authority, represents health care in Kenya as a whole. Although the results of this data are not identical in the United States, the results of this data set suggest that the share of health"], "perturbed_original": ["Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to the specific needs of all Kenyans. The Kenyan health sector is clearly inequitable and benefits are distributed on the basis of need. Deliberate efforts have been directed to restructuring the Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care when they need it.", "Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to the criteria of need. Answer: The Kenyan health sector is clearly inequitable and benefits are not largely treated on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address health problems and ensure that all people should benefit from health care when they need it.", "coverage policy, to ensure that the distribution of health care benefits in Kenya meet the principles of universal coverage. The principles of universal coverage require that all should benefit from healthcare according to need. The Kenyan health sector is poor, and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address the issue and ensure that all Kenyans benefit from health care when they need it.", "Question: Does the distribution of health care benefits in Kenya exceed the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits can be distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care as they need it.", "Question: Does provision of health care benefits in Kenya meet the requirements for universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address the need and ensure that all Kenyans benefit from health care when they need it.", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address access barriers and ensure that all people should benefit from health care according to need and need it.", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care services in need. The health care sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to ensure access to health care services and ensure that all Kenyans benefit from health care when they need it.", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to ensure that the Kenyan health system does not place access barriers to access. The Kenyan health sector should also make clear that all should benefit from health care when they need it.", "Question: Does the principles of universal health care in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage are clearly unjust and all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care when they need it.", "Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to the principle of universal coverage. The Kenyan health sector is clearly inequitable and can be not distributed on the basis of need. Deliberate efforts should be made for restructuring the Kenyan health system to address access barriers and ensure that all Kenyans benefit from health care when they need it."], "original_ll": -2.94423508644104, "sampled_ll": -2.310852527618408, "all_perturbed_sampled_ll": [-2.402862310409546, -2.390085220336914, -2.458576202392578, -2.5357635021209717, -2.8111987113952637, -2.6962954998016357, -2.4198412895202637, -2.40453839302063, -2.6228418350219727, -2.393259286880493], "all_perturbed_original_ll": [-2.919844388961792, -3.019611358642578, -3.030461072921753, -2.9945058822631836, -2.9945549964904785, -3.006633996963501, -2.8299272060394287, -2.8461873531341553, -3.0884156227111816, -2.9184305667877197], "perturbed_sampled_ll": -2.5135262250900268, "perturbed_original_ll": -2.964857244491577, "perturbed_sampled_ll_std": 0.1414499755128306, "perturbed_original_ll_std": 0.0790854571644243}, {"original": "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The", "sampled": "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes.\n\n", "perturbed_sampled": ["Question: Does cognitive function predict frequency compressed frequency in listeners with normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive function predict frequency compressed speech recognition in conjunction with normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive function predict frequency compressed speech recognition in conjunction with normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive function predict frequency compressed air in listeners with normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive function predict frequency compressed speech recognition in listeners ' normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive function predict frequency and recognition in listeners with normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal cognition? Answer: Will cognitive function predict frequency compressed speech recognition in listeners with normal cognition? Answer: Yes.\n\n", "Question: Does this predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive function predict frequency compressed frequency in listeners with normal hearing and normal cognition? Answer: Yes.\n\n", "Question: Does cognitive frequency compressed speech recognition improve high frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes.\n\n"], "perturbed_original": ["hearing cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal cognition? Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal cognition? Answer: The", "Question: Does cognitive function increase memory to compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The", "Question: Can our function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The", "Question: Does cognitive function predict frequency compressed hearing in listeners with normal hearing and normal cognition? Answer: The", "Question: Does cognitive expression boost high frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The", "Question: Does cognitive function predict frequency compressed speech recognition in memory by function determinant memory in normal hearing and normal cognition? Answer: The", "Question: Does cognitive function predict frequency compressed speech recognition in listeners \u2019 hearing and normal cognition? Answer: The", "Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal hearing? The", "Question: Does cognitive function predict frequency compressed speech recognition in both normal hearing and normal cognition? Answer: The"], "original_ll": -4.984091758728027, "sampled_ll": -4.731563568115234, "all_perturbed_sampled_ll": [-4.973910808563232, -4.880407810211182, -4.880407810211182, -4.94902229309082, -5.62044095993042, -4.434909820556641, -3.4676125049591064, -4.779281139373779, -4.973910808563232, -4.844791412353516], "all_perturbed_original_ll": [-5.92311954498291, -2.999000310897827, -5.145340919494629, -5.3638691902160645, -4.9994096755981445, -5.223842620849609, -5.61733341217041, -6.435161590576172, -5.170882701873779, -5.078610420227051], "perturbed_sampled_ll": -4.780469536781311, "perturbed_original_ll": -5.19565703868866, "perturbed_sampled_ll_std": 0.5172929741513973, "perturbed_original_ll_std": 0.8457619729514384}, {"original": "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.", "sampled": "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: No, but it's an important factor in predicting which cells have what type of cancer. So, it's not just about how many cells you have, it's about where you have those cells. This is a very", "perturbed_sampled": ["induction of the platelet count in esophageal squamous cell carcinoma: is it a factor? Answer: No, but it's an important factor in predicting which cells are going to develop this type of cancer. So, it's not just about how many cells you have, it's about where you have those cells. This is a very", "the platelet count in cells with cell carcinoma: is it a prognostic factor? Answer: No, but it's an important factor in predicting which cells have what type of cancer. So, it's not just about how many cells you have, it's about where you have those cells. This is a very", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is this a prognostic factor? Answer: No, but it's a crucial factor in predicting which cells have what type of cancer. This is not just about how many cells you have, it's about where you have those cells. This is a very", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: No, but it's a prognostic factor in predicting which cells have what type of cancer. So, it's not just about how many cells you have, it's where you have those cells. This is pretty very", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is preoperative platelet count the most appropriate prognostic factor? Answer: No, but it's an important factor in predicting which cells have what type of cancer. So, it's not just about how many cells you have, it's about where you have those cells. The percentage of cancer is a very", "Question: Preoperative platelet cancer of esophageal squamous cell carcinoma: is it a prognostic ? No, but it's an important factor in predicting which cells have what type of cancer. So, it's not just about how many types of cell you have, it's about where you have those cells. This is a very", "Question: Preoperative platelet and esophageal squamous cell disease are it a prognostic factor? Answer: No, but it's an important factor in predicting which cells have what type of cancer. So, it's not just about how much cancer you have, it's about where you have those cells. This is a very", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: No, but it's an important factor determining which cells have what type of cancer. It's not just about how many cells you have, it's about where you have those cells. This is a very", "Question: Preoperative platelet count in which cell is it a prognostic factor? Answer: No, but it's an important factor in predicting which cells have what type of cancer. So, it's not just about how many cells you have, it's about where you have those cells. This is a very", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: No, it's an important factor in predicting whether you have what type of cancer. So, not just about how many cells you have, it's about where you have those cells. This is a very"], "perturbed_original": ["Preoperative platelet count in esophageal squamous cell carcinoma: is this a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive cell carcinoma. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.", "Question: Preoperative platelet count is for squamous cell carcinoma: is it a prognostic ? Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the optimum time for platelet count in predicting survival in ESCC patients.", "Question: Preoperative platelet count is the predictor factor for long-term survival in esophageal carcinoma or nodal carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for the survival factor in predicting survival in ESCC patients.", "Question: Preoperative platelet count on esophageal squamous cell carcinoma: is platelet count a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in ESCC patients. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for platelet count in ESCC, particularly in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the focal point for platelet count in predicting survival in ESCC patients.", "Question: Preoperative platelet count in esophageal squamous patients, is it a prognostic factor? Answer: Preoperative platelet count is a model for long-term survival in ESCC, especially in nodal-positive patients. We conclude that platelet count (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.", "Question: Preoperative platelet count in esophageal squamous patients. Or is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for survival in ESCC in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a predictive factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that platelet count may be the optimum cutoff point for platelet count in predicting long-term survival in ESCC patients.", "Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a good prognostic factor for survival in ESCC, especially in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count to increase survival in ESCC patients.", "Question: Preoperative platelet count in ESCC patients with cell cell carcinoma: is it a prognostic factor? Answer: Platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (\u00d710(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients."], "original_ll": -3.098870038986206, "sampled_ll": -2.343740701675415, "all_perturbed_sampled_ll": [-2.439096212387085, -2.518923044204712, -2.488908052444458, -2.5999362468719482, -2.467792272567749, -2.6871402263641357, -2.711719274520874, -2.417929172515869, -2.7986629009246826, -2.6713593006134033], "all_perturbed_original_ll": [-3.209594249725342, -3.597545623779297, -3.2534077167510986, -2.9547953605651855, -3.232456922531128, -3.283487558364868, -3.4622316360473633, -2.6612133979797363, -3.152118682861328, -3.3270492553710938], "perturbed_sampled_ll": -2.5801466703414917, "perturbed_original_ll": -3.213390040397644, "perturbed_sampled_ll_std": 0.1249502950263535, "perturbed_original_ll_std": 0.24593363570445204}, {"original": "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.", "sampled": "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Some postictal psychotic episodes are associated with increased levels of risk of suicide. This may be due to changes in levels of serotonin (5-HT), as well as changes in the", "perturbed_sampled": ["Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Interictal psychotic episodes are associated with increased levels of risk of infection; this may be due to changes in the synthesis of serotonin (5-HT), as well as changes in the", "Question: Long-term implications for postictal psychotic episodes II. Are they predictive of postictal psychotic episodes? Answer: Some postictal psychotic episodes are associated with increased levels of risk of suicide. This may be influenced by changes in levels of serotonin (5-HT), as well as changes in the", ". There is a recent study on the significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Some postictal psychotic episodes are associated with increased levels of somalia and the incidence of suicide. This may be due to changes in levels of serotonin (5-HT), as well as changes in the", "Question: Does the prevalence of interictal psychotic episodes of postictal psychotic episodes II. Is it also predictive of interictal psychotic episodes? Answer: Some postictal psychotic episodes are associated with increased mental health and increased risk of suicide. This may be due to changes in levels of serotonin (5-HT), as well as changes in the", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Some acute pre-ictal psychotic episodes are associated with increased levels of risk of suicide. This may be due to changes in levels of serotonin , as well as changes in the", "Question: Long-term significance of postictal psychotic episodes of class II. Are they predictive of interictal psychotic episodes? Answer: Some postictal psychotic episodes may be associated with increased levels of self suicide. This may be due to changes in levels of serotonin (5-HT), as well as changes in the", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Some postictal psychotic episodes are caused by increased levels of risk of suicide. This may be due to changes in the levels of serotonin (5-HT), or as changes in the", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Some postictal psychotic episodes are associated with increased levels of risk . This may be due to changes in levels of risk as well as more variability in the", "Question: Long-term significance of psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Some postictal psychotic episodes are associated with increased levels of risk of suicide. This may be due to changes in the prevalence of serotonin (5-HT), as well as changes in the", "Question: Long-term significance of interictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Some postictal psychotic episodes are characterized by increased levels of risk . This may be due to changes in levels of serotonin (5-HT), as well as changes in the"], "perturbed_original": ["Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes II? A history of PIPE may be the important factor for the development of IPE. Yet, a study of significance on multivariate analysis indicates that it is not an independent predictor.", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: The disappearance of interictal psychotic episodes II may be a risk factor for the development of IPE. Yet, the disappearance of interictal psychotic episodes II in multivariate analysis indicates that it is not an independent predictor.", "Question: Long-term significance of postictal psychotic episodes II. Are they correlated with interictal psychotic episodes? Answer: A risk factor for PIPE may be a risk factor for the development of IPE. Yet, the large variation in significance on multivariate analysis indicates that it is not an independent predictor.", "Question: Long-term significance of psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: The absence of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of IPE through multivariate analysis indicates that it is not an independent predictor.", "Question: Long-term predictive of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A prospective predictor of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it could be an independent predictor.", "Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes II? Answer: A history of IPE may be the key factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.", "Question: Long-term significance of postictal psychotic episodes II. Are they important to develop for interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis shows it is not a reliable predictor.", "Question: Long-term diagnosis of postictal psychotic episodes , were they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk of the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.", "Question: Long-term significance of postictal episodes was defined in the development of IPE in espionage. II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE is a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that IPE is not an independent predictor.", "Question: Long-term significance of postictal IPE, postictal II. Are they predictive of interictal II? Answer: A short-term significance of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor."], "original_ll": -3.4959616661071777, "sampled_ll": -2.6270575523376465, "all_perturbed_sampled_ll": [-2.779472827911377, -2.567500114440918, -2.9920992851257324, -2.79304575920105, -2.9866907596588135, -2.8649098873138428, -2.9482202529907227, -3.0729289054870605, -2.915724515914917, -2.909851551055908], "all_perturbed_original_ll": [-3.6831600666046143, -2.9218780994415283, -3.466031312942505, -3.4376401901245117, -3.735147476196289, -3.5278737545013428, -3.814040184020996, -3.9966914653778076, -3.566676616668701, -3.3748598098754883], "perturbed_sampled_ll": -2.883044385910034, "perturbed_original_ll": -3.5523998975753783, "perturbed_sampled_ll_std": 0.13544373333281706, "perturbed_original_ll_std": 0.2769220893930865}, {"original": "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.", "sampled": "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: There is no answer to this question. However, it seems likely that the number of bone markers of bone return (BMRs) may be slightly different than those recorded in", "perturbed_sampled": ["Question: Are Biochemical Markers of Bone Turnover Different from Bone Histomorphometry in 370 Postmenopausal Women? Answer: There is no answer to this question. However, it seems likely that the number of bone & bone return (BMRs) observations would be slightly different than those recorded in", "Question: Are the Body of Bone Turnover Representative of Bone Histomorphometry in 370 D Narrows? Answer: There is no answer to this question. However, it seems that the number of bone markers of bone return (BMRs) may be slightly different than those recorded in", "Question: Are Biochemical Markers of Differential Radiation Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: There is no answer to this question. However, it seems likely that the number of indicators of bone return may be slightly different than those recorded in", "Question: Are Biochemical Markers of Bone Turnover Representative of a Role in 370 Postmenopausal Women? Answer: There is a lot of talk to this question. However, it seems likely that the number of numbers of bone return (BMRs) may be slightly different than those recorded in", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry among the Most Effective Postmenopausal Women? Answer: There is no answer to this question. However, it seems likely that the number of bone markers of bone turnsover may be slightly different than those recorded in", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: There is no answer to this question; it seems that the biochemical indices of bone markers of bone return (BMRs) may be slightly different than those recorded in", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: There is no answer to this question. However, it seems that the number of bone markers of Bone Turnover (BMRs) may be slightly different than those recorded in", "Are Biochemical Markers of Bone Turnover to Bone Histomorphometry in 370 Postmenopausal Women? Answer: There is no answer to this question. However, it seems likely that the number of bone markers of bone return (BMRs) may be slightly different than those recorded in", "Question: Are Biochemical Markers of Bone Turnover in Bone Histomorphometry in Young Women? Answer: There is no answer to this question. However, it is true that the number of bone markers of bone return (BMRs) may be slightly different than those recorded in", "Question: Are the number of Bone Turnover Representative of Bone s 370 Postmenopausal Women? Answer: There is no answer to this question. However, it seems likely that the number of bone markers of bone return (BMRs) may be different than those recorded in"], "perturbed_original": ["Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? The bone turnover markers were significantly but not significantly consistent with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly defined bone turnover.", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover parameters are significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent any significant, but it is not representative of whole bone turnover.", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry & Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover and was measured in iliac crest bone. The iliac crest bone may not represent perfectly the whole bone turnover.", "Question: Are Bone Growth Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in the right crest bone. The iliac crest bone may be defined perfectly the whole bone turnover.", "Question: Are Biochemical s: Are Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover is significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may perform perfectly the whole bone turnover.", "Question: Are Biochemical Markers in Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover were more modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.", "Question: Are Biochemical Impact of the Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover parameters were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac cancellous bone may not represent perfectly the whole bone turnover.", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers is remarkably but modestly associated with bone turnover parameters measured by cancellous bone. The iliac crest bone may not represent perfectly insufficient markers of bone turnover.", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone turnover markers from 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in bone rotation bone. The iliac crest bone may not represent perfectly the structure for bone turnover.", "Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly more associated with bone turnover parameters measured in iliac cancellous bone. The iliac cancellous bone may not represent perfectly the whole bone turnover."], "original_ll": -4.224788665771484, "sampled_ll": -3.1788341999053955, "all_perturbed_sampled_ll": [-3.5150537490844727, -3.874772787094116, -3.441737174987793, -3.57127046585083, -3.4889936447143555, -3.588214159011841, -3.250393867492676, -3.344599485397339, -3.1241018772125244, -3.5003459453582764], "all_perturbed_original_ll": [-4.249000072479248, -3.8885481357574463, -3.9757378101348877, -4.601031303405762, -4.6639533042907715, -4.512153148651123, -3.94523024559021, -4.440896511077881, -4.314528942108154, -4.0254340171813965], "perturbed_sampled_ll": -3.4699483156204223, "perturbed_original_ll": -4.261651349067688, "perturbed_sampled_ll_std": 0.19385024979929866, "perturbed_original_ll_std": 0.27417789718782726}, {"original": "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.", "sampled": "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: No. The results are consistent with a significant decrease in the rates of hemorrhaging after the operation. The findings of the present study support a possible causal", "perturbed_sampled": ["Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery after spinal surgery? No. The results are consistent with a significant decrease in the rates of fluid fluid drainage after the spine surgery. The findings of the present study support a possible causal", "Question: Is lumbar drainage of postoperative the fistula after spine surgery effective? Answer: No. The results are used to show a significant decrease in the rates of hemorrhaging after the spine surgery. The findings of the present study support a possible causal", "Question: Is the inhibition of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: The results are significant. As seen here, there is a significant decrease in the rates of hemorrhaging after the operation. The findings of the present study support a possible causal", "Question: Is lumbar drainage of postoperative cerebrospinal fluid before spine surgery effective? Answer: No. The results are consistent with a significant decrease in the rates of spine surgery after the operation. The results of the present study support a possible causal", "Question: Is drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: No. The results are obtained from a significant decrease in the rates of hemorrhaging after spine surgery. The findings of the present study support a possible causal", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: No. The results are consistent with a result from an increase in the rates of pain during the implantation after the operation. The results of the present study support a possible causal", "and lumbar drainage of postoperative cerebrospinal fluid fistula after spine aches. Answer: No. The results are consistent with a significant decrease in the rates of hemorrhaging after the operation. The findings of the present report provide a possible causal", "Question: Is lumbar drainage of the cerebrospinal fluid fistula after spine surgery effective? Answer: No. The results are consistent with a significant decrease in the frequency of hemorrhaging after the operation. The findings of the present study support a possible causal", "Question: Is a recurrence reduction of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: No. The results are that there is a significant decrease in the rates of hemorrhaging after spine surgery. The findings of the present study support a possible causal", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: No. The results are consistent with a significant decrease in the risk of hemorrhaging following spine operation. The findings of the present study support a possible causal"], "perturbed_original": ["Question: Is lumbar drainage of CSF fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and causing large CSF leaks.", "Question: Is lumbar drainage effective for preventing postoperative cerebrospinal fluid fistula after spine surgery ? Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems very effective and safe both in preventing CSF fistula in cases of inflammation and for syringes, tears and debilitated/irradiated fluids as well as in treating CSF leaks.", "Question: Is lumbar drainage safer on postoperative cerebrospinal fluid fistula after spine surgery ? Lumbar drainage seems to be effective and safe both in preventing CSF fistula , the formation of large dural tears and debilitated/irradiated patients and in treating CSF leaks.", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine discharge? Answer: Lumbar drainage seems to be effective in both a posterior operation of CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.", "Question: Is lumbar drainage after postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe for preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and patients with CSF leaks.", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems very effective and safe both in preventing CSF leaks in cases of back tears and debilitated/irradiated patients and in treating CSF leaks.", "Question: Is drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? <unk> The drainage seems to be effective and safe both in treating CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.", "Question: Is lumbar drainage of postoperative cerebrospinal patients after spine surgery? Answer: Lumbar drainage seems to be effective and effective in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.", "Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage has been shown to be effective and safe in preventing CSF fistula in patients with large dural tears and debilitated/irradiated patients and in treating CSF leaks."], "original_ll": -3.729109048843384, "sampled_ll": -3.250746726989746, "all_perturbed_sampled_ll": [-3.483905076980591, -3.688929319381714, -3.2538063526153564, -3.133963108062744, -3.4993114471435547, -3.488769292831421, -3.556819438934326, -3.0916736125946045, -3.208405017852783, -3.286695718765259], "all_perturbed_original_ll": [-3.941208600997925, -3.6721813678741455, -3.841179847717285, -4.036182880401611, -4.2081804275512695, -3.8370351791381836, -3.8625128269195557, -4.381191730499268, -3.9594972133636475, -3.4836513996124268], "perturbed_sampled_ll": -3.3692278385162355, "perturbed_original_ll": -3.9222821474075316, "perturbed_sampled_ll_std": 0.18977510651735152, "perturbed_original_ll_std": 0.24071076293324536}, {"original": "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "sampled": "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: One primary problem with MPH programs that has plagued the field has been lack of quality. To put it simply, a high-income community in a country that is struggling with health care inequality is unlikely to have access to comprehensive health care and quality care for the long-term, especially on a long-term basis.\n\nHow is MPH better than", "perturbed_sampled": ["Question: Impact of MPH programs: contributing to system strengthening in low- and middle-income countries? Answer: One primary problem with MPH programs that has been in this field has been lack of quality. To put it simply, a high-income community in a country otherwise struggling with health care inequality is unlikely to have access to quality health care and quality care for the long-term, especially on a long-term basis.\n\nHow is MPH better than", "Question: Impact of MPH on contributing to health system strengthening and integration in low and middle-income countries? Answer: One primary problem with MPH programs that has plagued the field is the lack of quality. To put it simply, a poorer country in a country that is struggling with health care inequality is unlikely to have access to comprehensive health care and quality care for the long-term, especially on a low level. Question: How much is MPH better than", "Question: Are you struggling with MPH programs: contributing to health system problems for low- and middle-income countries? Answer: One primary problem with MPH programs that has plagued the field has been lack of quality. To put it simply, a high-income community in a country that is struggling with health care inequality needs to have access to comprehensive health care and quality care over the long-term, especially on a long-term basis. How can we make MPH better than", "Question: Impact of MPH programs: contributing to poverty reduction and system strengthening in low- and middle-income countries? Answer: One primary problem with MPH programs that has plagued the field has been the quality. To put it simply, a high-income community in a country that is struggling with gender inequality is lucky enough to have access to comprehensive health care and quality care for their clients, especially on a long-term basis.\n\nHow is MPH better than", "Question: Impact of MPH programs: contributing to health care in low- and middle-income countries? Answer: One primary problem with MPH programs that has plagued the field has been lack of quality. To put it simply, a high-income community in a country that is struggling with health care inequality is unlikely to have access to comprehensive health care quality care for the poor on a long-term basis.\n\nHow is MPH better than", "Question: Impact of MPH programs: contributing to health system to low- income countries? Answer: One primary problem with MPH programs that has arisen in this field has been lack of quality. To put it simply, a high-income community in a country that is struggling with health care inequality is unlikely to have access to comprehensive health care and quality care for the long-term, especially on a long-term basis.\n\nHow is MPH better than", "Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? The primary concern for MPH programs that has plagued the field has been lack of quality. To put it simply, a high-income community in the country that is struggling with health care inequality is fortunate to have access to comprehensive health care and quality care for the long-term, and on a long-term basis.\n\nHow is MPH better than", "future of MPH programs: contributing to health care inequality in low- and middle-income countries? Answer: One primary problem with MPH that has plagued the field has been lack of quality. To put it simply, a high-income community in a country with high-income families struggling with health care inequality is unlikely to have access to comprehensive health care and quality care for the long-term, especially on a multidisciplinary basis.\n\nHow is MPH better than", "Question: Impact of MPH programs: contributing to health system strengthening in middle- and middle-income countries? Answer: One primary problem with MPH programs that are lacking in the field has been lack of quality. To put it simply, a high-income community in a country that is struggling with health care inequality is unlikely to have access to comprehensive health care and quality care for the long-term, especially on a long-term basis.\n\nHow is MPH better than", "Question: Impact of MPH programs: contributing to health system strengthening in low- income countries? Answer: One primary problem with MPH programs that has plagued the field is lack of quality. To put it simply, a high-income community in a country that is struggling to manage health care inequality is unlikely to have access to comprehensive health services and quality care for the long-term, especially on a long-term basis.\n\nHow far is this better than"], "perturbed_original": ["Question: Globalization of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were expected to be able to contribute significantly to their education. Public health education often had influence on the national level. Much of the impact was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of MPH programs: contributing to the global education system in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often work at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of MPH programs: contributing to system strengthening in low- and middle-income countries? Employment reforms and education reform in countries that were low-income was considerable impact at many levels; graduates were perceived to be the most difficult choice and important to adapt to their workplaces and often had influence at the national level. Furthermore, the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of MPH programs: is the public health system strengthening in low and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had a significant impact on the national health system. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of how graduates were perceived to contribute to their employment as well as their career pathways.", "Question: Impact of MPH graduates to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had significant impact at the national level. But the impact described was in turn, rather than about public health educational aims. The result of this study revealed more in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of public health educational programs: contributing to health system strengthening in low- and middle-income countries? There was considerable impact at many levels; graduates were perceived to have to contribute significantly to health system building in their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates\u2019 role as well as their career pathways.", "Question: Can MEBAs contribute to MPH programs: contributing to health system health in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative results revealed more in-depth understanding of graduates as well as their career pathways.", "Question: How were MPH programs: contributing to health education and public health education programs in low- and middle-income countries? Answer: There was considerable impact at many countries in which graduate graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The initial study provided an in-depth understanding of graduates' impact as well as their career pathways.", "Question: Impact of MPH and MPH to health system strengthening in low- and middle-income countries? Answer: There was an increase in impact at many levels; graduates were perceived to be able to contribute significantly to workplaces and often had influence at the national level. Much of the impact was in line with public health educational aims. The qualitative method study revealed the role of MPH in the understanding of graduates' impact as well as their career pathways.", "Question: How to strengthen MPH programs: contributing to health system strengthening in low- and middle-income countries? The health system was considerable impact at many levels; graduates were expected to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in the public health educational aims. This method study revealed more in-depth understanding of graduates' impact as well as their career pathways."], "original_ll": -3.994440793991089, "sampled_ll": -2.9140422344207764, "all_perturbed_sampled_ll": [-3.047436475753784, -3.2716903686523438, -3.0153722763061523, -3.1952579021453857, -2.8818299770355225, -3.0963668823242188, -3.2017226219177246, -2.9360480308532715, -3.082406759262085, -3.22308611869812], "all_perturbed_original_ll": [-3.8788089752197266, -3.8681399822235107, -4.358773708343506, -3.6663355827331543, -3.9430840015411377, -4.230024337768555, -4.123640537261963, -3.7510390281677246, -3.929359197616577, -4.167604923248291], "perturbed_sampled_ll": -3.095121741294861, "perturbed_original_ll": -3.9916810274124144, "perturbed_sampled_ll_std": 0.12187586529951798, "perturbed_original_ll_std": 0.20926860751907395}, {"original": "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.", "sampled": "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: In the clinical trials of the Nd-YAG laser-induced thermo therapy for rats, rats with paclitaxel-induced thermo therapy developed a neurodegenerative disease characterized by", "perturbed_sampled": ["the opening of a blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: In the clinical trials of the Nd-YAG laser-induced thermo therapy for paclitaxel: Patients with paclitaxel-induced thermo therapy developed a neurodegenerative disease characterized by", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy for rats, a new concept of adjuvant therapeutics is required. Answer: In the clinical trials of the Nd-YAG laser-induced thermo therapy for rats, rats with paclitaxel-induced thermo therapy have neurodegenerative disease characterized by", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: In recent trials of the Nd-YAG laser-induced thermo therapy for paclitaxel patients with paclitaxel-induced thermo therapy developed a neurodegenerative disease characterized by", "Question: Locoregional opening of rodent rodents for the Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: In the clinical trials of the Nd-YAG laser-induced thermo therapy for rats, rats with paclitaxel-induced thermo therapy developed a neurodegenerative disease characterized by", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a therapeutic method of adjuvant glioma therapy? Answer: In the clinical trials of Nd:YAG laser-induced thermo therapy for rats, rats with paclitaxel-induced thermo therapy developed a neurodegenerative disease characterized by", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: In the clinical trials of Nd:YAG laser-induced thermo therapy for rats, rats with paclitaxel-induced thermo therapy treat a neurodegenerative disease characterized by", "Question: Is the possibility of the therapeutic barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of paclitaxel-induced thermo therapy? Answer: In the clinical trials of the Nd-YAG laser-induced thermo therapy for rats, rats with paclitaxel-induced thermo therapy developed a neurodegenerative disease characterized by", "Question: Locoregional opening of the rodent blood-brain barrier , which was revealed using Nd:YAG laser-induced thermo therapy, can rats support the new concept of adjuvant glioma therapy? Answer: In the clinical trials of the Nd-YAG laser-induced thermo therapy for rats, rats with paclitaxel-induced thermo therapy developed a neurodegenerative system triggered by", "Question: Locoregional opening of a blood-brain barrier with therapeutic control using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: In three clinical trials of the Nd-YAG laser-induced thermo therapy for rats, rats with paclitaxel-induced thermo therapy developed a neurodegenerative disease characterized by", "Question: Locoregional opening of the natural barrier and the isolation barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma . In the clinical trials of the Nd-YAG laser-induced thermo therapy for rats, rats with paclitaxel-induced thermo therapy develop neurodegenerative disease characterized by"], "perturbed_original": ["Question: The treatment of the rodent blood-brain barrier for paclitaxel -induced laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of breast tumors.", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept for glioma therapy? Answer: LITT induces a locoregional passage of mouse mouse cells into the brain tissue. This is of potential interest for the prevention and rehabilitation of the pathogenesis of rats\u2019 brain tumors.", ": opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG i therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into brain tissue. This is of potential interest for the treatment of brain tumors.", "Question: Locoregional passage of chemotherapeutic agents into the rodent brain (BLA) for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept for glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.", "Question: Locoregional opening of the blood-brain barrier for paclitaxel stimulation with laser-induced thermo therapy? What is the new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.", "Question: Locoregional opening of the rodent cells for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT LE: X: YAG laser-induced thermotherapy provides locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the identification of brain tumors.", "Question: Does the use of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a combination of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of rodent blood-brain tumors.", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic light in the brain tissue. This study is of potential interest for the treatment of brain tumors.", "Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced glioma therapy? Could you have a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of agents into the brain tissue. This is of potential interest for the removal of brain tumors.", "Question: Locoregional opening of the rodent glioma therapy: a new concept for paclitaxel using Nd:YAG -induced glioma therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the development of brain tumors."], "original_ll": -4.175081253051758, "sampled_ll": -3.2207107543945312, "all_perturbed_sampled_ll": [-3.0649473667144775, -3.375671625137329, -3.336179494857788, -3.5199296474456787, -3.1961002349853516, -3.3050456047058105, -2.861489772796631, -3.8680002689361572, -3.4847888946533203, -3.7706995010375977], "all_perturbed_original_ll": [-4.107309341430664, -4.519937992095947, -4.377577304840088, -3.8778223991394043, -3.907376289367676, -4.28353214263916, -4.253582954406738, -4.273980617523193, -4.2182512283325195, -3.98874568939209], "perturbed_sampled_ll": -3.3782852411270143, "perturbed_original_ll": -4.180811595916748, "perturbed_sampled_ll_std": 0.28823761919476504, "perturbed_original_ll_std": 0.1971075962226207}, {"original": "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings suggest potential differences in attentional processing between chronic and episodic headache subforms.", "sampled": "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Yes. If you experience some difficulty concentrating on your job, you will notice that headache-related visual stimuli are very distracting, and might be a better option.\n\nDoes migraine work for you, too? Yes, migraine can be a very challenging pain for your system, and is sometimes accompanied by some other physical or", "perturbed_sampled": ["Question: Do episodic headaches help you attend to headache-related visual stimuli? Answer: If you experience some difficulty concentrating on your job, you will notice that headache-related visual stimuli can become painful, distracting, and might be a better option.\n\nDoes migraine work for you, too? Yes, migraine can be a very challenging pain for your system, and is sometimes accompanied by some other physical or", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Yes. If you experience some difficulty concentrating on your job, then you'll notice that headache-related visual stimuli are very distracting, and might be a better option.\n\nDoes migraine help you, too? Yes, migraine can be a very distracting experience for your system, and is sometimes accompanied by some other physical or", "Question: Do episodic migraineurs selectively attend headache-related visual stimuli? Answer: Yes. If you experience some difficulty concentrating on your job, you might also notice that headache-related visual stimuli are very distracting, and might be a better option.\n\nDoes migraine work for you, too? Yes, migraine is a very challenging pain for your system, and is sometimes accompanied by some other physical or", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Yes. If you experience some difficulty concentrating on your job, you will know that these headache-related visual stimuli are very distracting, and might be a result of migraine surgery. Does episodic migraine work for you, too? Yes, migraine can be a real pain for your system, and is sometimes accompanied by some other physical or", "Question: Do episodic work attend to headache-related visual stimuli? Yes. If you experience some difficulty concentrating on your job, you will notice that headache-related visual stimuli are very distracting, and they may be a better option.\n\nDoes migraine distract you, too? Yes, migraine can be a very challenging pain for your system, and is sometimes accompanied by some other physical or", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Yes. If you experience some difficulty concentrating on your job, you will notice that headache-related visual stimuli are not optimum, and might be a better option.\n\nDoes migraine work for you, in fact? Headaches and migraine can be a very challenging pain for your system, and can be accompanied by some other physical or", "Question: Do episodic migraineurs selectively attend to visual stimuli? Answer: Yes. If you have some difficulty concentrating on your job, you will notice that visual stimuli are very distracting, and might be a better option.\n\nDoes migraine work for you, too? Yes, migraine can be a very challenging pain for your system, and could be accompanied by some other physical or", "Question: Do you selectively attend to headache-related visual stimuli? Answer: Yes. If you experience some difficulty concentrating on your job, you will notice that headache-related visual stimuli are very distracting, and might be a better option.\n\nDoes migraine distract you, too? Yes, migraine can be a very distracting experience for your system, and is sometimes accompanied by some other physical or", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Yes. If you have some difficulty concentrating on your job, you will notice that migraine visual stimuli are very distracting, and might be a better option.\n\nDoes migraine work for you, too? Answer: migraine can be a very challenging pain for your system, and is sometimes accompanied by other physical or", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Yes. If you experience some migraine on your job, you will notice that headache-related visual stimuli are very distracting, and might be a better option.\n\nDoes migraine work for migraine? Yes, migraine can be a very challenging pain for your system, and is sometimes accompanied by some other physical or"], "perturbed_original": ["Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size of prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest data and modest attentional biases among experimental samples, these findings suggest potential differences in attentional processing between chronic and episodic headache subforms.", "Question: Do episodic migraineurs attend to headache-related visual stimuli? Answer: In light of a large sample size and prior pilot testing of presented images, results have been presented that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic migraineurs in samples, these findings suggest potential differences in attentional processing between chronic and episodic headache subforms.", "Question: Do episodic migraineurs differentially attend to headache-related visual stimuli? Answer: In light of large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic migraine patients, these findings suggest potential differences in attentional processing between chronic migraines and episodic headache subforms.", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size of pilot testing for visual stimuli images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of subtle and persistent biases among chronic headache samples, these findings suggest potential differences in sensitivity between chronic and episodic headache subforms.", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented study, these findings suggest episodic migraineurs do not differentially attend to headache-related facial stimuli. Given the presence of attentional biases among chronic headache samples, these findings suggest potential differences in attentional processing between chronic and episodic headache subforms.", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of a sample size of pilot testing of presented images, results indicated that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings suggest potential for attentional processing between chronic and episodic headache subforms.", "Question: Do episodic migraineurs diverge in attention to headache-related visual stimuli? Answer: In light of chronic headache sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings suggest potential differences in attentional processing between chronic and persistent headache subforms.", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size of prior pilot testing of presented images, results suggest that episodic migraineurs selectively differentially attend to headache-related visual stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings suggest potential differences in attentional biases between chronic and episodic headache subforms.", "Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? In light of the large sample size and prior pilot testing of all chronic headache images, results suggest that episodic migraineurs do not differentially approach headache-related visual stimuli. Given modest evidence of attentional biases among chronic headache samples, these findings suggest potential differences in attentional processing between chronic and episodic headache subforms.", "Question: Do episodic migraineurs relate to headache-related visual stimuli? Answer: In light of the large sample size of prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given the large diversity of attentional biases among chronic headache samples, these findings suggest potential differences in attentional processing between chronic and episodic headache subforms."], "original_ll": -3.521576404571533, "sampled_ll": -2.9697115421295166, "all_perturbed_sampled_ll": [-3.024404764175415, -2.98911714553833, -3.090226650238037, -3.068856954574585, -3.183281421661377, -3.1927597522735596, -3.0412871837615967, -2.9498484134674072, -3.145775079727173, -3.165587902069092], "all_perturbed_original_ll": [-3.7223315238952637, -3.6436474323272705, -3.342711925506592, -3.78141450881958, -3.4828386306762695, -3.878257989883423, -3.7948012351989746, -3.494513988494873, -3.4836297035217285, -3.6180548667907715], "perturbed_sampled_ll": -3.085114526748657, "perturbed_original_ll": -3.6242201805114744, "perturbed_sampled_ll_std": 0.08049178404300802, "perturbed_original_ll_std": 0.162545207651701}, {"original": "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower margin of L3 can best reflect interval changes in VAT volume and body weight, VAT area measurement should be selected at this location.", "sampled": "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: No, it cannot. To the extent that your skin can become visceral adipose tissue, it is more than likely that it would not be able to be divided into your visceral adipose tissue if you were to remove it from your body. Furthermore, this type of measuring is unlikely to be very accurate in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "perturbed_sampled": ["Question: Visceral adipose tissue area measurement at a single time, is it possible to quantify the adipose tissue volume? Answer: No, it cannot. To the extent that your skin can become visceral adipose tissue, it is more than likely that it would not be able to be divided into your visceral adipose tissue volume if you were to remove it from your body. Furthermore, this type of measurement is unlikely to be very accurate in quantifying the amount of visceral adipose tissue you have. Therefore, it", "Question: Can it represent a single visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: No, it cannot. To the extent that your tissue has become visceral adipose tissue, if you measure it by more than one side of the body, it would not be able to be divided into your visceral adipose tissue if you were to remove it from your body. Furthermore, this type of measuring is unlikely to be very accurate in quantifying the volume of visceral adipose tissue you actually have. Therefore, it", "Question: Visceral adipose tissue area measurement at a time, can it represent visceral adipose tissue volume? Answer: No, it cannot. To the extent that your skin can become visceral adipose , it is more important that it would be able to be divided into your visceral adipose tissue area measurement if you were to remove it from your body. Furthermore, this type of measuring is not intended to be very accurate in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "Question: Visceral adipose tissue area measurement at high level: can it represent visceral adipose tissue volume? Answer: No, it cannot. To determine that your skin can become visceral adipose tissue, it is more than likely that it would not be able to be divided into your visceral adipose tissue volume if you were to remove it from your body. Furthermore, this particular measuring is unlikely to be very helpful in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "Question: Visceral adipose tissue area measurement at a single level: can it be used to measure adipose tissue volume? Answer: No, it cannot. To find that your skin can become visceral , it is more than likely that it would not be able to be affected by your visceral adipose tissue if you were to remove it from your skin. However, this type of measuring is unlikely to be very accurate in determining the amount of visceral adipose tissue you actually have. Therefore, it", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue area measurement? No, it cannot. To the extent that your skin can become visceral adipose tissue, it is more than likely that it will not be able to be converted into your visceral adipose tissue if you plan to remove it from your body. Furthermore, this type of measuring is unlikely to be effective in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "A visceral adipose tissue area measurement at a single level: does this represent visceral adipose tissue volume? I can't do it cannot. To the extent that your skin can become visceral adipose tissue, it is more than likely that it will not be able to be incorporated into your visceral adipose tissue if you were to remove it from your body. Furthermore, this type of measuring is unlikely to be very accurate in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "Question: Visceral adipose tissue volume is at a fractional level: can it represent visceral adipose tissue volume? Answer: No, it cannot. To the extent that your skin can become an important tissue, it is more than likely that it would not be able to be divided into your visceral adipose tissue if you had to remove it from your body. Furthermore, this type of measuring is unlikely to be very accurate in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "Question: Visceral adipose tissue area measurement at a single level: can it represent a certain area of the tissue volume? Answer: You cannot. To the extent that your skin can become visceral adipose tissue, it is more likely that it would not need to be divided into your visceral adipose tissue if you were to remove it from your body. Furthermore, this type of measuring is unlikely to be very accurate in quantifying the amount of visceral adipose tissue you actually have. Therefore, it", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: No, please? To ensure that your skin can become visceral adipose tissue, it is more than likely that it would not be going to be divided into visceral adipose tissue if you were to remove it from your body. Furthermore, this type of measuring is found to be very accurate with the amount of visceral adipose tissue you actually have. Therefore, it"], "perturbed_original": ["volume from visceral adipose tissue volume at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level and about 3 cm above the lower margin of the L3 vertebra is feasible to reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower margin of the L3 vertebra is feasible to best reflect interval changes in VAT volume and body weight, a CT slice as VAT area measurement should be selected at this location.", "Question: Visceral adipose tissue area measurement at a single level: can it represent changes in VAT volume and body weight and then reflect tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area measurements at a CT slice 3cm above the lower margin of L3 can best reflect interval changes in VAT volume and body weight, VAT area measurements should be selected by location.", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible to best reflect changes in VAT volume and body weight. Answer in knowledge: As VAT area measuring of CT CT slice 3cm above the lower margin of L3 can best reflect interval changes in VAT volume and body weight, VAT area measurement should be at this location.", "Question: Visceral adipose tissue volume measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and may represent significant changes in VAT volume and body weight. Advances ? Answer: As VAT area at a CT slice 3cm above the lower margin of the L3 can best reflect the changes in VAT volume and body weight, VAT area measurement should be selected at this location.", "tissue area adipose tissue area measurement at a single level: can it represent visceral adipose tissue area measurement? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra e and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area measurement at a CT slice 3cm above the lower margin of L3 vertebrae can reflect interval changes in VAT volume and body weight, VAT area measurement should be selected at this location.", "for a adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above a lower margin of the L3 vertebra is feasible and can best reflect the difference in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above the lower margin of L3 can best reflect the difference in VAT volume and body weight, then VAT area measurement should be selected at this location.", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue area measurement at the VAT area is feasible and can reflect changes in VAT volume and body weight? As VAT area at a CT slice 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Other knowledge: As VAT area at a CT slice 3cm above the lower margin of the L3 vertebra can best reflect interval changes in VAT volume and body weight, VAT area measurement should be selected at this location.", "Question: Visceral tax area measurement at a single level: can it reflect the adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is ideal. It can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area measurement is preferred, a CT slice 3cm above the lower margin of L3 can best reflect interval changes in the mass volume and body weight, VAT area measurement should be selected at this location.", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the vertebra is feasible and can best reflect interval changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice r is in fact the lower margin and can best reflect interval changes in VAT volume and body weight, VAT area measurement should be selected at this location.", "Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a CT level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect interval changes in VAT volume and body weight. Advances in time are required. Advances in VAT area measurement at a CT slice 3cm above the lower margin of the L3 vertebra can best reflect interval changes in VAT volume and body weight, or measurement should be selected at this location."], "original_ll": -3.576467990875244, "sampled_ll": -2.426393985748291, "all_perturbed_sampled_ll": [-2.378878116607666, -2.660656452178955, -2.738784074783325, -2.674417495727539, -2.668733596801758, -2.5499565601348877, -2.7837870121002197, -2.510610580444336, -2.7608728408813477, -2.8938629627227783], "all_perturbed_original_ll": [-3.6189897060394287, -3.5676701068878174, -3.6251282691955566, -3.3804426193237305, -3.64731502532959, -3.6559765338897705, -3.2402117252349854, -3.8801779747009277, -3.6726348400115967, -3.3107991218566895], "perturbed_sampled_ll": -2.6620559692382812, "perturbed_original_ll": -3.5599345922470094, "perturbed_sampled_ll_std": 0.14145527263068586, "perturbed_original_ll_std": 0.18341828897323398}, {"original": "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.", "sampled": "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: The Australian Aborigine Census shows a very significant increase in birthweight between 1973 and 1978, as well as a significant increase in birthweight for Australian aboriginal males between 1970", "perturbed_sampled": ["Question: Does gestational age affect the difference in birthweights for Australian aborigines and whites? Answer: The Australian Aborigine Census shows a significant increase in birthweight between 1973 and 1970 as well as a significant increase in birthweight for Australian aboriginal males between 1970", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? The Australian Aborigine Census shows a very significant increase in birthweight between 1973 and 1961 as well as a significant increase in birthweight for Australian aboriginal males between 1970", "Question: Does gestational age mean the difference in birthweights for Australian aborigines and whites? Answer: The Australian Aborigine Census found a very significant increase in birthweight between 1973 and 1978, as well as a significant increase in birthweight for aboriginal males between 1970", "Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: The Australian birthweight survey shows a very significant increase in birthweight between 1973 and 1978, as well as a significant increase in birthweight for Australian aborigines and whites between 1970", "Question: Does gestational age misclassification indicate an abnormal difference in birthweights for Australian aborigines and whites? Answer: The Australian census shows a very significant increase in birthweight between 1973 and 1978, as well as a significant increase in birthweight for both males between 1970", "and gestational characteristics? How can we explain the difference in birthweights for Australian aborigines and whites? Answer: The Australian Aborigine Census shows a very significant increase in birthweight between 1973 and 1978, as well as a very significant increase in birthweight for Australian aboriginal males between 1970", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: The Australian Aborigine Census shows a very significant increase in birthweight between 1973 and 1978, as well as a significant increase in birthweight for Australian aboriginal males between 1970", "Question: Can an age misclassification explain the difference in birthweights for Australian aborigines and whites? The 2016 Australian Aborigine Census data from the Australian Aborigine Census shows a very significant increase in birthweight between 1973 and 1973, as well as a significant increase in birthweight for Australian aboriginal males between 1970", "Question: Does gestational age have to do with the proportion of birthweights for Australian aborigines and whites? Answer: The Australian Aborigine Census shows a very significant increase in birthweight between 1973 and 1978, as well as a significant increase in birthweight for Australian aboriginal males between 1970", "Question: Could age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: The latest Census shows a very significant increase in birthweight between 1973 and 1969 as well as a significant increase in birthweight for Australian aboriginal males between 1970"], "perturbed_original": ["Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average size differences in Australia's birthweights. Aborigines and whites say a correlation of this results might help with the interpretation of other between-population comparisons.", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported differences in average birth-weights for Aborigines and whites. The results are associated with the interpretation of other between-population comparisons.", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in birth-weights for Aborigines and whites. The results may help with the interpretation of other between-population comparisons.", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported differences in the average birth-weights for Aborigines and whites. The results might help an interpretation of other between-population comparisons.", "Question: Does gestational age misclassification explain the apparent divergence in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birthweights for Australian Aborigines and whites. The results might help with the interpretation of this from comparisons or the comparisons.", "Question: Does gestational misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Female misclassification is an unlikely explanation for the reported divergence in average birth-weights for Australian aborigines and whites. The results might help with the interpretation of other between-population comparisons.", "Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and blacks? Gestational age misclassification is perhaps a useful explanation for the reported divergence in average birth-weights for Australians and whites. The results might help with the interpretation of other between-population comparisons.", "Question: Does gestational age misclassification explain the difference in average birth weights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The problem can help with the basis of other between-population comparisons.", "Question: Does the misclassification explain the difference in birthweights for Australian aborigines and whites? Moreover, age misclassification is an unlikely explanation for the reported divergence in average birthweights for Australian Aborigines and whites. The results might help with the interpretation of other between-population comparisons.", "Question: Does gestational age misclassification explain the divergence in average birthweights for Australian and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons."], "original_ll": -3.12014102935791, "sampled_ll": -2.7083327770233154, "all_perturbed_sampled_ll": [-2.578894853591919, -2.912435293197632, -2.6764562129974365, -2.737356185913086, -3.2063746452331543, -2.891115427017212, -2.7083327770233154, -2.866415500640869, -2.794245958328247, -3.192601442337036], "all_perturbed_original_ll": [-3.574615716934204, -3.007171630859375, -3.0333967208862305, -3.104840040206909, -3.247295379638672, -3.291421413421631, -3.531320333480835, -3.2361035346984863, -3.3742871284484863, -3.2929060459136963], "perturbed_sampled_ll": -2.8564228296279905, "perturbed_original_ll": -3.2693357944488524, "perturbed_sampled_ll_std": 0.19730849246441245, "perturbed_original_ll_std": 0.1808137591095316}, {"original": "Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.", "sampled": "Question: Is there a correlation between androgens and sexual desire in women? Answer: If your answer to the first question was yes, you're asking what the testosterone levels are in women at any given time. There are a range of hormones, including testosterone, that affect the penis. You can use the following to measure the level of", "perturbed_sampled": ["Question: Is there a correlation between androgens and sexual desire in women? Answer: If your answer to the first question was yes, you're asking what the testosterone levels are in women at any given time. There are a range of hormones, including testosterone, that can increase fertility levels in penis. You can use the following test and test the level of", "Question: Is there a correlation between male and sexual orientation in women? Answer: If your answer to the first question was yes, you're asking yourself how high the testosterone levels are in women at any given time. There are a wide range of hormones, including testosterone, that affect the penis. You can use the following to measure the level of", "Is there a correlation between physical and sexual desire in women? Answer: If your answer to the first question was yes, you're asking what the testosterone levels are in women at any given time? There are a range of hormones, including testosterone, that affect the testosterone levels and are linked to one's testosterone levels. You can use the following to measure the level of", "Question: Is there a correlation between gender satisfaction and sexual desire in women? Answer: If your answer to the first question was yes, you're asking what the testosterone levels are in women at any given time. There are a range of factors, including testosterone, that affect the penis. You can use the term uterus to measure the level of", "Question: Is there a correlation between androgens and sexual desire in women? Answer: If your answer is first , yes, you're asking what the testosterone levels in women were at a given time. There are a range of hormones, including testosterone, that affect the penis. You can use the following to measure the level of", "Question: Is there a correlation between androgens and sexual desire in women? Answer: If your answer to the first question was yes, you're asking what the testosterone levels are or how long you have been getting at any given time. There are a lot of hormones, including testosterone, that affect women's reproductive ability. You can use the following to measure the level of", "Question: Is there a correlation between androgens and sexual desire ? Answer: If your answer to the first question was yes, you're asking what the testosterone levels are actually at any point. There are a range of hormones, including hormones, that affect the penis. You can use the following to measure the level of", "Question: Is there a correlation between androgens and sexual desire in women? Answer: If the answer to the first question was yes, you're asking what the testosterone levels are in women at the same time. There are a vast range of factors, like testosterone, that affect the penis. You can use the following to measure the level of", "Question: Is there an association between androgens and sexual desire in women? Answer: If you answer to the first question , you're asking what the testosterone levels are in women at any given time. You can measure a range of hormones, including testosterone, that affect the penis. You can use the following to measure the level of", "Question: Is there a correlation between androgens and sexual desire in women? Answer: If your answer to that question is simple, you're asking what the testosterone levels are in women at any given time. There are a range of hormones, including testosterone, that affect the penis. You can use the following to determine the level of"], "perturbed_original": ["Question: Is there no correlation between androgens and sexual desire in women? Answer: In the YCT study, FT and androstenedione were statistically compatible with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.", "Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the cohort of women. ADT-G did not correlate more often the correlates of circulating androgens with sexual desire. ADT-G is therefore not useful for measuring circulating androgens by mass spectrometry.", "Question: Is there a correlation between sexual desire and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire , therefore not superior to the circulating androgens by mass spectrometry.", "Question: Is there a correlation between androgens and sexual desire in women? In the present study, FT and androstenedione were statistically significantly related to sexual desire in the total cohort of women. ADT-G did not influence sexual desire significantly as strongly than circulating androgens with sexual desire and is therefore not superior to circulating androgens by mass spectrometry.", "Question: Is there a correlation between androgens and sexual desire in women? Answer: In the inverse, FT and androstenedione were statistically significantly correlated with sexual desire in the study of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens over spectrometry.", "Question: Is there a correlation between androgens and sexual desire in FT in our cohort? In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is not superior to measuring circulating androgens by mass spectrometry.", "Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT Y were statistically linked with sexual desire in the total cohort of women. ADT-G did not correlate higher than circulating androgens with sexual desire and is therefore relevant to measuring circulating androgens by mass spectrometry.", "Are there a correlation between androgens with sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in a cohort of women. ADT-G and FT were found to correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.", "Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G et FT also correlate more of circulating androgens with sexual desire. This is therefore not superior to androstenedione circulating androgens by mass spectrometry.", "Question: Is there a correlation between FT and sexual desire in the cohort? Answer: In the present study, FT and androstenedione did not correlate more strongly than androstenedione-G and FT. It is not significantly correlated with sexual desire in the cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry."], "original_ll": -3.092439889907837, "sampled_ll": -2.3461618423461914, "all_perturbed_sampled_ll": [-2.730884552001953, -2.5127251148223877, -2.6578426361083984, -2.803262710571289, -2.7779452800750732, -2.5085513591766357, -2.7926011085510254, -2.6436104774475098, -2.651819944381714, -2.3981189727783203], "all_perturbed_original_ll": [-3.4141945838928223, -3.080458164215088, -3.3965089321136475, -3.345848798751831, -3.497159242630005, -3.271256685256958, -3.498917579650879, -3.2383244037628174, -3.5164034366607666, -3.1149444580078125], "perturbed_sampled_ll": -2.6477362155914306, "perturbed_original_ll": -3.3374016284942627, "perturbed_sampled_ll_std": 0.13003361179398318, "perturbed_original_ll_std": 0.1492689912934302}, {"original": "Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy", "sampled": "Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, but it's not recommended for all cases.\n\n", "perturbed_sampled": ["Question: Is there a way for fondaparinux in perioperative bridging? Answer: Yes, but it's not recommended for all cases.\n\n", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: I know it's not recommended for all cases.\n\n", "Question: Is there a solution for fondaparinux in perioperative bridging? Answer: Yes, but it's not recommended for all cases.\n\n", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, but it's not recommended for all cases.\n\n", "Question: Is there a role for fondaparinux in fondaparinux? Answer: Yes, but it's not recommended for all cases.\n\n", "Question: Is there a role for fondaparinux in perioperative s? Yes, but it's not recommended for all cases.\n\n", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, but it's not for all cases.\n\n", "Question: Is there a difference for fondaparinux in perioperative bridging? Answer: Yes, but it's not recommended for all cases.\n\n", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: Yes, this solution is not recommended for all cases.\n\n", "Question: Is there a role for fondaparinux in perioperative bridging? Question: Yes, but it's not recommended for all cases.\n\n"], "perturbed_original": ["Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role for fondaparinux in perioperative bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role for fondaparinux in perioperative bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridge therapy for bridge bridging? Answer: The role of fondaparinux in perioperative bridge therapy", "Question: Is the role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridge therapy? The role of fondaparinux in perioperative bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: Are there role of fondaparinux in perioperative bridge therapy", "Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridging therapy is discussed in the main bridge therapy"], "original_ll": -3.7739946842193604, "sampled_ll": -3.8494129180908203, "all_perturbed_sampled_ll": [-4.149325370788574, -4.199178218841553, -4.098363399505615, -3.8494129180908203, -3.739170789718628, -4.3916544914245605, -3.9619851112365723, -4.040652751922607, -4.089468955993652, -4.025964260101318], "all_perturbed_original_ll": [-3.7739946842193604, -3.8910698890686035, -3.8910698890686035, -3.5324511528015137, -4.1217827796936035, -3.9418272972106934, -3.4707586765289307, -3.7739946842193604, -4.024195671081543, -3.5067946910858154], "perturbed_sampled_ll": -4.05451762676239, "perturbed_original_ll": -3.792793941497803, "perturbed_sampled_ll_std": 0.17256936953846833, "perturbed_original_ll_std": 0.21384460616603937}, {"original": "Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.", "sampled": "Question: Do African American women require fewer calories to maintain weight? Answer: Yes, of course, and this is something that will have to be addressed on a national level, and if not, we will need to", "perturbed_sampled": ["Question: Do African American women require fewer calories to maintain weight? Answer: Yes, of course, and this is a problem that will have to be resolved on a national level, and if not, we will need to", "Question: Do African American women require fewer calories to maintain weight? The question is certainly one of course, and this is something that will have to be addressed on a national level, and if not, the need to", "Question: Do men and women require fewer calories to maintain weight? Answer: Yes, of course, and this is something that will have to happen on a national level, and if not, we will need to", "Question: Do African American American obesity requires fewer calories to maintain weight? Answer: Yes, of course, and is something that will have to be addressed on a national level, and if not, we will need to", "Question: Do African American women require fewer calories to maintain weight? Answer: Yes, Africa needs more calories and this issue requires another level of concern that will have to be addressed on a national level, and if not, we will need to", "Question: Do African s require fewer calories to maintain weight? Answer: Yes, of course, and this is something that will have to be addressed on a national level, and if the majority of our populations require weight, we will need to", "Question: Do African American women require fewer calories to maintain weight? Answer: Yes, of course, and this is something that will have to be addressed on the national level, and to think about it or not, we will need to", "Question: Do African American women require fewer calories to maintain weight? Answer: Yes, of course, and this is not just a case of racism. This will have to be addressed on a national level, and if not, it will need to", "Question: Do African American women require fewer calories to maintain weight? Yes, of course, and this is something that will have to change on a national level, and if not, we will need to", "Question: Do African American women require fewer calories to maintain weight? Answer: Yes, women may need much smaller calories to keep weight, and this is something that needs to be addressed on a national level, and if not, we will need to"], "perturbed_original": ["Question: Do African American women require fewer calories to maintain weight? Answer: These results do not necessarily reflect the view that AA women have a greater risk for obesity because they require fewer calories to maintain weight.", "Question: Do African American women require adequate weight to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require adequate weight to maintain weight.", "Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women at AA have a greater risk for obesity because they require fewer calories to maintain weight.", "Question: Do African American women require fewer calories to maintain weight? These results do not support the assertion that AA women are at greater risk for obesity because they require fewer calories to maintain weight.", "Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk of losing weight because they require fewer calories to maintain weight.", "Question: Do African American women require fewer calories to maintain weight? The above results do not support the view that AA women are at greater risk for developing obese women because they require fewer calories to maintain weight.", "Question: Do African American women require fewer calories to maintain weight? Answer: These results do not help. The view that AA women are at greater risk for obesity because African American women require fewer calories to maintain weight.", "Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they don\u2019t have much fewer calories to maintain weight.", "Why African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for overweight women, but they require fewer calories to maintain weight.", "Question: Do African American women require fewer calories to maintain weight? Answer: These results together support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight."], "original_ll": -2.708817720413208, "sampled_ll": -2.585548162460327, "all_perturbed_sampled_ll": [-2.654538631439209, -3.0322155952453613, -2.69053316116333, -3.0950169563293457, -3.1367404460906982, -3.207831859588623, -2.8586058616638184, -2.7313172817230225, -2.8212692737579346, -2.836448907852173], "all_perturbed_original_ll": [-3.04036808013916, -2.9690513610839844, -3.0953989028930664, -2.762965440750122, -2.755667209625244, -3.0602447986602783, -3.197932243347168, -3.3543624877929688, -3.220837354660034, -3.0475029945373535], "perturbed_sampled_ll": -2.9064517974853517, "perturbed_original_ll": -3.050433087348938, "perturbed_sampled_ll_std": 0.18719910664765296, "perturbed_original_ll_std": 0.1793160159422069}, {"original": "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.", "sampled": "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, prescription drugs are being marketed", "perturbed_sampled": ["Question: Is there \"crisis\" associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, prescription drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? No. Is crime linked with \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, prescription drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Is there a \"crisis\" in over-the-counter pharmacy syringe sales? There is no crisis. In the United States, prescription drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, syringe sales are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? There is no crime, however. In the United States, prescription drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Can it be a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is a financial crisis. In the United States, prescription drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy sales? Answer: No. Is there any interest in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, prescription drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there criminality in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, many drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, prescription drugs are being marketed", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: No. Is there a \"crisis\" in over-the-counter pharmacy syringe sales? Answer: There is no crisis. In the United States, commercial drugs are being marketed"], "perturbed_original": ["Question: Is crime associated with over-the-counter pharmacy sales? Question: Have no answer? Answer: Our findings demonstrate that OTC pharmacy syringe sales were decreased in 2006-2008. Compared with increases in reported crime in local communities in Los Angeles during 2006-2008.", "Question: Is crime associated with pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with crime in reported crime in local communities in Los Angeles during 2006-2008.", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported activity in local communities in Los Angeles from 2006-2008.", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that over-counter pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles, California in 2006-2008.", "Question: What are associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities around Los Angeles during 2006-2008.", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with high-resolution sales. However, only one-third of reported crime in local communities in Los Angeles during 2006-2008.", "Question: What was associated with over-the-counter pharmacy syringe sales? Answer: Our findings are consistent. OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Recent studies demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.", "Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings include, compared with OTC pharmacy syringe sales , is associated with increases in reported crime in local communities in Los Angeles during 2006-2008."], "original_ll": -3.2163238525390625, "sampled_ll": -2.229689598083496, "all_perturbed_sampled_ll": [-2.1352474689483643, -2.7497317790985107, -2.433913230895996, -2.3143768310546875, -2.4720327854156494, -2.6005148887634277, -2.716076612472534, -2.680943250656128, -2.229689598083496, -2.3681154251098633], "all_perturbed_original_ll": [-4.010372161865234, -3.7018961906433105, -3.3334460258483887, -3.2163238525390625, -3.0606377124786377, -3.4001173973083496, -3.4614028930664062, -3.394674777984619, -3.2727560997009277, -3.7774581909179688], "perturbed_sampled_ll": -2.4700641870498656, "perturbed_original_ll": -3.4629085302352904, "perturbed_sampled_ll_std": 0.2015064485764391, "perturbed_original_ll_std": 0.2720143669105524}, {"original": "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "sampled": "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: In this study, the present results indicate that plasma glucose level, in the first 6 h after the study of Kowalski et al., was not significantly different among patients with type 2 diabetes. Therefore, a better understanding of whether fasting plasma glucose levels in the first 6", "perturbed_sampled": ["Question: How to determine fasting plasma glucose levels at diagnosis of type 2 diabetes associated with type 2 diabetes Answer: In this study, the present results indicate that plasma glucose level, in the first 6 h after the study of Kowalski et al., was not significantly different among patients with type 2 diabetes. We are hoping to gain a better understanding of whether fasting plasma glucose levels in the first 6", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: In the study, the present results indicate that plasma glucose level, in the first 6 h after the study of Kowalski et al., was not significantly different from those with type 2 diabetes. Therefore, this is a better understanding of whether fasting plasma glucose levels in the first 6", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: In this study, the present results indicate that plasma glucose level, in the first 6 h after the study of Kowalski diabetic diabetes, was not significantly different among the diagnosed type 2. Therefore, a study of whether fasting plasma glucose levels in the first 6", "Question: Are lower fasting plasma glucose levels at diagnosis of type II diabetes associated with improved outcomes? Answer: In this study, the results of this study indicate that plasma glucose levels in the first 6 h after the study of Kowalski et al., was not significantly different among patients with type 2 diabetes. Therefore, a better understanding of whether fasting plasma glucose levels in the first 6", "Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: In this study, the present results indicate that plasma glucose level, in the first 6 h after the study of e.g. Hexar et al., was not significantly different among patients with type 2 diabetes. They offer a better understanding of whether fasting plasma glucose levels in the first 6", "Question: Is fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: In this study, the results indicate that the blood glucose level, in the first 6 h after the study of Kowalski et al., was not significantly different among patients with type 2 diabetes. Therefore, a better understanding of whether fasting plasma glucose levels in the first 6", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: In this paper, the present results indicate that fasting plasma glucose level, in the first 2 weeks after the study of Kowalski et al., was not significantly different among patients with type 2 diabetes. Therefore, a better understanding of the fasting plasma glucose levels in the first 6", "Question: Are lower fasting plasma glucose levels in patients of type 2 diabetes associated with improved outcomes? Answer: In this study, the present results indicate that the fasting plasma glucose level, in the first 6 h after the study of Kowalski et al., is significantly different among patients with type 2 diabetes. Therefore, a better understanding of whether fasting plasma glucose levels significantly differ between the first 6", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: In this study, the present results indicate that plasma glucose level, in the first 6 h after the study of Kowalski et al., was not significantly different among patients with type 2 diabetes. Therefore, a better understanding of all of these factors can be useful in assessing aging plasma glucose levels in the first 6", "how to lower fasting plasma glucose levels at diagnosis of type 2 diabetes with improved outcomes? Answer: In this study, the present results indicate that plasma glucose level, in the first 6 h after the study of Kowalski et al., is not significantly different among patients with type 2 diabetes. Therefore, a better understanding is found whether fasting plasma glucose levels in the first 6"], "perturbed_original": ["Question: Are cholesterol, plasma glucose and diagnosis of type 2 diabetes associated with improved outcomes? People presenting with type 2 diabetes with lower blood glucose in their diabetes who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with adverse clinical outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia symptoms, who might be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such disease were asymptomatic at diagnosis, active case detection programs would be necessary to identify them.", "Question: Are lower fasting plasma plasma treatment at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes for similar glycemic progression. Since most such people are asymptomatic at diagnosis, case detection programs would be required to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting type 2 diabetes with lower initial glycemia who may be delayed over the course of their treatment can have fewer adverse clinical outcomes despite similar glycemic progression. Since most such people don\u2019t participate at diagnosis, active case detection programs would be required to identify them.", "Question: Is fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had adverse clinical outcomes despite similar glycemic progression. Since most such people can be fasting glucose levels at diagnosis, active case detection programs would be appropriate to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with type 2 diabetes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease have adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case studies would be required to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most patients are asymptomatic at diagnosis, active identification programs are required to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse effects despite a gradual progression. Considering that such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with adverse clinical outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be presenting in the course of a clinical trial had fewer adverse outcomes and had fewer adverse clinical outcomes and glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.", "Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial level of glucose levels at diagnosis may be earlier in the course of the treatment period and have had fewer adverse clinical outcomes despite similar glycemic progression. If such people are asymptomatic at diagnosis, active case detection programs would be required to identify them."], "original_ll": -3.5304787158966064, "sampled_ll": -2.33132004737854, "all_perturbed_sampled_ll": [-2.417461395263672, -2.487685441970825, -2.9047601222991943, -2.343374252319336, -2.852832794189453, -2.346198797225952, -2.4297661781311035, -2.4189159870147705, -2.5859577655792236, -2.703137159347534], "all_perturbed_original_ll": [-3.7301688194274902, -3.6126112937927246, -3.846076011657715, -4.07608699798584, -3.746680974960327, -3.3924899101257324, -3.5815811157226562, -3.5417447090148926, -3.426018714904785, -3.493112087249756], "perturbed_sampled_ll": -2.5490089893341064, "perturbed_original_ll": -3.6446570634841917, "perturbed_sampled_ll_std": 0.19483697831610242, "perturbed_original_ll_std": 0.19858898754782578}], "metrics": {"roc_auc": 0.8019333333333334, "fpr": [0.0, 0.0, 0.0, 0.006666666666666667, 0.006666666666666667, 0.013333333333333334, 0.013333333333333334, 0.02, 0.02, 0.02666666666666667, 0.02666666666666667, 0.03333333333333333, 0.03333333333333333, 0.04, 0.04, 0.04666666666666667, 0.04666666666666667, 0.05333333333333334, 0.05333333333333334, 0.06, 0.06, 0.06666666666666667, 0.06666666666666667, 0.07333333333333333, 0.07333333333333333, 0.08, 0.08, 0.08666666666666667, 0.08666666666666667, 0.09333333333333334, 0.09333333333333334, 0.10666666666666667, 0.10666666666666667, 0.11333333333333333, 0.11333333333333333, 0.12, 0.12, 0.12666666666666668, 0.12666666666666668, 0.13333333333333333, 0.13333333333333333, 0.14666666666666667, 0.14666666666666667, 0.15333333333333332, 0.15333333333333332, 0.16666666666666666, 0.16666666666666666, 0.17333333333333334, 0.17333333333333334, 0.19333333333333333, 0.19333333333333333, 0.2, 0.2, 0.21333333333333335, 0.21333333333333335, 0.22666666666666666, 0.22666666666666666, 0.23333333333333334, 0.23333333333333334, 0.24666666666666667, 0.24666666666666667, 0.26666666666666666, 0.26666666666666666, 0.28, 0.28, 0.29333333333333333, 0.29333333333333333, 0.30666666666666664, 0.30666666666666664, 0.32, 0.32, 0.32666666666666666, 0.32666666666666666, 0.3466666666666667, 0.3466666666666667, 0.36, 0.36, 0.36666666666666664, 0.36666666666666664, 0.38, 0.38, 0.3933333333333333, 0.3933333333333333, 0.4, 0.4, 0.4266666666666667, 0.4266666666666667, 0.44666666666666666, 0.44666666666666666, 0.4533333333333333, 0.4533333333333333, 0.52, 0.52, 0.5333333333333333, 0.5333333333333333, 0.54, 0.54, 0.5733333333333334, 0.5733333333333334, 0.58, 0.58, 0.5866666666666667, 0.5866666666666667, 0.62, 0.62, 0.6533333333333333, 0.6533333333333333, 0.7266666666666667, 0.7266666666666667, 0.8066666666666666, 0.8066666666666666, 0.8466666666666667, 0.8533333333333334, 0.94, 0.94, 1.0, 1.0], "tpr": [0.0, 0.006666666666666667, 0.04, 0.04, 0.08, 0.08, 0.1, 0.1, 0.11333333333333333, 0.11333333333333333, 0.12666666666666668, 0.12666666666666668, 0.16, 0.16, 0.18666666666666668, 0.18666666666666668, 0.25333333333333335, 0.25333333333333335, 0.28, 0.28, 0.30666666666666664, 0.30666666666666664, 0.31333333333333335, 0.31333333333333335, 0.36, 0.36, 0.38, 0.38, 0.41333333333333333, 0.41333333333333333, 0.4266666666666667, 0.4266666666666667, 0.44666666666666666, 0.44666666666666666, 0.4666666666666667, 0.4666666666666667, 0.48, 0.48, 0.5333333333333333, 0.5333333333333333, 0.5466666666666666, 0.5466666666666666, 0.56, 0.56, 0.6, 0.6, 0.6133333333333333, 0.6133333333333333, 0.6333333333333333, 0.6333333333333333, 0.6466666666666666, 0.6466666666666666, 0.66, 0.66, 0.68, 0.68, 0.7, 0.7, 0.7066666666666667, 0.7066666666666667, 0.7133333333333334, 0.7133333333333334, 0.72, 0.72, 0.7466666666666667, 0.7466666666666667, 0.7533333333333333, 0.7533333333333333, 0.7666666666666667, 0.7666666666666667, 0.7866666666666666, 0.7866666666666666, 0.8, 0.8, 0.8066666666666666, 0.8066666666666666, 0.8133333333333334, 0.8133333333333334, 0.82, 0.82, 0.84, 0.84, 0.8466666666666667, 0.8466666666666667, 0.8666666666666667, 0.8666666666666667, 0.8733333333333333, 0.8733333333333333, 0.88, 0.88, 0.9, 0.9, 0.9133333333333333, 0.9133333333333333, 0.92, 0.92, 0.9266666666666666, 0.9266666666666666, 0.9333333333333333, 0.9333333333333333, 0.94, 0.94, 0.9466666666666667, 0.9466666666666667, 0.96, 0.96, 0.9666666666666667, 0.9666666666666667, 0.9733333333333334, 0.9733333333333334, 0.98, 0.98, 0.9866666666666667, 0.9866666666666667, 0.9933333333333333, 0.9933333333333333, 1.0]}, "pr_metrics": {"pr_auc": 0.775930803508969, "precision": [0.5, 0.4983277591973244, 0.5, 0.5016835016835017, 0.5033783783783784, 0.5050847457627119, 0.5068027210884354, 0.5085324232081911, 0.5102739726027398, 0.5120274914089347, 0.5137931034482759, 0.5121107266435986, 0.5138888888888888, 0.5156794425087108, 0.5174825174825175, 0.519298245614035, 0.5211267605633803, 0.5229681978798587, 0.524822695035461, 0.5266903914590747, 0.5285714285714286, 0.5304659498207885, 0.5323741007194245, 0.5342960288808665, 0.5362318840579711, 0.5364963503649635, 0.5384615384615384, 0.5404411764705882, 0.5424354243542435, 0.5444444444444444, 0.5464684014869888, 0.5485074626865671, 0.5468164794007491, 0.5488721804511278, 0.5509433962264151, 0.553030303030303, 0.5551330798479087, 0.5572519083969466, 0.5593869731800766, 0.5615384615384615, 0.5637065637065637, 0.5658914728682171, 0.5680933852140078, 0.5703125, 0.5725490196078431, 0.5708661417322834, 0.5731225296442688, 0.5753968253968254, 0.5776892430278885, 0.58, 0.5823293172690763, 0.5846774193548387, 0.5870445344129555, 0.5894308943089431, 0.5918367346938775, 0.5942622950819673, 0.5967078189300411, 0.5950413223140496, 0.5975103734439834, 0.6, 0.602510460251046, 0.6050420168067226, 0.6075949367088608, 0.6059322033898306, 0.6042553191489362, 0.6068376068376068, 0.6094420600858369, 0.6120689655172413, 0.6147186147186147, 0.6173913043478261, 0.6157205240174672, 0.618421052631579, 0.6167400881057269, 0.6194690265486725, 0.6177777777777778, 0.6205357142857143, 0.6233183856502242, 0.6261261261261262, 0.6289592760180995, 0.6318181818181818, 0.6301369863013698, 0.6330275229357798, 0.631336405529954, 0.6342592592592593, 0.6372093023255814, 0.6355140186915887, 0.6338028169014085, 0.6367924528301887, 0.6398104265402843, 0.6428571428571429, 0.645933014354067, 0.6490384615384616, 0.6521739130434783, 0.6553398058252428, 0.6585365853658537, 0.6617647058823529, 0.6650246305418719, 0.6633663366336634, 0.6616915422885572, 0.66, 0.6633165829145728, 0.6616161616161617, 0.6649746192893401, 0.6683673469387755, 0.6717948717948717, 0.6701030927835051, 0.6735751295336787, 0.6770833333333334, 0.680628272251309, 0.6842105263157895, 0.6825396825396826, 0.6808510638297872, 0.679144385026738, 0.6827956989247311, 0.6810810810810811, 0.6847826086956522, 0.6885245901639344, 0.6868131868131868, 0.6850828729281768, 0.6833333333333333, 0.6871508379888268, 0.6910112359550562, 0.6892655367231638, 0.6931818181818182, 0.6914285714285714, 0.6954022988505747, 0.6994219653179191, 0.6976744186046512, 0.7017543859649122, 0.7058823529411765, 0.7100591715976331, 0.7083333333333334, 0.7065868263473054, 0.7108433734939759, 0.7090909090909091, 0.7073170731707317, 0.7055214723926381, 0.7098765432098766, 0.7142857142857143, 0.7125, 0.710691823899371, 0.7151898734177216, 0.7197452229299363, 0.717948717948718, 0.7225806451612903, 0.7272727272727273, 0.7254901960784313, 0.7236842105263158, 0.7218543046357616, 0.72, 0.7248322147651006, 0.7297297297297297, 0.7278911564625851, 0.7328767123287672, 0.7379310344827587, 0.7430555555555556, 0.7412587412587412, 0.7464788732394366, 0.75177304964539, 0.75, 0.7553956834532374, 0.7536231884057971, 0.7518248175182481, 0.75, 0.7555555555555555, 0.7611940298507462, 0.7593984962406015, 0.7575757575757576, 0.7557251908396947, 0.7615384615384615, 0.7674418604651163, 0.765625, 0.7637795275590551, 0.7698412698412699, 0.768, 0.7661290322580645, 0.7723577235772358, 0.7786885245901639, 0.7851239669421488, 0.7833333333333333, 0.7815126050420168, 0.7796610169491526, 0.7863247863247863, 0.7844827586206896, 0.782608695652174, 0.7894736842105263, 0.7964601769911505, 0.7946428571428571, 0.7927927927927928, 0.7909090909090909, 0.7889908256880734, 0.7870370370370371, 0.7850467289719626, 0.7924528301886793, 0.7904761904761904, 0.7884615384615384, 0.7961165048543689, 0.803921568627451, 0.801980198019802, 0.8, 0.8080808080808081, 0.8061224489795918, 0.8041237113402062, 0.8020833333333334, 0.8, 0.7978723404255319, 0.7956989247311828, 0.7934782608695652, 0.7912087912087912, 0.8, 0.797752808988764, 0.7954545454545454, 0.8045977011494253, 0.8023255813953488, 0.8, 0.7976190476190477, 0.8072289156626506, 0.8048780487804879, 0.8024691358024691, 0.8, 0.810126582278481, 0.8205128205128205, 0.8181818181818182, 0.8157894736842105, 0.8266666666666667, 0.8243243243243243, 0.821917808219178, 0.8194444444444444, 0.8169014084507042, 0.8142857142857143, 0.8260869565217391, 0.8235294117647058, 0.8208955223880597, 0.8181818181818182, 0.8307692307692308, 0.828125, 0.8253968253968254, 0.8225806451612904, 0.819672131147541, 0.8166666666666667, 0.8135593220338984, 0.8103448275862069, 0.8245614035087719, 0.8214285714285714, 0.8363636363636363, 0.8333333333333334, 0.8301886792452831, 0.8269230769230769, 0.8235294117647058, 0.84, 0.8367346938775511, 0.8333333333333334, 0.8297872340425532, 0.8260869565217391, 0.8444444444444444, 0.8409090909090909, 0.8372093023255814, 0.8333333333333334, 0.8292682926829268, 0.825, 0.8205128205128205, 0.8157894736842105, 0.8108108108108109, 0.8055555555555556, 0.8, 0.8235294117647058, 0.8181818181818182, 0.8125, 0.8064516129032258, 0.8, 0.8275862068965517, 0.8214285714285714, 0.8148148148148148, 0.8076923076923077, 0.8, 0.7916666666666666, 0.8260869565217391, 0.8181818181818182, 0.8095238095238095, 0.85, 0.8421052631578947, 0.8333333333333334, 0.8823529411764706, 0.875, 0.8666666666666667, 0.8571428571428571, 0.9230769230769231, 0.9166666666666666, 0.9090909090909091, 0.9, 0.8888888888888888, 0.875, 0.8571428571428571, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0], "recall": [1.0, 0.9933333333333333, 0.9933333333333333, 0.9933333333333333, 0.9933333333333333, 0.9933333333333333, 0.9933333333333333, 0.9933333333333333, 0.9933333333333333, 0.9933333333333333, 0.9933333333333333, 0.9866666666666667, 0.9866666666666667, 0.9866666666666667, 0.9866666666666667, 0.9866666666666667, 0.9866666666666667, 0.9866666666666667, 0.9866666666666667, 0.9866666666666667, 0.9866666666666667, 0.9866666666666667, 0.9866666666666667, 0.9866666666666667, 0.9866666666666667, 0.98, 0.98, 0.98, 0.98, 0.98, 0.98, 0.98, 0.9733333333333334, 0.9733333333333334, 0.9733333333333334, 0.9733333333333334, 0.9733333333333334, 0.9733333333333334, 0.9733333333333334, 0.9733333333333334, 0.9733333333333334, 0.9733333333333334, 0.9733333333333334, 0.9733333333333334, 0.9733333333333334, 0.9666666666666667, 0.9666666666666667, 0.9666666666666667, 0.9666666666666667, 0.9666666666666667, 0.9666666666666667, 0.9666666666666667, 0.9666666666666667, 0.9666666666666667, 0.9666666666666667, 0.9666666666666667, 0.9666666666666667, 0.96, 0.96, 0.96, 0.96, 0.96, 0.96, 0.9533333333333334, 0.9466666666666667, 0.9466666666666667, 0.9466666666666667, 0.9466666666666667, 0.9466666666666667, 0.9466666666666667, 0.94, 0.94, 0.9333333333333333, 0.9333333333333333, 0.9266666666666666, 0.9266666666666666, 0.9266666666666666, 0.9266666666666666, 0.9266666666666666, 0.9266666666666666, 0.92, 0.92, 0.9133333333333333, 0.9133333333333333, 0.9133333333333333, 0.9066666666666666, 0.9, 0.9, 0.9, 0.9, 0.9, 0.9, 0.9, 0.9, 0.9, 0.9, 0.9, 0.8933333333333333, 0.8866666666666667, 0.88, 0.88, 0.8733333333333333, 0.8733333333333333, 0.8733333333333333, 0.8733333333333333, 0.8666666666666667, 0.8666666666666667, 0.8666666666666667, 0.8666666666666667, 0.8666666666666667, 0.86, 0.8533333333333334, 0.8466666666666667, 0.8466666666666667, 0.84, 0.84, 0.84, 0.8333333333333334, 0.8266666666666667, 0.82, 0.82, 0.82, 0.8133333333333334, 0.8133333333333334, 0.8066666666666666, 0.8066666666666666, 0.8066666666666666, 0.8, 0.8, 0.8, 0.8, 0.7933333333333333, 0.7866666666666666, 0.7866666666666666, 0.78, 0.7733333333333333, 0.7666666666666667, 0.7666666666666667, 0.7666666666666667, 0.76, 0.7533333333333333, 0.7533333333333333, 0.7533333333333333, 0.7466666666666667, 0.7466666666666667, 0.7466666666666667, 0.74, 0.7333333333333333, 0.7266666666666667, 0.72, 0.72, 0.72, 0.7133333333333334, 0.7133333333333334, 0.7133333333333334, 0.7133333333333334, 0.7066666666666667, 0.7066666666666667, 0.7066666666666667, 0.7, 0.7, 0.6933333333333334, 0.6866666666666666, 0.68, 0.68, 0.68, 0.6733333333333333, 0.6666666666666666, 0.66, 0.66, 0.66, 0.6533333333333333, 0.6466666666666666, 0.6466666666666666, 0.64, 0.6333333333333333, 0.6333333333333333, 0.6333333333333333, 0.6333333333333333, 0.6266666666666667, 0.62, 0.6133333333333333, 0.6133333333333333, 0.6066666666666667, 0.6, 0.6, 0.6, 0.5933333333333334, 0.5866666666666667, 0.58, 0.5733333333333334, 0.5666666666666667, 0.56, 0.56, 0.5533333333333333, 0.5466666666666666, 0.5466666666666666, 0.5466666666666666, 0.54, 0.5333333333333333, 0.5333333333333333, 0.5266666666666666, 0.52, 0.5133333333333333, 0.5066666666666667, 0.5, 0.49333333333333335, 0.4866666666666667, 0.48, 0.48, 0.47333333333333333, 0.4666666666666667, 0.4666666666666667, 0.46, 0.4533333333333333, 0.44666666666666666, 0.44666666666666666, 0.44, 0.43333333333333335, 0.4266666666666667, 0.4266666666666667, 0.4266666666666667, 0.42, 0.41333333333333333, 0.41333333333333333, 0.4066666666666667, 0.4, 0.3933333333333333, 0.38666666666666666, 0.38, 0.38, 0.37333333333333335, 0.36666666666666664, 0.36, 0.36, 0.35333333333333333, 0.3466666666666667, 0.34, 0.3333333333333333, 0.32666666666666666, 0.32, 0.31333333333333335, 0.31333333333333335, 0.30666666666666664, 0.30666666666666664, 0.3, 0.29333333333333333, 0.2866666666666667, 0.28, 0.28, 0.2733333333333333, 0.26666666666666666, 0.26, 0.25333333333333335, 0.25333333333333335, 0.24666666666666667, 0.24, 0.23333333333333334, 0.22666666666666666, 0.22, 0.21333333333333335, 0.20666666666666667, 0.2, 0.19333333333333333, 0.18666666666666668, 0.18666666666666668, 0.18, 0.17333333333333334, 0.16666666666666666, 0.16, 0.16, 0.15333333333333332, 0.14666666666666667, 0.14, 0.13333333333333333, 0.12666666666666668, 0.12666666666666668, 0.12, 0.11333333333333333, 0.11333333333333333, 0.10666666666666667, 0.1, 0.1, 0.09333333333333334, 0.08666666666666667, 0.08, 0.08, 0.07333333333333333, 0.06666666666666667, 0.06, 0.05333333333333334, 0.04666666666666667, 0.04, 0.04, 0.03333333333333333, 0.02666666666666667, 0.02, 0.013333333333333334, 0.006666666666666667, 0.0]}, "loss": 0.22406919649103096}